
<html lang="en"     class="pb-page"  data-request-id="49f59674-59c1-4da0-aa23-ffe70f09427a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.8b01691;website:website:acspubs;issue:issue:10.1021/jmcmar.2019.62.issue-7;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Development of a Highly Potent Analogue and a Long-Acting Analogue of Oxytocin for the Treatment of Social Impairment-Like Behaviors" /></meta><meta name="dc.Creator" content="Wataru  Ichinose" /></meta><meta name="dc.Creator" content="Stanislav M.  Cherepanov" /></meta><meta name="dc.Creator" content="Anna A.  Shabalova" /></meta><meta name="dc.Creator" content="Shigeru  Yokoyama" /></meta><meta name="dc.Creator" content="Teruko  Yuhi" /></meta><meta name="dc.Creator" content="Hiroaki  Yamaguchi" /></meta><meta name="dc.Creator" content="Ayu  Watanabe" /></meta><meta name="dc.Creator" content="Yasuhiko  Yamamoto" /></meta><meta name="dc.Creator" content="Hiroshi  Okamoto" /></meta><meta name="dc.Creator" content="Shinichi  Horike" /></meta><meta name="dc.Creator" content="Junpei  Terakawa" /></meta><meta name="dc.Creator" content="Takiko  Daikoku" /></meta><meta name="dc.Creator" content="Mizuki  Watanabe" /></meta><meta name="dc.Creator" content="Nariyasu  Mano" /></meta><meta name="dc.Creator" content="Haruhiro  Higashida" /></meta><meta name="dc.Creator" content="Satoshi  Shuto" /></meta><meta name="dc.Description" content="The nonapeptide hormone oxytocin (OT) has pivotal brain roles in social recognition and interaction and is thus a promising therapeutic drug for social deficits. Because of its peptide structure, h..." /></meta><meta name="Description" content="The nonapeptide hormone oxytocin (OT) has pivotal brain roles in social recognition and interaction and is thus a promising therapeutic drug for social deficits. Because of its peptide structure, h..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 21, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01691" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01691" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01691" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01691" /></link>
        
    
    

<title>Development of a Highly Potent Analogue and a Long-Acting Analogue of Oxytocin for the Treatment of Social Impairment-Like Behaviors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01691" /></meta><meta property="og:title" content="Development of a Highly Potent Analogue and a Long-Acting Analogue of Oxytocin for the Treatment of Social Impairment-Like Behaviors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0011.jpeg" /></meta><meta property="og:description" content="The nonapeptide hormone oxytocin (OT) has pivotal brain roles in social recognition and interaction and is thus a promising therapeutic drug for social deficits. Because of its peptide structure, however, OT is rapidly eliminated from the bloodstream, which decreases its potential therapeutic effects in the brain. We found that newly synthesized OT analogues in which the Pro7 of OT was replaced with N-(p-fluorobenzyl)glycine (2) or N-(3-hydroxypropyl)glycine (5) exhibited highly potent binding affinities for OT receptors and Ca2+ mobilization effects by selectively activating OT receptors over vasopressin receptors in HEK cells, where 2 was identified as a superagonist (EMax = 131%) for OT receptors. Furthermore, the two OT analogues had a remarkably long-acting effect, up to 16–24 h, on recovery from impaired social behaviors in two strains of CD38 knockout mice that exhibit autism spectrum disorder-like social behavioral deficits, whereas the effect of OT itself rapidly diminished." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01691"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01691">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01691&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01691&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01691&amp;href=/doi/10.1021/acs.jmedchem.8b01691" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 3297-3310</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01642" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01704" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development of a Highly Potent Analogue and a Long-Acting Analogue of Oxytocin for the Treatment of Social Impairment-Like Behaviors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Wataru Ichinose</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wataru Ichinose</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmaceutical Sciences and, Hokkaido University, Sapporo 060-0812, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wataru++Ichinose">Wataru Ichinose</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stanislav M. Cherepanov</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stanislav M. Cherepanov</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Basic Research on Social Recognition, Research Center for Child Mental Development, Kanazawa University, Kanazawa 920-8640, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stanislav+M.++Cherepanov">Stanislav M. Cherepanov</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anna A. Shabalova</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anna A. Shabalova</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Basic Research on Social Recognition, Research Center for Child Mental Development, Kanazawa University, Kanazawa 920-8640, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anna+A.++Shabalova">Anna A. Shabalova</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shigeru Yokoyama</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shigeru Yokoyama</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Basic Research on Social Recognition, Research Center for Child Mental Development, Kanazawa University, Kanazawa 920-8640, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shigeru++Yokoyama">Shigeru Yokoyama</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Teruko Yuhi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Teruko Yuhi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Basic Research on Social Recognition, Research Center for Child Mental Development, Kanazawa University, Kanazawa 920-8640, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Teruko++Yuhi">Teruko Yuhi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hiroaki Yamaguchi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hiroaki Yamaguchi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmaceutical Sciences, Tohoku University and Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai 980-8574, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hiroaki++Yamaguchi">Hiroaki Yamaguchi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ayu Watanabe</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ayu Watanabe</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmaceutical Sciences, Tohoku University and Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai 980-8574, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ayu++Watanabe">Ayu Watanabe</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yasuhiko Yamamoto</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yasuhiko Yamamoto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Molecular Vascular Biology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa 920-8640, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yasuhiko++Yamamoto">Yasuhiko Yamamoto</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hiroshi Okamoto</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hiroshi Okamoto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Molecular Vascular Biology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa 920-8640, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hiroshi++Okamoto">Hiroshi Okamoto</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shinichi Horike</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shinichi Horike</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Kanazawa University Advanced Science Research Center, Kanazawa 920-8640, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shinichi++Horike">Shinichi Horike</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Junpei Terakawa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Junpei Terakawa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Kanazawa University Advanced Science Research Center, Kanazawa 920-8640, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Junpei++Terakawa">Junpei Terakawa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Takiko Daikoku</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Takiko Daikoku</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Kanazawa University Advanced Science Research Center, Kanazawa 920-8640, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Takiko++Daikoku">Takiko Daikoku</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mizuki Watanabe</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mizuki Watanabe</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmaceutical Sciences and, Hokkaido University, Sapporo 060-0812, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mizuki++Watanabe">Mizuki Watanabe</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7209-5713" title="Orcid link">http://orcid.org/0000-0001-7209-5713</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nariyasu Mano</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nariyasu Mano</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmaceutical Sciences, Tohoku University and Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai 980-8574, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nariyasu++Mano">Nariyasu Mano</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Haruhiro Higashida</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Haruhiro Higashida</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Basic Research on Social Recognition, Research Center for Child Mental Development, Kanazawa University, Kanazawa 920-8640, Japan</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#670f0615120f0e1508270a0203490c0609061d0610064a12490604490d17"><span class="__cf_email__" data-cfemail="026a6370776a6b706d426f67662c69636c63786375632f772c63612c6872">[email protected]</span></a>. Phone/Fax: +81-76-234-4213 (H.H.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Haruhiro++Higashida">Haruhiro Higashida</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Satoshi Shuto</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Satoshi Shuto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmaceutical Sciences,  Center for Research and Education on Drug Discovery,  and, Hokkaido University, Sapporo 060-0812, Japan</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#790a110c390911180b14571116120c1d181057181a571309"><span class="__cf_email__" data-cfemail="80f3e8f5c0f0e8e1f2edaee8efebf5e4e1e9aee1e3aeeaf0">[email protected]</span></a>. Phone/Fax: +81-11-706-3769 (S.S.).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Satoshi++Shuto">Satoshi Shuto</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7850-8064" title="Orcid link">http://orcid.org/0000-0001-7850-8064</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01691&amp;href=/doi/10.1021%2Facs.jmedchem.8b01691" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 3297–3310</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 21, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>31 October 2018</li><li><span class="item_label"><b>Published</b> online</span>21 March 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 April 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01691" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01691</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3297%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DWataru%2BIchinose%252C%2BStanislav%2BM.%2BCherepanov%252C%2BAnna%2BA.%2BShabalova%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D7%26contentID%3Dacs.jmedchem.8b01691%26title%3DDevelopment%2Bof%2Ba%2BHighly%2BPotent%2BAnalogue%2Band%2Ba%2BLong-Acting%2BAnalogue%2Bof%2BOxytocin%2Bfor%2Bthe%2BTreatment%2Bof%2BSocial%2BImpairment-Like%2BBehaviors%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3310%26publicationDate%3DApril%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01691"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2083</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">7</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01691" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development of a Highly Potent Analogue and a Long-Acting Analogue of Oxytocin for the Treatment of Social Impairment-Like Behaviors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Wataru&quot;,&quot;last_name&quot;:&quot;Ichinose&quot;},{&quot;first_name&quot;:&quot;Stanislav&quot;,&quot;last_name&quot;:&quot;M. Cherepanov&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;A. Shabalova&quot;},{&quot;first_name&quot;:&quot;Shigeru&quot;,&quot;last_name&quot;:&quot;Yokoyama&quot;},{&quot;first_name&quot;:&quot;Teruko&quot;,&quot;last_name&quot;:&quot;Yuhi&quot;},{&quot;first_name&quot;:&quot;Hiroaki&quot;,&quot;last_name&quot;:&quot;Yamaguchi&quot;},{&quot;first_name&quot;:&quot;Ayu&quot;,&quot;last_name&quot;:&quot;Watanabe&quot;},{&quot;first_name&quot;:&quot;Yasuhiko&quot;,&quot;last_name&quot;:&quot;Yamamoto&quot;},{&quot;first_name&quot;:&quot;Hiroshi&quot;,&quot;last_name&quot;:&quot;Okamoto&quot;},{&quot;first_name&quot;:&quot;Shinichi&quot;,&quot;last_name&quot;:&quot;Horike&quot;},{&quot;first_name&quot;:&quot;Junpei&quot;,&quot;last_name&quot;:&quot;Terakawa&quot;},{&quot;first_name&quot;:&quot;Takiko&quot;,&quot;last_name&quot;:&quot;Daikoku&quot;},{&quot;first_name&quot;:&quot;Mizuki&quot;,&quot;last_name&quot;:&quot;Watanabe&quot;},{&quot;first_name&quot;:&quot;Nariyasu&quot;,&quot;last_name&quot;:&quot;Mano&quot;},{&quot;first_name&quot;:&quot;Haruhiro&quot;,&quot;last_name&quot;:&quot;Higashida&quot;},{&quot;first_name&quot;:&quot;Satoshi&quot;,&quot;last_name&quot;:&quot;Shuto&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;21&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;3297-3310&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01691&quot;},&quot;abstract&quot;:&quot;The nonapeptide hormone oxytocin (OT) has pivotal brain roles in social recognition and interaction and is thus a promising therapeutic drug for social deficits. Because of its peptide structure, however, OT is rapidly eliminated from the bloodstream, which decreases its potential therapeutic effects in the brain. We found that newly synthesized OT analogues in which the Pro7 of OT was replaced with N-(p-fluorobenzyl)glycine (2) or N-(3-hydroxypropyl)glycine (5) exhibited highly potent binding affinities for OT receptors and Ca2+ mobilization effects by selectively activating OT receptors over vasopressin receptors in HEK cells, where 2 was identified as a superagonist (EMax = 131%) for OT receptors. Furthermore, the two OT analogues had a remarkably long-acting effect, up to 16–24 h, on recovery from impaired social behaviors in two strains of CD38 knockout mice that exhibit autism spectrum disorder-like social behavioral deficits, whereas the effect of OT itself rapidly diminished.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01691&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01691" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01691&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01691" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01691&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01691" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01691&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01691&amp;href=/doi/10.1021/acs.jmedchem.8b01691" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01691" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01691" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01691%26sid%3Dliteratum%253Aachs%26pmid%3D30896946%26genre%3Darticle%26aulast%3DIchinose%26date%3D2019%26atitle%3DDevelopment%2Bof%2Ba%2BHighly%2BPotent%2BAnalogue%2Band%2Ba%2BLong-Acting%2BAnalogue%2Bof%2BOxytocin%2Bfor%2Bthe%2BTreatment%2Bof%2BSocial%2BImpairment-Like%2BBehaviors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D7%26spage%3D3297%26epage%3D3310%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290925" title="Carbohydrates">Carbohydrates</a>,</li><li><a href="/action/doSearch?ConceptID=291503" title="Organic polymers">Organic polymers</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/jmcmar.2019.62.issue-7/20190411/jmcmar.2019.62.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/medium/jm-2018-01691m_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01691&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The nonapeptide hormone oxytocin (OT) has pivotal brain roles in social recognition and interaction and is thus a promising therapeutic drug for social deficits. Because of its peptide structure, however, OT is rapidly eliminated from the bloodstream, which decreases its potential therapeutic effects in the brain. We found that newly synthesized OT analogues in which the Pro<sup>7</sup> of OT was replaced with <i>N</i>-(<i>p</i>-fluorobenzyl)glycine (<b>2</b>) or <i>N</i>-(3-hydroxypropyl)glycine (<b>5</b>) exhibited highly potent binding affinities for OT receptors and Ca<sup>2+</sup> mobilization effects by selectively activating OT receptors over vasopressin receptors in HEK cells, where <b>2</b> was identified as a superagonist (<i>E</i><sub>Max</sub> = 131%) for OT receptors. Furthermore, the two OT analogues had a remarkably long-acting effect, up to 16–24 h, on recovery from impaired social behaviors in two strains of CD38 knockout mice that exhibit autism spectrum disorder-like social behavioral deficits, whereas the effect of OT itself rapidly diminished.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25837" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25837" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Oxytocin (OT) is a peptide hormone and neuromodulator that exists in peripheral organs and tissues such as the uterus and mammary glands as well as in the central nervous system, and is mainly synthesized in the neurons of the supraoptic and paraventricular nuclei of the hypothalamus.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> OT in peripheral organs induces uterine contractions and milk ejection during delivery and lactation in the female reproductive period.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> OT also acts as a key molecule for neurotropic functions in both sexes.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The molecule enhances social communication, such as social behavior, recognition, and memory in many species of mammals, including humans.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">Autism spectrum disorder (ASD) is a congenital neurodevelopmental disease characterized by impairments in social communication, social interactions, repetitive behaviors, and restricted interests.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Several therapeutic strategies have been applied to the treatment of ASD to improve the social impairment,<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> including some small-molecule drugs under clinical studies such as bumetanide,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> but there are still no sufficiently effective medications in the market. Therefore, OT may be a valuable lead for the development of a new medicine that takes advantage of the biological basis of social behavior in healthy subjects and restores normal social behavior in patients with psychiatric diseases such as ASD, depression, and schizophrenia.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">As a central neuromodulator, defects in the OT system may be related to the abnormal social communication behavior of patients with ASD because the concentration of OT in the blood or salivary glands is low in ASD patients,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and gene mutations of the OT receptor (OTR) coding and noncoding regions are detected at a higher rate in ASD patients.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> In addition, gene mutations of transmembrane proteins, such as CD38 and CD157, which are related to the cascade of events induced by OT secretion,<a onclick="showRef(event, 'ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16">(13−16)</a> lead to autism-like social memory defects and hyperactivity, and mice lacking these genes provide a possible behavioral model of attention-deficit hyperactivity disorder.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Single nucleotide polymorphisms of <i>CD38</i> and <i>CD157</i> genes are associated with ASD,<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> which suggest the importance of OT signaling mediated by CD38 and CD157 in social behavior. According to these findings, we previously developed CD38 knockout (CD38KO) mice<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> that exhibited social amnesia,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> which is a key deficiency in ASD patients. Other remarkable features of CD38KO mice are a deficit in paternal nurturing behavior<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and in reward activity in male mice in the sucrose-intake test.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Male CD38KO mice exhibit a notable decrease in immobility time in the tail suspension test,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> which represents hypermobility as a type of neurodevelopmental disorder such as attention-deficit hyperactivity disorder-like behavior, rather than depression. Interestingly, administration of OT rescued these impairments in CD38KO mice.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> Because these behavioral modifications were an important point in studies on OT analogues as described below, we were interested in further validating the pharmacological effects of OT and its analogues on these phenotypes with CD38 null mutant mice newly created by using the CRISPR/CAS9 gene-editing method (CD38KOCC).</div><div class="NLM_p">Some recent clinical trials of single intranasal OT administration in ASD patients restored emotional recognition and steady eye gaze.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> The optimal dosing regimen of repeated applications of OT in ASD patients has not yet been determined because repeated intranasal application of OT failed to produce positive effects on the primary endpoints in some clinical trials.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> Several reports have indicated that intranasal OT administration increases episodes of social interactions as scored by caregivers and family observations at home,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> which suggests that OT has therapeutic benefits for ASD patients.<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27−29)</a></div><div class="NLM_p">We previously reported three OT analogues, designated lipooxytocins (LOTs), in which a palmitoyl group was linked to the cysteine terminal amino group and/or the tyrosine aromatic hydroxyl group of OT.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> These OT analogues and OT displayed curative effects against social impairments in CD38 and CD157 knockout mice, which exhibit ASD-like social behavioral deficits,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> with a single i.p. injection at a dose of 1–3 ng/g of body weight .<a onclick="showRef(event, 'ref22 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref22 ref30 ref31">(22,30,31)</a> Unlike OT, the LOT analogues are not immediately effective for the treatment of ASD-related behavioral deficits in these knockout mice, consistent with the finding that LOT analogues fail to elicit cytosolic Ca<sup>2+</sup> mobilization by activating OTRs immediately after application in OTR-expressing HEK 293 cells in the culture.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> In sharp contrast to OT, however, their efficiency lasted approximately 24 h longer than that of OT because OT, a natural peptide, is rapidly eliminated in the body. We previously reported that i.p. injections of a LOT analogue resulted in a long-lasting elevation of the OT concentration in the cerebrospinal fluid (CSF), and the concentration was higher than that produced by i.p. injections of OT,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> which suggested that the LOT analogue was easily transported into the CSF because of its lipophilic property.</div><div class="NLM_p last">In the present paper, we describe highly potent OT analogues <b>2</b> and <b>5</b>; in particular, <b>2</b> seems to be a “superagonist” that expresses greater agonistic efficacy than the natural full agonist OT and the clinically applied 1-deamino-1-carba-2-tyrosine(<i>O</i>-methyl)-oxytocin (carbetocin).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Analogues <b>2</b> and <b>5</b> ameliorated social behavioral deficits more effectively and for a remarkably longer time than OT, like LOTs, in spite of their lacking lipophilic chains unlike LOTs. We studied the effects of these analogues on pup retrieval as a parental behavior, abnormal emotional deficits in the sucrose preference test, and hypermobility in tail suspension tests, with two types of CD38 knockout mouse models of a developmental disorder such as ASD, in which the behaviors are sensitive to OT.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17013" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17013" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Design of New OT Analogues</h3><div class="NLM_p">Many structure–activity relationship (SAR) studies have focused on enhancing the binding potency of the ligand to OTRs, as well as on decreasing the binding affinity for vasopressin receptor (AVPR) subtypes (V<sub>1a</sub>R, V<sub>1b</sub>R, and V<sub>2</sub>R) to minimize nonspecific effects on peripheral organs.<a onclick="showRef(event, 'ref33 ref34 ref35 ref36 ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35 ref36 ref37 ref38 ref39 ref40">(33−40)</a> These SAR studies revealed that deamination at the terminal cysteine residue, Cys<sup>1</sup>, induces an increase in OTR selectivity over AVPR. The modification was adopted as the first option in recent SAR studies because deamination also improved the hydrophobicity and chemical stability of OT. The medicine used clinically to induce uterine contraction, carbetocin, is also a deamino-OT analogue.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41,42)</a></div><div class="NLM_p">Recently, Wiśniewski and co-workers have reported an excellent study on OT analogues.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> They synthesized a series of deamino-OT derivatives in which Pro<sup>7</sup> and the disulfide linkage (−S–S−) between Cys<sup>1</sup> and Cys<sup>6</sup> in OT were replaced with N-substituted glycine residues and a thioether linkage (−CH<sub>2</sub>–S−), respectively.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> In their screening, some OT analogues, such as <b>1</b> and <b>4</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), exhibited high agonistic activity on hOTR (EC<sub>50</sub>: 0.025 nM for <b>1</b> and 0.27 nM for <b>4</b>) and significantly lower activity on hAVPRs (EC<sub>50</sub>: >10 nM (hV<sub>1a</sub>R and hV<sub>1b</sub>R) for <b>1</b> and EC<sub>50</sub>: >10 nM (hV<sub>1a</sub>R), 7.7 nM (hV<sub>1a</sub>R) for <b>4</b>). Analogue <b>1</b>, named merotocin, is now in clinical trials for inducing milk ejection in premature labor.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> We were very interested in these results in relation to our previous studies on LOTs with long-acting anti-anxiety effects, as described above, in which we conjugated long acyl chains at the terminal amino group on Cys<sup>1</sup> and the phenolic hydroxyl group on Tyr<sup>2</sup> of OT.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> We postulated that, in LOTs, the hydrophobic acyl chains would enhance intracerebral transfer, which leads to slow release of OT as a prodrug. Therefore, we expected that, using peptides such as <b>1</b> and <b>4</b> instead of OT, development of efficient prodrugs without AVPR activity might be achieved by their lipidation.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Molecular Structures of OT and Its Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/medium/jm-2018-01691m_0009.gif" alt="" id="GRAPHIC-d7e627-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/medium/jm-2018-01691m_0010.gif" alt="" id="gr9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Reported in ref <a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a>.</p></div></div><div></div></div><div class="NLM_p last">As OT-related compounds, merotocin and its derivatives exhibit potent and selective OT agonistic activity. Thus, in the present study, we designed OT analogues <b>2</b>, <b>3</b>, <b>5</b>, and <b>6</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) in which Pro<sup>7</sup> was replaced with <i>N</i>-<i>p</i>-fluorobenzyl- or <i>N</i>-(3-hydroxypropyl)glycine, similar to Wiśniewski’s deamino-OT analogues <b>1</b> and <b>4</b>, respectively,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> but the terminal amine at Cys<sup>1</sup> of OT was preserved because of its potential exploitation for lipidation.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Synthesis</h3><div class="NLM_p">OT analogues <b>2</b>, <b>3</b>, <b>5</b>, and <b>6</b> were synthesized by the Fmoc strategy<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> with the Rink amide resin as summarized in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The standard amino acid coupling was conducted with a solution of Fmoc-Xaa-OH (3.0 equiv), diisopropylcarbodiimide (DIC) (3.0 equiv), and HOAt (3.0 equiv) in N-methyl-2-pyrrolidone (NMP) and the Fmoc group was removed with 20% piperidine in dimethylformamide (DMF). To introduce the <i>N</i>-(<i>p</i>-fluorobenzyl)- or <i>N</i>-(3-(<i>tert</i>-butoxy)propyl) group at the glycine residue, the resin was successively treated with bromoacetic acid/DIC/HOAt in NMP and <i>p</i>-fluorobenzylamine or 3-(<i>tert</i>-butoxy)propylamine in DMF at room temperature.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/medium/jm-2018-01691m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of OT Analogues <b>2</b>, <b>3</b>, <b>5</b>, and <b>6</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01691&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For the synthesis of <b>2</b> and <b>5</b>, the terminal Fmoc group was removed on the resin. After treating the resin with trifluoroacetic acid (TFA)/triisopropylsilane (TIS)/H<sub>2</sub>O (96/2/2), the cleaved linear precursor peptide was subjected to a cyclization reaction under oxidative conditions with I<sub>2</sub> in MeOH. The high-performance liquid chromatography (HPLC) purification gave the desired cyclic peptides <b>2</b> (total yield 38%) and <b>5</b> (total yield 26%).</div><div class="NLM_p">For the synthesis of <b>3</b> and <b>6</b>, after completing the amino acid coupling on the resin, the resulting resin was successively treated with Pd(PPh<sub>3</sub>)<sub>4</sub> and piperidine to remove the allyl group and Fmoc group, respectively, which was then treated with PyBop, HOAt, and DIPEA to give the corresponding cyclized peptides. After the cleavage of the peptides from the resin with TFA/TIS/H<sub>2</sub>O (96/2/2), hydrogenation of the cleaved cyclic peptides and HPLC purification provided the cyclic peptides <b>3</b> (total yield 23%) and <b>6</b> (total yield 11%).</div><div class="NLM_p last">Known <b>1</b> and <b>4</b> were also prepared as reference ligands for biological evaluation by the previously reported method.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Receptor Binding Assay</h3><div class="NLM_p">We first examined the [<sup>3</sup>H]OT binding of compounds to the human OTRs (hOTRs) in crude membrane fractions of HEK cells expressing hOTRs, and the data are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. [<sup>3</sup>H]OT bounds specifically and reversibly to OTRs with a <i>K</i><sub>d</sub> of 0.3 ± 0.06 nM (data obtained from two experiments, each performed in duplicate; <a href="/doi/suppl/10.1021/acs.jmedchem.8b01691/suppl_file/jm8b01691_si_001.pdf" class="ext-link">Figure S1</a>), whereas nonspecific binding was defined in the presence of 1 μM unlabeled OT. The binding affinities of OT, AVP, carbetocin, and compounds <b>1–6</b> were determined by using a radioactive competitive assay. Displacement of bound [<sup>3</sup>H]OT was measured over a concentration range of 1 pM to 1 μM (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/medium/jm-2018-01691m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative radioligand concentration displacement curves for OT, AVP, OT, and compounds <b>1–6</b>. All curves were normalized to the percentage of displacement of [<sup>3</sup>H]OT. Data are means ± standard error of the mean from results obtained from two experiments, each performed in duplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01691&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Binding Affinity and Biological Activities of OT, AVP, and Analogs<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center">binding affinity <i>K</i><sub>i</sub> nM(95% CI)</th><th class="rowsep1 colsep0" colspan="3" align="center">agonist potency EC<sub>50</sub>, nM(95% confidence interval)</th><th class="rowsep1 colsep0" colspan="2" align="center">selectivity</th><th class="rowsep1 colsep0" align="center">agonist efficacy <i>E</i><sub>max</sub> %</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">hOTR</th><th class="colsep0 rowsep0" align="center">hOTR</th><th class="colsep0 rowsep0" align="center">hV<sub>1a</sub>R</th><th class="colsep0 rowsep0" align="center">hV<sub>1b</sub>R</th><th class="colsep0 rowsep0" align="center">hV<sub>1a</sub>R/hOTR</th><th class="colsep0 rowsep0" align="center">hV<sub>1b</sub>R/hOTR</th><th class="colsep0 rowsep0" align="center">hOTR</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">OT</td><td class="colsep0 rowsep0" align="left">0.58 (0.42–0.80)</td><td class="colsep0 rowsep0" align="left">0.01 (0.004–0.02)</td><td class="colsep0 rowsep0" align="left">0.19 (0.1–0.32)</td><td class="colsep0 rowsep0" align="left">0.24 (0.19–0.3)</td><td class="colsep0 rowsep0" align="left">18.8</td><td class="colsep0 rowsep0" align="left">24.2</td><td class="colsep0 rowsep0" align="left">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AVP</td><td class="colsep0 rowsep0" align="left">2.0 (1.42–2.86)</td><td class="colsep0 rowsep0" align="left">0.1 (0.053–0.21)</td><td class="colsep0 rowsep0" align="left">0.004 (0.001–0.011)</td><td class="colsep0 rowsep0" align="left">0.0035 (0.0007–0.016)</td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">carbetocin</td><td class="colsep0 rowsep0" align="left">1.8 (1.17–2.80)</td><td class="colsep0 rowsep0" align="left">0.01 (0.001–0.09)</td><td class="colsep0 rowsep0" align="left">2.3 (0.2–25)</td><td class="colsep0 rowsep0" align="left">4.8 (1.28–17.8)</td><td class="colsep0 rowsep0" align="left">226</td><td class="colsep0 rowsep0" align="left">479</td><td class="colsep0 rowsep0" align="left">57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">1.1 (0.85–1.43)</td><td class="colsep0 rowsep0" align="left">0.025 (0.01–0.062)</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>400</td><td class="colsep0 rowsep0" align="left">>400</td><td class="colsep0 rowsep0" align="left">61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">0.51 (0.44–0.72)</td><td class="colsep0 rowsep0" align="left">0.028 (0.01–0.062)</td><td class="colsep0 rowsep0" align="left">2.2 (0.55–8.47)</td><td class="colsep0 rowsep0" align="left">0.50 (0.15–1.6)</td><td class="colsep0 rowsep0" align="left">75.3</td><td class="colsep0 rowsep0" align="left">17.5</td><td class="colsep0 rowsep0" align="left">131</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">0.90 (0.63–1.30)</td><td class="colsep0 rowsep0" align="left">0.089 (0.02–0.36)</td><td class="colsep0 rowsep0" align="left">4.0 (0.79–20.6)</td><td class="colsep0 rowsep0" align="left">0.80 (0.35–1.85)</td><td class="colsep0 rowsep0" align="left">45.0</td><td class="colsep0 rowsep0" align="left">9.0</td><td class="colsep0 rowsep0" align="left">82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">1.4 (1.02–1.9)</td><td class="colsep0 rowsep0" align="left">0.27 (0.061–1.19)</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">7.7 (3.58–16.49)</td><td class="colsep0 rowsep0" align="left">>37</td><td class="colsep0 rowsep0" align="left">28.4</td><td class="colsep0 rowsep0" align="left">57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">1.4 (0.92–2.10)</td><td class="colsep0 rowsep0" align="left">0.031 (0.004–0.26)</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>323</td><td class="colsep0 rowsep0" align="left">>322</td><td class="colsep0 rowsep0" align="left">88</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">3.0 (2.10–4.23)</td><td class="colsep0 rowsep0" align="left">0.15 (0.021–1)</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>66.6</td><td class="colsep0 rowsep0" align="left">>66.6</td><td class="colsep0 rowsep0" align="left">50</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last"><i>K</i><sub>i</sub> was determined by the radioactive binding displacement assay and experiments were performed twice in duplicate.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">EC<sub>50</sub> values of agonist activities were determined at hOTR, hV<sub>1a</sub>R, and hV<sub>1b</sub>R using the [Ca<sup>2+</sup>]<sub>i</sub> measurement with a microspectrofluorometric system, number of independent experiments: <i>n</i> = 3. Each experiment was performed in duplicate, number of measured cells in each cell dish: 20.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last"><i>E</i><sub>max</sub> values of agonist potencies were calculated from EC<sub>50</sub> curves for hOTR, hV<sub>1a</sub>R, and hV<sub>1b</sub>R.</p></div></div></div><div class="NLM_p last">AVP and all-screened analogues showed strong binding affinity for hOTR (<i>K</i><sub>i</sub> ≤ 3.0 nM). Particularly, compound <b>2</b> exhibited high binding affinity for hOTR comparable to that of native OT (<i>K</i><sub>i</sub> = 0.58 nM vs 0.51 nM), whereas the affinities of other examined compounds slightly decreased relative to that of OT. Compounds <b>2</b> (<i>K</i><sub>i</sub> = 0.51 nM) and <b>3</b> (<i>K</i><sub>i</sub> = 0.90 nM) derived from analogue <b>1</b> with <i>N</i>-(<i>p</i>-fluorobenzyl)glycine had higher affinity than those of compounds <b>5</b> (<i>K</i><sub>i</sub> = 1.4 nM) and <b>6</b> (<i>K</i><sub>i</sub> = 3.0 nM) derived from analogue <b>4</b> with <i>N</i>-(3-hydroxypropyl)glycine. The affinity of carbetocin (<i>K</i><sub>i</sub> = 1.81 nM) was in accordance with the reported value.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Agonist-Induced Increase in Intracellular Ca<sup>2+</sup> Concentrations</h3><div class="NLM_p">We examined receptor activation followed by Ca<sup>2+</sup> mobilization from intracellular inositol-1,4,5-trisphosphate-sensitive Ca<sup>2+</sup> stores by measuring cytosolic-free Ca<sup>2+</sup> concentrations ([Ca<sup>2+</sup>]<sub>i</sub>) in HEK-293 cells expressing hOTRs, human vasopressin 1a receptors (hV<sub>1a</sub>Rs), and human vasopressin 1b receptors (hV<sub>1b</sub>Rs). Overall data, including the half-maximal effective concentration (EC<sub>50</sub>), <i>E</i><sub>max</sub>, and thus selectivity, for OT, AVP, carbetocin, and OT analogues <b>1–6</b> are presented in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>.</div><div class="NLM_p">Their potency for hOTR is ranked with EC<sub>50</sub> values as OT (0.010 nM), carbetocin (0.010 nM) > <b>1</b> (0.025 nM) ≈ <b>2</b> (0.028 nM) ≈ <b>5</b> (0.031 nM) > <b>3</b> (0.089 nM) ≈ AVP (0.10 nM) ≈ <b>6</b> (0.15 nM) > <b>4</b> (0.27 nM). Compounds <b>1</b>, <b>3</b>, <b>4</b>, and <b>6</b> maintained partial agonist properties for hOTR (<i>E</i><sub>max</sub> = 61% for <b>1</b>, 82% for <b>3</b>, 57% for <b>4</b>, and 50% for <b>6</b>), while <b>5</b> showed almost full agonistic potency (<i>E</i><sub>max</sub> = 88%), as summarized in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. Surprisingly, <b>2</b> demonstrated “superagonistic” potency compared with OT (<i>E</i><sub>max</sub> = 131% vs 100%; <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A,C). Partial agonistic effects on both hV<sub>1a</sub>R and hV<sub>1b</sub>R were induced by <b>2</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A), while almost no agonistic effect on either receptor was induced by <b>5</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B).</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/medium/jm-2018-01691m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Agonistic activities of OT analogues: Agonistic activities of <b>2</b> (A) and <b>5</b> (B) for hOTR, hV<sub>1a</sub>R, and hV<sub>1b</sub>R. Activities of OT, AVP, <b>2</b>, and <b>5</b> for hOTR (C) and hV<sub>1a</sub>R (D), determined by [Ca<sup>2+</sup>]<sub>i</sub> microspectrofluorometric measurement. A value of 100% indicated the maximum Ca<sup>2+</sup>-release after OT application. Number of independent experiments: <i>n</i> = 3. Each experiment was performed in duplicate and number of measured cells in each cell dish: 20.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01691&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The hOTR selectivity versus hV<sub>1a</sub>R and hV<sub>1b</sub>R of compounds was also summarized in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. The hOTR selectivity versus hV<sub>1a</sub>R of peptides <b>1–6</b> was higher than that of OT; particularly, <b>2</b> and <b>5</b> showed high selectivity of >400-fold and >323-fold, respectively. Also, <b>2</b> and <b>5</b> showed high hOTR selectivity versus hV<sub>1b</sub>R >400-fold and >323-fold, respectively.</div><div class="NLM_p last">On the basis of these in vitro experimental results, particularly with regard to their hOTR selectivity and agonistic potency, we focused on OT analogues <b>2</b> and <b>5</b>, in which the Pro<sup>7</sup> of OT was replaced with <i>N</i>-(<i>p</i>-fluorobenzyl)glycine or <i>N</i>-(3-hydroxypropyl)glycine, respectively, and the terminal amino group and S–S linkage of OT were preserved, different from carbetocin and its deamino-OT derivatives <b>1</b> and <b>4</b>. Thereafter, we tested and compared the in vivo effects of compounds <b>2</b> and <b>5</b> with that of OT.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Parental Retrieval Test</h3><div class="NLM_p">We examined the effects of OT, <b>2</b>, and <b>5</b> on parental behavior by using the latency to retrieve pups by WT and CD38KO sires, a social behavior test that we previously developed.<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20−22)</a> Thirty minutes after a single intraperitoneal injection of phosphate-buffered saline (PBS), WT sires showed retrieval behavior with a mean latency of 233 ± 68 s (<i>n</i> = 10), whereas CD38KO sires had a mean latency of 600 ± 0 (<i>n</i> = 13, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A), which replicated previous results.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The latencies to retrieve pups by CD38KO sires 30 min after a single intraperitoneal injection of 100 ng/100 g body weight of OT, <b>2</b>, or <b>5</b> were 240 ± 69 s (<i>n</i> = 10), 297 ± 87 s (<i>n</i> = 10), and 346 ± 82 s (<i>n</i> = 10), respectively. One-way ANOVA revealed significant differences between groups (<i>F</i><sub>4,45</sub> = 8.45, <i>p</i> = 0.0001). Bonferroni’s <i>post hoc</i> tests showed significant differences between CD38KO sires treated with OT (<i>p</i> = 0.006), <b>2</b> (<i>p</i> = 0.032), and <b>5</b> (<i>P</i> = 0.048).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/medium/jm-2018-01691m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Pup retrieval behavior by sires: The latencies for pup retrieval by WT or CD38KO sires at 30 min (A) and the time-course (B) after a single intraperitoneal injection of PBS, OT, <b>2</b>, or <b>5</b> (100 ng/100 g body weight); <i>n</i> = 10/group. One-way ANOVA followed by Bonferroni’s post hoc test was performed for 30 min (<i>F</i><sub>4,45</sub> = 8.45 and <i>p</i> = 0.0001), and two-way ANOVA followed by Bonferroni’s post hoc test was performed for the time course (time <i>F</i><sub>4,180</sub> = 3.74, <i>p</i> = 0.006; treatment <i>F</i><sub>3,180</sub> = 28.94, <i>p</i> = 0.0001; interaction <i>F</i><sub>12,180</sub> = 4.31, <i>p</i> = 0.0001). The significance levels of the Bonferroni post hoc test performed to compare the test treatments with the CD38KO treated by PBS were *<i>p</i> < 0.05 and **<i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01691&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Next, we examined how long the effects of OT, <b>2</b>, and <b>5</b> lasted. As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B, the activity of OT was completely lost at 6 h. Treatment with both <b>2</b> and <b>5</b> significantly affected the latency to retrieve pups to the nest at 6 and 12 h; at 24 h, however, only <b>5</b> was still active. Compared with the PBS controls, the latencies to retrieve pups at 5, 12, and 24 h after injection of <b>2</b> (10 mice/group) were 381 ± 65 s (<i>p</i> = 0.045), 155 ± 65 s (<i>p</i> = 0.0001), and 413 ± 79 s (<i>p</i> = 0.16); and after injection of <b>5</b> were 293 ± 86 s (<i>p</i> = 0.0013), 386 ± 75 s (<i>p</i> = 0.0001), and 100 ± 94 s (<i>p</i> = 0.00013), respectively. Two-way ANOVA indicated significant effects of interaction (<i>F</i><sub>12,180</sub> = 4.31 and <i>p</i> = 0.0001), time (<i>F</i><sub>4,180</sub> = 3.74 and <i>p</i> = 0.006), and treatment conditions (<i>F</i><sub>3,180</sub> = 28.943 and <i>p</i> = 0.0001).</div><div class="NLM_p last">To clarify the long-acting effects of <b>2</b> and <b>5</b> in comparison with OT, we evaluated them with two additional mouse models described below.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Tail Suspension Test</h3><div class="NLM_p">The long-acting effects of <b>2</b> and <b>5</b> were next examined in a tail suspension test, which evaluates depression-like emotional behavior. Our previous findings<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> revealed a shorter duration of immobility in male CD38KO mice than in WT mice. CD38KO mice exhibit hyperactivity rather than the decreased activity that is typical in this task.<a onclick="showRef(event, 'ref13 ref22'); return false;" href="javascript:void(0);" class="ref ref13 ref22">(13,22)</a> This was confirmed by newly created <i>Cd38</i> gene-knockout mice using the CRISP-CAS9 gene-editing method,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> designated as CD38KOCC mice. CD38KOCC mice exhibited a shorter duration of immobility than WT ICR mice and similar hyperactivity as CD38KO (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01691/suppl_file/jm8b01691_si_001.pdf" class="ext-link">Figure S2</a>) mice. Therefore, we used this new mouse line as a mouse model of hyperactivity.</div><div class="NLM_p">The effects of OT, <b>2</b>, and <b>5</b> were examined at 30 min and 24 h after injection (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Immobility was enhanced in CD38KOCC male mice at 30 min (74.2 ± 2.9 s and <i>n</i> = 5) and treatment with OT, <b>2</b>, or <b>5</b> significantly increased the immobility to 171 ± 13.46 s (<i>n</i> = 5, <i>p</i> = 0.012), 149.5 ± 13.8 s (<i>n</i> = 8, <i>p</i> = 0.029), and 151.83 ± 21.3 s (<i>n</i> = 6), respectively. After 24 h, only compound <b>5</b> significantly increased immobility (157.3 ± 21.4 s, <i>n</i> = 5, <i>p</i> = 0.039) compared with that after PBS treatment (56.5 ± 18.8 s, <i>n</i> = 5; <i>p</i> = 0.0135). A two-way ANOVA revealed significance of time (<i>F</i><sub>1,31</sub> = 7.103, <i>p</i> = 0.0121) and treatment (<i>F</i><sub>3,31</sub> = 10.55, <i>p</i> = 0.0001). No statistically significant difference in effects was observed between CD38KOCC mice treated with OT or <b>2</b> and those treated with PBS at 24 h after the injection.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/medium/jm-2018-01691m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Tail suspension test: Immobility time of male CD38KOCC mice at 30 min and 24 h after a single intraperitoneal injection of PBS, OT, 2, and 5. <i>n</i> = 5–8 per group. Two-way ANOVA followed by Bonferroni’s post hoc test showed a significant effect of treatment (<i>F</i><sub>3,31</sub> = 10.55, <i>p</i> = 0.0001) and time (<i>F</i><sub>1,31</sub> = 7.103, <i>p</i> = 0.0121). *<i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01691&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Sucrose Preference</h3><div class="NLM_p">We previously reported that OT was associated with paternal behavior in the mouse.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> Therefore, to confirm the long-lasting effects of <b>2</b> and <b>5</b> compared with that of OT, we performed a sucrose preference test that allowed us to quantify the sensory system and anhedonia, which is an indicator of nucleus accumbens dysfunction.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> We used a 1% sucrose solution in this task in which mice were allowed to freely choose between water and sucrose solutions.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> Sucrose consumption was significantly lower in CD38KOCC male mice than in WT mice, similar to CD38KO mice (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01691/suppl_file/jm8b01691_si_001.pdf" class="ext-link">Figure S3</a>). CD38KOCC male mice treated with PBS showed no sucrose preference (0.46 ± 0.04, <i>n</i> = 8), whereas CD38KOCC mice showed significant recovery of sucrose preference following administration of OT (0.80 ± 0.02, <i>p</i> = 0.0001, <i>n</i> = 5), <b>2</b> (0.79 ± 0.02, <i>p</i> = 0.0001, <i>n</i> = 5), and <b>5</b> (0.72 ± 0.05, <i>p</i> = 0.001, <i>n</i> = 5) at 60 min (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). One-way ANOVA revealed significant differences between groups (<i>F</i><sub>3,19</sub> = 22.13, <i>p</i> = 0.0001).</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/medium/jm-2018-01691m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Sucrose preference test: Preference of CD38KOCC males for 1% sucrose solution consumption at 1 (A) or 24 h (B) after treatment with PBS, OT, <b>2</b>, or <b>5</b> (single intraperitoneal injection), <i>n</i> = 5–8. One-way ANOVA followed by Bonferroni’s post hoc test was performed for 60 min (<i>F</i><sub>3,19</sub> = 22.13 and <i>p</i> = 0.0001) and 24 h (time <i>F</i><sub>3,19</sub> = 3.26, <i>p</i> = 0.044) after and showed significant differences for *<i>p</i> < 0.05 and **<i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01691&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">At 24 h after the injection, only <b>5</b> demonstrated a significant elevation in sucrose consumption (0.67 ± 0.02, <i>n</i> = 5, <i>p</i> = 0.046), with a tendency toward a long-lasting effect (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B), whereas injection of OT or <b>2</b> had no effect. One-way ANOVA revealed significant differences between groups (<i>F</i><sub>3,19</sub> = 3.26, <i>p</i> = 0.044).</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Pharmacokinetics</h3><div class="NLM_p">To understand the pharmacological potency and duration of action, we tested the pharmacokinetics of OT, <b>2</b>, and <b>5</b>. <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> shows the plasma concentration of OT, <b>2</b>, and <b>5</b> after intravenous administration, measured by the LC–mass spectrometry (MS)/MS method. The plasma concentrations immediately after administration of OT, <b>2</b>, and <b>5</b> were 334 ± 155 ng/mL (<i>n</i> = 5), 118 ± 60 ng/mL (<i>n</i> = 3), and 108 ± 35 ng/mL (<i>n</i> = 3), respectively. These three compounds rapidly disappeared from the plasma with a half-life (<i>t</i><sub>1/2</sub>) of almost 10 min (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B,C; the <i>t</i><sub>1/2</sub> values in the fast phase for OT, <b>2</b>, and <b>5</b> were 2.91, 2.84, and 3.1 min, respectively; the <i>t</i><sub>1/2</sub> values in the slow phase were 8.84, 2.86, and 4.23 min, respectively; <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>), which suggested that <b>2</b> cleared from the blood more rapidly than OT and <b>5</b> did. Within 60 min after i.v. administration of compounds <b>2</b> and <b>5</b>, OT levels were significantly elevated to 1.21 ± 0.86 and 0.6 ± 0.11 ng/mL, respectively. <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> shows the CSF concentrations of <b>2</b> and <b>5</b> after intravenous administration. The CSF concentration of <b>2</b> at 30 min after the injection was 100 pg/mL (93 pM). Surprisingly, 12 h after injection, the concentration of compound <b>2</b> in the CSF increased to 380 pg/mL (350 pM). The presence of <b>5</b> was determined at both 30 min and 12 h, but its exact concentration was not determined because the obtained values were below the detection limit.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/medium/jm-2018-01691m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Plasma concentrations of OT, and <b>2</b>, or <b>5</b> after intravenous administration of OT (A), <b>2</b> (B), and <b>5</b> (C). ICR mice were administered with OT, <b>2</b>, or <b>5</b> at a dose of 3 μg/mouse via the tail vein. Blood samples were collected at the indicated times after injection. Each point represents the mean ± standard error of three to five mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01691&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Kinetic Parameters of OT, <b>2</b>, and <b>5</b> after Intravenous Administration<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center"><i>t</i><sub>1/2</sub> (min)</th><th class="rowsep1 colsep0" colspan="2" align="center">CSF concentration (pg/mL)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">plasma fast</th><th class="colsep0 rowsep0" align="center">plasma slow</th><th class="colsep0 rowsep0" align="center">30 min</th><th class="colsep0 rowsep0" align="center">12 h</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">OT</td><td class="colsep0 rowsep0" align="left"><b>2.91</b> (1.48–8.4)</td><td class="colsep0 rowsep0" align="left"><b>8.84</b> (5.83–18.2)</td><td class="colsep0 rowsep0" align="left">not determined</td><td class="colsep0 rowsep0" align="left">not determined</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left"><b>2.84</b> (2.83–2.85)</td><td class="colsep0 rowsep0" align="left"><b>2.86</b> (2.77–2.96)</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">380</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left"><b>3.1</b> (2.59–3.82)</td><td class="colsep0 rowsep0" align="left"><b>4.23</b> (3.73–4.89)</td><td class="colsep0 rowsep0" align="left">below lower limit of quantification</td><td class="colsep0 rowsep0" align="left">below lower limit of quantification</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Concentrations were obtained by LC–MS/MS. Compounds (3 μg/mouse) were administered via the tail vein. Number of measurements in each time point <i>n</i> = 3–5. The <i>t</i><sub>1/2</sub> for the fast phase of decay calculated for 15 min and for the slow phase for 15–60 min.</p></div></div></div><div class="NLM_p last">The stability of the compounds in the serum was assessed by calculating the percent of the initial concentration in the fresh sample and was considered acceptable if it was 85–115% (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01691/suppl_file/jm8b01691_si_001.pdf" class="ext-link">Figure S4</a>). All analyses were within the acceptable value and were stable in mouse plasma after 2 h at 37 °C. These data indicate that the disappearance of OT, <b>2</b>, and <b>5</b> in the blood was not due to decomposition by enzymatic digestion but rather by clearance or adsorption to various tissues and organs.</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Kinetics of Resurrection</h3><div class="NLM_p">To calculate the kinetic parameters (<i>K</i><sub>on</sub>, <i>K</i><sub>off≠</sub>, and <i>t</i><sub>1/2</sub>) of the compounds, we used the equations of Motulsky and Mahan.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Initially the kinetic parameters of [<sup>3</sup>H]OT were determined, which were obtained through construction of a family of association kinetic curves using a range of three different [<sup>3</sup>H]OT concentrations (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01691/suppl_file/jm8b01691_si_001.pdf" class="ext-link">Figure S5</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Comparison of the Receptor Kinetic Parameters of OT Agonists<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="×" /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> nM</th><th class="colsep0 rowsep0" align="center" char="×"><i>K</i><sub>on</sub> M<sup>–1</sup> min<sup>–1</sup></th><th class="colsep0 rowsep0" align="center" char="±"><i>K</i><sub>off</sub> min<sup>–1</sup></th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> min</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]OT</td><td class="colsep0 rowsep0" align="left">0.3 (0.18–0.42)</td><td class="colsep0 rowsep0" align="char" char="×">1.737 × 10<sup>8</sup></td><td class="colsep0 rowsep0" align="char" char="±">0.05433 ± 0.007</td><td class="colsep0 rowsep0" align="char" char=".">11.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">OT</td><td class="colsep0 rowsep0" align="left">0.58 (0.42–0.8)</td><td class="colsep0 rowsep0" align="char" char="×">8.065 × 10<sup>6</sup></td><td class="colsep0 rowsep0" align="char" char="±">0.04222 ± 0.009</td><td class="colsep0 rowsep0" align="char" char=".">15.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">0.51 (0.44–0.72)</td><td class="colsep0 rowsep0" align="char" char="×">1.05 × 10<sup>8</sup></td><td class="colsep0 rowsep0" align="char" char="±">0.1003 ± 0.048</td><td class="colsep0 rowsep0" align="char" char=".">6.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">1.4 (0.92–2.1)</td><td class="colsep0 rowsep0" align="char" char="×">7.473 × 10<sup>6</sup></td><td class="colsep0 rowsep0" align="char" char="±">0.01746 ± 0.007</td><td class="colsep0 rowsep0" align="char" char=".">36.65</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Kinetic parameters were determined by the radioactive binding competitive kinetics assay. Number of independent experiments, <i>n</i> = 2. Each experiment was performed in duplicate.</p></div></div></div><div class="NLM_p"><a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a> shows kinetic competition curves for OT (A), <b>2</b> (B), and <b>5</b> (C), which were assessed at three concentrations (near <i>K</i><sub>i</sub>, 5-fold <i>K</i><sub>i</sub>, or 10-fold <i>K</i><sub>i</sub>). The data indicated differences in both the <i>K</i><sub>on</sub> and <i>K</i><sub>off</sub> parameters for the compounds (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Compound <b>2</b> exhibited fast kinetics with a <i>t</i><sub>1/2</sub> that was approximately three times lower than that of [<sup>3</sup>H]OT and eight times lower than that of <b>5</b>. Compound <b>5</b> demonstrated slower association and dissociation rates than [<sup>3</sup>H]OT.</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/medium/jm-2018-01691m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Competition kinetics curves for OT (A), <b>2</b> (B), and <b>5</b> (C). HEK-293 hOTR membranes were incubated with 500 pM [<sup>3</sup>H]OT and varying concentrations of the competitors. Plates were incubated for the indicated times, and nonspecific binding levels were determined in the presence of cold OT (1 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01691&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Discussion</h3><div class="NLM_p">The four newly synthesized OT analogues showed their high affinity for hOTRs in the <i>K</i><sub>i</sub> range of 0.51–3.0 nM, with the lowest values of 0.51 nM for analogue <b>2</b>, whereas OT had a value of 0.58 nM, which suggested that <b>2</b> is equipotent to natural OT. Furthermore, the in vitro agonist potency of different concentrations of these compounds was in a range of 10–147 pM, as calculated based on the EC<sub>50</sub> of [Ca<sup>2+</sup>]<sub>i</sub> changes in hOTR-expressing HEK cells, with the highest EC<sub>50</sub> of 10 pM for OT and carbetocin and 28 pM for <b>2</b>. These results indicated the very potent agonistic characteristics of these compounds. Interestingly, the dose–response curves revealed that <b>2</b> had 131% of the agonist potency of natural OT (100%).</div><div class="NLM_p">Some reports have described “superagonists” as compounds that have efficacy in the assay greater than that of the natural full agonist for membrane receptors, such as nicotinic acetylcholine receptors or adrenergic β<sub>2</sub>-receptors.<a onclick="showRef(event, 'ref48 ref49 ref50 ref51 ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref48 ref49 ref50 ref51 ref52 ref53">(48−53)</a> Therefore, the above data showed that compound <b>2</b> possesses agonistic ability superior to natural agonist OT, which indicated that it is a superagonist. This is the first example of a superagonist for OTR. Historically, fluorination of ligands has improved their pharmacological and pharmacokinetic properties.<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54,55)</a> Therefore, the unique transformation from the proline residue at position seven to an <i>N</i>-(<i>p</i>-fluorobenzyl)glycine residue resulted in compound <b>2</b>, which could be considered a superagonist.</div><div class="NLM_p">However, for a stricter conclusion about superior agonistic activities of compound <b>2</b>, we should determine pharmacological parameters in calcium assays by using cell cultures expressing mouse OTRs for explanation of actions of OT analogues in mouse behavior. Alternatively, different functional assays, such as BRET assay or ex vivo assays, such as myometrial contraction in human or mouse uterus, can be used.</div><div class="NLM_p">Parental behavior was examined by evaluating the retrieval of biological pups by sires, as we reported previously.<a onclick="showRef(event, 'ref21 ref22 ref56'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref56">(21,22,56)</a> This is a clear defective phenotype in CD38KO sires because wild-type ICR sires typically display nurturing behavior that is essentially similar to dam’s parental behavior by retrieving pups placed outside the nest. As expected from their immediate binding to OTRs, these analogues exhibited effects on retrieval immediately or 30 min or 1 h post injection. This immediate action (similar to OT) and long-lasting action (unlike OT) could be beneficial for the therapeutic use of these analogues. The CD38KO sires retrieved almost no pups, as evidenced by a mean latency of 600 s to start retrieval, which was the maximum (ceiling) level allowed in the trial.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The latency decreased approximately to 200–300 s by the administration of <b>2</b> or <b>5</b>, which indicated that CD38KO sires began to nurture, and similar levels were exhibited by WT sires and CD38KO sires treated with OT or its analogues.</div><div class="NLM_p">Restoration of social/parental behavior continued for at least 16 h after intraperitoneal administration of <b>2</b> and <b>5</b> in CD38KO sires, at which time the effect by OT completely disappeared. After 24 h, significant remission was observed only in sires treated with <b>5</b>, which suggested long-lasting action by both OT analogues with slight difference in the duration of the sustained effects between <b>2</b> and <b>5</b>. LOT1 having two palmitoyl chains has been shown to have no immediate effects at 30 min because of its prodrug property<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> but had effects lasting 24 h, whereas <b>2</b> and <b>5</b> not only had both immediate and long-lasting effects. In this respect, <b>2</b> and <b>5</b> appear to be better OT analogues.</div><div class="NLM_p">We used two additional models namely tail suspension test and sucrose preference models to investigate that whether peptides <b>2</b> and <b>5</b> have more efficient effects in vivo than OT as OTR ligands from pharmacological and pharmacokinetic viewpoints.</div><div class="NLM_p">Thus, we used a new mouse line with <i>Cd38</i> deletion,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> in which the <i>Cd38</i> gene was knocked out by using the CRISP-CAS9 method<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> in the ICR strain. A significant effect of <b>5</b>, but not <b>2</b>, was observed at 24 h in a sucrose preference test evaluating the memory of a sweet drink as well as anhedonia in CD38KOCC male mice. Restoration from hyperactive behavior at the control (WT) level by treatment with <b>5</b>, but not <b>2</b>, also persisted for 24 h in CD38KOCC male mice. These experiments using this knockout line (CD38KOCC) demonstrated that the long-lasting effect of <b>5</b> is not mouse strain (CD38KO)-specific.</div><div class="NLM_p">The concentration profiles of OT, <b>2</b>, and <b>5</b> in the plasma after intravenous administration revealed that the levels of all three compounds decreased rapidly, with approximately the same half-life (2–4 min) of the rapid phase and slightly different half-lives for the slower phase. This difference in the half-life decay in the blood may not be sufficient evidence by itself for the long-acting effect of compounds <b>2</b> and <b>5</b>. Compound <b>2</b> was detected in the CSF, however, even at 12 h after intravenous administration, which may relate to its long-acting potency, while we could not detect <b>5</b> in the CSF in the present experiments.</div><div class="NLM_p">The fast decay in the plasma and the low levels of compounds in the CSF are informative about the possible involvement of other mechanisms of action of OT, <b>2</b>, and <b>5</b>: peripheral activity of OT on the sympathetic nervous system,<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> OT-induced endogenous OT release,<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> prosocial activity of OT metabolites,<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> and OT activation of V<sub>1A</sub>R.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Because the in vivo behavioral effects of compound <b>5</b>, which has almost no V<sub>1A</sub>R activity, are similar to those of OT, we consider that V<sub>1A</sub>R activation has only a small role in the current behavioral experiments. In any event, we cannot exclude V<sub>1A</sub>R antagonism and this question should be addressed in future research that includes detailed studies of blood–brain barrier permeability.</div><div class="NLM_p">The data presented in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> indicate stable elevations of plasma OT concentrations for at least 1 h after i.v. administration of <b>2</b> and <b>5</b>. As reported previously, we found OT-induced OT release in the hypothalamus mediated by ADPR,<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> which resulted in increased OT secretion from the pituitary into the blood. Compounds <b>2</b> and <b>5</b> may activate similar mechanisms of OT autoregulation.</div><div class="NLM_p last">Here, we first time used the competitive kinetics assay for hOTRs, which was previously used for muscarinic receptors<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> suggesting a relation between the long-lasting effects of the compound and a long residence time on the receptor as well as a small <i>K</i><sub>off</sub>.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> In our experiment, the receptor binding kinetics of [<sup>3</sup>H]OT were measured in the presence of OT, <b>2</b>, and <b>5</b>, and the <i>K</i><sub>off</sub> of <b>5</b> was smaller than those of OT and <b>2</b>. This low kinetic parameter value seems to indicate a longer receptor residence time. The longer receptor residence time might be related to the long-acting effects of compound <b>5</b>. We cannot directly compare the residence time and long-lasting effects on behavior, however, because different parameters, such as the buffers used and physiologic conditions, may affect the receptor kinetics.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42462" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42462" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We developed OT analogues <b>2</b> and <b>5</b>, which are very active OTR ligands both in vitro and in vivo evaluation systems. Notably, only a subtle modification of OT, that is, replacement of Pro<sup>7</sup> with N-substituted glycine residues, significantly changed the pharmacological effects to provide a superagonist, <b>2</b>, and a very long-acting agonist, <b>5</b>. The remarkable improvement in the effective duration, which overcomes the critical disadvantages of short-acting OT, suggests that these analogues could be superior alternatives to OT for the treatment of several diseases in which social impairments are prominent. OT itself is currently being applied in clinical trials in ASD,<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> schizophrenia,<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> and depression.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Thus, OT analogues <b>2</b> and <b>5</b> have potential therapeutic merit. In addition, we are interested in lipidation of <b>2</b> and <b>5</b> as described above, which is now under investigation.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62181" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62181" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Methods of Chemistry</h3><div class="NLM_p last"><sup>1</sup>H NMR spectra were recorded in CDCl<sub>3</sub> at ambient temperature unless otherwise noted, at 400 or 500 MHz, with TMS as an internal standard. <sup>13</sup>C NMR spectra were recorded in CDCl<sub>3</sub> at ambient temperature. Silica gel column chromatography was performed with silica gel 60 N (spherical, neutral, 63–210 μm, Kanto Chemical Co., Inc.). Flash column chromatography was performed with silica gel 60 N (spherical, neutral, 40–50 μm, Kanto Chemical Co., Inc.). Purities of final compounds were determined by HPLC: column, Kanto C18 GP, 250 × 4.6 (mm); column temperature, 30 °C; flow rate, 1.0 mL/min; solvent A, water containing 0.1% TFA; solvent B, acetonitrile containing 0.1% TFA; and detection, 240 nm. The purities of all final compounds exceeded 95%.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Procedure for Peptide Coupling on Resins</h3><div class="NLM_p last">The peptides were assembled on the Rink amide resin by the Fmoc strategy. The fully protected peptide resin was synthesized manually, starting from 150 mg (0.10 mmol) of Rink Amide resin Nova Gel (200–400 mesh, loading 0.67 mmol/g, Novabiochem). The deprotection of the Fmoc group was conducted by adding 20% piperidine solution in DMF (1 mL) for 10 min twice at room temperature, and then the resin was washed with DMF (5 × 1 mL). The standard amino acid coupling was conducted with a solution of Fmoc-Xaa-OH (3.0 equiv), DIC (3.0 equiv), and HOAt (3.0 equiv) in NMP (0.7 mL) at room temperature for 2 h, and then the resin was washed with DMF (5 × 1 mL). Each process was held in a shaker. To introduce the <i>N</i>-(<i>p</i>-fluorobenzyl)- or <i>N</i>-(3-(<i>tert</i>-butoxy)propyl)-glycine residue, the resin was treated with bromoacetic acid (4.0 equiv), DIC (4.0 equiv), and HOAt (4.0 equiv) in NMP (1 mL) at room temperature for 2 h, and then treated with <i>p</i>-fluorobenzylamine (10 equiv) or 3-(<i>tert</i>-butoxy)propylamine (10 equiv) in DMF (1.0 M, 1 mL) at room temperature for 2 h. In the coupling just after the acylation, 4 equiv of amino acid was used.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Peptides <b>2</b> and <b>5</b></h3><div class="NLM_p last">The following amino acid derivatives were used for the coupling: Fmoc-Gly-OH, Fmoc-Leu-OH, Fmoc-Cys(Trt)-OH, Fmoc-Asn(Trt)-OH, Fmoc-Gln(Trt)-OH, Fmoc-Ile-OH, and Fmoc-Tyr(<i>t</i>Bu)-OH. Upon completion of the solid-phase synthesis, the resin was treated with TFA/TIS/H<sub>2</sub>O 96/2/2 (v/v/v) solution (10 mL) at room temperature for 1.5 h and filtered off. The filtrate was poured into diethyl ether (40 mL), and the resulting mixture was centrifuged to give the crude peptide as the precipitate. After being dried over in vacuo, the precipitate was dissolved in H<sub>2</sub>O/acetonitrile 1/4 (v/v, ca. 1 mg/mL). To the solution, a MeOH solution of I<sub>2</sub> (0.1 M) was added slowly until the solution showed yellow color. After stirring the resulting mixture at room temperature for 6 h, solid sodium ascorbate was added until yellow color disappeared. The mixture was concentrated in vacuo, and then loaded onto a HPLC column and purified using H<sub>2</sub>O/acetonitrile gradient containing trifluoroacetic acid (0.1% v/v). The fractions containing the desired peptide was pooled and lyophilized. The peptide was obtained as white powder (<b>2</b>: 45 mg, 0.038 mmol, 38%; <b>5</b>: 30 mg, 0.026 mmol, 26%, as a trifluoroacetic acid salt). <b>2</b>; HPLC: <i>R</i><sub><i>t</i></sub> = 11.1 min, solvent A/B = 75/25; purity: 97.8%; LRMS (ESI) <i>m</i>/<i>z</i>: 1075.45 [(M + H)<sup>+</sup>], 1097.43 [(M + Na)<sup>+</sup>]; HRMS (ESI): calcd for C<sub>47</sub>H<sub>67</sub>FN<sub>12</sub>O<sub>12</sub>S<sub>2</sub>Na, 1097.4319 [(M + Na)<sup>+</sup>]; found: 1097.4321. <b>5</b>; HPLC: <i>R</i><sub><i>t</i></sub> = 5.61 min, solvent A/B = 80/20; purity: 98.8%; LRMS (ESI) <i>m</i>/<i>z</i>: 1025.45 [(M + H)<sup>+</sup>], 1047.44 [(M + Na)<sup>+</sup>]; HRMS (ESI): calcd for C<sub>43</sub>H<sub>69</sub>N<sub>12</sub>O<sub>13</sub>S<sub>2</sub>Na, 1025.4543 [(M + Na)<sup>+</sup>]; found: 1025.4540.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Peptides <b>3</b> and <b>6</b></h3><div class="NLM_p last">The following amino acid derivatives were used for the coupling: Fmoc-Gly-OH, Fmoc-Leu-OH, Fmoc-Cys((CH<sub>2</sub>)<sub>2</sub>CH(NH-<i>p</i>NZ)CO<sub>2</sub>Allyl)-OH,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Fmoc-Asn(Trt)-OH, Fmoc-Gln(Trt)-OH, Fmoc-Ile-OH, and Fmoc-Tyr(<i>t</i>Bu)-OH. Upon completion of the solid-phase peptide coupling, the resin was treated with Pd(PPh<sub>3</sub>)<sub>4</sub> (347 mg, 0.3 mmol) in chloroform/<i>N</i>-methyl morphorine/acetic acid 37/1/2 (v/v/v, 3 mL) solution at room temperature for 2.5 h, and then washed with DMF, 0.5% DIEA in DMF, 0.5% sodium diethyldithiocarbamate in DMF, and finally DMF. After treating with 20% piperidine in DMF, the resin was treated with PyBOP (260 mg, 0.5 mmol), HOAt (68 mg, 0.5 mmol), and DIPEA (0.17 mL, 1.0 mmol) in DMF (1 mL). The resin was treated with cleaving cocktail, and the crude peptide was precipitated and centrifuged in diethyl ether, by the procedure described above for the coupling of <b>2</b> and <b>5</b>. After being dried over in vacuo, the crude peptide was treated with Pd–C (10%, 45 mg, 0.42 equiv) in EtOH/MeOH (1/1, 10 mL) under the hydrogen atmosphere for 7 h. After removal of the Pd catalyst by filtration through Celite, the filtrate was concentrated in vacuo and loaded onto a HPLC column and purified using H<sub>2</sub>O/acetonitrile gradient containing trifluoroacetic acid (0.1% v/v). The fractions containing the desired peptide were pooled and lyophilized. The peptide was obtained as white powder (<b>3</b>: 27 mg, 0.023 mmol, 23%; <b>6</b>: 12 mg, 0.011 mmol, 11%, as a trifluoroacetic acid salt). <b>3</b>; HPLC, <i>R</i><sub><i>t</i></sub> = 5.4 min, solvent A/B = 70/30; purity: 97.4%; LRMS (ESI) <i>m</i>/<i>z</i>: 1057.50 [(M + H)<sup>+</sup>], 1079.48 [(M + Na)<sup>+</sup>]; HRMS (ESI): calcd for C<sub>48</sub>H<sub>69</sub>FN<sub>12</sub>O<sub>12</sub>SNa, 1079.4755 [(M + Na)<sup>+</sup>]; found: 1079.4773. <b>6</b>; HPLC, <i>R</i><sub><i>t</i></sub> = 4.9 min, solvent A/B = 80/20; purity: 96.1%; LRMS (ESI): <i>m</i>/<i>z</i> 1007.50 [(M + H)<sup>+</sup>], 1029.48 [(M + Na)<sup>+</sup>]; HRMS (ESI): calcd for C<sub>44</sub>H<sub>70</sub>N<sub>12</sub>O<sub>13</sub>SNa, 1029.4798 [(M + Na)<sup>+</sup>]; found: 1029.4812.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> OTR Expression Plasmid Construction</h3><div class="NLM_p last">The plasmid for hOTRs (pcDNAHOXTR) was constructed as reported previously.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> AVP Receptors Plasmid Construction</h3><div class="NLM_p last">Human brain total RNA (1 μg; Clontech, Mountain View, CA, USA) was reverse-transcribed using a kit (Transcriptor First Strand cDNA Synthesis Kit; Roche Applied Science, Penzberg, Germany), according to the manufacturer’s instruction. The resulting cDNA was subjected to the nested polymerase chain reaction (PCR) using KOD FX DNA polymerase (Toyobo, Osaka, Japan) essentially as described previously.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> The primers for the initial PCR were as follows: 5′-CCGAAGAGGGCCGAGTAGGA-3′ (sense) and 5′-CTAGCTCAATTCAGCTAATGAGC-3′ (antisense) for HAVP1AR and 5′-TCCACTTGCATCCACACCCTC-3′ (sense) and 5′-GAGAACCTCCACTAGTCCTGG-3′ (antisense) for HAVP1BR. The aliquots (2 μL) were subjected to the secondary PCR as described above using another set of primers: 5′-CCGAAGAGGGCCGAGTAGGA-3′ (sense) and 5′-GCAAGGCTCAAGTTGAAACAGGA-3′ (antisense) for HAVP1AR and 5′-CCTGCCACTCCATTTTATCCATC-3′ (sense) and 5′-CCTAAAAGATGATGGTCTCAGC-3′ (antisense) for HAVP1BR. The resulting products, carrying entire protein-coding sequences of human AVPR1AR and AVP1BR, were treated with Ex Taq (Takara, Otsu, Japan) for 10 min at 72 °C and cloned into a pCR2.1-TOPO vector (Invitrogen, Carlsbad, CA, USA) to gain pCHV1AR and pCHV1BR, respectively. Then, the 1.4-kb <i>Eco</i>RV (vector)/<i>Spe</i>I (vector) fragment obtained from pCHV1AR and the 1.4-kb <i>Hin</i>dIII (vector)/<i>Not</i>I (vector) fragment obtained from pCHV1BR were ligated to the <i>Xba</i>I/<i>Eco</i>RV-cleaved pcDNA3 (+) (Invitrogen) and <i>Not</i>I/<i>Hin</i>dIII-cleaved pcDNA3 (+), respectively, to yield respective expression plasmids designated as pcDNAHV1AR and pcDNAHV1BR.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Cell Culture and Transfection</h3><div class="NLM_p last">Human embryonic kidney HEK-293 cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37 °C in a humidified atmosphere of 95% air and 5% CO<sub>2</sub>.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Cells were grown in culture dishes to 80–90% confluence and transfected with pcDNAHV1AR or pcDNAHV1BR using GeneJuice Transfection Reagent (EMD Millipore, Temecula, CA, USA), following the manufacturer’s instruction. Cells were selected in DMEM supplemented with 5% FBS and 800 μg/mL G418 (geneticin; Sigma Chemical Co., St Louis, MO, USA). The resulting transformed cells, as well as HEK-293 cells stably expressing human OXTRs<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and those transfected with pcDNA3 (+) (mock-transfected cells<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a>), were maintained in DMEM supplemented with 10% FBS and 100 μg/mL G418.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Preparation of the Membrane Fraction</h3><div class="NLM_p last">Frozen hOTR-expressed HEK cells were thawed and suspended in 20 mL of a cold lysis buffer containing 1 mM EDTA, 50 mM HEPES, 10 mM MgCl<sub>2</sub>, pH 7.4, with the addition of complete cocktail of protease inhibitor (Roche Diagnostics) as described previously.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> The cells allowed to swell for 20 min and were homogenized with a Teflon-glass homogenizer.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Intact cells and nuclei pellets were removed by centrifugation at 500<i>g</i> for 10 min. at 4 °C. The supernatant was then centrifugated at 19 000 rpm for 60 min at 4 °C, and the pellet was resuspended in the cold lysis buffer and sucrose (10%). This procedure was repeated twice. The final pellet was kept frozen at −80 °C with no loss of binding.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Binding Affinity Measurement</h3><div class="NLM_p last">Binding for hOTRs was measured by filtration binding using 500 pM [<sup>3</sup>H]-OT final concentration in binding buffer 50 mM Tris, 10 mM MgCl<sub>2</sub>, and 0.1% BSA (pH 7.4) containing membranes (5 μg per well). A multiscreen-FC glass filter containing 96-well plates (Millipore) was used. For total binding measurement, 25 μL of binding buffer was added to the respective wells, for nonspecific binding, 25 μL of 12 μM cold OT was added. For compound testing, 25 μL of a serial dilution of each compound in binding buffer was added. After compound addition and 1 h of incubation at room temperature, the binding was terminated by rapid filtration under vacuum through GF/C filters<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> and washed five times with ice-cold binding buffer before counting. Nonspecific binding counts were subtracted from each well and data normalized to the maximum specific binding set at 100%.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Ki values were calculated using the Cheng–Prusoff equation.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Saturation binding experiments were performed in the presence of <sup>3</sup>H-OT in the concentration range from 50 pM up to 4 nM. Nonlinear regression analysis by the GraphPad prism was performed to obtain the <i>K</i><sub>d</sub> value. Additionally, the Rosenthal–Scatchard plot was constructed and did not indicate positive or negative cooperativity. Saturation binding experiments indicated that a single homogenous population of binding sites was being labeled. In all experiments, total binding never exceeded 10% of that added, limiting complications associated with depletion of the free radioligand concentration. Saturation and competitive binding experiments, for each compound, were performed two times, each experiment in duplicate.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> OTR Kinetics</h3><div class="NLM_p last">To determine the <i>K</i><sub>on</sub>, <i>K</i><sub>off</sub> and <i>K</i><sub>obs</sub> were calculated at three different concentrations of <sup>3</sup>H-OT (200 pM, 500 pM, 1 nM). The experiment was initiated by the addition of <sup>3</sup>H-OT to membranes in binding buffer. Free <sup>3</sup>H-OT was separated at multiple time points to construct association kinetic curves. After incubation, bound was separated from free by rapid filtration. Washing and counting were performed as described previously. The hill equation was used to determine <i>K</i><sub>on</sub> and <i>K</i><sub>off</sub>. The <i>t</i><sub>1/2</sub> was calculated by equation <i>K</i><sub>off</sub> = ln 2/<i>t</i><sub>1/2</sub>. For evaluation of kinetic parameters of tested compounds, competitive kinetics experiments were obtained.<a onclick="showRef(event, 'ref62 ref68'); return false;" href="javascript:void(0);" class="ref ref62 ref68">(62,68)</a> Similar procedure as described above was performed with the addition of test compounds in three concentrations (app. <i>K</i><sub>i</sub>, 5<i>K</i><sub>i</sub>, and 10<i>K</i><sub>i</sub>). All experiments were performed two times, each in duplicate.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> [Ca<sup>2+</sup>]<sub>i</sub> Measurement</h3><div class="NLM_p last">The method was previously described.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Briefly, transfected HEK-293 cells were loaded with fura-2/AM to a final concentration of 1 μM in complete medium and incubated at 37 °C. After 30 min loading, the cells were washed three times with HEPES-buffered saline (HBS) solution (145 mM NaCl, 5 mM KCl, 1 mM MgCl<sub>2</sub>, 20 mM HEPES–NaOH, 2 mM CaCl<sub>2</sub>, 20 mM glucose, and pH 7.4). The fluorescence of the cells loaded with fura-2/AM was then measured at 37 °C, at the determined sites, through a pinhole (10–20 μm in diameter). We used alternating excitation wavelengths of 340 and 380 nm in a Ca<sup>2+</sup> microspectrofluorometric system (IX-73 Model; Olympus, Tokyo, Japan) and MetaFluor software (Molecular Devices, Sunnyvale, CA). The Ca<sup>2+</sup> emission was detected every 3 s for 5 min after the application of PBS, OT, AVP, or analogues. The ratio of fluorescence at 340 and 380 nm (<i>F</i><sub>340</sub>/<i>F</i><sub>380</sub>) was used to determine [Ca<sup>2+</sup>]<sub>i</sub>. All data were normalized to the baseline fluorescence (<i>F</i><sub>0</sub>) recorded 10 s before application of compounds and given as percentage from the maximum response obtained by OT for hOTRs and AVP for hV1ARs and hV1BRs. OT, AVP, and analogues for experiments were diluted in 50% ethanol to a concentration of 10<sup>–3</sup> M and then diluted in distilled water to obtain the required concentrations. Each experiment was performed three times, each triplicated.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Animals</h3><div class="NLM_p last">Male and female Slc:ICR mice (Institute of Cancer Research of the Charles River Laboratories, Inc., Wilmington, MA, USA) were obtained from Japan SLC, Inc. (Hamamatsu, Japan) through a local distributor (Sankyo Laboratory Service Corporation, Toyama, Japan). The procedure to produce the CD38 KO mice was described previously.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> CD38KOCC was produced as follows: the candidate sgRNA was designed to target exon 2 of the Cd38 locus by using the CRISPR Design. The sgRNA nucleotides were then inserted to pX330 (addgene), which is the human codon-optimized SpCas9 and chimeric gRNA expression plasmid. For RNA synthesis, the human codon-optimized SpCas9<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> and chimeric sgRNA were excised from pX330, and then placed downstream of the T7 promoter in the pCMV T<sub>N</sub>T vector (Promega). Then, the hCas9 mRNA and chimeric sgRNA were synthesized using an in vitro RNA transcription kit (mMESSAGE mMACHINE T7 Transcription Kit), according to the manufacturer’s instructions. The synthesized mRNA and sgRNA were dissolved in Opti-MEM I at 1–2 μg/μL and introduced them into eggs using a super electroporator NEPA 21 (NEPA GENE). After DNA isolation from mouse tails in the <i>F</i><sub>0</sub> generation, we amplified the genomic regions spanning the sgRNA binding site using PCR. Then, we screened more than 30 pups by using the Guide-it Mutation Detection Kit (TAKARA). Finally, we identified a pup which possessed a mutation with an insertion of two base pairs. This insertion leads to premature stop codons within the open reading frame of the <i>Cd38</i> gene. The ideal end result is a loss-of-function mutation within the <i>Cd38</i> gene. The offspring of wild-type, CD38KO, and CD38KOCC mice were born in our laboratory colony. The pups were weaned at 21–28 days of age and housed in same-sex groups of five animals until pairing. A male and female of each genotype were paired and housed in a nursing cage in our laboratory under standard conditions (24 °C; 12 h light/dark cycle, lights on at 08:00) with food and water provided ad libitum. All animal experiments were performed in accordance with the Fundamental Guidelines for the Proper Conduct of Animal Experiments and Related Activities in Academic Research Institutions under the jurisdiction of the Ministry of Education, Culture, Sports, Science, and Technology of Japan and were approved by the Committee on Animal Experimentation of Kanazawa University (ethics approval code AP-173824).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Parental Retrieval Test</h3><div class="NLM_p last">The design of the experiments for parental retrieval behavior was described previously.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> Virgin males and females of identical genotypes were paired at 56–64 days. A single male and a single female were continuously housed together in a standard mouse maternity cage from the mating period to the delivery of pups and then to postnatal days (3–5). All family units consisted of a new sire and dam, and their first litter of each genotype was used. All mice were experimentally naive. Thirty minutes before starting the experiment, the cages with the families were placed in the experimental room for habituation. The sire and dam were placed in a new clean cage with new woodchip bedding for 10 min, while the pups were left in the nest in the original cage. Five pups were randomly selected from the litter and placed individually at a site remote from the nest in the original cage. The sires were returned to the original home cage in the presence of their five biological pups to assess parental behavior. Parental retrieval behavior (latency to retrieve the first pup to the nest) was measured by observing the parent behavior for 10 min following the reunion. The sire received a single intraperitoneal injection of 0.3 mL of PBS or 0.3 mL of OT (1 mL per 100 g of body weight), compounds <b>2</b> or <b>5</b> at a concentration of 100 ng/mL dissolved in PBS. Thirty minutes, 6, 12, 24 or 48 h after the injection, paternal retrieval behavior was examined only once. The behavioral tests were carried out in a randomly mixed sequence of the experimental groups. For each time-point and each compound, 10 mice were used. The experiments were performed between 10:00 and 15:00 for each time-point. One-way ANOVA test was performed for comparison compound effects for 30 min. If the ANOVA test showed significance, Bonferroni’s post hoc test was performed. Two-way ANOVA followed by Bonferroni’s post hoc test was performed for time-course.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Tail Suspension</h3><div class="NLM_p last">The tail suspension test method was previously described.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> After 30 min of habituation in the experimental room, the WT and CD38KOCC mice were injected i.p. with 0.3 mL of PBS or OT at a concentration of 100 ng/mL dissolved in PBS. Thirty minutes after the injection, the mice were hanged by fixing their tails by tape to the suspension bar in a plastic suspension box (55 cm height × 60 cm width × 11.5 cm depth). To prevent observing or interacting with each mouse, the mouse was separated with walls but was not able contact or touch to the walls. Behavior was recorded for 6 min on a video source and was analyzed using ANY-Maze behavioral tracking software (Stoelting Co, USA). Total immobility time during the last 4 of the 6 min was used. Number of animals for test: <i>n</i> = 8 for compound <b>2</b>, 30 min; <i>n</i> = 6 for compound <b>5</b>, 30 min; <i>n</i> = 5 for all other groups. Two-way ANOVA test was performed. If the ANOVA test showed significance, Bonferroni’s post hoc test was performed.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Sucrose Preference</h3><div class="NLM_p last">Experimentally naïve, young male adult mice (6–8 weeks old) of WT and CD38KOCC strains were given a two-bottle choice between distilled water and sucrose solution at a 1% concentration based on our previous results,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> which were both available ad libitum. The bottle positions remained constant. Fresh sucrose solution was prepared each day. Cumulative water and sucrose intakes during 24 h were calculated by weighing. Food was provided ad libitum, but food intake was not recorded in this experiment. Number of animals: <i>n</i> = 8 for PBS-treated group; <i>n</i> = 5 for all other groups. The one-way ANOVA test was performed for 60 min and 24 h comparison independently. If ANOVA tests showed significance, Bonferroni’s post hoc test was performed.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Dosing and Sampling</h3><div class="NLM_p last">Male ICR mice weighing 30 g were used. OT, <b>2</b>, or <b>5</b> was injected intravenously at a dose of 100 ng/g of body weight. Mice were sacrificed using i.p. injection of 10% somnopenthyl (0.6 mL) immediately at 5, 15, and 30 min after the end of the injection, and blood samples were collected by cardiac puncture. CSF was collected 30 min or 12 h after injection. Plasma and CSF levels of OT and compound <b>2</b> and <b>5</b> were determined by LC–MS/MS. The OT level after administration of not only OT but also compound <b>2</b> and <b>5</b> was determined.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Analysis of the Compounds in Plasma and CSF</h3><div class="NLM_p last">100 μL of plasma was deproteinized by adding 400 μL of acetonitrile/methanol = 1:1 (v/v) containing the internal standard [<sup>13</sup>C<sub>6</sub>, <sup>15</sup>N]OT. The mixture was vortexed and centrifuged at 15 000<i>g</i> for 10 min at room temperature. The resultant supernatant was transferred to another 1.5 mL polypropylene tube and evaporated to dryness under a nitrogen gas stream at 40 °C. The residue was reconstituted in 50 μL of mobile phase, and 2 μL aliquots were injected into the LC–MS/MS system. Chromatographic separation was performed using a Shimadzu Nexera high-performance LC system (Shimadzu, Kyoto) with a CAPCELL PAK C8DD column (50 mm × 2.0 mm i.d., 5 mm; Shiseido) and the analytical column was kept at 40 °C. The mobile phase consisted of solution A (10 mM ammonium formate in water) and solution B (acetonitrile), which formed the following gradient: 15–30% B (0–3 min); 30–90% B (3–5 min); 90% B (5–7 min); and 15% B (7–12 min). The flow rate was 0.3 mL/min. Positive-ion electrospray (ESI) tandem mass spectrometric analysis was performed using a TSQ Vantage EMR LC–MS/MS System (Thermo Scientific, Waltham, MA) at unit resolution with selected reaction monitoring. The transitions by selected reaction monitoring were <i>m</i>/<i>z</i> 1007.5 → 723.2 for OT, <i>m</i>/<i>z</i> 1075.2 → 723.2 for compound <b>2</b>, <i>m</i>/<i>z</i> 1025.2 → 723.2 for compound <b>5</b>, and <i>m</i>/<i>z</i> 1014.4 → 730.1 for internal standard. Data were acquired and analyzed using Xcalibur software (version 2.1; Thermo Scientific). The calibration curves were constructed by spiking the ten different concentrations of analytes with the mouse plasma pool. The calibration curves for OT and compound <b>5</b> and compound <b>2</b> were all linear in the ranges 0.005–150 and 0.015–150 ng/mL, respectively. The calibration curves were obtained by linear regression for all analytes with a weighting factor of 1/<i>x</i> and linearity (<i>R</i>) of the method in surrogate is greater than 0.998. The detection limits of OT, compound <b>2</b>, and compound <b>5</b> were 0.05, 0.15, and 0.05 pg/mL, respectively.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Stability Assay</h3><div class="NLM_p last">One hundred microliters of pooled mouse plasma containing OT, compound <b>2</b>, or compound <b>5</b> (final concentration: 50 ng/mL) was incubated for 1, 5, 15, 30, 60, and 120 min at 37 °C. After designated time, 400 μL of acetonitrile/methanol = 1:1 (v/v) containing the internal standard was added and analyzed by LC–MS/MS.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01691" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10516" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10516" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01691" class="ext-link">10.1021/acs.jmedchem.8b01691</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Data on [<sup>3</sup>H]OT binding to membranes from hOTR-expressing HEK293 cells, comparison of wild type, CD38KO, and CD38KOCC mice in tail suspended and sucrose preference tests and characterization of the kinetic parameters of [<sup>3</sup>H]OT (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01691/suppl_file/jm8b01691_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01691/suppl_file/jm8b01691_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01691/suppl_file/jm8b01691_si_001.pdf">jm8b01691_si_001.pdf (256.51 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01691/suppl_file/jm8b01691_si_002.csv">jm8b01691_si_002.csv (1.09 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01691" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04216" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04216" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haruhiro Higashida</span> - <span class="hlFld-Affiliation affiliation">Department of Basic Research on Social
Recognition, Research Center
for Child Mental Development, and , Kanazawa University, Kanazawa 920-8640, Japan</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#acc4cdded9c4c5dec3ecc1c9c882c7cdc2cdd6cddbcd81d982cdcf82c6dc"><span class="__cf_email__" data-cfemail="99f1f8ebecf1f0ebf6d9f4fcfdb7f2f8f7f8e3f8eef8b4ecb7f8fab7f3e9">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Satoshi Shuto</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, 
    Center for Research and Education
on Drug Discovery, 
     and, Hokkaido University, Sapporo 060-0812, Japan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7850-8064" title="Orcid link">http://orcid.org/0000-0001-7850-8064</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7f0c170a3f0f171e0d12511710140a1b1e16511e1c51150f"><span class="__cf_email__" data-cfemail="27544f5267574f46554a094f484c5243464e094644094d57">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wataru Ichinose</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences and, Hokkaido University, Sapporo 060-0812, Japan</span>; 
    <span>Present Address:
                        Graduate School of Pharmaceutical Sciences, Tohoku University, Aramakiaza Aoba 6-3, Aoba-ku, Sendai 980-8578, Japan (W.I.)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stanislav M. Cherepanov</span> - <span class="hlFld-Affiliation affiliation">Department of Basic Research on Social
Recognition, Research Center
for Child Mental Development, and , Kanazawa University, Kanazawa 920-8640, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna A. Shabalova</span> - <span class="hlFld-Affiliation affiliation">Department of Basic Research on Social
Recognition, Research Center
for Child Mental Development, and , Kanazawa University, Kanazawa 920-8640, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shigeru Yokoyama</span> - <span class="hlFld-Affiliation affiliation">Department of Basic Research on Social
Recognition, Research Center
for Child Mental Development, and , Kanazawa University, Kanazawa 920-8640, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Teruko Yuhi</span> - <span class="hlFld-Affiliation affiliation">Department of Basic Research on Social
Recognition, Research Center
for Child Mental Development, and , Kanazawa University, Kanazawa 920-8640, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hiroaki Yamaguchi</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Tohoku University and Department of Pharmaceutical
Sciences, Tohoku University Hospital, Sendai 980-8574, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ayu Watanabe</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Tohoku University and Department of Pharmaceutical
Sciences, Tohoku University Hospital, Sendai 980-8574, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yasuhiko Yamamoto</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry and Molecular Vascular
Biology, Graduate School of Medical Sciences, and , Kanazawa University, Kanazawa 920-8640, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hiroshi Okamoto</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry and Molecular Vascular
Biology, Graduate School of Medical Sciences, and , Kanazawa University, Kanazawa 920-8640, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shinichi Horike</span> - <span class="hlFld-Affiliation affiliation">Kanazawa
University Advanced Science Research Center, Kanazawa 920-8640, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Junpei Terakawa</span> - <span class="hlFld-Affiliation affiliation">Kanazawa
University Advanced Science Research Center, Kanazawa 920-8640, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Takiko Daikoku</span> - <span class="hlFld-Affiliation affiliation">Kanazawa
University Advanced Science Research Center, Kanazawa 920-8640, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mizuki Watanabe</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences and, Hokkaido University, Sapporo 060-0812, Japan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7209-5713" title="Orcid link">http://orcid.org/0000-0001-7209-5713</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nariyasu Mano</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Tohoku University and Department of Pharmaceutical
Sciences, Tohoku University Hospital, Sendai 980-8574, Japan</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>W.I. and S.M.C. contributed equally to this work. The manuscript was written with contributions of all the authors. All the authors gave approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24308" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24308" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the Industry-Academia Collaborative R & D Programs (COI) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and partly by Platform Project for Supporting Drug Discovery and Life Science Research (BINDS) from AMED under grant number JP18am0101093. W.I. acknowledged the support of the JSPS program (15J02083).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">ANOVA</td><td class="NLM_def"><p class="first last">analysis of variance</p></td></tr><tr><td class="NLM_term">ASD</td><td class="NLM_def"><p class="first last">autism spectrum disorder</p></td></tr><tr><td class="NLM_term">CD</td><td class="NLM_def"><p class="first last">cluster of differentiation</p></td></tr><tr><td class="NLM_term">CRISPR</td><td class="NLM_def"><p class="first last">clustered regularly interspaced short palindromic repeats</p></td></tr><tr><td class="NLM_term">CSFsss</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">DIC</td><td class="NLM_def"><p class="first last">diisopropylcarbodiimide</p></td></tr><tr><td class="NLM_term">HEK</td><td class="NLM_def"><p class="first last">human embryonic kidney</p></td></tr><tr><td class="NLM_term">HOAt</td><td class="NLM_def"><p class="first last">1-hydroxy-7-azabenzotriazole</p></td></tr><tr><td class="NLM_term">5-HT3</td><td class="NLM_def"><p class="first last">5-hydroxytryptamine type 3 receptor</p></td></tr><tr><td class="NLM_term">KO</td><td class="NLM_def"><p class="first last">knock out</p></td></tr><tr><td class="NLM_term">LOT</td><td class="NLM_def"><p class="first last">lipo-oxytocin</p></td></tr><tr><td class="NLM_term">OT</td><td class="NLM_def"><p class="first last">oxytocin</p></td></tr><tr><td class="NLM_term">OTR</td><td class="NLM_def"><p class="first last">oxytocin receptor</p></td></tr><tr><td class="NLM_term">pNz</td><td class="NLM_def"><p class="first last"><i>para</i>-nitrobenzyloxycarbonyl</p></td></tr><tr><td class="NLM_term">PyBOP</td><td class="NLM_def"><p class="first last">benzotriazol-1-yl-oxytripyrrolidinophosphosphate hexafluorophosphate</p></td></tr><tr><td class="NLM_term">RP-HPLC</td><td class="NLM_def"><p class="first last">reverse phase high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">TIS</td><td class="NLM_def"><p class="first last">triisopropylsilane</p></td></tr><tr><td class="NLM_term">Trt</td><td class="NLM_def"><p class="first last">trityl</p></td></tr><tr><td class="NLM_term">VR</td><td class="NLM_def"><p class="first last">vasopressin receptor</p></td></tr><tr><td class="NLM_term">V1aR</td><td class="NLM_def"><p class="first last">vasopressin type 1a receptor</p></td></tr><tr><td class="NLM_term">V1bR</td><td class="NLM_def"><p class="first last">vasopressin type 1b receptor</p></td></tr><tr><td class="NLM_term">V2R</td><td class="NLM_def"><p class="first last">vasopressin type 2 receptor</p></td></tr><tr><td class="NLM_term">WT</td><td class="NLM_def"><p class="first last">wild type</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15864" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15864" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 69 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kirsch, P.</span></span> <span> </span><span class="NLM_article-title">Oxytocin in the socioemotional brain: implications for psychiatric disorders</span>. <i>Dialogues Clin Neurosci</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=26869847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BC28jgt1SmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=463-476&author=P.+Kirsch&title=Oxytocin+in+the+socioemotional+brain%3A+implications+for+psychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin in the socioemotional brain: implications for psychiatric disorders</span></div><div class="casAuthors">Kirsch Peter</div><div class="citationInfo"><span class="NLM_cas:title">Dialogues in clinical neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">463-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The neuropeptide oxytocin (OXT), highly conserved during evolution, is an important modulator of social and emotional processes across many species.  During the last decade, a large body of literature has revealed its effects on different aspects of social behavior, including social stress and anxiety, social memory, affiliation and bonding, emotion recognition, mentalizing, empathy, and interpersonal trust.  In addition, as impairments in these social domains can be observed in a number of neuropsychiatric disorders, such as autism, social anxiety disorder, depression, schizophrenia, and borderline personality disorder, the role of OXT in mental disorders and their treatment has been intensively studied.  The present paper gives a short overview of these lines of research and shows how OXT has become a promising target for novel treatment approaches for mental disorders characterized by social impairments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5nHtyXvC7wb0AGQpJZWpJfW6udTcc2eYD--7m5VHB97ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jgt1SmtQ%253D%253D&md5=5bce2dbeaa3a3a4afe7dc5f02a39c4e7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKirsch%26aufirst%3DP.%26atitle%3DOxytocin%2520in%2520the%2520socioemotional%2520brain%253A%2520implications%2520for%2520psychiatric%2520disorders%26jtitle%3DDialogues%2520Clin%2520Neurosci%26date%3D2015%26volume%3D17%26spage%3D463%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bealer, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, W. R.</span></span> <span> </span><span class="NLM_article-title">Oxytocin release in magnocellular nuclei: neurochemical mediators and functional significance during gestation</span>. <i>Am. J. Physiol.: Regul., Integr. Comp. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>299</i></span>,  <span class="NLM_fpage">R452</span>– <span class="NLM_lpage">R458</span>, <span class="refDoi"> DOI: 10.1152/ajpregu.00217.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1152%2Fajpregu.00217.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=20554931" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2010&pages=R452-R458&author=S.+L.+Bealerauthor=W.+E.+Armstrongauthor=W.+R.+Crowley&title=Oxytocin+release+in+magnocellular+nuclei%3A+neurochemical+mediators+and+functional+significance+during+gestation&doi=10.1152%2Fajpregu.00217.2010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1152%2Fajpregu.00217.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpregu.00217.2010%26sid%3Dliteratum%253Aachs%26aulast%3DBealer%26aufirst%3DS.%2BL.%26aulast%3DArmstrong%26aufirst%3DW.%2BE.%26aulast%3DCrowley%26aufirst%3DW.%2BR.%26atitle%3DOxytocin%2520release%2520in%2520magnocellular%2520nuclei%253A%2520neurochemical%2520mediators%2520and%2520functional%2520significance%2520during%2520gestation%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Regul.%252C%2520Integr.%2520Comp.%2520Physiol.%26date%3D2010%26volume%3D299%26spage%3DR452%26epage%3DR458%26doi%3D10.1152%2Fajpregu.00217.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rilling, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, L. J.</span></span> <span> </span><span class="NLM_article-title">The biology of mammalian parenting and its effect on offspring social development</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>345</i></span>,  <span class="NLM_fpage">771</span>– <span class="NLM_lpage">776</span>, <span class="refDoi"> DOI: 10.1126/science.1252723</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1126%2Fscience.1252723" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=25124431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlejtL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2014&pages=771-776&author=J.+K.+Rillingauthor=L.+J.+Young&title=The+biology+of+mammalian+parenting+and+its+effect+on+offspring+social+development&doi=10.1126%2Fscience.1252723"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The biology of mammalian parenting and its effect on offspring social development</span></div><div class="casAuthors">Rilling, James K.; Young, Larry J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">345</span>
        (<span class="NLM_cas:issue">6198</span>),
    <span class="NLM_cas:pages">771-776</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Parents know the transformative nature of having and caring for a child.  Among many mammals, giving birth leads from an aversion to infant stimuli to irresistible attraction.  Here, we review the biol. mechanisms governing this shift in parental motivation in mammals.  Estrogen and progesterone prep. the uterus for embryo implantation and placental development.  Prolactin stimulates milk prodn., whereas oxytocin initiates labor and triggers milk ejection during nursing.  These same mols., interacting with dopamine, also activate specific neural pathways to motivate parents to nurture, bond with, and protect their offspring.  Parenting in turn shapes the neural development of the infant social brain.  Recent work suggests that many of the principles governing parental behavior and its effect on infant development are conserved from rodent to humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTAg-8FTVmQrVg90H21EOLACvtfcHk0ljC-s0zrlYpHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlejtL%252FI&md5=2dbd540da66206ee5d63adad70075f95</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.1252723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1252723%26sid%3Dliteratum%253Aachs%26aulast%3DRilling%26aufirst%3DJ.%2BK.%26aulast%3DYoung%26aufirst%3DL.%2BJ.%26atitle%3DThe%2520biology%2520of%2520mammalian%2520parenting%2520and%2520its%2520effect%2520on%2520offspring%2520social%2520development%26jtitle%3DScience%26date%3D2014%26volume%3D345%26spage%3D771%26epage%3D776%26doi%3D10.1126%2Fscience.1252723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marlin, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froemke, R. C.</span></span> <span> </span><span class="NLM_article-title">Oxytocin modulation of neural circuits for social behavior</span>. <i>Dev. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1002/dneu.22452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1002%2Fdneu.22452" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=27626613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslWhtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2017&pages=169-189&author=B.+J.+Marlinauthor=R.+C.+Froemke&title=Oxytocin+modulation+of+neural+circuits+for+social+behavior&doi=10.1002%2Fdneu.22452"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin modulation of neural circuits for social behavior</span></div><div class="casAuthors">Marlin, Bianca J.; Froemke, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Neurobiology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">169-189</span>CODEN:
                <span class="NLM_cas:coden">DNEEAM</span>;
        ISSN:<span class="NLM_cas:issn">1932-8451</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Oxytocin is a hypothalamic neuropeptide that has gained attention for the effects on social behavior.  Recent findings shed new light on the mechanisms of oxytocin in synaptic plasticity and adaptively modifying neural circuits for social interactions such as conspecific recognition, pair bonding, and maternal care.  Here, we review several of these newer studies on oxytocin in the context of previous findings, with an emphasis on social behavior and circuit plasticity in various brain regions shown to be enriched for oxytocin receptors.  We provide a framework that highlights current circuit-level mechanisms underlying the widespread action of oxytocin. © 2016 Wiley Periodicals, Inc.  Develop Neurobiol 77: 169-189, 2017.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMnT0PBU34W7Vg90H21EOLACvtfcHk0ljC-s0zrlYpHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslWhtLo%253D&md5=e7b4a4e9fb709259f3397844c8058b8e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fdneu.22452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fdneu.22452%26sid%3Dliteratum%253Aachs%26aulast%3DMarlin%26aufirst%3DB.%2BJ.%26aulast%3DFroemke%26aufirst%3DR.%2BC.%26atitle%3DOxytocin%2520modulation%2520of%2520neural%2520circuits%2520for%2520social%2520behavior%26jtitle%3DDev.%2520Neurobiol.%26date%3D2017%26volume%3D77%26spage%3D169%26epage%3D189%26doi%3D10.1002%2Fdneu.22452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lai, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baron-Cohen, S.</span></span> <span> </span><span class="NLM_article-title">Autism</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>383</i></span>,  <span class="NLM_fpage">896</span>– <span class="NLM_lpage">910</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(13)61539-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fs0140-6736%2813%2961539-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=24074734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FhvFeqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=383&publication_year=2014&pages=896-910&author=M.-C.+Laiauthor=M.+V.+Lombardoauthor=S.+Baron-Cohen&title=Autism&doi=10.1016%2Fs0140-6736%2813%2961539-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Autism</span></div><div class="casAuthors">Lai Meng-Chuan; Lombardo Michael V; Baron-Cohen Simon</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">383</span>
        (<span class="NLM_cas:issue">9920</span>),
    <span class="NLM_cas:pages">896-910</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Autism is a set of heterogeneous neurodevelopmental conditions, characterised by early-onset difficulties in social communication and unusually restricted, repetitive behaviour and interests.  The worldwide population prevalence is about 1%.  Autism affects more male than female individuals, and comorbidity is common (>70% have concurrent conditions).  Individuals with autism have atypical cognitive profiles, such as impaired social cognition and social perception, executive dysfunction, and atypical perceptual and information processing.  These profiles are underpinned by atypical neural development at the systems level.  Genetics has a key role in the aetiology of autism, in conjunction with developmentally early environmental factors.  Large-effect rare mutations and small-effect common variants contribute to risk.  Assessment needs to be multidisciplinary and developmental, and early detection is essential for early intervention.  Early comprehensive and targeted behavioural interventions can improve social communication and reduce anxiety and aggression.  Drugs can reduce comorbid symptoms, but do not directly improve social communication.  Creation of a supportive environment that accepts and respects that the individual is different is crucial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSyg9jmEI_2w1WTCLT8lX9SfW6udTcc2eZf_4H_gGoYobntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FhvFeqtQ%253D%253D&md5=146b8454fe450b91073c3751e7b41699</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fs0140-6736%2813%2961539-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0140-6736%252813%252961539-1%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DM.-C.%26aulast%3DLombardo%26aufirst%3DM.%2BV.%26aulast%3DBaron-Cohen%26aufirst%3DS.%26atitle%3DAutism%26jtitle%3DLancet%26date%3D2014%26volume%3D383%26spage%3D896%26epage%3D910%26doi%3D10.1016%2Fs0140-6736%2813%2961539-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peñagarikano, O.</span></span> <span> </span><span class="NLM_article-title">New therapeutic options for autism spectrum disorder: experimental evidences</span>. <i>Exp. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">311</span>, <span class="refDoi"> DOI: 10.5607/en.2015.24.4.301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.5607%2Fen.2015.24.4.301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=26713078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BC28rls12iuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=301-311&author=O.+Pe%C3%B1agarikano&title=New+therapeutic+options+for+autism+spectrum+disorder%3A+experimental+evidences&doi=10.5607%2Fen.2015.24.4.301"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">New Therapeutic Options for Autism Spectrum Disorder: Experimental Evidences</span></div><div class="casAuthors">Penagarikano Olga</div><div class="citationInfo"><span class="NLM_cas:title">Experimental neurobiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">301-11</span>
        ISSN:<span class="NLM_cas:issn">1226-2560</span>.
    </div><div class="casAbstract">Autism spectrum disorder (ASD) is characterized by impairment in two behavioral domains: social interaction/communication together with the presence of stereotyped behaviors and restricted interests.  The heterogeneity in the phenotype among patients and the complex etiology of the disorder have long impeded the advancement of the development of successful pharmacotherapies.  However, in the recent years, the integration of findings of multiple levels of research, from human genetics to mouse models, have made considerable progress towards the understanding of ASD pathophysiology, allowing the development of more effective targeted drug therapies.  The present review discusses the current state of pharmacological research in ASD based on the emerging common pathophysiology signature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRrttl-His734McDoIzZtNkfW6udTcc2eZf_4H_gGoYobntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rls12iuw%253D%253D&md5=26f70a17e704f9073e5b0b45ec9497c6</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.5607%2Fen.2015.24.4.301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5607%252Fen.2015.24.4.301%26sid%3Dliteratum%253Aachs%26aulast%3DPe%25C3%25B1agarikano%26aufirst%3DO.%26atitle%3DNew%2520therapeutic%2520options%2520for%2520autism%2520spectrum%2520disorder%253A%2520experimental%2520evidences%26jtitle%3DExp.%2520Neurobiol.%26date%3D2015%26volume%3D24%26spage%3D301%26epage%3D311%26doi%3D10.5607%2Fen.2015.24.4.301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lacivita, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margari, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leopoldo, M.</span></span> <span> </span><span class="NLM_article-title">Targets for drug therapy for autism spectrum disorder: challenges and future directions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">9114</span>– <span class="NLM_lpage">9141</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00965</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00965" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1KnsLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9114-9141&author=E.+Lacivitaauthor=R.+Perroneauthor=L.+Margariauthor=M.+Leopoldo&title=Targets+for+drug+therapy+for+autism+spectrum+disorder%3A+challenges+and+future+directions&doi=10.1021%2Facs.jmedchem.7b00965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions</span></div><div class="casAuthors">Lacivita, Enza; Perrone, Roberto; Margari, Lucia; Leopoldo, Marcello</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9114-9141</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by persistent deficits in social communication and interaction and restricted, repetitive patterns of behavior, interests, and activities.  Various factors are involved in the etiopathogenesis of ASD, including genetic factors, environmental toxins and stressors, impaired immune responses, mitochondrial dysfunction, and neuroinflammation.  The heterogeneity in the phenotype among ASD patients and the complex etiol. of the condition have long impeded the advancement of the development of pharmacol. therapies.  In the recent years, the integration of findings from mouse models to human genetics resulted in considerable progress toward the understanding of ASD pathophysiol.  Currently, strategies to treat core symptoms of ASD are directed to correct synaptic dysfunctions, abnormalities in central oxytocin, vasopressin, and serotonin neurotransmission, and neuroinflammation.  Here, we present a survey of the studies that have suggested mol. targets for drug development for ASD and the state-of-the-art of medicinal chem. efforts in related areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBnoRlTN2U9rVg90H21EOLACvtfcHk0lgsb5WnM0wVyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1KnsLnL&md5=32311ccf6d8bc345129c00fe6dc0a23a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00965%26sid%3Dliteratum%253Aachs%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DMargari%26aufirst%3DL.%26aulast%3DLeopoldo%26aufirst%3DM.%26atitle%3DTargets%2520for%2520drug%2520therapy%2520for%2520autism%2520spectrum%2520disorder%253A%2520challenges%2520and%2520future%2520directions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D9114%26epage%3D9141%26doi%3D10.1021%2Facs.jmedchem.7b00965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">James, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gales, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gales, B. J.</span></span> <span> </span><span class="NLM_article-title">Bumetanide for Autism Spectrum Disorder in Children: A Review of Randomized Controlled Trials</span>. <i>Ann. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">106002801881730</span>, <span class="refDoi"> DOI: 10.1177/1060028018817304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1177%2F1060028018817304" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2018&pages=106002801881730&author=B.+J.+Jamesauthor=M.+A.+Galesauthor=B.+J.+Gales&title=Bumetanide+for+Autism+Spectrum+Disorder+in+Children%3A+A+Review+of+Randomized+Controlled+Trials&doi=10.1177%2F1060028018817304"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1177%2F1060028018817304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1060028018817304%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DB.%2BJ.%26aulast%3DGales%26aufirst%3DM.%2BA.%26aulast%3DGales%26aufirst%3DB.%2BJ.%26atitle%3DBumetanide%2520for%2520Autism%2520Spectrum%2520Disorder%2520in%2520Children%253A%2520A%2520Review%2520of%2520Randomized%2520Controlled%2520Trials%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2018%26volume%3D52%26spage%3D106002801881730%26doi%3D10.1177%2F1060028018817304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shamay-Tsoory, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, L. J.</span></span> <span> </span><span class="NLM_article-title">Understanding the oxytocin system and its relevance to psychiatry</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">150</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2015.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.biopsych.2015.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=26723107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BC28rmsFyksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=150-152&author=S.+Shamay-Tsooryauthor=L.+J.+Young&title=Understanding+the+oxytocin+system+and+its+relevance+to+psychiatry&doi=10.1016%2Fj.biopsych.2015.10.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the Oxytocin System and Its Relevance to Psychiatry</span></div><div class="casAuthors">Shamay-Tsoory Simone; Young Larry J</div><div class="citationInfo"><span class="NLM_cas:title">Biological psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">150-2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSo-UULW7rzwiEJCPKhJPuqfW6udTcc2ebN5Su41XcW1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rmsFyksQ%253D%253D&md5=cf90449ad5cf959338cb2af3b19ce468</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2015.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2015.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DShamay-Tsoory%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DL.%2BJ.%26atitle%3DUnderstanding%2520the%2520oxytocin%2520system%2520and%2520its%2520relevance%2520to%2520psychiatry%26jtitle%3DBiol.%2520Psychiatry%26date%3D2016%26volume%3D79%26spage%3D150%26epage%3D152%26doi%3D10.1016%2Fj.biopsych.2015.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alabdali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Ayadhi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Ansary, A.</span></span> <span> </span><span class="NLM_article-title">Association of social and cognitive impairment and biomarkers in autism spectrum disorders</span>. <i>J. Neuroinflammation</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">4</span>, <span class="refDoi"> DOI: 10.1186/1742-2094-11-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1186%2F1742-2094-11-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=24400970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivVagu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=4&author=A.+Alabdaliauthor=A.+Al-Ayadhiauthor=A.+El-Ansary&title=Association+of+social+and+cognitive+impairment+and+biomarkers+in+autism+spectrum+disorders&doi=10.1186%2F1742-2094-11-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Association of social and cognitive impairment and biomarkers in autism spectrum disorders</span></div><div class="casAuthors">Alabdali, Altaf; Al-Ayadhi, Laila; El-Ansary, Afaf</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4/1-4/14, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Objectives: The neurol. basis for autism is still not fully understood, and the role of the interaction between neuro-inflammation and neurotransmission impairment needs to be clearer.  This study aims to test the possible assocn. between impaired levels of gamma aminobutyric acid (GABA), serotonin, dopamine, oxytocin, and interferon-γ-induced protein-16 (IFI16) and the severity of social and cognitive dysfunctions in individuals with autism spectrum disorders.  Materials and methods: GABA, serotonin, dopamine, oxytocin, and IFI16 as biochem. parameters related to neurochem. and inflammation were detd. in the plasma of 52 Saudi autistic male patients, categorized as mild-moderate and severe as indicated by their Childhood Autism Rating Scale (CARS) or social responsiveness scale (SRS), and compared to 30 age- and gender-matched control samples.  Results: The data indicated that Saudi patients with autism have remarkably impaired plasma levels of the measured parameters compared to age and gender-matched controls.  While serotonin in platelet-free plasma and dopamine did not correlated with the severity in social and cognitive dysfunction, GABA, oxytocin, and IFI16 were remarkably assocd. with the severity of both tested scores (SRS and CARS).  Conclusions: The relationship between the selected parameters confirms the role of impaired neurochem. and neuro-inflammation in the etiol. of autism spectrum disorders and the possibility of using GABA, oxytocin, and IFI16 as markers of autism severity.  Receiver operating characteristic anal. together with predictiveness diagrams proved that the measured parameters could be used as predictive biomarkers of clin. symptoms and provide significant guidance for future therapeutic strategy to re-establish physiol. homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU2x5EzxJ6jrVg90H21EOLACvtfcHk0lhm_sfJ_5t83Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivVagu7w%253D&md5=790ed1e8c3e6ab5e5ee79e2712b7ce5d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-11-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-11-4%26sid%3Dliteratum%253Aachs%26aulast%3DAlabdali%26aufirst%3DA.%26aulast%3DAl-Ayadhi%26aufirst%3DA.%26aulast%3DEl-Ansary%26aufirst%3DA.%26atitle%3DAssociation%2520of%2520social%2520and%2520cognitive%2520impairment%2520and%2520biomarkers%2520in%2520autism%2520spectrum%2520disorders%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2014%26volume%3D11%26spage%3D4%26doi%3D10.1186%2F1742-2094-11-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagoory-Sharon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisman, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneiderman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maoz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shalev, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebstein, R. P.</span></span> <span> </span><span class="NLM_article-title">Sensitive parenting is associated with plasma oxytocin and polymorphisms in the OXTR and CD38 genes</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">181</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2011.12.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.biopsych.2011.12.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=22336563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVehsLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=175-181&author=R.+Feldmanauthor=O.+Zagoory-Sharonauthor=O.+Weismanauthor=I.+Schneidermanauthor=I.+Gordonauthor=R.+Maozauthor=I.+Shalevauthor=R.+P.+Ebstein&title=Sensitive+parenting+is+associated+with+plasma+oxytocin+and+polymorphisms+in+the+OXTR+and+CD38+genes&doi=10.1016%2Fj.biopsych.2011.12.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitive Parenting Is Associated with Plasma Oxytocin and Polymorphisms in the OXTR and CD38 Genes</span></div><div class="casAuthors">Feldman, Ruth; Zagoory-Sharon, Orna; Weisman, Omri; Schneiderman, Inna; Gordon, Ilanit; Maoz, Rina; Shalev, Idan; Ebstein, Richard P.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">175-181</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Research in mammals has demonstrated the involvement of oxytocin (OT) in social bond formation; yet, its role in human bonding remains unclear.  Plasma OT has been used as a proxy for central activity and studies indicate its assocn. with human affiliative behaviors.  Mol. genetic studies also reveal a role for OT neuropathways in shaping the social brain.  However, the links between peripheral OT, genetic markers, and their combined contribution to human parenting are unknown.  Participants included 352 individuals: 272 mothers and fathers and their 4- to 6-mo-old-infants and 80 nonparents.  Plasma OT was assayed from adults who were genotyped for oxytocin receptor (OXTR) and CD38 risk alleles assocd. with social dysfunctions.  CD38 is an ectoenzyme that mediates the release of brain OT.  Parent-infant interactions were microcoded for parental touch and gaze synchrony and participants reported on parental care in childhood.  OXTR (rs2254298 and rs1042778) and CD38 (rs3796863) risk alleles were each assocd. with lower plasma OT.  Reduced plasma OT and both OXTR and CD38 risk alleles were related to less parental touch.  The interaction of high plasma OT and low-risk CD38 alleles predicted longer durations of parent-infant gaze synchrony.  Parents reporting greater parental care showed higher plasma OT, low-risk CD38 alleles, and more touch toward their infants.  Results indicate that peripheral and genetic markers of the extended OT pathway are interrelated and underpin core behaviors assocd. with human parenting and social engagement.  These findings may have important implications for understanding neuropsychiatric disorders marked by early social dysfunctions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbCvDRP9RKALVg90H21EOLACvtfcHk0lhm_sfJ_5t83Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVehsLfP&md5=a72b304d6ed7f40cd6f2a4d39d41fc04</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2011.12.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2011.12.025%26sid%3Dliteratum%253Aachs%26aulast%3DFeldman%26aufirst%3DR.%26aulast%3DZagoory-Sharon%26aufirst%3DO.%26aulast%3DWeisman%26aufirst%3DO.%26aulast%3DSchneiderman%26aufirst%3DI.%26aulast%3DGordon%26aufirst%3DI.%26aulast%3DMaoz%26aufirst%3DR.%26aulast%3DShalev%26aufirst%3DI.%26aulast%3DEbstein%26aufirst%3DR.%2BP.%26atitle%3DSensitive%2520parenting%2520is%2520associated%2520with%2520plasma%2520oxytocin%2520and%2520polymorphisms%2520in%2520the%2520OXTR%2520and%2520CD38%2520genes%26jtitle%3DBiol.%2520Psychiatry%26date%3D2012%26volume%3D72%26spage%3D175%26epage%3D181%26doi%3D10.1016%2Fj.biopsych.2011.12.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">LoParo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldman, I. D.</span></span> <span> </span><span class="NLM_article-title">The oxytocin receptor gene (<i>OXTR</i>) is associated with autism spectrum disorder: a meta-analysis</span>. <i>Mol. Psychiatr.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">640</span>– <span class="NLM_lpage">646</span>, <span class="refDoi"> DOI: 10.1038/mp.2014.77</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1038%2Fmp.2014.77" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=25092245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BC2cbovVSmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=640-646&author=D.+LoParoauthor=I.+D.+Waldman&title=The+oxytocin+receptor+gene+%28OXTR%29+is+associated+with+autism+spectrum+disorder%3A+a+meta-analysis&doi=10.1038%2Fmp.2014.77"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The oxytocin receptor gene (OXTR) is associated with autism spectrum disorder: a meta-analysis</span></div><div class="casAuthors">LoParo D; Waldman I D</div><div class="citationInfo"><span class="NLM_cas:title">Molecular psychiatry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">640-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The oxytocin receptor gene (OXTR) has been studied as a risk factor for autism spectrum disorder (ASD) owing to converging evidence from multiple levels of analysis that oxytocin (OXT) has an important role in the regulation of affiliative behavior and social bonding in both nonhuman mammals and humans.  Inconsistency in the effect sizes of the OXTR variants included in association studies render it unclear whether OXTR is truly associated with ASD, and, if so, which OXTR single-nucleotide polymorphisms (SNPs) are associated.  Thus, a meta-analytic review of extant studies is needed to determine whether OXTR shows association with ASD, and to elucidate which specific SNPs have a significant effect on ASD.  The current meta-analysis of 16 OXTR SNPs included 3941 individuals with ASD from 11 independent samples, although analyses of each individual SNP included a subset of this total.  We found significant associations between ASD and the SNPs rs7632287, rs237887, rs2268491 and rs2254298.  OXTR was also significantly associated with ASD in a gene-based test.  The current meta-analysis is the largest and most comprehensive investigation of the association of OXTR with ASD and the findings suggest directions for future studies of the etiology of ASD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTXbTryRKs-MBjv2lLSLOxFfW6udTcc2eakvMshplaRSbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbovVSmsA%253D%253D&md5=c4f507ef2ccd3c7a208b654e2bc69bcb</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fmp.2014.77&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmp.2014.77%26sid%3Dliteratum%253Aachs%26aulast%3DLoParo%26aufirst%3DD.%26aulast%3DWaldman%26aufirst%3DI.%2BD.%26atitle%3DThe%2520oxytocin%2520receptor%2520gene%2520%2528OXTR%2529%2520is%2520associated%2520with%2520autism%2520spectrum%2520disorder%253A%2520a%2520meta-analysis%26jtitle%3DMol.%2520Psychiatr.%26date%3D2015%26volume%3D20%26spage%3D640%26epage%3D646%26doi%3D10.1038%2Fmp.2014.77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torashima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopatina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shnayder, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seike, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takasawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koizumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiraishi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashii, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshihara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Islam, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsushima, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munesue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mochida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span> <span> </span><span class="NLM_article-title">CD38 is critical for social behaviour by regulating oxytocin secretion</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>446</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1038/nature05526</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1038%2Fnature05526" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=17287729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1arsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=446&publication_year=2007&pages=41-45&author=D.+Jinauthor=H.-X.+Liuauthor=H.+Hiraiauthor=T.+Torashimaauthor=T.+Nagaiauthor=O.+Lopatinaauthor=N.+A.+Shnayderauthor=K.+Yamadaauthor=M.+Nodaauthor=T.+Seikeauthor=K.+Fujitaauthor=S.+Takasawaauthor=S.+Yokoyamaauthor=K.+Koizumiauthor=Y.+Shiraishiauthor=S.+Tanakaauthor=M.+Hashiiauthor=T.+Yoshiharaauthor=K.+Higashidaauthor=M.+S.+Islamauthor=N.+Yamadaauthor=K.+Hayashiauthor=N.+Noguchiauthor=I.+Katoauthor=H.+Okamotoauthor=A.+Matsushimaauthor=A.+Salminaauthor=T.+Munesueauthor=N.+Shimizuauthor=S.+Mochidaauthor=M.+Asanoauthor=H.+Higashida&title=CD38+is+critical+for+social+behaviour+by+regulating+oxytocin+secretion&doi=10.1038%2Fnature05526"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">CD38 is critical for social behavior by regulating oxytocin secretion</span></div><div class="casAuthors">Jin, Duo; Liu, Hong-Xiang; Hirai, Hirokazu; Torashima, Takashi; Nagai, Taku; Lopatina, Olga; Shnayder, Natalia A.; Yamada, Kiyofumi; Noda, Mami; Seike, Toshihiro; Fujita, Kyota; Takasawa, Shin; Yokoyama, Shigeru; Koizumi, Keita; Shiraishi, Yoshitake; Tanaka, Shigenori; Hashii, Minako; Yoshihara, Toru; Higashida, Kazuhiro; Islam, Mohammad Saharul; Yamada, Nobuaki; Hayashi, Kenshi; Noguchi, Naoya; Kato, Ichiro; Okamoto, Hiroshi; Matsushima, Akihiro; Salmina, Alla; Munesue, Toshio; Shimizu, Nobuaki; Mochida, Sumiko; Asano, Masahide; Higashida, Haruhiro</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">446</span>
        (<span class="NLM_cas:issue">7131</span>),
    <span class="NLM_cas:pages">41-45</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">CD38, a transmembrane glycoprotein with ADP-Ribosyl cyclase activity, catalyzes the formation of Ca2+ signaling mols., but its role in the neuroendocrine system is unknown.  Here we show that adult CD38 knockout (CD38-/-) female and male mice show marked defects in maternal nurturing and social behavior, resp., with higher locomotor activity.  Consistently, the plasma level of oxytocin (OT), but not vasopressin, was strongly decreased in CD38-/- mice.  Replacement of OT by s.c. injection or lentiviral-vector-mediated delivery of human CD38 in the hypothalamus rescued social memory and maternal care in CD38-/- mice.  Depolarization-induced OT secretion and Ca2+ elevation in oxytocinergic neurohypophysial axon terminals were disrupted in CD38-/- mice; this was mimicked by CD38 metabolite antagonists in CD38+/+ mice.  These results reveal that CD38 has a key role in neuropeptide release, thereby critically regulating maternal and social behaviors, and may be an element in neuro-developmental disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplMtCpmjbVNrVg90H21EOLACvtfcHk0li3h1zt84uqQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1arsLw%253D&md5=f9e5a484caaeefd77260e712553d915f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature05526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05526%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DH.-X.%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DTorashima%26aufirst%3DT.%26aulast%3DNagai%26aufirst%3DT.%26aulast%3DLopatina%26aufirst%3DO.%26aulast%3DShnayder%26aufirst%3DN.%2BA.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DNoda%26aufirst%3DM.%26aulast%3DSeike%26aufirst%3DT.%26aulast%3DFujita%26aufirst%3DK.%26aulast%3DTakasawa%26aufirst%3DS.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DKoizumi%26aufirst%3DK.%26aulast%3DShiraishi%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DHashii%26aufirst%3DM.%26aulast%3DYoshihara%26aufirst%3DT.%26aulast%3DHigashida%26aufirst%3DK.%26aulast%3DIslam%26aufirst%3DM.%2BS.%26aulast%3DYamada%26aufirst%3DN.%26aulast%3DHayashi%26aufirst%3DK.%26aulast%3DNoguchi%26aufirst%3DN.%26aulast%3DKato%26aufirst%3DI.%26aulast%3DOkamoto%26aufirst%3DH.%26aulast%3DMatsushima%26aufirst%3DA.%26aulast%3DSalmina%26aufirst%3DA.%26aulast%3DMunesue%26aufirst%3DT.%26aulast%3DShimizu%26aufirst%3DN.%26aulast%3DMochida%26aufirst%3DS.%26aulast%3DAsano%26aufirst%3DM.%26aulast%3DHigashida%26aufirst%3DH.%26atitle%3DCD38%2520is%2520critical%2520for%2520social%2520behaviour%2520by%2520regulating%2520oxytocin%2520secretion%26jtitle%3DNature%26date%3D2007%26volume%3D446%26spage%3D41%26epage%3D45%26doi%3D10.1038%2Fnature05526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lopatina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshihara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fakhrul, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuhara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inahata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koizumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petugina, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumarokov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmina, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hori, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiba, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span> <span> </span><span class="NLM_article-title">Anxiety- and depression-like behavior in mice lacking the CD157/BST1 gene, a risk factor for Parkinson’s disease</span>. <i>Front. Behav. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">133</span>, <span class="refDoi"> DOI: 10.3389/fnbeh.2014.00133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.3389%2Ffnbeh.2014.00133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=24795584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1GltLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=133&author=O.+Lopatinaauthor=T.+Yoshiharaauthor=T.+Nishimuraauthor=J.+Zhongauthor=S.+Aktherauthor=A.+A.+Fakhrulauthor=M.+Liangauthor=C.+Higashidaauthor=K.+Sumiauthor=K.+Furuharaauthor=Y.+Inahataauthor=J.+J.+Huangauthor=K.+Koizumiauthor=S.+Yokoyamaauthor=T.+Tsujiauthor=Y.+Petuginaauthor=A.+Sumarokovauthor=A.+B.+Salminaauthor=K.+Hashidaauthor=Y.+Kitaoauthor=O.+Horiauthor=M.+Asanoauthor=Y.+Kitamuraauthor=T.+Kozakaauthor=K.+Shibaauthor=F.+Zhongauthor=M.+J.+Xieauthor=M.+Satoauthor=K.+Ishiharaauthor=H.+Higashida&title=Anxiety-+and+depression-like+behavior+in+mice+lacking+the+CD157%2FBST1+gene%2C+a+risk+factor+for+Parkinson%E2%80%99s+disease&doi=10.3389%2Ffnbeh.2014.00133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Anxiety-and depression-like behavior in mice lacking the CD157/BST1 gene, a risk factor for Parkinson's disease</span></div><div class="casAuthors">Lopatina, Olga; Yoshihara, Toru; Nishimura, Tomoko; Zhong, Jing; Akther, Shirin; Fakhrul, Azam A. K. M.; Liang, Mingkun; Higashida, Chiharu; Sumi, Kohei; Furuhara, Kazumi; Inahata, Yuki; Huang, Jian-Jung; Koizumi, Keita; Yokoyama, Shigeru; Tsuji, Takahiro; Petugina, Yulia; Sumarokov, Andrei; Salmina, Alla B.; Hashida, Koji; Kitao, Yasuko; Hori, Osamu; Asano, Masahide; Kitamura, Yoji; Kozaka, Takashi; Shiba, Kazuhiro; Zhong, Fangfang; Xie, Min-Jue; Sato, Makoto; Ishihara, Katsuhiko; Higashida, Haruhiro</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Behavioral Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">133/1-133/18, 18 pp.</span>CODEN:
                <span class="NLM_cas:coden">FBNRAA</span>;
        ISSN:<span class="NLM_cas:issn">1662-5153</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">CD157, known as bone marrow stromal cell antigen-1, is a glycosylphosphatidylinositol-anchored ADP-ribosyl cyclase that supports the survival and function of B-lymphocytes and hematopoietic or intestinal stem cells.  Although CD157/Bst1 is a risk locus in Parkinson's disease (PD), little is known about the function of CD157 in the nervous system and contribution to PD progression.  Here, we show that no apparent motor dysfunction was obsd. in young knockout (CD157-/-) male mice under less aging-related effects on behaviors.  CD157-/- mice exhibited anxiety-related and depression-like behaviors compared with wild-type mice.  These behaviors were rescued through treatment with anti-psychiatric drugs and oxytocin.  CD157 was weakly expressed in the amygdala and c-Fos immunoreactivity in the amygdala was less evident in CD157-/- mice than in wild-type mice.  These results demonstrate for the first time that CD157 plays a role as a neuro-regulator and suggest a potential role in pre-motor symptoms in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEM-N-VwlsBrVg90H21EOLACvtfcHk0li3h1zt84uqQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1GltLzK&md5=66eb8215cbfe7970071c3440ed94c731</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.3389%2Ffnbeh.2014.00133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnbeh.2014.00133%26sid%3Dliteratum%253Aachs%26aulast%3DLopatina%26aufirst%3DO.%26aulast%3DYoshihara%26aufirst%3DT.%26aulast%3DNishimura%26aufirst%3DT.%26aulast%3DZhong%26aufirst%3DJ.%26aulast%3DAkther%26aufirst%3DS.%26aulast%3DFakhrul%26aufirst%3DA.%2BA.%26aulast%3DLiang%26aufirst%3DM.%26aulast%3DHigashida%26aufirst%3DC.%26aulast%3DSumi%26aufirst%3DK.%26aulast%3DFuruhara%26aufirst%3DK.%26aulast%3DInahata%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DJ.%2BJ.%26aulast%3DKoizumi%26aufirst%3DK.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DTsuji%26aufirst%3DT.%26aulast%3DPetugina%26aufirst%3DY.%26aulast%3DSumarokov%26aufirst%3DA.%26aulast%3DSalmina%26aufirst%3DA.%2BB.%26aulast%3DHashida%26aufirst%3DK.%26aulast%3DKitao%26aufirst%3DY.%26aulast%3DHori%26aufirst%3DO.%26aulast%3DAsano%26aufirst%3DM.%26aulast%3DKitamura%26aufirst%3DY.%26aulast%3DKozaka%26aufirst%3DT.%26aulast%3DShiba%26aufirst%3DK.%26aulast%3DZhong%26aufirst%3DF.%26aulast%3DXie%26aufirst%3DM.%2BJ.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DIshihara%26aufirst%3DK.%26aulast%3DHigashida%26aufirst%3DH.%26atitle%3DAnxiety-%2520and%2520depression-like%2520behavior%2520in%2520mice%2520lacking%2520the%2520CD157%252FBST1%2520gene%252C%2520a%2520risk%2520factor%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DFront.%2520Behav.%2520Neurosci.%26date%3D2014%26volume%3D8%26spage%3D133%26doi%3D10.3389%2Ffnbeh.2014.00133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuhi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amina, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopatina, O.</span></span> <span> </span><span class="NLM_article-title">Oxytocin release via activation of TRPM2 and CD38 in the hypothalamus during hyperthermia in mice: implication for autism spectrum disorder</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1016/j.neuint.2017.07.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.neuint.2017.07.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=28736241" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2017&pages=42-48&author=H.+Higashidaauthor=T.+Yuhiauthor=S.+Aktherauthor=S.+Aminaauthor=J.+Zhongauthor=M.+Liangauthor=T.+Nishimuraauthor=H.-X.+Liuauthor=O.+Lopatina&title=Oxytocin+release+via+activation+of+TRPM2+and+CD38+in+the+hypothalamus+during+hyperthermia+in+mice%3A+implication+for+autism+spectrum+disorder&doi=10.1016%2Fj.neuint.2017.07.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2017.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2017.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DHigashida%26aufirst%3DH.%26aulast%3DYuhi%26aufirst%3DT.%26aulast%3DAkther%26aufirst%3DS.%26aulast%3DAmina%26aufirst%3DS.%26aulast%3DZhong%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DM.%26aulast%3DNishimura%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DH.-X.%26aulast%3DLopatina%26aufirst%3DO.%26atitle%3DOxytocin%2520release%2520via%2520activation%2520of%2520TRPM2%2520and%2520CD38%2520in%2520the%2520hypothalamus%2520during%2520hyperthermia%2520in%2520mice%253A%2520implication%2520for%2520autism%2520spectrum%2520disorder%26jtitle%3DNeurochem.%2520Int.%26date%3D2017%26volume%3D119%26spage%3D42%26epage%3D48%26doi%3D10.1016%2Fj.neuint.2017.07.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshihara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fakhrul, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherepanov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahmuda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerasimenko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopatina, O.</span></span> <span> </span><span class="NLM_article-title">An immunohistochemical, enzymatic, and behavioral study of CD157/BST-1 as a neuroregulator</span>. <i>BMC Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">35</span>, <span class="refDoi"> DOI: 10.1186/s12868-017-0350-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1186%2Fs12868-017-0350-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=28340569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkvVaiur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=35&author=H.+Higashidaauthor=M.+Liangauthor=T.+Yoshiharaauthor=S.+Aktherauthor=A.+Fakhrulauthor=S.+Cherepanovauthor=T.+S.+Namauthor=U.+H.+Kimauthor=S.+Kasaiauthor=T.+Nishimuraauthor=N.+Mahmudaauthor=S.+Yokoyamaauthor=K.+Ishiharaauthor=M.+Gerasimenkoauthor=A.+Salminaauthor=J.+Zhongauthor=T.+Tsujiauthor=C.+Tsujiauthor=O.+Lopatina&title=An+immunohistochemical%2C+enzymatic%2C+and+behavioral+study+of+CD157%2FBST-1+as+a+neuroregulator&doi=10.1186%2Fs12868-017-0350-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">An immunohistochemical, enzymatic, and behavioral study of CD157/BST-1 as a neuroregulator</span></div><div class="casAuthors">Higashida, Haruhiro; Liang, Mingkun; Yoshihara, Toru; Akther, Shirin; Fakhrul, Azam; Stanislav, Cherepanov; Nam, Tae-Sik; Kim, Uh-Hyun; Kasai, Satoka; Nishimura, Tomoko; Al Mahmuda, Naila; Yokoyama, Shigeru; Ishihara, Katsuhiko; Gerasimenko, Maria; Salmina, Alla; Zhong, Jing; Tsuji, Takahiro; Tsuji, Chiharu; Lopatina, Olga</div><div class="citationInfo"><span class="NLM_cas:title">BMC Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35/1-35/12</span>CODEN:
                <span class="NLM_cas:coden">BNMEA6</span>;
        ISSN:<span class="NLM_cas:issn">1471-2202</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Recent rodent and human studies provide evidence in support of the fact that CD157, well known as bone marrow stromal cell antigen-1 (BST-1) and a risk factor in Parkinson's disease, also meaningfully acts in the brain as a neuroregulator and affects social behaviors.  It has been shown that social behaviors are impaired in CD157 knockout mice without severe motor dysfunction and that CD157/BST1 gene single nucleotide polymorphisms are assocd. with autism spectrum disorder in humans.  However, it is still necessary to det. how this mol. contributes to the brain's physiol. and pathophysiol. functions.  Methods: To gain fresh insights about the relationship between the presence of CD157 in the brain and its enzymic activity, and aberrant social behavior, CD157 knockout mice of various ages were tested.  Results: CD157 immunoreactivity colocalized with nestin-pos. cells and elements in the ventricular zones in E17 embryos.  Brain CD157 mRNA levels were high in neonates but low in adults.  Weak but distinct immunoreactivity was detected in several areas in the adult brain, including the amygdala.  CD157 has little or no base exchange activity, but some ADP-ribosyl cyclase activity, indicating that CD157 formed cyclic ADP-ribose but much less nicotinic acid adenine dinucleotide phosphate, with both mobilizing Ca2+ from intracellular Ca2+ pools.  Social avoidance in CD157 knockout mice was rescued by a single i.p. injection of oxytocin.  Conclusions: CD157 may play a role in the embryonic and adult nervous systems.  The functional features of CD157 can be explained in part through the prodn. of cyclic ADP-ribose rather than nicotinic acid adenine dinucleotide phosphate.  Further expts. are required to elucidate how the embryonic expression of CD157 in neural stem cells contributes to behaviors in adults or to psychiatric symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2SEjqYOsYI7Vg90H21EOLACvtfcHk0ljTw99sd-b00g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkvVaiur0%253D&md5=2d2812c40e3f954e6426adaf36357902</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1186%2Fs12868-017-0350-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12868-017-0350-7%26sid%3Dliteratum%253Aachs%26aulast%3DHigashida%26aufirst%3DH.%26aulast%3DLiang%26aufirst%3DM.%26aulast%3DYoshihara%26aufirst%3DT.%26aulast%3DAkther%26aufirst%3DS.%26aulast%3DFakhrul%26aufirst%3DA.%26aulast%3DCherepanov%26aufirst%3DS.%26aulast%3DNam%26aufirst%3DT.%2BS.%26aulast%3DKim%26aufirst%3DU.%2BH.%26aulast%3DKasai%26aufirst%3DS.%26aulast%3DNishimura%26aufirst%3DT.%26aulast%3DMahmuda%26aufirst%3DN.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DIshihara%26aufirst%3DK.%26aulast%3DGerasimenko%26aufirst%3DM.%26aulast%3DSalmina%26aufirst%3DA.%26aulast%3DZhong%26aufirst%3DJ.%26aulast%3DTsuji%26aufirst%3DT.%26aulast%3DTsuji%26aufirst%3DC.%26aulast%3DLopatina%26aufirst%3DO.%26atitle%3DAn%2520immunohistochemical%252C%2520enzymatic%252C%2520and%2520behavioral%2520study%2520of%2520CD157%252FBST-1%2520as%2520a%2520neuroregulator%26jtitle%3DBMC%2520Neurosci.%26date%3D2017%26volume%3D18%26spage%3D35%26doi%3D10.1186%2Fs12868-017-0350-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munesue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anitha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koizumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Islam, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, U.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ono, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakatani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyachi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichugina, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soumarokov, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takei, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsujii, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamagishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasue, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniike, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamada, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ooi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamiyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopatina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashii, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amina, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malavasi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsushima, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span> <span> </span><span class="NLM_article-title">Two genetic variants of CD38 in subjects with autism spectrum disorder and controls</span>. <i>Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1016/j.neures.2010.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.neures.2010.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=20435366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFaisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=181-191&author=T.+Munesueauthor=S.+Yokoyamaauthor=K.+Nakamuraauthor=A.+Anithaauthor=K.+Yamadaauthor=K.+Hayashiauthor=T.+Asakaauthor=H.-X.+Liuauthor=D.+Jinauthor=K.+Koizumiauthor=M.+S.+Islamauthor=J.-J.+Huangauthor=W.-J.+Maauthor=U.-H.+Kimauthor=S.-J.+Kimauthor=K.+Parkauthor=D.+Kimauthor=M.+Kikuchiauthor=Y.+Onoauthor=H.+Nakataniauthor=S.+Sudaauthor=T.+Miyachiauthor=H.+Hiraiauthor=A.+Salminaauthor=Y.+A.+Pichuginaauthor=A.+A.+Soumarokovauthor=N.+Takeiauthor=N.+Moriauthor=M.+Tsujiiauthor=T.+Sugiyamaauthor=K.+Yagiauthor=M.+Yamagishiauthor=T.+Sasakiauthor=H.+Yamasueauthor=N.+Katoauthor=R.+Hashimotoauthor=M.+Taniikeauthor=Y.+Hayashiauthor=J.+Hamadaauthor=S.+Suzukiauthor=A.+Ooiauthor=M.+Nodaauthor=Y.+Kamiyamaauthor=M.+A.+Kidoauthor=O.+Lopatinaauthor=M.+Hashiiauthor=S.+Aminaauthor=F.+Malavasiauthor=E.+J.+Huangauthor=J.+Zhangauthor=N.+Shimizuauthor=T.+Yoshikawaauthor=A.+Matsushimaauthor=Y.+Minabeauthor=H.+Higashida&title=Two+genetic+variants+of+CD38+in+subjects+with+autism+spectrum+disorder+and+controls&doi=10.1016%2Fj.neures.2010.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Two genetic variants of CD38 in subjects with autism spectrum disorder and controls</span></div><div class="casAuthors">Munesue, Toshio; Yokoyama, Shigeru; Nakamura, Kazuhiko; Anitha, Ayyappan; Yamada, Kazuo; Hayashi, Kenshi; Asaka, Tomoya; Liu, Hong-Xiang; Jin, Duo; Koizumi, Keita; Islam, Mohammad Saharul; Huang, Jian-Jun; Ma, Wen-Jie; Kim, Uh-Hyun; Kim, Sun-Jun; Park, Keunwan; Kim, Dongsup; Kikuchi, Mitsuru; Ono, Yasuki; Nakatani, Hideo; Suda, Shiro; Miyachi, Taishi; Hirai, Hirokazu; Salmina, Alla; Pichugina, Yu A.; Soumarokov, Andrei A.; Takei, Nori; Mori, Norio; Tsujii, Masatsugu; Sugiyama, Toshiro; Yagi, Kunimasa; Yamagishi, Masakazu; Sasaki, Tsukasa; Yamasue, Hidenori; Kato, Nobumasa; Hashimoto, Ryota; Taniike, Masako; Hayashi, Yutaka; Hamada, Junichiro; Suzuki, Shioto; Ooi, Akishi; Noda, Mami; Kamiyama, Yuko; Kido, Mizuho A.; Lopatina, Olga; Hashii, Minako; Amina, Sarwat; Malavasi, Fabio; Huang, Eric J.; Zhang, Jiasheng; Shimizu, Nobuaki; Yoshikawa, Takeo; Matsushima, Akihiro; Minabe, Yoshio; Higashida, Haruhiro</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Research (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-191</span>CODEN:
                <span class="NLM_cas:coden">NERADN</span>;
        ISSN:<span class="NLM_cas:issn">0168-0102</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">The neurobiol. basis of autism spectrum disorder (ASD) remains poorly understood.  Given the role of CD38 in social recognition through oxytocin (OT) release, we hypothesized that CD38 may play a role in the etiol. of ASD.  Here, we first examd. the immunohistochem. expression of CD38 in the hypothalamus of post-mortem brains of non-ASD subjects and found that CD38 was colocalized with OT in secretory neurons.  In studies of the assocn. between CD38 and autism, we analyzed 10 single nucleotide polymorphisms (SNPs) and mutations of CD38 by re-sequencing DNAs mainly from a case-control study in Japan, and Caucasian cases mainly recruited to the Autism Genetic Resource Exchange (AGRE).  The SNPs of CD38, rs6449197 (p < 0.040) and rs3796863 (p < 0.005) showed significant assocns. with a subset of ASD (IQ > 70; designated as high-functioning autism (HFA)) in the U.S. 104 AGRE family trios, but not with Japanese 188 HFA subjects.  A mutation that caused tryptophan to replace arginine at amino acid residue 140 (R140W; (rs1800561, 4693C>T)) was found in 0.6-4.6% of the Japanese population and was assocd. with ASD in the smaller case-control study.  The SNP was clustered in pedigrees in which the fathers and brothers of T-allele-carrier probands had ASD or ASD traits.  In this cohort OT plasma levels were lower in subjects with the T allele than in those without.  One proband with the T allele who was taking nasal OT spray showed relief of symptoms.  The two variant CD38 polymorphisms tested may be of interest with regard of the pathophysiol. of ASD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGox0YlYfJ3bVg90H21EOLACvtfcHk0ljTw99sd-b00g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFaisLo%253D&md5=94428a0093d578814f7e35b4330fb4ce</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.neures.2010.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neures.2010.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DMunesue%26aufirst%3DT.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DAnitha%26aufirst%3DA.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DHayashi%26aufirst%3DK.%26aulast%3DAsaka%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DH.-X.%26aulast%3DJin%26aufirst%3DD.%26aulast%3DKoizumi%26aufirst%3DK.%26aulast%3DIslam%26aufirst%3DM.%2BS.%26aulast%3DHuang%26aufirst%3DJ.-J.%26aulast%3DMa%26aufirst%3DW.-J.%26aulast%3DKim%26aufirst%3DU.-H.%26aulast%3DKim%26aufirst%3DS.-J.%26aulast%3DPark%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DKikuchi%26aufirst%3DM.%26aulast%3DOno%26aufirst%3DY.%26aulast%3DNakatani%26aufirst%3DH.%26aulast%3DSuda%26aufirst%3DS.%26aulast%3DMiyachi%26aufirst%3DT.%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DSalmina%26aufirst%3DA.%26aulast%3DPichugina%26aufirst%3DY.%2BA.%26aulast%3DSoumarokov%26aufirst%3DA.%2BA.%26aulast%3DTakei%26aufirst%3DN.%26aulast%3DMori%26aufirst%3DN.%26aulast%3DTsujii%26aufirst%3DM.%26aulast%3DSugiyama%26aufirst%3DT.%26aulast%3DYagi%26aufirst%3DK.%26aulast%3DYamagishi%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DYamasue%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DN.%26aulast%3DHashimoto%26aufirst%3DR.%26aulast%3DTaniike%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DHamada%26aufirst%3DJ.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DOoi%26aufirst%3DA.%26aulast%3DNoda%26aufirst%3DM.%26aulast%3DKamiyama%26aufirst%3DY.%26aulast%3DKido%26aufirst%3DM.%2BA.%26aulast%3DLopatina%26aufirst%3DO.%26aulast%3DHashii%26aufirst%3DM.%26aulast%3DAmina%26aufirst%3DS.%26aulast%3DMalavasi%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DE.%2BJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DShimizu%26aufirst%3DN.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DMatsushima%26aufirst%3DA.%26aulast%3DMinabe%26aufirst%3DY.%26aulast%3DHigashida%26aufirst%3DH.%26atitle%3DTwo%2520genetic%2520variants%2520of%2520CD38%2520in%2520subjects%2520with%2520autism%2520spectrum%2520disorder%2520and%2520controls%26jtitle%3DNeurosci.%2520Res.%26date%3D2010%26volume%3D67%26spage%3D181%26epage%3D191%26doi%3D10.1016%2Fj.neures.2010.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Mahmuda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munesue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamagishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span> <span> </span><span class="NLM_article-title">Association study between the CD157/BST1 gene and autism spectrum disorders in a Japanese population</span>. <i>Brain Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">188</span>– <span class="NLM_lpage">200</span>, <span class="refDoi"> DOI: 10.3390/brainsci5020188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.3390%2Fbrainsci5020188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=26010484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsVKis7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=188-200&author=S.+Yokoyamaauthor=N.+Al+Mahmudaauthor=T.+Munesueauthor=K.+Hayashiauthor=K.+Yagiauthor=M.+Yamagishiauthor=H.+Higashida&title=Association+study+between+the+CD157%2FBST1+gene+and+autism+spectrum+disorders+in+a+Japanese+population&doi=10.3390%2Fbrainsci5020188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Association study between the CD157/BST1 gene and Autism spectrum disorders in a Japanese population</span></div><div class="casAuthors">Yokoyama, Shigeru; Al Mahmuda, Naila; Munesue, Toshio; Hayashi, Kenshi; Yagi, Kunimasa; Yamagishi, Masakazu; Higashida, Haruhiro</div><div class="citationInfo"><span class="NLM_cas:title">Brain Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">188-200</span>CODEN:
                <span class="NLM_cas:coden">BSRCCS</span>;
        ISSN:<span class="NLM_cas:issn">2076-3425</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">CD157, also referred to as bone marrow stromal cell antigen-1 (BST-1), is a glycosylphosphatidylinositol-anchored mol. that promotes pre-B-cell growth.  Previous studies have reported assocns. between single-nucleotide polymorphisms (SNPs) of the CD157/BST1 gene with Parkinson's disease.  In an attempt to det. whether SNPs or haplotypes in the CD157/BST1 are assocd. with other brain disorders, we performed a case-control study including 147 autism spectrum disorder (ASD) patients at Kanazawa University Hospital in Japan and 150 unselected Japanese volunteers by the sequence-specific primer-polymerase chain reaction method combined with fluorescence correlation spectroscopy.  Of 93 SNPs examd., two SNPs showed significantly higher allele frequencies in cases with ASDs than in unaffected controls (rs4301112, OR = 6.4, 95% CI = 1.9 to 22, p = 0.0007; and rs28532698, OR = 6.2, 95% CI = 1.8 to 21, p = 0.0012; Fisher's exact test; p < 0.002 was considered significant after multiple testing correction).  In addn., CT genotype in rs10001565 was more frequently obsd. in the ASD group than in the control group (OR = 15, 95% CI = 2.0 to 117, p = 0.0007; Fisher's exact test).  The present data indicate that genetic variation of the CD157/BST1 gene might confer susceptibility to ASDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmxmi8Q-5gv7Vg90H21EOLACvtfcHk0ljpbqC55dpyRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsVKis7w%253D&md5=6243d9db1fb74b0e9c581bc84f982007</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.3390%2Fbrainsci5020188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbrainsci5020188%26sid%3Dliteratum%253Aachs%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DAl%2BMahmuda%26aufirst%3DN.%26aulast%3DMunesue%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DK.%26aulast%3DYagi%26aufirst%3DK.%26aulast%3DYamagishi%26aufirst%3DM.%26aulast%3DHigashida%26aufirst%3DH.%26atitle%3DAssociation%2520study%2520between%2520the%2520CD157%252FBST1%2520gene%2520and%2520autism%2520spectrum%2520disorders%2520in%2520a%2520Japanese%2520population%26jtitle%3DBrain%2520Sci.%26date%3D2015%26volume%3D5%26spage%3D188%26epage%3D200%26doi%3D10.3390%2Fbrainsci5020188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kato, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takasawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, H.</span></span> <span> </span><span class="NLM_article-title">CD38 Disruption Impairs Glucose-induced Increases in Cyclic ADP-ribose, [Ca2+]i, and Insulin Secretion</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">1869</span>– <span class="NLM_lpage">1872</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.4.1869</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1074%2Fjbc.274.4.1869" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=1869-1872&author=I.+Katoauthor=Y.+Yamamotoauthor=M.+Fujimuraauthor=N.+Noguchiauthor=S.+Takasawaauthor=H.+Okamoto&title=CD38+Disruption+Impairs+Glucose-induced+Increases+in+Cyclic+ADP-ribose%2C+%5BCa2%2B%5Di%2C+and+Insulin+Secretion&doi=10.1074%2Fjbc.274.4.1869"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.4.1869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.4.1869%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DI.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DFujimura%26aufirst%3DM.%26aulast%3DNoguchi%26aufirst%3DN.%26aulast%3DTakasawa%26aufirst%3DS.%26aulast%3DOkamoto%26aufirst%3DH.%26atitle%3DCD38%2520Disruption%2520Impairs%2520Glucose-induced%2520Increases%2520in%2520Cyclic%2520ADP-ribose%252C%2520%255BCa2%252B%255Di%252C%2520and%2520Insulin%2520Secretion%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D1869%26epage%3D1872%26doi%3D10.1074%2Fjbc.274.4.1869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munesue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopatina, O.</span></span> <span> </span><span class="NLM_article-title">CD38 gene knockout juvenile mice: a model of oxytocin signal defects in autism</span>. <i>Biol. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1369</span>– <span class="NLM_lpage">1372</span>, <span class="refDoi"> DOI: 10.1248/bpb.34.1369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1248%2Fbpb.34.1369" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=21881219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlGks7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2011&pages=1369-1372&author=H.+Higashidaauthor=S.+Yokoyamaauthor=T.+Munesueauthor=M.+Kikuchiauthor=Y.+Minabeauthor=O.+Lopatina&title=CD38+gene+knockout+juvenile+mice%3A+a+model+of+oxytocin+signal+defects+in+autism&doi=10.1248%2Fbpb.34.1369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Cd38 gene knockout juvenile mice: a model of oxytocin signal defects in autism</span></div><div class="casAuthors">Higashida, Haruhiro; Yokoyama, Shigeru; Munesue, Toshio; Kikuchi, Mitsuru; Minabe, Yoshio; Lopatina, Olga</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1369-1372</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A review.  Oxytocin (OXT) in the hypothalamus is the biol. basis of social recognition, trust, and bonding.  We showed that CD38, a leukemia cell marker, plays an important role in the hypothalamus in the process of OXT release in adult mice.  Disruption of Cd38 (Cd38-/-) produced impairment of maternal behavior and male social recognition in mice, similar to the behavior obsd. in Oxt and OXT receptor (Oxtr) gene knockout (Oxt-/- and Oxtr-/-, resp.) mice.  Locomotor activity induced by sepn. from the dam was higher and the no. of ultrasonic vocalization (USV) calls was lower in Cd38-/- than Cd38+/+ pups.  These phenotypes seemed to be caused by the high plasma OXT levels during development from neonates to 3-wk-old juvenile mice.  ADP-ribosyl cyclase activity was markedly lower in the knockout mice from birth, suggesting that weaning for mice is a crit. time window of differentiating plasma OXT.  Contribution by breastfeeding was an important exogenous source for regulating plasma OXT before weaning by the presence of OXT in milk and the dam's mammary glands.  The dissimilarity of Cd38-/- infant behavior to Oxt-/- or Oxtr-/- mice can be explained partly by this exogenous source of OXT.  These results suggest that secretion of OXT into the brain in a CD38-dependent manner may play an important role in the development of social behavior, and mice with OXT signaling deficiency, including Cd38-/-, Oxt-/- and Oxtr-/- mice are good animal models for developmental disorders, such as autism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD672oxj06vbVg90H21EOLACvtfcHk0ljpbqC55dpyRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlGks7%252FN&md5=9a4f91334b50b1eeeb9fdf27860b5c93</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1248%2Fbpb.34.1369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.34.1369%26sid%3Dliteratum%253Aachs%26aulast%3DHigashida%26aufirst%3DH.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DMunesue%26aufirst%3DT.%26aulast%3DKikuchi%26aufirst%3DM.%26aulast%3DMinabe%26aufirst%3DY.%26aulast%3DLopatina%26aufirst%3DO.%26atitle%3DCD38%2520gene%2520knockout%2520juvenile%2520mice%253A%2520a%2520model%2520of%2520oxytocin%2520signal%2520defects%2520in%2520autism%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2011%26volume%3D34%26spage%3D1369%26epage%3D1372%26doi%3D10.1248%2Fbpb.34.1369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korshnova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherepanov, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopatina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komleva, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmina, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fakhrul, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takasawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span> <span> </span><span class="NLM_article-title">CD38 in the nucleus accumbens and oxytocin are related to paternal behavior in mice</span>. <i>Mol. Brain</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">41</span>, <span class="refDoi"> DOI: 10.1186/1756-6606-6-41</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1186%2F1756-6606-6-41" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=24059452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntVKitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=41&author=S.+Aktherauthor=N.+Korshnovaauthor=J.+Zhongauthor=M.+Liangauthor=S.+M.+Cherepanovauthor=O.+Lopatinaauthor=Y.+K.+Komlevaauthor=A.+B.+Salminaauthor=T.+Nishimuraauthor=A.+A.+Fakhrulauthor=H.+Hiraiauthor=I.+Katoauthor=Y.+Yamamotoauthor=S.+Takasawaauthor=H.+Okamotoauthor=H.+Higashida&title=CD38+in+the+nucleus+accumbens+and+oxytocin+are+related+to+paternal+behavior+in+mice&doi=10.1186%2F1756-6606-6-41"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">CD38 in the nucleus accumbens and oxytocin are related to paternal behavior in mice</span></div><div class="casAuthors">Akther, Shirin; Korshnova, Natalia; Zhong, Jing; Liang, Mingkun; Cherepanov, Stanislav M.; Lopatina, Olga; Komleva, Yulia K.; Salmina, Alla B.; Nishimura, Tomoko; Fakhrul, Azam A. K. M.; Hirai, Hirokazu; Kato, Ichiro; Yamamoto, Yasuhiko; Takasawa, Shin; Okamoto, Hiroshi; Higashida, Haruhiro</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">41/1-41/10</span>CODEN:
                <span class="NLM_cas:coden">MBORAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-6606</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Mammalian sires participate in infant care.  We previously demonstrated that sires of a strain of nonmonogamous lab. mice initiate parental retrieval behavior in response to olfactory and auditory signals from the dam during isolation in a new environment.  This behavior is rapidly lost in the absence of such signals when the sires are caged alone.  The neural circuitry and hormones that control paternal behavior are not well understood.  CD38, a membrane glycoprotein, catalyzes synthesis of cyclic ADP-ribose and facilitates oxytocin (OT) secretion due to cyclic ADP-ribose-dependent increases in cytosolic free calcium concns. in oxytocinergic neurons in the hypothalamus.  In this paper, we studied CD38 in the nucleus accumbens (NAcc) and the role of OT on paternal pup retrieval behavior using CD38 knockout (CD38-/-) mice of the ICR strain.  Results: CD38-/- sires failed to retrieve when they were reunited with their pups after isolation together with the mate dams, but not with pup, in a novel cage for 10 min.  CD38-/- sires treated with a single s.c. injection of OT exhibited recovery in the retrieval events when caged with CD38-/- dams treated with OT.  We introduced human CD38 in the NAcc of CD38-/- sires using a lentiviral infection technique and examd. the effects of local expression of CD38.  Pairs of knockout dams treated with OT and sires expressing CD38 in the NAcc showed more retrieval (83% of wild-type sire levels).  Complete recovery of retrieval was obtained in sires with the expression of CD38 in the NAcc in combination with OT administration.  Other paternal behaviors, including pup grooming, crouching and huddling, were also more common in CD38-/- sires with CD38 expression in the NAcc compared with those in CD38-/- sires without CD38 expression in the NAcc.  Conclusions: CD38 in the NAcc and OT are crit. in paternal behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf8ou2Wt3BmLVg90H21EOLACvtfcHk0ljpbqC55dpyRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntVKitb8%253D&md5=456d349e437d62b905debd4729d100da</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1186%2F1756-6606-6-41&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-6606-6-41%26sid%3Dliteratum%253Aachs%26aulast%3DAkther%26aufirst%3DS.%26aulast%3DKorshnova%26aufirst%3DN.%26aulast%3DZhong%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DM.%26aulast%3DCherepanov%26aufirst%3DS.%2BM.%26aulast%3DLopatina%26aufirst%3DO.%26aulast%3DKomleva%26aufirst%3DY.%2BK.%26aulast%3DSalmina%26aufirst%3DA.%2BB.%26aulast%3DNishimura%26aufirst%3DT.%26aulast%3DFakhrul%26aufirst%3DA.%2BA.%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DI.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DTakasawa%26aufirst%3DS.%26aulast%3DOkamoto%26aufirst%3DH.%26aulast%3DHigashida%26aufirst%3DH.%26atitle%3DCD38%2520in%2520the%2520nucleus%2520accumbens%2520and%2520oxytocin%2520are%2520related%2520to%2520paternal%2520behavior%2520in%2520mice%26jtitle%3DMol.%2520Brain%26date%3D2013%26volume%3D6%26spage%3D41%26doi%3D10.1186%2F1756-6606-6-41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cherepanov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shabalova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichinose, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span> <span> </span><span class="NLM_article-title">Effects of three lipidated oxytocin analogs on behavioral deficits in CD38 knockout mice</span>. <i>Brain Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">132</span>, <span class="refDoi"> DOI: 10.3390/brainsci7100132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.3390%2Fbrainsci7100132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvVKlt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=132&author=S.+Cherepanovauthor=S.+Aktherauthor=T.+Nishimuraauthor=A.+Shabalovaauthor=A.+Mizunoauthor=W.+Ichinoseauthor=S.+Shutoauthor=Y.+Yamamotoauthor=S.+Yokoyamaauthor=H.+Higashida&title=Effects+of+three+lipidated+oxytocin+analogs+on+behavioral+deficits+in+CD38+knockout+mice&doi=10.3390%2Fbrainsci7100132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of three lipidated oxytocin analogs on behavioral deficits in CD38 knockout mice</span></div><div class="casAuthors">Cherepanov, Stanislav M.; Akther, Shirin; Nishimura, Tomoko; Shabalova, Anna A.; Mizuno, Akira; Ichinose, Wataru; Shuto, Satoshi; Yamamoto, Yasuhiko; Yokoyama, Shigeru; Higashida, Haruhiro</div><div class="citationInfo"><span class="NLM_cas:title">Brain Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">132/1-132/15</span>CODEN:
                <span class="NLM_cas:coden">BSRCCS</span>;
        ISSN:<span class="NLM_cas:issn">2076-3425</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Oxytocin (OT) is a nonapeptide that plays an important role in social behavior.  Nasal administration of OT has been shown to improve trust in healthy humans and social interaction in autistic subjects.  As is consistent with the nature of a peptide, OT has some unfavorable characteristics: it has a short half-life in plasma and shows poor permeability across the blood-brain barrier.  Analogs with long-lasting effects may overcome these drawbacks.  To this end, we have synthesized three analogs: lipo-oxytocin-1 (LOT-1), in which two palmitoyl groups are conjugated to the cysteine and tyrosine residues, lipo-oxytocin-2 (LOT-2) and lipo-oxytocin-3 (LOT-3), which include one palmitoyl group conjugated at the cysteine or tyrosine residue, resp.  The following behavioral deficits were obsd. in CD38 knockout (CD38-/-) mice: a lack of paternal nurturing in CD38-/- sires, decreased ability for social recognition, and decreased sucrose consumption.  OT demonstrated the ability to recover these disturbances to the level of wild-type mice for 30 min after injection.  LOT-2 and LOT-3 partially recovered the behaviors for a short period.  Conversely, LOT-1 restored the behavioral parameters, not for 30 min, but for 24 h.  These data suggest that the lipidation of OT has some therapeutic benefits, and LOT-1 would be most useful because of its long-last activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrinQahzSd3g7Vg90H21EOLACvtfcHk0lhDNfPgYiINmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvVKlt7Y%253D&md5=531162bc51ca6aa31131d548c302db4d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.3390%2Fbrainsci7100132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbrainsci7100132%26sid%3Dliteratum%253Aachs%26aulast%3DCherepanov%26aufirst%3DS.%26aulast%3DAkther%26aufirst%3DS.%26aulast%3DNishimura%26aufirst%3DT.%26aulast%3DShabalova%26aufirst%3DA.%26aulast%3DMizuno%26aufirst%3DA.%26aulast%3DIchinose%26aufirst%3DW.%26aulast%3DShuto%26aufirst%3DS.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DHigashida%26aufirst%3DH.%26atitle%3DEffects%2520of%2520three%2520lipidated%2520oxytocin%2520analogs%2520on%2520behavioral%2520deficits%2520in%2520CD38%2520knockout%2520mice%26jtitle%3DBrain%2520Sci.%26date%3D2017%26volume%3D7%26spage%3D132%26doi%3D10.3390%2Fbrainsci7100132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Domes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrichs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumbier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauenstein, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herpertz, S. C.</span></span> <span> </span><span class="NLM_article-title">Effects of intranasal oxytocin on the neural basis of face processing in autism spectrum disorder</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">164</span>– <span class="NLM_lpage">171</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2013.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.biopsych.2013.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=23510581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksV2jtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2013&pages=164-171&author=G.+Domesauthor=M.+Heinrichsauthor=E.+Kumbierauthor=A.+Grossmannauthor=K.+Hauensteinauthor=S.+C.+Herpertz&title=Effects+of+intranasal+oxytocin+on+the+neural+basis+of+face+processing+in+autism+spectrum+disorder&doi=10.1016%2Fj.biopsych.2013.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Intranasal Oxytocin on the Neural Basis of Face Processing in Autism Spectrum Disorder</span></div><div class="casAuthors">Domes, Gregor; Heinrichs, Markus; Kumbier, Ekkehardt; Grossmann, Annette; Hauenstein, Karlheinz; Herpertz, Sabine C.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">164-171</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Background: Autism spectrum disorder (ASD) is assocd. with altered face processing and decreased activity in brain regions involved in face processing.  The neuropeptide oxytocin has been shown to promote face processing and modulate brain activity in healthy adults.  The present study examd. the effects of oxytocin on the neural basis of face processing in adults with Asperger syndrome (AS).  Methods: A group of 14 individuals with AS and a group of 14 neurotypical control participants performed a face-matching and a house-matching task during functional magnetic resonance imaging.  The effects of a single dose of 24 IU intranasally administered oxytocin were tested in a randomized, placebo-controlled, within-subject, cross-over design.  Results: Under placebo, the AS group showed decreased activity in the right amygdala, fusiform gyrus, and inferior occipital gyrus compared with the control group during face processing.  After oxytocin treatment, right amygdala activity to facial stimuli increased in the AS group.  Conclusions: These findings indicate that oxytocin increases the saliency of social stimuli and in ASD and suggest that oxytocin might promote face processing and eye contact in individuals with ASD as prerequisites for neurotypical social interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrThR5xUWpbIrVg90H21EOLACvtfcHk0lhDNfPgYiINmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksV2jtbk%253D&md5=cd0d31448b6374b0f42d208bea69749e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2013.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2013.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DDomes%26aufirst%3DG.%26aulast%3DHeinrichs%26aufirst%3DM.%26aulast%3DKumbier%26aufirst%3DE.%26aulast%3DGrossmann%26aufirst%3DA.%26aulast%3DHauenstein%26aufirst%3DK.%26aulast%3DHerpertz%26aufirst%3DS.%2BC.%26atitle%3DEffects%2520of%2520intranasal%2520oxytocin%2520on%2520the%2520neural%2520basis%2520of%2520face%2520processing%2520in%2520autism%2520spectrum%2520disorder%26jtitle%3DBiol.%2520Psychiatry%26date%3D2013%26volume%3D74%26spage%3D164%26epage%3D171%26doi%3D10.1016%2Fj.biopsych.2013.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Auyeung, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrichs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakrabarti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sule, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deakin, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bethlehem, R. A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickens, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mooney, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sipple, J. A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiemann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baron-Cohen, S.</span></span> <span> </span><span class="NLM_article-title">Oxytocin increases eye contact during a real-time, naturalistic social interaction in males with and without autism</span>. <i>Transl. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e507</span> <span class="refDoi"> DOI: 10.1038/tp.2014.146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1038%2Ftp.2014.146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=25668435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFCgt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&author=B.+Auyeungauthor=M.+V.+Lombardoauthor=M.+Heinrichsauthor=B.+Chakrabartiauthor=A.+Suleauthor=J.+B.+Deakinauthor=R.+A.+I.+Bethlehemauthor=L.+Dickensauthor=N.+Mooneyauthor=J.+A.+N.+Sippleauthor=P.+Thiemannauthor=S.+Baron-Cohen&title=Oxytocin+increases+eye+contact+during+a+real-time%2C+naturalistic+social+interaction+in+males+with+and+without+autism&doi=10.1038%2Ftp.2014.146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin increases eye contact during a real-time, naturalistic social interaction in males with and without autism</span></div><div class="casAuthors">Auyeung, B.; Lombardo, M. V.; Heinrichs, M.; Chakrabarti, B.; Sule, A.; Deakin, J. B.; Bethlehem, R. A. I.; Dickens, L.; Mooney, N.; Sipple, J. A. N.; Thiemann, P.; Baron-Cohen, S.</div><div class="citationInfo"><span class="NLM_cas:title">Translational Psychiatry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e507</span>CODEN:
                <span class="NLM_cas:coden">TPRSCF</span>;
        ISSN:<span class="NLM_cas:issn">2158-3188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autism spectrum conditions (autism) affect ∼1% of the population and are characterized by deficits in social communication.  Oxytocin has been widely reported to affect social-communicative function and its neural underpinnings.  Here we report the first evidence that intranasal oxytocin administration improves a core problem that individuals with autism have in using eye contact appropriately in real-world social settings.  A randomized double-blind, placebo-controlled, within-subjects design is used to examine how intranasal administration of 24 IU of oxytocin affects gaze behavior for 32 adult males with autism and 34 controls in a real-time interaction with a researcher.  This interactive paradigm bypasses many of the limitations encountered with conventional static or computer-based stimuli.  Eye movements are recorded using eye tracking, providing an objective measurement of looking patterns.  The measure is shown to be sensitive to the reduced eye contact commonly reported in autism, with the autism group spending less time looking to the eye region of the face than controls.  Oxytocin administration selectively enhanced gaze to the eyes in both the autism and control groups (transformed mean eye-fixation difference per s=0.082; 95% CI:0.025-0.14, P=0.006).  Within the autism group, oxytocin has the most effect on fixation duration in individuals with impaired levels of eye contact at baseline (Cohen's d=0.86).  These findings demonstrate that the potential benefits of oxytocin in autism extend to a real-time interaction, providing evidence of a therapeutic effect in a key aspect of social communication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplKgtAe3rzhbVg90H21EOLACvtfcHk0lj-3Jkoi3k6Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFCgt7c%253D&md5=6bd13bfd402ab6df8b4ee8682cced347</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Ftp.2014.146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Ftp.2014.146%26sid%3Dliteratum%253Aachs%26aulast%3DAuyeung%26aufirst%3DB.%26aulast%3DLombardo%26aufirst%3DM.%2BV.%26aulast%3DHeinrichs%26aufirst%3DM.%26aulast%3DChakrabarti%26aufirst%3DB.%26aulast%3DSule%26aufirst%3DA.%26aulast%3DDeakin%26aufirst%3DJ.%2BB.%26aulast%3DBethlehem%26aufirst%3DR.%2BA.%2BI.%26aulast%3DDickens%26aufirst%3DL.%26aulast%3DMooney%26aufirst%3DN.%26aulast%3DSipple%26aufirst%3DJ.%2BA.%2BN.%26aulast%3DThiemann%26aufirst%3DP.%26aulast%3DBaron-Cohen%26aufirst%3DS.%26atitle%3DOxytocin%2520increases%2520eye%2520contact%2520during%2520a%2520real-time%252C%2520naturalistic%2520social%2520interaction%2520in%2520males%2520with%2520and%2520without%2520autism%26jtitle%3DTransl.%2520Psychiatry%26date%3D2015%26volume%3D5%26doi%3D10.1038%2Ftp.2014.146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dadds, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cauchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, J.</span></span> <span> </span><span class="NLM_article-title">Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial</span>. <i>J. Autism Dev. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">521</span>– <span class="NLM_lpage">531</span>, <span class="refDoi"> DOI: 10.1007/s10803-013-1899-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1007%2Fs10803-013-1899-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=23888359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BC3sfktFyntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2014&pages=521-531&author=M.+R.+Daddsauthor=E.+MacDonaldauthor=A.+Cauchiauthor=K.+Williamsauthor=F.+Levyauthor=J.+Brennan&title=Nasal+oxytocin+for+social+deficits+in+childhood+autism%3A+a+randomized+controlled+trial&doi=10.1007%2Fs10803-013-1899-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial</span></div><div class="casAuthors">Dadds Mark R; MacDonald Elayne; Cauchi Avril; Williams Katrina; Levy Florence; Brennan John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of autism and developmental disorders</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">521-31</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The last two decades have witnessed a surge in research investigating the application of oxytocin as a method of enhancing social behaviour in humans.  Preliminary evidence suggests oxytocin may have potential as an intervention for autism.  We evaluated a 5-day 'live-in' intervention using a double-blind randomized control trial. 38 male youths (7-16 years old) with autism spectrum disorders were administered 24 or 12 international units (depending on weight) intranasal placebo or oxytocin once daily over four consecutive days.  The oxytocin or placebo was administered during parent-child interaction training sessions.  Parent and child behaviours were assessed using parent reports, clinician ratings, and independent observations, at multiple time points to measure side-effects; social interaction skills; repetitive behaviours; emotion recognition and diagnostic status.  Compared to placebo, intranasal oxytocin did not significantly improve emotion recognition, social interaction skills, or general behavioral adjustment in male youths with autism spectrum disorders.  The results show that the benefits of nasal oxytocin for young individuals with autism spectrum disorders may be more circumscribed than suggested by previous studies, and suggest caution in recommending it as an intervention that is broadly effective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCr6Wb1tqsnNy3lHz94U-GfW6udTcc2eYxTe_Gl5FcUrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfktFyntQ%253D%253D&md5=dd8a1a7c59e80f2dd8d04f52e522d6ab</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs10803-013-1899-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10803-013-1899-3%26sid%3Dliteratum%253Aachs%26aulast%3DDadds%26aufirst%3DM.%2BR.%26aulast%3DMacDonald%26aufirst%3DE.%26aulast%3DCauchi%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DLevy%26aufirst%3DF.%26aulast%3DBrennan%26aufirst%3DJ.%26atitle%3DNasal%2520oxytocin%2520for%2520social%2520deficits%2520in%2520childhood%2520autism%253A%2520a%2520randomized%2520controlled%2520trial%26jtitle%3DJ.%2520Autism%2520Dev.%2520Disord.%26date%3D2014%26volume%3D44%26spage%3D521%26epage%3D531%26doi%3D10.1007%2Fs10803-013-1899-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guastella, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rinehart, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvares, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonge, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickie, I. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keating, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacciotti-Saija, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Einfeld, S. L.</span></span> <span> </span><span class="NLM_article-title">The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial</span>. <i>J. Child Psychol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">444</span>– <span class="NLM_lpage">452</span>, <span class="refDoi"> DOI: 10.1111/jcpp.12305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1111%2Fjcpp.12305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=25087908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BC2cbotlKrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=444-452&author=A.+J.+Guastellaauthor=K.+M.+Grayauthor=N.+J.+Rinehartauthor=G.+A.+Alvaresauthor=B.+J.+Tongeauthor=I.+B.+Hickieauthor=C.+M.+Keatingauthor=C.+Cacciotti-Saijaauthor=S.+L.+Einfeld&title=The+effects+of+a+course+of+intranasal+oxytocin+on+social+behaviors+in+youth+diagnosed+with+autism+spectrum+disorders%3A+a+randomized+controlled+trial&doi=10.1111%2Fjcpp.12305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial</span></div><div class="casAuthors">Guastella Adam J; Gray Kylie M; Rinehart Nicole J; Alvares Gail A; Tonge Bruce J; Hickie Ian B; Keating Caroline M; Cacciotti-Saija Cristina; Einfeld Stewart L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of child psychology and psychiatry, and allied disciplines</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">444-52</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  There is increasing interest in oxytocin as a therapeutic to treat social deficits in autism spectrum disorders (ASD).  The aim of this study was to investigate the efficacy of a course of oxytocin nasal spray to improve social behavior in youth with ASD.  METHODS:  In a double-blind, placebo-controlled trial across two Australian university sites between February 2009 and January 2012, 50 male participants aged between 12 and 18 years, with Autistic or Asperger's Disorder, were randomized to receive either oxytocin (n = 26) or placebo (n = 24) nasal sprays (either 18 or 24 International Units), administered twice-daily for 8 weeks.  Participants were assessed at baseline, after 4- and 8-weeks of treatment, and at 3-month follow-up.  Primary outcomes were change in total scores on the caregiver-completed Social Responsiveness Scale and clinician-ratings on the Clinical Global Impressions-Improvement scale.  Secondary assessments included caregiver reports of repetitive and other developmental behaviors and social cognition.  CLINICAL TRIAL REGISTRATION:  Australian New Zealand Clinical Trials Registry www.anzctr.org.au ACTRN12609000513213.  RESULTS:  Participants who received oxytocin showed no benefit following treatment on primary or secondary outcomes.  However, caregivers who believed their children received oxytocin reported greater improvements compared to caregivers who believed their child received placebo.  Nasal sprays were well tolerated and there was no evidence of increased side effects resulting from oxytocin administration.  CONCLUSIONS:  This is the first evaluation of the efficacy for a course of oxytocin treatment for youth with ASD.  Although results did not suggest clinical efficacy, further research is needed to explore alternative delivery methods, earlier age of intervention, and the influence of caregiver expectation on treatment response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKShCj3lOaLPIW7hznt0zpfW6udTcc2eYxTe_Gl5FcUrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbotlKrtQ%253D%253D&md5=2c2dd0ea7341ef28cfbd32de2da7c83a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1111%2Fjcpp.12305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjcpp.12305%26sid%3Dliteratum%253Aachs%26aulast%3DGuastella%26aufirst%3DA.%2BJ.%26aulast%3DGray%26aufirst%3DK.%2BM.%26aulast%3DRinehart%26aufirst%3DN.%2BJ.%26aulast%3DAlvares%26aufirst%3DG.%2BA.%26aulast%3DTonge%26aufirst%3DB.%2BJ.%26aulast%3DHickie%26aufirst%3DI.%2BB.%26aulast%3DKeating%26aufirst%3DC.%2BM.%26aulast%3DCacciotti-Saija%26aufirst%3DC.%26aulast%3DEinfeld%26aufirst%3DS.%2BL.%26atitle%3DThe%2520effects%2520of%2520a%2520course%2520of%2520intranasal%2520oxytocin%2520on%2520social%2520behaviors%2520in%2520youth%2520diagnosed%2520with%2520autism%2520spectrum%2520disorders%253A%2520a%2520randomized%2520controlled%2520trial%26jtitle%3DJ.%2520Child%2520Psychol.%2520Psychiatry%26date%3D2015%26volume%3D56%26spage%3D444%26epage%3D452%26doi%3D10.1111%2Fjcpp.12305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munesue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anme, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanba, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsubouchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horike, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakatani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span> <span> </span><span class="NLM_article-title">Oxytocin for male subjects with autism spectrum disorder and comorbid intellectual disabilities: a randomized pilot study</span>. <i>Front. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2</span>, <span class="refDoi"> DOI: 10.3389/fpsyt.2016.00002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.3389%2Ffpsyt.2016.00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=26834651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BC28nmslOmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=2&author=T.+Munesueauthor=H.+Nakamuraauthor=M.+Kikuchiauthor=Y.+Miuraauthor=N.+Takeuchiauthor=T.+Anmeauthor=E.+Nanbaauthor=K.+Adachiauthor=K.+Tsubouchiauthor=Y.+Saiauthor=K.+Miyamotoauthor=S.+Horikeauthor=S.+Yokoyamaauthor=H.+Nakataniauthor=Y.+Niidaauthor=H.+Kosakaauthor=Y.+Minabeauthor=H.+Higashida&title=Oxytocin+for+male+subjects+with+autism+spectrum+disorder+and+comorbid+intellectual+disabilities%3A+a+randomized+pilot+study&doi=10.3389%2Ffpsyt.2016.00002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin for Male Subjects with Autism Spectrum Disorder and Comorbid Intellectual Disabilities: A Randomized Pilot Study</span></div><div class="casAuthors">Munesue Toshio; Kikuchi Mitsuru; Miura Yui; Takeuchi Noriyuki; Yokoyama Shigeru; Higashida Haruhiro; Nakamura Hiroyuki; Anme Tokie; Nanba Eiji; Adachi Kaori; Tsubouchi Kiyotaka; Sai Yoshimichi; Miyamoto Ken-Ichi; Horike Shin-Ichi; Nakatani Hideo; Minabe Yoshio; Niida Yo; Kosaka Hirotaka</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2</span>
        ISSN:<span class="NLM_cas:issn">1664-0640</span>.
    </div><div class="casAbstract">UNLABELLED:  Approximately half of autism spectrum disorder (ASD) individuals suffer from comorbid intellectual disabilities (IDs).  Oxytocin (OXT) receptors are highly expressed in temporal lobe structures and are likely to play a modulatory role in excitatory/inhibitory balance, at least based on animal model findings.  Thus, it is feasible that in the highly representative group of Kanner-type ASD subjects, OXT could have a beneficial effect on social communication and social interaction.  The aim of this pilot study is to investigate the feasibility and adverse events, such as epilepsy, of the long-term administration of intranasal OXT for adolescent and adult ASD subjects with ID because such patients frequently have seizures.  We also addressed the question on how to scale the OXT effects to the core symptoms of social deficits because of the relative difficulty in obtaining objective measurements.  Twenty-nine males (aged 15-40 years old) participated in a randomized, double-blind, and placebo-controlled crossover study (each for 8 weeks) with OXT (16 IU/day).  Except for seizures experienced by one participant, other serious adverse events did not occur.  The primary and secondary outcomes measured using the Childhood Autism Rating Scale and several standard scales, respectively, revealed no difference between the OXT and placebo groups.  Instead, in an exploratory analysis, the social interactions observed in the play sessions or in daily life were significantly more frequent in the initial half period in the OXT-first arm of the crossover trial.  There were also significant correlations between the plasma OXT concentration and subscale scores for irritability on the Aberrant Behavior Checklist.  In conclusion, this pilot study demonstrates that long-term administration of intranasal OXT is tolerable in a representative cohort of ASD individuals with ID and suggests that future multicenter trials of OXT are warranted and should include measurements of reciprocal social interactions based on daily life under closer surveillance for epilepsy.  TRIAL REGISTRATION:  UMIN000007250.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQGkT-vVqjel4qdXsLcGTEUfW6udTcc2ebny3DGT_LiuLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28nmslOmug%253D%253D&md5=e322f9798adde3575b34cf0e83bbf0d5</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.3389%2Ffpsyt.2016.00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffpsyt.2016.00002%26sid%3Dliteratum%253Aachs%26aulast%3DMunesue%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DKikuchi%26aufirst%3DM.%26aulast%3DMiura%26aufirst%3DY.%26aulast%3DTakeuchi%26aufirst%3DN.%26aulast%3DAnme%26aufirst%3DT.%26aulast%3DNanba%26aufirst%3DE.%26aulast%3DAdachi%26aufirst%3DK.%26aulast%3DTsubouchi%26aufirst%3DK.%26aulast%3DSai%26aufirst%3DY.%26aulast%3DMiyamoto%26aufirst%3DK.%26aulast%3DHorike%26aufirst%3DS.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DNakatani%26aufirst%3DH.%26aulast%3DNiida%26aufirst%3DY.%26aulast%3DKosaka%26aufirst%3DH.%26aulast%3DMinabe%26aufirst%3DY.%26aulast%3DHigashida%26aufirst%3DH.%26atitle%3DOxytocin%2520for%2520male%2520subjects%2520with%2520autism%2520spectrum%2520disorder%2520and%2520comorbid%2520intellectual%2520disabilities%253A%2520a%2520randomized%2520pilot%2520study%26jtitle%3DFront.%2520Psychiatry%26date%3D2016%26volume%3D7%26spage%3D2%26doi%3D10.3389%2Ffpsyt.2016.00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parker, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oztan, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libove, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumiyoshi, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karhson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summers, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinman, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motonaga, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garner, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardan, A. Y.</span></span> <span> </span><span class="NLM_article-title">Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">8119</span>– <span class="NLM_lpage">8124</span>, <span class="refDoi"> DOI: 10.1073/pnas.1705521114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1073%2Fpnas.1705521114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=8119-8124&author=K.+J.+Parkerauthor=O.+Oztanauthor=R.+A.+Liboveauthor=R.+D.+Sumiyoshiauthor=L.+P.+Jacksonauthor=D.+S.+Karhsonauthor=J.+E.+Summersauthor=K.+E.+Hinmanauthor=K.+S.+Motonagaauthor=J.+M.+Phillipsauthor=D.+S.+Carsonauthor=J.+P.+Garnerauthor=A.+Y.+Hardan&title=Intranasal+oxytocin+treatment+for+social+deficits+and+biomarkers+of+response+in+children+with+autism&doi=10.1073%2Fpnas.1705521114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1705521114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1705521114%26sid%3Dliteratum%253Aachs%26aulast%3DParker%26aufirst%3DK.%2BJ.%26aulast%3DOztan%26aufirst%3DO.%26aulast%3DLibove%26aufirst%3DR.%2BA.%26aulast%3DSumiyoshi%26aufirst%3DR.%2BD.%26aulast%3DJackson%26aufirst%3DL.%2BP.%26aulast%3DKarhson%26aufirst%3DD.%2BS.%26aulast%3DSummers%26aufirst%3DJ.%2BE.%26aulast%3DHinman%26aufirst%3DK.%2BE.%26aulast%3DMotonaga%26aufirst%3DK.%2BS.%26aulast%3DPhillips%26aufirst%3DJ.%2BM.%26aulast%3DCarson%26aufirst%3DD.%2BS.%26aulast%3DGarner%26aufirst%3DJ.%2BP.%26aulast%3DHardan%26aufirst%3DA.%2BY.%26atitle%3DIntranasal%2520oxytocin%2520treatment%2520for%2520social%2520deficits%2520and%2520biomarkers%2520of%2520response%2520in%2520children%2520with%2520autism%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2017%26volume%3D114%26spage%3D8119%26epage%3D8124%26doi%3D10.1073%2Fpnas.1705521114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yatawara, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Einfeld, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickie, I. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davenport, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guastella, A. J.</span></span> <span> </span><span class="NLM_article-title">The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial</span>. <i>Mol. Psychiatr.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1225</span>– <span class="NLM_lpage">1231</span>, <span class="refDoi"> DOI: 10.1038/mp.2015.162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1038%2Fmp.2015.162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=26503762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsleks7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=1225-1231&author=C.+J.+Yatawaraauthor=S.+L.+Einfeldauthor=I.+B.+Hickieauthor=T.+A.+Davenportauthor=A.+J.+Guastella&title=The+effect+of+oxytocin+nasal+spray+on+social+interaction+deficits+observed+in+young+children+with+autism%3A+a+randomized+clinical+crossover+trial&doi=10.1038%2Fmp.2015.162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial</span></div><div class="casAuthors">Yatawara, C. J.; Einfeld, S. L.; Hickie, I. B.; Davenport, T. A.; Guastella, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1225-1231</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Interventions for autism are limited.  The synthetic hormone oxytocin may provide a potential treatment to improve core social and behavioral difficulties in autism, but its efficacy has yet to be evaluated in young children who potentially may benefit to a greater extent.  We investigated the efficacy, tolerability and safety of oxytocin treatment in young children with autism using a double-blind, randomized, placebo-controlled, crossover, clin. trial.  Thirty-one children with autism received 12 IU (IU) of oxytocin and placebo nasal spray morning and night (24 IU per day) for 5 wk, with a 4-wk washout period between each treatment.  Compared with placebo, oxytocin led to significant improvements on the primary outcome of caregiver-rated social responsiveness.  Overall, nasal spray was well tolerated, and the most common reported adverse events were thirst, urination and constipation.  This study is the first clin. trial to support the potential of oxytocin as an early intervention for young children with autism to help improve social interaction deficits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYvRBN9eJKqLVg90H21EOLACvtfcHk0liR0_zBd9Tm9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsleks7zI&md5=37397699a7098e3572851c47c2ff2948</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fmp.2015.162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmp.2015.162%26sid%3Dliteratum%253Aachs%26aulast%3DYatawara%26aufirst%3DC.%2BJ.%26aulast%3DEinfeld%26aufirst%3DS.%2BL.%26aulast%3DHickie%26aufirst%3DI.%2BB.%26aulast%3DDavenport%26aufirst%3DT.%2BA.%26aulast%3DGuastella%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520effect%2520of%2520oxytocin%2520nasal%2520spray%2520on%2520social%2520interaction%2520deficits%2520observed%2520in%2520young%2520children%2520with%2520autism%253A%2520a%2520randomized%2520clinical%2520crossover%2520trial%26jtitle%3DMol.%2520Psychiatr.%26date%3D2016%26volume%3D21%26spage%3D1225%26epage%3D1231%26doi%3D10.1038%2Fmp.2015.162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mizuno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherepanov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fakhrul, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshihara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span> <span> </span><span class="NLM_article-title">Lipo-oxytocin-1, a novel oxytocin Analog conjugated with two palmitoyl groups, has long-lasting effects on anxiety-related behavior and social avoidance in <i>CD157</i> knockout mice</span>. <i>Brain Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.3390/brainsci5010003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.3390%2Fbrainsci5010003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=25612002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsVKjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=3-13&author=A.+Mizunoauthor=S.+Cherepanovauthor=Y.+Kikuchiauthor=A.+Fakhrulauthor=S.+Aktherauthor=K.+Deguchiauthor=T.+Yoshiharaauthor=K.+Ishiharaauthor=S.+Shutoauthor=H.+Higashida&title=Lipo-oxytocin-1%2C+a+novel+oxytocin+Analog+conjugated+with+two+palmitoyl+groups%2C+has+long-lasting+effects+on+anxiety-related+behavior+and+social+avoidance+in+CD157+knockout+mice&doi=10.3390%2Fbrainsci5010003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Lipo-oxytocin-1, a novel oxytocin analog conjugated with two palmitoyl groups, has long-lasting effects on anxiety-related behavior and social avoidance in CD157 knockout mice</span></div><div class="casAuthors">Mizuno, Akira; Cherepanov, Stanislav M.; Kikuchi, Yusuke; Fakhrul, Azam A. K. M.; Akther, Shirin; Deguchi, Kisaburo; Yoshihara, Toru; Ishihara, Katsuhiko; Shuto, Satoshi; Higashida, Haruhiro</div><div class="citationInfo"><span class="NLM_cas:title">Brain Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-13</span>CODEN:
                <span class="NLM_cas:coden">BSRCCS</span>;
        ISSN:<span class="NLM_cas:issn">2076-3425</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Oxytocin (OT) is a nonapeptide hormone that is secreted into the brain and blood circulation.  OT has not only classical neurohormonal roles in uterine contraction and milk ejection during the reproductive phase in females, but has also been shown to have new pivotal neuromodulatory roles in social recognition and interaction in both genders.  A single administration of OT through nasal spray increases mutual recognition and trust in healthy subjects and psychiatric patients, suggesting that OT is a potential therapeutic drug for autism spectrum disorders, schizophrenia, and some other psychiatric disorders.  Although the mechanism is not well understood, it is likely that OT can be transported into the brain where it activates OT receptors to exert its function in the brain.  However, the amt. transported into the brain may be low.  To ensure equiv. effects, an OT analog with long-lasting and effective blood-brain barrier penetration properties would be beneficial for use as a therapeutic drug.  Here, we designed and synthesized a new oxytocin analog, lipo-oxytocin-1 (LOT-1), in which two palmitoyl groups are conjugated at the amino group of the cysteine9 residue and the phenolic hydroxyl group of the tyrosine8 residue of the OT mol.  To det. whether LOT-1 actually has an effect on the central nervous system, we examd. its effects in a CD157 knockout model mouse of the non-motor psychiatric symptoms of Parkinson's disease.  Similar to OT, this analog rescued anxiety-like behavior and social avoidance in the open field test with the social target in a central arena 30 min after i.p. injection in CD157 knockout mice.  When examd. 24 h after injection, the mice treated with LOT-1 displayed more recovery than those given OT.  The results suggest that LOT-1 has a functional advantage in recovery of social behavioral impairment, such as those caused by neurodegenerative diseases, autism spectrum disorders, and schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKKlOuCvYJ4LVg90H21EOLACvtfcHk0lg9wZe9rjze9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsVKjtbc%253D&md5=79df6ed1c81b50d0521049bf38decef0</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.3390%2Fbrainsci5010003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbrainsci5010003%26sid%3Dliteratum%253Aachs%26aulast%3DMizuno%26aufirst%3DA.%26aulast%3DCherepanov%26aufirst%3DS.%26aulast%3DKikuchi%26aufirst%3DY.%26aulast%3DFakhrul%26aufirst%3DA.%26aulast%3DAkther%26aufirst%3DS.%26aulast%3DDeguchi%26aufirst%3DK.%26aulast%3DYoshihara%26aufirst%3DT.%26aulast%3DIshihara%26aufirst%3DK.%26aulast%3DShuto%26aufirst%3DS.%26aulast%3DHigashida%26aufirst%3DH.%26atitle%3DLipo-oxytocin-1%252C%2520a%2520novel%2520oxytocin%2520Analog%2520conjugated%2520with%2520two%2520palmitoyl%2520groups%252C%2520has%2520long-lasting%2520effects%2520on%2520anxiety-related%2520behavior%2520and%2520social%2520avoidance%2520in%2520CD157%2520knockout%2520mice%26jtitle%3DBrain%2520Sci.%26date%3D2015%26volume%3D5%26spage%3D3%26epage%3D13%26doi%3D10.3390%2Fbrainsci5010003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cherepanov, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichinose, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopatina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shabalova, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmina, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span> <span> </span><span class="NLM_article-title">Structure-specific effects of lipidated oxytocin analogs on intracellular calcium levels, parental behavior, and oxytocin concentrations in the plasma and cerebrospinal fluid in mice</span>. <i>Pharmacol. Res. Perspect.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e00290</span> <span class="refDoi"> DOI: 10.1002/prp2.290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1002%2Fprp2.290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=28596839" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2017&author=S.+M.+Cherepanovauthor=S.+Yokoyamaauthor=A.+Mizunoauthor=W.+Ichinoseauthor=O.+Lopatinaauthor=A.+A.+Shabalovaauthor=A.+B.+Salminaauthor=Y.+Yamamotoauthor=H.+Okamotoauthor=S.+Shutoauthor=H.+Higashida&title=Structure-specific+effects+of+lipidated+oxytocin+analogs+on+intracellular+calcium+levels%2C+parental+behavior%2C+and+oxytocin+concentrations+in+the+plasma+and+cerebrospinal+fluid+in+mice&doi=10.1002%2Fprp2.290"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fprp2.290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprp2.290%26sid%3Dliteratum%253Aachs%26aulast%3DCherepanov%26aufirst%3DS.%2BM.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DMizuno%26aufirst%3DA.%26aulast%3DIchinose%26aufirst%3DW.%26aulast%3DLopatina%26aufirst%3DO.%26aulast%3DShabalova%26aufirst%3DA.%2BA.%26aulast%3DSalmina%26aufirst%3DA.%2BB.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DOkamoto%26aufirst%3DH.%26aulast%3DShuto%26aufirst%3DS.%26aulast%3DHigashida%26aufirst%3DH.%26atitle%3DStructure-specific%2520effects%2520of%2520lipidated%2520oxytocin%2520analogs%2520on%2520intracellular%2520calcium%2520levels%252C%2520parental%2520behavior%252C%2520and%2520oxytocin%2520concentrations%2520in%2520the%2520plasma%2520and%2520cerebrospinal%2520fluid%2520in%2520mice%26jtitle%3DPharmacol.%2520Res.%2520Perspect.%26date%3D2017%26volume%3D5%26doi%3D10.1002%2Fprp2.290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Widmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piaggio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osoti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owa, O. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coomarasamy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Aleem, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallapur, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qureshi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lumbiganon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawole, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goudar, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujar, Y. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neilson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmeyr, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira de Carvalho, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugerwa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiragur, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byamugisha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gülmezoglu, A. M.</span></span> <span> </span><span class="NLM_article-title">Heat-stable carbetocin versus oxytocin to prevent hemorrhage after vaginal birth</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>379</i></span>,  <span class="NLM_fpage">743</span>– <span class="NLM_lpage">752</span>, <span class="refDoi"> DOI: 10.1056/nejmoa1805489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1056%2Fnejmoa1805489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=29949473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1eqsrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=2018&pages=743-752&author=M.+Widmerauthor=G.+Piaggioauthor=T.+M.+H.+Nguyenauthor=A.+Osotiauthor=O.+O.+Owaauthor=S.+Misraauthor=A.+Coomarasamyauthor=H.+Abdel-Aleemauthor=A.+A.+Mallapurauthor=Z.+Qureshiauthor=P.+Lumbiganonauthor=A.+B.+Patelauthor=G.+Carroliauthor=B.+Fawoleauthor=S.+S.+Goudarauthor=Y.+V.+Pujarauthor=J.+Neilsonauthor=G.+J.+Hofmeyrauthor=L.+L.+Suauthor=J.+Ferreira+de+Carvalhoauthor=U.+Pandeyauthor=K.+Mugerwaauthor=S.+S.+Shiragurauthor=J.+Byamugishaauthor=D.+Giordanoauthor=D.+Giordanoauthor=A.+M.+G%C3%BClmezoglu&title=Heat-stable+carbetocin+versus+oxytocin+to+prevent+hemorrhage+after+vaginal+birth&doi=10.1056%2Fnejmoa1805489"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Heat-stable carbetocin versus oxytocin to prevent hemorrhage after vaginal birth</span></div><div class="casAuthors">Widmer, M.; Piaggio, G.; Nguyen, T. M. H.; Osoti, A.; Owa, O. O.; Misra, S.; Coomarasamy, A.; Abdel-Aleem, H.; Mallapur, A. A.; Qureshi, Z.; Lumbiganon, P.; Patel, A. B.; Carroli, G.; Fawole, B.; Goudar, S. S.; Pujar, Y. V.; Neilson, J.; Hofmeyr, G. J.; Su, L. L.; Ferreira de Carvalho, J.; Pandey, U.; Mugerwa, K.; Shiragur, S. S.; Byamugisha, J.; Giordano, D.; Gulmezoglu, A. M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">743-752</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background Postpartum hemorrhage is the most common cause of maternal death.  Oxytocin is the std. therapy for the prevention of postpartum hemorrhage, but it requires cold storage, which is not available in many countries.  In a large trial, we compared a novel formulation of heat-stable carbetocin with oxytocin. methods We enrolled women across 23 sites in 10 countries in a randomized, double-blind, noninferiority trial comparing i.m. injections of heat-stable carbetocin (at a dose of 100 μg) with oxytocin (at a dose of 10 IU) administered immediately after vaginal birth.  Both drugs were kept in cold storage (2 to 8°C) to maintain double-blinding.  There were two primary outcomes: the proportion of women with blood loss of at least 500 mL or the use of addnl. uterotonic agents, and the proportion of women with blood loss of at least 1000 mL.  The noninferiority margins for the relative risks of these outcomes were 1.16 and 1.23, resp. results A total of 29,645 women underwent randomization.  The frequency of blood loss of at least 500 mL or the use of addnl. uterotonic agents was 14.5% in the carbetocin group and 14.4% in the oxytocin group (relative risk, 1.01; 95% confidence interval [CI], 0.95 to 1.06), a finding that was consistent with noninferiority.  The frequency of blood loss of at least 1000 mL was 1.51% in the carbetocin group and 1.45% in the oxytocin group (relative risk, 1.04; 95% CI, 0.87 to 1.25), with the confidence interval crossing the margin of noninferiority.  The use of addnl. uterotonic agents, interventions to stop bleeding, and adverse effects did not differ significantly between the two groups. conclusions Heat-stable carbetocin was noninferior to oxytocin for the prevention of blood loss of at least 500 mL or the use of addnl. uterotonic agents.  Noninferiority was not shown for the outcome of blood loss of at least 1000 mL; low event rates for this outcome reduced the power of the trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowHGuSePtWz7Vg90H21EOLACvtfcHk0lg9wZe9rjze9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1eqsrbE&md5=d3d1de818397fbba0d68000b4b1f416c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1056%2Fnejmoa1805489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252Fnejmoa1805489%26sid%3Dliteratum%253Aachs%26aulast%3DWidmer%26aufirst%3DM.%26aulast%3DPiaggio%26aufirst%3DG.%26aulast%3DNguyen%26aufirst%3DT.%2BM.%2BH.%26aulast%3DOsoti%26aufirst%3DA.%26aulast%3DOwa%26aufirst%3DO.%2BO.%26aulast%3DMisra%26aufirst%3DS.%26aulast%3DCoomarasamy%26aufirst%3DA.%26aulast%3DAbdel-Aleem%26aufirst%3DH.%26aulast%3DMallapur%26aufirst%3DA.%2BA.%26aulast%3DQureshi%26aufirst%3DZ.%26aulast%3DLumbiganon%26aufirst%3DP.%26aulast%3DPatel%26aufirst%3DA.%2BB.%26aulast%3DCarroli%26aufirst%3DG.%26aulast%3DFawole%26aufirst%3DB.%26aulast%3DGoudar%26aufirst%3DS.%2BS.%26aulast%3DPujar%26aufirst%3DY.%2BV.%26aulast%3DNeilson%26aufirst%3DJ.%26aulast%3DHofmeyr%26aufirst%3DG.%2BJ.%26aulast%3DSu%26aufirst%3DL.%2BL.%26aulast%3DFerreira%2Bde%2BCarvalho%26aufirst%3DJ.%26aulast%3DPandey%26aufirst%3DU.%26aulast%3DMugerwa%26aufirst%3DK.%26aulast%3DShiragur%26aufirst%3DS.%2BS.%26aulast%3DByamugisha%26aufirst%3DJ.%26aulast%3DGiordano%26aufirst%3DD.%26aulast%3DGiordano%26aufirst%3DD.%26aulast%3DG%25C3%25BClmezoglu%26aufirst%3DA.%2BM.%26atitle%3DHeat-stable%2520carbetocin%2520versus%2520oxytocin%2520to%2520prevent%2520hemorrhage%2520after%2520vaginal%2520birth%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2018%26volume%3D379%26spage%3D743%26epage%3D752%26doi%3D10.1056%2Fnejmoa1805489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asami, T.</span></span> <span> </span><span class="NLM_article-title">Potent and selective oxytocin receptor agonists without disulfide bridges</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2331</span>– <span class="NLM_lpage">2335</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.04.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.bmcl.2017.04.030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2331-2335&author=Y.+Adachiauthor=K.+Sakimuraauthor=Y.+Shimizuauthor=M.+Nakayamaauthor=Y.+Teraoauthor=T.+Yanoauthor=T.+Asami&title=Potent+and+selective+oxytocin+receptor+agonists+without+disulfide+bridges&doi=10.1016%2Fj.bmcl.2017.04.030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.04.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.04.030%26sid%3Dliteratum%253Aachs%26aulast%3DAdachi%26aufirst%3DY.%26aulast%3DSakimura%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DY.%26aulast%3DNakayama%26aufirst%3DM.%26aulast%3DTerao%26aufirst%3DY.%26aulast%3DYano%26aufirst%3DT.%26aulast%3DAsami%26aufirst%3DT.%26atitle%3DPotent%2520and%2520selective%2520oxytocin%2520receptor%2520agonists%2520without%2520disulfide%2520bridges%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2331%26epage%3D2335%26doi%3D10.1016%2Fj.bmcl.2017.04.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="note"><p class="first last">Muttenthaler has reported that the transformation at the disulfide linker was also important for modulating the OT potency and deamination at Cys<sup>1</sup> residue to earn the chemical stability and hydrophobicity: see ref <a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muttenthaler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Araujo, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alewood, P. F.</span></span> <span> </span><span class="NLM_article-title">Modulating oxytocin activity and plasma stability by disulfide bond engineering</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">8585</span>– <span class="NLM_lpage">8596</span>, <span class="refDoi"> DOI: 10.1021/jm100989w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100989w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2gtrvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8585-8596&author=M.+Muttenthalerauthor=A.+Anderssonauthor=A.+D.+De+Araujoauthor=Z.+Dekanauthor=R.+J.+Lewisauthor=P.+F.+Alewood&title=Modulating+oxytocin+activity+and+plasma+stability+by+disulfide+bond+engineering&doi=10.1021%2Fjm100989w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Modulating Oxytocin Activity and Plasma Stability by Disulfide Bond Engineering</span></div><div class="casAuthors">Muttenthaler, Markus; Andersson, Asa; de Araujo, Aline D.; Dekan, Zoltan; Lewis, Richard J.; Alewood, Paul F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8585-8596</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Disulfide bond engineering is an important approach to improve the metabolic half-life of cysteine-contg. peptides.  Eleven analogs of oxytocin were synthesized including disulfide bond replacements by thioether, selenylsulfide, diselenide, and ditelluride bridges, and their stabilities in human plasma and activity at the human oxytocin receptor were assessed.  The cystathionine (Ki = 1.5 nM, and EC50 = 32 nM), selenylsulfide (Ki = 0.29/0.72 nM, and EC50 = 2.6/154 nM), diselenide (Ki = 11.8 nM, and EC50 = 18 nM), and ditelluride analogs (Ki = 7.6 nM, and EC50 = 27.3 nM) retained considerable affinity and functional potency as compared to oxytocin (Ki = 0.79 nM, and EC50 = 15 nM), while shortening the disulfide bridge abolished binding and functional activity.  The mimetics showed a 1.5-3-fold enhancement of plasma stability as compared to oxytocin (t1/2 = 12 h).  By contrast, the all-D-oxytocin and head to tail cyclic oxytocin analogs, while significantly more stable with half-lives greater than 48 h, had little or no detectable binding or functional activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0MUtVq6ITRbVg90H21EOLACvtfcHk0lgaFD3nVfj2UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2gtrvN&md5=19509d7aa69dd0c6e1751db0c4d1339f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm100989w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100989w%26sid%3Dliteratum%253Aachs%26aulast%3DMuttenthaler%26aufirst%3DM.%26aulast%3DAndersson%26aufirst%3DA.%26aulast%3DDe%2BAraujo%26aufirst%3DA.%2BD.%26aulast%3DDekan%26aufirst%3DZ.%26aulast%3DLewis%26aufirst%3DR.%2BJ.%26aulast%3DAlewood%26aufirst%3DP.%2BF.%26atitle%3DModulating%2520oxytocin%2520activity%2520and%2520plasma%2520stability%2520by%2520disulfide%2520bond%2520engineering%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8585%26epage%3D8596%26doi%3D10.1021%2Fjm100989w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Araujo, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetter, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muttenthaler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brierley, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alewood, P. F.</span></span> <span> </span><span class="NLM_article-title">Selenoether oxytocin analogues have analgesic properties in a mouse model of chronic abdominal pain</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">3165</span>, <span class="refDoi"> DOI: 10.1038/ncomms4165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1038%2Fncomms4165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=24476666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BC2cvgtlOrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=3165&author=A.+D.+De%0AAraujoauthor=M.+Mobliauthor=J.+Castroauthor=A.+M.+Harringtonauthor=I.+Vetterauthor=Z.+Dekanauthor=M.+Muttenthalerauthor=J.+Wanauthor=R.+J.+Lewisauthor=G.+F.+Kingauthor=S.+M.+Brierleyauthor=P.+F.+Alewood&title=Selenoether+oxytocin+analogues+have+analgesic+properties+in+a+mouse+model+of+chronic+abdominal+pain&doi=10.1038%2Fncomms4165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Selenoether oxytocin analogues have analgesic properties in a mouse model of chronic abdominal pain</span></div><div class="casAuthors">de Araujo Aline Dantas; Vetter Irina; Dekan Zoltan; Wan JingJing; Lewis Richard J; King Glenn F; Alewood Paul F; Mobli Mehdi; Castro Joel; Harrington Andrea M; Muttenthaler Markus; Brierley Stuart M</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3165</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Poor oral availability and susceptibility to reduction and protease degradation is a major hurdle in peptide drug development.  However, drugable receptors in the gut present an attractive niche for peptide therapeutics.  Here we demonstrate, in a mouse model of chronic abdominal pain, that oxytocin receptors are significantly upregulated in nociceptors innervating the colon.  Correspondingly, we develop chemical strategies to engineer non-reducible and therefore more stable oxytocin analogues.  Chemoselective selenide macrocyclization yields stabilized analogues equipotent to native oxytocin.  Ultra-high-field nuclear magnetic resonance structural analysis of native oxytocin and the seleno-oxytocin derivatives reveals that oxytocin has a pre-organized structure in solution, in marked contrast to earlier X-ray crystallography studies.  Finally, we show that these seleno-oxytocin analogues potently inhibit colonic nociceptors both in vitro and in vivo in mice with chronic visceral hypersensitivity.  Our findings have potentially important implications for clinical use of oxytocin analogues and disulphide-rich peptides in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTleAzA3UqCBVw2ofyr07jXfW6udTcc2eaH_RlEHuZ_v7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cvgtlOrsw%253D%253D&md5=6da2e2a79c2576eaff8b641e61b84da0</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fncomms4165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms4165%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BAraujo%26aufirst%3DA.%2BD.%26aulast%3DMobli%26aufirst%3DM.%26aulast%3DCastro%26aufirst%3DJ.%26aulast%3DHarrington%26aufirst%3DA.%2BM.%26aulast%3DVetter%26aufirst%3DI.%26aulast%3DDekan%26aufirst%3DZ.%26aulast%3DMuttenthaler%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DR.%2BJ.%26aulast%3DKing%26aufirst%3DG.%2BF.%26aulast%3DBrierley%26aufirst%3DS.%2BM.%26aulast%3DAlewood%26aufirst%3DP.%2BF.%26atitle%3DSelenoether%2520oxytocin%2520analogues%2520have%2520analgesic%2520properties%2520in%2520a%2520mouse%2520model%2520of%2520chronic%2520abdominal%2520pain%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D3165%26doi%3D10.1038%2Fncomms4165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muttenthaler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, Å.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetter, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busnelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragnarsson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergmayr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuis, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palpant, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wray, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruber, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alewood, P. F.</span></span> <span> </span><span class="NLM_article-title">Subtle modifications to oxytocin produce ligands that retain potency and improved selectivity across species</span>. <i>Sci. Signal.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">eaan3398</span> <span class="refDoi"> DOI: 10.1126/scisignal.aan3398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1126%2Fscisignal.aan3398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=29208680" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&author=M.+Muttenthalerauthor=%C3%85.+Anderssonauthor=I.+Vetterauthor=R.+Menonauthor=M.+Busnelliauthor=L.+Ragnarssonauthor=C.+Bergmayrauthor=S.+Arrowsmithauthor=J.+R.+Deuisauthor=H.+S.+Chiuauthor=N.+J.+Palpantauthor=M.+O%E2%80%99Brienauthor=T.+J.+Smithauthor=S.+Wrayauthor=I.+D.+Neumannauthor=C.+W.+Gruberauthor=R.+J.+Lewisauthor=P.+F.+Alewood&title=Subtle+modifications+to+oxytocin+produce+ligands+that+retain+potency+and+improved+selectivity+across+species&doi=10.1126%2Fscisignal.aan3398"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.aan3398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.aan3398%26sid%3Dliteratum%253Aachs%26aulast%3DMuttenthaler%26aufirst%3DM.%26aulast%3DAndersson%26aufirst%3D%25C3%2585.%26aulast%3DVetter%26aufirst%3DI.%26aulast%3DMenon%26aufirst%3DR.%26aulast%3DBusnelli%26aufirst%3DM.%26aulast%3DRagnarsson%26aufirst%3DL.%26aulast%3DBergmayr%26aufirst%3DC.%26aulast%3DArrowsmith%26aufirst%3DS.%26aulast%3DDeuis%26aufirst%3DJ.%2BR.%26aulast%3DChiu%26aufirst%3DH.%2BS.%26aulast%3DPalpant%26aufirst%3DN.%2BJ.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DT.%2BJ.%26aulast%3DWray%26aufirst%3DS.%26aulast%3DNeumann%26aufirst%3DI.%2BD.%26aulast%3DGruber%26aufirst%3DC.%2BW.%26aulast%3DLewis%26aufirst%3DR.%2BJ.%26aulast%3DAlewood%26aufirst%3DP.%2BF.%26atitle%3DSubtle%2520modifications%2520to%2520oxytocin%2520produce%2520ligands%2520that%2520retain%2520potency%2520and%2520improved%2520selectivity%2520across%2520species%26jtitle%3DSci.%2520Signal.%26date%3D2017%26volume%3D10%26doi%3D10.1126%2Fscisignal.aan3398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scibola, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetz, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duplantier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanase-Frawley, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kablaoui, N. M.</span></span> <span> </span><span class="NLM_article-title">Systematic <i>N</i>-methylation of oxytocin: Impact on pharmacology and intramolecular hydrogen bonding network</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3513</span>– <span class="NLM_lpage">3520</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.05.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.bmc.2016.05.062" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=3513-3520&author=S.+Scibolaauthor=G.+H.+Goetzauthor=G.+Baiauthor=B.+N.+Rogersauthor=D.+L.+Grayauthor=A.+Duplantierauthor=K.+R.+Fonsecaauthor=M.+A.+Vanase-Frawleyauthor=N.+M.+Kablaoui&title=Systematic+N-methylation+of+oxytocin%3A+Impact+on+pharmacology+and+intramolecular+hydrogen+bonding+network&doi=10.1016%2Fj.bmc.2016.05.062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DScibola%26aufirst%3DS.%26aulast%3DGoetz%26aufirst%3DG.%2BH.%26aulast%3DBai%26aufirst%3DG.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DGray%26aufirst%3DD.%2BL.%26aulast%3DDuplantier%26aufirst%3DA.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DVanase-Frawley%26aufirst%3DM.%2BA.%26aulast%3DKablaoui%26aufirst%3DN.%2BM.%26atitle%3DSystematic%2520N-methylation%2520of%2520oxytocin%253A%2520Impact%2520on%2520pharmacology%2520and%2520intramolecular%2520hydrogen%2520bonding%2520network%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D3513%26epage%3D3520%26doi%3D10.1016%2Fj.bmc.2016.05.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Modi, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majchrzak, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osgood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanase-Frawley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feyfant, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McInnes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darvari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhl, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kablaoui, N. M.</span></span> <span> </span><span class="NLM_article-title">Peripheral administration of a long-acting peptide oxytocin receptor agonist inhibits fear-induced freezing</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>358</i></span>,  <span class="NLM_fpage">164</span>– <span class="NLM_lpage">172</span>, <span class="refDoi"> DOI: 10.1124/jpet.116.232702</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1124%2Fjpet.116.232702" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=27217590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslCqtbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2016&pages=164-172&author=M.+E.+Modiauthor=M.+J.+Majchrzakauthor=K.+R.+Fonsecaauthor=A.+Doranauthor=S.+Osgoodauthor=M.+Vanase-Frawleyauthor=E.+Feyfantauthor=H.+McInnesauthor=R.+Darvariauthor=D.+L.+Buhlauthor=N.+M.+Kablaoui&title=Peripheral+administration+of+a+long-acting+peptide+oxytocin+receptor+agonist+inhibits+fear-induced+freezing&doi=10.1124%2Fjpet.116.232702"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral administration of a long-acting peptide oxytocin receptor agonist inhibits fear-induced freezing</span></div><div class="casAuthors">Modi, Meera E.; Majchrzak, Mark J.; Fonseca, Kari R.; Doran, Angela; Osgood, Sarah; Vanase-Frawley, Michelle; Feyfant, Eric; McInnes, Heather; Darvari, Ramin; Buhl, Derek L.; Kablaoui, Natasha M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">164-172</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Oxytocin (OT) modulates the expression of social and emotional behaviors and consequently has been proposed as a pharmacol. treatment of psychiatric diseases, including autism spectrum disorders and schizophrenia; however, endogenous OT has a short half-life in plasma and poor permeability across the blood-brain barrier.  Recent efforts have focused on the development of novel drug delivery methods to enhance brain penetration, but few efforts have aimed at improving its half-life.  To explore the behavioral efficacy of an OT analog with enhanced plasma stability, we developed PF-06655075 (PF1), a novel non-brain-penetrant OT receptor agonist with increased selectivity for the OT receptor and significantly increased pharmaco- kinetic stability.  PF-06478939 was generated with only increased stability to disambiguate changes to selectivity vs. stability.  The efficacy of these compds. in evoking behavioral effects was tested in a conditioned fear paradigm.  Both central and peripheral administration of PF1 inhibited freezing in response to a conditioned fear stimulus.  Peripheral administration of PF1 resulted in a sustained level of plasma concns. for greater than 20 h but no detectable accumulation in brain tissue, suggesting that plasma or cerebrospinal fluid exposure was sufficient to evoke behavioral effects.  Behavioral efficacy of peripherally administered OT receptor agonists on conditioned fear response opens the door to potential peripheral mechanisms in other behavioral paradigms, whether they are mediated by direct peripheral activation or feed-forward responses.  Compd. PF1 is freely available as a tool compd. to further explore the role of peripheral OT in behavioral response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzDYP-scpGKbVg90H21EOLACvtfcHk0lhW0EoVx6wUeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslCqtbbM&md5=923c89516e0c712184e9a4c826a0b79a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1124%2Fjpet.116.232702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.116.232702%26sid%3Dliteratum%253Aachs%26aulast%3DModi%26aufirst%3DM.%2BE.%26aulast%3DMajchrzak%26aufirst%3DM.%2BJ.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DDoran%26aufirst%3DA.%26aulast%3DOsgood%26aufirst%3DS.%26aulast%3DVanase-Frawley%26aufirst%3DM.%26aulast%3DFeyfant%26aufirst%3DE.%26aulast%3DMcInnes%26aufirst%3DH.%26aulast%3DDarvari%26aufirst%3DR.%26aulast%3DBuhl%26aufirst%3DD.%2BL.%26aulast%3DKablaoui%26aufirst%3DN.%2BM.%26atitle%3DPeripheral%2520administration%2520of%2520a%2520long-acting%2520peptide%2520oxytocin%2520receptor%2520agonist%2520inhibits%2520fear-induced%2520freezing%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D358%26spage%3D164%26epage%3D172%26doi%3D10.1124%2Fjpet.116.232702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ring, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schechter, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platt, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grauer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulicicchio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Resnick, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sukoff Rizzo, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyer, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logue, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig-Lipson, S.</span></span> <span> </span><span class="NLM_article-title">Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2009.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.neuropharm.2009.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=19615387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BD1Mjjs1GqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2010&pages=69-77&author=R.+H.+Ringauthor=L.+E.+Schechterauthor=S.+K.+Leonardauthor=J.+M.+Dwyerauthor=B.+J.+Plattauthor=R.+Grafauthor=S.+Grauerauthor=C.+Pulicicchioauthor=L.+Resnickauthor=Z.+Rahmanauthor=S.+J.+Sukoff+Rizzoauthor=B.+Luoauthor=C.+E.+Beyerauthor=S.+F.+Logueauthor=K.+L.+Marquisauthor=Z.+A.+Hughesauthor=S.+Rosenzweig-Lipson&title=Receptor+and+behavioral+pharmacology+of+WAY-267464%2C+a+non-peptide+oxytocin+receptor+agonist&doi=10.1016%2Fj.neuropharm.2009.07.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist</span></div><div class="casAuthors">Ring Robert H; Schechter Lee E; Leonard Sarah K; Dwyer Jason M; Platt Brian J; Graf Radka; Grauer Steven; Pulicicchio Claudine; Resnick Lynn; Rahman Zia; Sukoff Rizzo Stacey J; Luo Bin; Beyer Chad E; Logue Sheree F; Marquis Karen L; Hughes Zoe A; Rosenzweig-Lipson Sharon</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-77</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The widely reported effects of oxytocin (OT) on CNS function has generated considerable interest in the therapeutic potential for targeting this system for a variety of human psychiatric diseases, including anxiety disorders, autism, schizophrenia, and depression.  The utility of synthetic OT, as both a research tool and neurotherapeutic, is limited by the physiochemical properties inherent in most neuropeptides, notably its short half-life and poor blood brain barrier penetration.  Subsequently, the discovery and development of non-peptide molecules that act as selective agonists of the oxytocin receptor (OTR) has been an important goal of the field.  In this study, we report the receptor and behavioral pharmacology of WAY-267464, a first generation small-molecule OTR agonist.  WAY-267464 is a high-affinity, potent, and selective (vs.  V1a, V2, V1b) agonist of the OTR.  In assays measuring both behavioral (four-plate test, elevated zero maze) and autonomic (stress-induced hyperthermia) parameters of the anxiety response, WAY-267464 exhibits an anxiolytic-like profile similar to OT.  We have demonstrated that the anxiolytic-like profile of WAY-267464 is mediated through central sites of action.  WAY-267464 also significantly reverses disruption in prepulse inhibition of the acoustic startle reflex induced by either MK-801 or amphetamine, similar to the antipsychotic-like effects previously reported for OT.  Interestingly, in the mouse tail suspension test, WAY-267464 failed to produce changes in immobility that are seen with OT, raising the question of whether the antidepressant-like activity of OT may be working independently of the OTR.  A selective OTR antagonist also failed to block the effects of OT on immobility in the TST.  The significance of these findings for shaping the clinical development of OTR agonists is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ8S-KlSxighgMthz5_Rx5rfW6udTcc2eYzcf36VVhPh7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mjjs1GqsQ%253D%253D&md5=699434bd2c444cd29345d24db54fbbb5</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2009.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2009.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DRing%26aufirst%3DR.%2BH.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DLeonard%26aufirst%3DS.%2BK.%26aulast%3DDwyer%26aufirst%3DJ.%2BM.%26aulast%3DPlatt%26aufirst%3DB.%2BJ.%26aulast%3DGraf%26aufirst%3DR.%26aulast%3DGrauer%26aufirst%3DS.%26aulast%3DPulicicchio%26aufirst%3DC.%26aulast%3DResnick%26aufirst%3DL.%26aulast%3DRahman%26aufirst%3DZ.%26aulast%3DSukoff%2BRizzo%26aufirst%3DS.%2BJ.%26aulast%3DLuo%26aufirst%3DB.%26aulast%3DBeyer%26aufirst%3DC.%2BE.%26aulast%3DLogue%26aufirst%3DS.%2BF.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26aulast%3DHughes%26aufirst%3DZ.%2BA.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26atitle%3DReceptor%2520and%2520behavioral%2520pharmacology%2520of%2520WAY-267464%252C%2520a%2520non-peptide%2520oxytocin%2520receptor%2520agonist%26jtitle%3DNeuropharmacology%26date%3D2010%26volume%3D58%26spage%3D69%26epage%3D77%26doi%3D10.1016%2Fj.neuropharm.2009.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Engstøm, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barth, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilhardt, H.</span></span> <span> </span><span class="NLM_article-title">Oxytocin receptor binding and uterotonic activity of carbetocin and its metabolites following enzymatic degradation</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>355</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">210</span>, <span class="refDoi"> DOI: 10.1016/s0014-2999(98)00513-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fs0014-2999%2898%2900513-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=9760035" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=1998&pages=203-210&author=T.+Engst%C3%B8mauthor=T.+Barthauthor=P.+Melinauthor=H.+Vilhardt&title=Oxytocin+receptor+binding+and+uterotonic+activity+of+carbetocin+and+its+metabolites+following+enzymatic+degradation&doi=10.1016%2Fs0014-2999%2898%2900513-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fs0014-2999%2898%2900513-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0014-2999%252898%252900513-5%26sid%3Dliteratum%253Aachs%26aulast%3DEngst%25C3%25B8m%26aufirst%3DT.%26aulast%3DBarth%26aufirst%3DT.%26aulast%3DMelin%26aufirst%3DP.%26aulast%3DVilhardt%26aufirst%3DH.%26atitle%3DOxytocin%2520receptor%2520binding%2520and%2520uterotonic%2520activity%2520of%2520carbetocin%2520and%2520its%2520metabolites%2520following%2520enzymatic%2520degradation%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1998%26volume%3D355%26spage%3D203%26epage%3D210%26doi%3D10.1016%2Fs0014-2999%2898%2900513-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rath, W.</span></span> <span> </span><span class="NLM_article-title">Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin</span>. <i>Eur. J. Obstet. Gynecol. Reprod. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>147</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1016/j.ejogrb.2009.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.ejogrb.2009.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=19616358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1OnsL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2009&pages=15-20&author=W.+Rath&title=Prevention+of+postpartum+haemorrhage+with+the+oxytocin+analogue+carbetocin&doi=10.1016%2Fj.ejogrb.2009.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of postpartum hemorrhage with the oxytocin analogue carbetocin</span></div><div class="casAuthors">Rath, Werner</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Obstetrics & Gynecology and Reproductive Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-20</span>CODEN:
                <span class="NLM_cas:coden">EOGRAL</span>;
        ISSN:<span class="NLM_cas:issn">0301-2115</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Postpartum hemorrhage is the leading cause of maternal mortality worldwide: 67-80% of cases are caused by uterine atony.  Preventive measures include prophylactic drug use to aid uterine contraction after delivery, thus avoiding severe blood loss and reducing maternal morbidity and mortality.  Carbetocin is a synthetic analog of oxytocin with a half-life approx. 4-10 times longer than that reported for oxytocin.  It combines the safety and tolerability profile of oxytocin with the sustained uterotonic activity of injectable ergot alkaloids.  Furthermore, carbetocin can be administered as a single dose injection either i.v. or i.m. rather than as an infusion over several hours as is the case with oxytocin.  Carbetocin is currently indicated for prevention of uterine atony after delivery by cesarean section in spinal or epidural anesthesia.  Data from three randomized controlled trials in cesarean delivery and a meta-anal. indicate that carbetocin significantly reduces the need for addnl. uterotonic agents or uterine massage to prevent excessive bleeding compared with placebo or oxytocin.  The risk of headache, tremor, hypotension, flushing, nausea, abdominal pain, pruritus and feeling of warmth was similar in women who received carbetocin or oxytocin.  The findings from two more recent double-blind randomized trials and one retrospective study suggest that carbetocin may also represent a good alternative to conventional uterotonic agents for prevention of postpartum hemorrhage after vaginal deliveries.  A reduced need for addnl. uterotonics was obsd. with carbetocin vs. oxytocin in high-risk women and carbetocin was at least as effective as syntometrine in low-risk women.  In these studies of vaginal deliveries, carbetocin was assocd. with a low incidence of adverse effects and demonstrated a better tolerability profile than syntometrine.  Carbetocin had a long duration of action compared with i.v. oxytocin alone and a better cardiovascular side effect profile compared with syntometrine.  In addn. to being an effective treatment for the prevention of postpartum hemorrhage following cesarean delivery, carbetocin may also become the drug of choice for postpartum hemorrhage prevention after vaginal delivery in high-risk women and those who suffer from hypertensive disorders in pregnancy.  Preeclampsia is still a contraindication to the administration of carbetocin in the EU, and further studies would be required to assess the cardiovascular effects of carbetocin before it can be advocated for routine use in preeclamptic patients.  Further research is required to assess whether prophylactic carbetocin is superior to conventional uterotonic agents following vaginal delivery in low-risk women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCwjaxvxKDx7Vg90H21EOLACvtfcHk0lhGbrSWp4tWJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1OnsL3N&md5=d8f9b4d738dc4245f18d280446ae7527</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.ejogrb.2009.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejogrb.2009.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DRath%26aufirst%3DW.%26atitle%3DPrevention%2520of%2520postpartum%2520haemorrhage%2520with%2520the%2520oxytocin%2520analogue%2520carbetocin%26jtitle%3DEur.%2520J.%2520Obstet.%2520Gynecol.%2520Reprod.%2520Biol.%26date%3D2009%26volume%3D147%26spage%3D15%26epage%3D20%26doi%3D10.1016%2Fj.ejogrb.2009.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wiśniewski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alagarsamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galyean, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tariga, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ly, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiśniewski, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croston, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laporte, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivière, P. J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schteingart, C. D.</span></span> <span> </span><span class="NLM_article-title">New, potent, and selective peptidic oxytocin receptor agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5306</span>– <span class="NLM_lpage">5317</span>, <span class="refDoi"> DOI: 10.1021/jm500365s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500365s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVWhs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5306-5317&author=K.+Wi%C5%9Bniewskiauthor=S.+Alagarsamyauthor=R.+Galyeanauthor=H.+Tarigaauthor=D.+Thompsonauthor=B.+Lyauthor=H.+Wi%C5%9Bniewskiauthor=S.+Qiauthor=G.+Crostonauthor=R.+Laporteauthor=P.+J.-M.+Rivi%C3%A8reauthor=C.+D.+Schteingart&title=New%2C+potent%2C+and+selective+peptidic+oxytocin+receptor+agonists&doi=10.1021%2Fjm500365s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">New, Potent, and Selective Peptidic Oxytocin Receptor Agonists</span></div><div class="casAuthors">Wisniewski, Kazimierz; Alagarsamy, Sudarkodi; Galyean, Robert; Tariga, Hiroe; Thompson, Dorain; Ly, Brian; Wisniewska, Halina; Qi, Steve; Croston, Glenn; Laporte, Regent; Riviere, Pierre J.-M.; Schteingart, Claudio D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5306-5317</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mothers of preterm babies frequently have difficulty establishing or maintaining lactation, thought to be due to interference with the milk ejection reflex.  Administration of exogenous oxytocin can produce alveolar contraction and adequate breast emptying resulting in establishment of successful lactation.  The natural hormone oxytocin is not receptor-selective and may cause hyponatremia via V2 receptor mediated antidiuresis.  We have designed a series of potent oxytocin analogs contg. N-alkylglycines in position 7 with excellent selectivity vs. the related V1a, V1b, and V2 vasopressin receptors and short half-life: agonists 31([2-ThiMeGly7]dOT), 47 (carba-6-[Phe2,BuGly7]dOT), 55 (carba-6-[3-MeBzlGly7]dOT), and 57 (carba-1-[4-FBzlGly7]dOT) have EC50 values at hOTR < 0.1 nM, selectivity ratios vs. related human vasopressin receptors of >2000, IC50 at hV1aR > 500 nM, and total clearance in rats in the range of 60-80 mL min-1 kg-1.  Compd. 57 (FE 202767) is currently in clin. development for the treatment of preterm mothers requiring lactation support.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_ykZz5KXVXbVg90H21EOLACvtfcHk0lhGbrSWp4tWJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVWhs78%253D&md5=8076f2bbeb06371908b462d1c8f25321</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm500365s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500365s%26sid%3Dliteratum%253Aachs%26aulast%3DWi%25C5%259Bniewski%26aufirst%3DK.%26aulast%3DAlagarsamy%26aufirst%3DS.%26aulast%3DGalyean%26aufirst%3DR.%26aulast%3DTariga%26aufirst%3DH.%26aulast%3DThompson%26aufirst%3DD.%26aulast%3DLy%26aufirst%3DB.%26aulast%3DWi%25C5%259Bniewski%26aufirst%3DH.%26aulast%3DQi%26aufirst%3DS.%26aulast%3DCroston%26aufirst%3DG.%26aulast%3DLaporte%26aufirst%3DR.%26aulast%3DRivi%25C3%25A8re%26aufirst%3DP.%2BJ.-M.%26aulast%3DSchteingart%26aufirst%3DC.%2BD.%26atitle%3DNew%252C%2520potent%252C%2520and%2520selective%2520peptidic%2520oxytocin%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5306%26epage%3D5317%26doi%3D10.1021%2Fjm500365s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">ClinicalTrials.gov, NIH</span>, <a href="https://www.clinicaltrials.gov/ct2/show/NCT02545127?lead=ferring&amp;gndr=Female&amp;phase=01&amp;rank=5" class="extLink">https://www.clinicaltrials.gov/ct2/show/NCT02545127?lead=ferring&gndr=Female&phase=01&rank=5</a> (accessed on February 26, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov%2C+NIH%2C+https%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT02545127%3Flead%3Dferring%26gndr%3DFemale%26phase%3D01%26rank%3D5+%28accessed+on+February+26%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wellings, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atherton, E.</span></span> <span> </span><span class="NLM_article-title">[4] Standard Fmoc protocols</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1016/s0076-6879(97)89043-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fs0076-6879%2897%2989043-x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1997&pages=44-67&author=D.+A.+Wellingsauthor=E.+Atherton&title=%5B4%5D+Standard+Fmoc+protocols&doi=10.1016%2Fs0076-6879%2897%2989043-x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fs0076-6879%2897%2989043-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0076-6879%252897%252989043-x%26sid%3Dliteratum%253Aachs%26aulast%3DWellings%26aufirst%3DD.%2BA.%26aulast%3DAtherton%26aufirst%3DE.%26atitle%3D%255B4%255D%2520Standard%2520Fmoc%2520protocols%26jtitle%3DMethods%2520Enzymol.%26date%3D1997%26volume%3D289%26spage%3D44%26epage%3D67%26doi%3D10.1016%2Fs0076-6879%2897%2989043-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ran, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konermann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwala, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fine, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shalem, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cradick, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marraffini, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span> <span> </span><span class="NLM_article-title">DNA targeting specificity of RNA-guided Cas9 nucleases</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">827</span>– <span class="NLM_lpage">832</span>, <span class="refDoi"> DOI: 10.1038/nbt.2647</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1038%2Fnbt.2647" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=23873081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFCit7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=827-832&author=P.+D.+Hsuauthor=D.+A.+Scottauthor=J.+A.+Weinsteinauthor=F.+A.+Ranauthor=S.+Konermannauthor=V.+Agarwalaauthor=Y.+Liauthor=E.+J.+Fineauthor=X.+Wuauthor=O.+Shalemauthor=T.+J.+Cradickauthor=L.+A.+Marraffiniauthor=G.+Baoauthor=F.+Zhang&title=DNA+targeting+specificity+of+RNA-guided+Cas9+nucleases&doi=10.1038%2Fnbt.2647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">DNA targeting specificity of RNA-guided Cas9 nucleases</span></div><div class="casAuthors">Hsu, Patrick D.; Scott, David A.; Weinstein, Joshua A.; Ran, F. Ann; Konermann, Silvana; Agarwala, Vineeta; Li, Yinqing; Fine, Eli J.; Wu, Xuebing; Shalem, Ophir; Cradick, Thomas J.; Marraffini, Luciano A.; Bao, Gang; Zhang, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">827-832</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Streptococcus pyogenes Cas9 (SpCas9) nuclease can be efficiently targeted to genomic loci by means of single-guide RNAs (sgRNAs) to enable genome editing.  Here, the authors characterize SpCas9 targeting specificity in human cells to inform the selection of target sites and avoid off-target effects.  This study evaluates >700 guide RNA variants and SpCas9-induced indel mutation levels at >100 predicted genomic off-target loci in 293T and 293FT cells.  SpCas9 tolerates mismatches between guide RNA and target DNA at different positions in a sequence-dependent manner, sensitive to the no., position and distribution of mismatches.  Also, SpCas9-mediated cleavage is unaffected by DNA methylation and that the dosage of SpCas9 and sgRNA can be titrated to minimize off-target modification.  To facilitate mammalian genome engineering applications, the authors provide a web-based software tool to guide the selection and validation of target sequences as well as off-target analyses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0dL9TCYREWbVg90H21EOLACvtfcHk0liqUuYOMHCLSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFCit7nJ&md5=0babfdd7b0a644ba422d8fd46dbdf8ae</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2647%26sid%3Dliteratum%253Aachs%26aulast%3DHsu%26aufirst%3DP.%2BD.%26aulast%3DScott%26aufirst%3DD.%2BA.%26aulast%3DWeinstein%26aufirst%3DJ.%2BA.%26aulast%3DRan%26aufirst%3DF.%2BA.%26aulast%3DKonermann%26aufirst%3DS.%26aulast%3DAgarwala%26aufirst%3DV.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DFine%26aufirst%3DE.%2BJ.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DShalem%26aufirst%3DO.%26aulast%3DCradick%26aufirst%3DT.%2BJ.%26aulast%3DMarraffini%26aufirst%3DL.%2BA.%26aulast%3DBao%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DF.%26atitle%3DDNA%2520targeting%2520specificity%2520of%2520RNA-guided%2520Cas9%2520nucleases%26jtitle%3DNat.%2520Biotechnol.%26date%3D2013%26volume%3D31%26spage%3D827%26epage%3D832%26doi%3D10.1038%2Fnbt.2647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Motulsky, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahan, L. C.</span></span> <span> </span><span class="NLM_article-title">The kinetics of competitive radioligand binding predicted by the law of mass action</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=6708928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADyaL2c7mslOmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1984&pages=1-9&author=H.+J.+Motulskyauthor=L.+C.+Mahan&title=The+kinetics+of+competitive+radioligand+binding+predicted+by+the+law+of+mass+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">The kinetics of competitive radioligand binding predicted by the law of mass action</span></div><div class="casAuthors">Motulsky H J; Mahan L C</div><div class="citationInfo"><span class="NLM_cas:title">Molecular pharmacology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">Although equilibrium competitive radioligand binding studies are often used to characterize hormone and neurotransmitter receptors, the kinetics of such experiments have not been extensively explored.  The interactions of the radioligand and competitor with the receptors can be described by two differential equations which can be solved to yield a single equation describing the binding of the radioligand as a function of time.  This equation has several applications: First, it can be used to simulate competitive binding reactions under defined conditions.  Second, fitting experimental data to this equation allows one to determine the association and dissociation rate constants of the competing ligand, parameters that cannot be derived from equilibrium experiments.  Furthermore, this method can be used to determine the KI of the competing drug from data acquired before equilibrium is reached.  Third, mathematical analysis of the binding equation allowed us to answer two specific questions regarding the kinetics of competitive radioligand binding: how long such an incubation takes to equilibrate, and how the IC50 varies over time.  The answers to these questions depended, to a large extent, on the relative values of the dissociation rate constants of the radioligand and competitor, which can be determined as noted above.  When the competitor dissociates from the receptors more rapidly than the radioligand, the IC50 first decreases and then increases, but never has a value less than the KI.  At low radioligand concentrations, equilibrium is reached in the same amount of time required of the radioligand to dissociate completely from the receptors as determined in an "off-rate experiment." At higher concentrations of radioligand this time is halved.  When the competitor dissociates from the receptor more slowly than does the radioligand, then the time required to equilibrate depends only on the dissociation rate constant of the competitor, and the IC50 decreases over time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRCXDwvoK7MbN1QT_1O5WBYfW6udTcc2eYeP6LwwRAxGLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2c7mslOmtQ%253D%253D&md5=f0c09a16d7f8947fe0d72c256e2e4914</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMotulsky%26aufirst%3DH.%2BJ.%26aulast%3DMahan%26aufirst%3DL.%2BC.%26atitle%3DThe%2520kinetics%2520of%2520competitive%2520radioligand%2520binding%2520predicted%2520by%2520the%2520law%2520of%2520mass%2520action%26jtitle%3DMol.%2520Pharmacol.%26date%3D1984%26volume%3D25%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ihara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimomura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattelle, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komai, K.</span></span> <span> </span><span class="NLM_article-title">Super Agonist Actions of Clothianidin and Related Compounds on the SADβ2 Nicotinic Acetylcholine Receptor Expressed inXenopus laevisOocytes</span>. <i>Biosci. Biotechnol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">763</span>, <span class="refDoi"> DOI: 10.1271/bbb.68.761</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1271%2Fbbb.68.761" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2004&pages=761-763&author=M.+Iharaauthor=K.+Matsudaauthor=M.+Shimomuraauthor=D.+B.+Sattelleauthor=K.+Komai&title=Super+Agonist+Actions+of+Clothianidin+and+Related+Compounds+on+the+SAD%CE%B22+Nicotinic+Acetylcholine+Receptor+Expressed+inXenopus+laevisOocytes&doi=10.1271%2Fbbb.68.761"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1271%2Fbbb.68.761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1271%252Fbbb.68.761%26sid%3Dliteratum%253Aachs%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DMatsuda%26aufirst%3DK.%26aulast%3DShimomura%26aufirst%3DM.%26aulast%3DSattelle%26aufirst%3DD.%2BB.%26aulast%3DKomai%26aufirst%3DK.%26atitle%3DSuper%2520Agonist%2520Actions%2520of%2520Clothianidin%2520and%2520Related%2520Compounds%2520on%2520the%2520SAD%25CE%25B22%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Expressed%2520inXenopus%2520laevisOocytes%26jtitle%3DBiosci.%2520Biotechnol.%2520Biochem.%26date%3D2004%26volume%3D68%26spage%3D761%26epage%3D763%26doi%3D10.1271%2Fbbb.68.761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckingham, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattelle, D. B.</span></span> <span> </span><span class="NLM_article-title">Neonicotinoid insecticides display partial and super agonist actions on native insect nicotinic acetylcholine receptors</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">608</span>– <span class="NLM_lpage">615</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2006.04084.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1111%2Fj.1471-4159.2006.04084.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=16899070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtF2rsLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2006&pages=608-615&author=L.+A.+Brownauthor=M.+Iharaauthor=S.+D.+Buckinghamauthor=K.+Matsudaauthor=D.+B.+Sattelle&title=Neonicotinoid+insecticides+display+partial+and+super+agonist+actions+on+native+insect+nicotinic+acetylcholine+receptors&doi=10.1111%2Fj.1471-4159.2006.04084.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Neonicotinoid insecticides display partial and super agonist actions on native insect nicotinic acetylcholine receptors</span></div><div class="casAuthors">Brown, Laurence A.; Ihara, Makoto; Buckingham, Steven D.; Matsuda, Kazuhiko; Sattelle, David B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">608-615</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Nicotinic acetylcholine receptors (nAChRs) are present in high d. in insect nervous tissue and are targeted by neonicotinoid insecticides.  Improved understanding of the actions of these insecticides will assist in the development of new compds.  Whole-cell patch-clamp recording of cholinergic neurons cultured from the central nervous system of 3rd instar Drosophila larvae were used to examine the actions of acetylcholine (ACh) and nicotine, as well as the neonicotinoids imidacloprid, clothianidin and P-CH-clothianidin on native nAChRs of these neurons.  Dose-response data yield an EC50 value for ACh of 19 μM.  Both nicotine and imidacloprid act as low efficacy agonists at native nAChRs, evoking maximal current amplitudes 10-14% of those obsd. for ACh.  Conversely, clothianidin and P-CH-clothianidin evoke maximal current amplitudes up to 56% greater than those evoked by 100 μM ACh in the same neurons.  This is the first demonstration of 'super' agonist actions of an insecticide on native insect nAChRs.  Cell-attached recordings indicate that super agonism results from more frequent openings at the largest (63.5 pS) conductance state obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPQFP6g23FGbVg90H21EOLACvtfcHk0liqUuYOMHCLSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtF2rsLnO&md5=e719f86c3f854c4adc29bf76301f9986</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04084.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04084.x%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DL.%2BA.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DBuckingham%26aufirst%3DS.%2BD.%26aulast%3DMatsuda%26aufirst%3DK.%26aulast%3DSattelle%26aufirst%3DD.%2BB.%26atitle%3DNeonicotinoid%2520insecticides%2520display%2520partial%2520and%2520super%2520agonist%2520actions%2520on%2520native%2520insect%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D99%26spage%3D608%26epage%3D615%26doi%3D10.1111%2Fj.1471-4159.2006.04084.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Engel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monga, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northup, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gershengorn, M. C.</span></span> <span> </span><span class="NLM_article-title">Low Affinity Analogs of Thyrotropin-releasing Hormone Are Super-agonists</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">13103</span>– <span class="NLM_lpage">13109</span>, <span class="refDoi"> DOI: 10.1074/jbc.m600440200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1074%2Fjbc.m600440200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=13103-13109&author=S.+Engelauthor=S.+Neumannauthor=N.+Kaurauthor=V.+Mongaauthor=R.+Jainauthor=J.+Northupauthor=M.+C.+Gershengorn&title=Low+Affinity+Analogs+of+Thyrotropin-releasing+Hormone+Are+Super-agonists&doi=10.1074%2Fjbc.m600440200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m600440200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m600440200%26sid%3Dliteratum%253Aachs%26aulast%3DEngel%26aufirst%3DS.%26aulast%3DNeumann%26aufirst%3DS.%26aulast%3DKaur%26aufirst%3DN.%26aulast%3DMonga%26aufirst%3DV.%26aulast%3DJain%26aufirst%3DR.%26aulast%3DNorthup%26aufirst%3DJ.%26aulast%3DGershengorn%26aufirst%3DM.%2BC.%26atitle%3DLow%2520Affinity%2520Analogs%2520of%2520Thyrotropin-releasing%2520Hormone%2520Are%2520Super-agonists%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D13103%26epage%3D13109%26doi%3D10.1074%2Fjbc.m600440200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Langmead, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">Supra-physiological efficacy at GPCRs: superstition or super agonists?</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1111/bph.12142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1111%2Fbph.12142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=23441648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvFSgt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2013&pages=353-356&author=C.+J.+Langmeadauthor=A.+Christopoulos&title=Supra-physiological+efficacy+at+GPCRs%3A+superstition+or+super+agonists%3F&doi=10.1111%2Fbph.12142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Supra-physiological efficacy at GPCRs: superstition or super agonists?</span></div><div class="casAuthors">Langmead, Christopher J.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The concept of "super agonism" has been described since the discovery of peptide hormone analogs that yielded greater functional responses than the endogenous agonists, in the early 1980s.  It has remained an area of debate as to whether such compds. can really display greater efficacy than an endogenous agonist.  However, recent pharmacol. data, combined with crystal structures of different GPCR conformations and improved anal. methods for quantifying drug action, are starting to shed light on this phenomenon and indicate that super agonists may be more than superstition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrquBL04A_rILVg90H21EOLACvtfcHk0lhnKNPw3lKSAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvFSgt7g%253D&md5=50b127c3cda2d82b859df07e556dc463</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1111%2Fbph.12142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12142%26sid%3Dliteratum%253Aachs%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DSupra-physiological%2520efficacy%2520at%2520GPCRs%253A%2520superstition%2520or%2520super%2520agonists%253F%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D169%26spage%3D353%26epage%3D356%26doi%3D10.1111%2Fbph.12142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alix, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosier, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casterlow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyce, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulte, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukat, M.</span></span> <span> </span><span class="NLM_article-title">Superagonist, full agonist, partial agonist, and antagonist actions of arylguanidines at 5-hydroxytryptamine-3 (5-HT<sub>3</sub>) subunit A receptors</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1565</span>– <span class="NLM_lpage">1574</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.6b00196</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00196" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlKnurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1565-1574&author=K.+Alixauthor=S.+Khatriauthor=P.+D.+Mosierauthor=S.+Casterlowauthor=D.+Yanauthor=H.+L.+Nyceauthor=M.+M.+Whiteauthor=M.+K.+Schulteauthor=M.+Dukat&title=Superagonist%2C+full+agonist%2C+partial+agonist%2C+and+antagonist+actions+of+arylguanidines+at+5-hydroxytryptamine-3+%285-HT3%29+subunit+A+receptors&doi=10.1021%2Facschemneuro.6b00196"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Superagonist, Full Agonist, Partial Agonist, and Antagonist Actions of Arylguanidines at 5-Hydroxytryptamine-3 (5-HT3) Subunit A Receptors</span></div><div class="casAuthors">Alix, Katie; Khatri, Shailesh; Mosier, Philip D.; Casterlow, Samantha; Yan, Dong; Nyce, Heather L.; White, Michael M.; Schulte, Marvin K.; Dukat, Malgorzata</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1565-1574</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Introduction of minor variations to the substitution pattern of arylguanidine 5-HT3 ligands resulted in a broad spectrum of functionally-active ligands from antagonist to super-agonist.  Introduction of an addnl. Cl-substituent(s) to the lead full agonist N-(3-chlorophenyl)guanidine (mCPG) I (efficacy % = 106) yielded three super-agonists (efficacy % = 186, 139, and 129, resp.).  A positional isomer of I, p-Cl analog, displayed partial agonist actions (efficacy % = 12) replacing the halogen atom at the meta or para position with an electron donating OCH3 group or a stronger electron withdrawing (i.e., CF3) group resulted in four more antagonists.  The authors conclude based on combined mutagenesis, crystallog., and computational analyses that for the 5-HT3 receptor, the arylguanidines that are better able to simultaneously engage the primary and complementary subunits, thus keeping them in close proximity, have greater agonist character while those that are deficient in this ability are antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOxZMYAx3GZrVg90H21EOLACvtfcHk0lhnKNPw3lKSAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlKnurfI&md5=b8b96cb2284ebec508a9f68b23930baf</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00196%26sid%3Dliteratum%253Aachs%26aulast%3DAlix%26aufirst%3DK.%26aulast%3DKhatri%26aufirst%3DS.%26aulast%3DMosier%26aufirst%3DP.%2BD.%26aulast%3DCasterlow%26aufirst%3DS.%26aulast%3DYan%26aufirst%3DD.%26aulast%3DNyce%26aufirst%3DH.%2BL.%26aulast%3DWhite%26aufirst%3DM.%2BM.%26aulast%3DSchulte%26aufirst%3DM.%2BK.%26aulast%3DDukat%26aufirst%3DM.%26atitle%3DSuperagonist%252C%2520full%2520agonist%252C%2520partial%2520agonist%252C%2520and%2520antagonist%2520actions%2520of%2520arylguanidines%2520at%25205-hydroxytryptamine-3%2520%25285-HT3%2529%2520subunit%2520A%2520receptors%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D1565%26epage%3D1574%26doi%3D10.1021%2Facschemneuro.6b00196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosethorne, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gherbi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattikar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trifilieff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairhurst, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlton, S. J.</span></span> <span> </span><span class="NLM_article-title">Long receptor residence time of C26 contributes to super agonist activity at the human β<sub>2</sub>-receptor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">467</span>– <span class="NLM_lpage">475</span>, <span class="refDoi"> DOI: 10.1124/mol.115.101253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1124%2Fmol.115.101253" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2016&pages=467-475&author=E.+M.+Rosethorneauthor=M.+E.+Bradleyauthor=K.+Gherbiauthor=D.+A.+Sykesauthor=A.+Sattikarauthor=J.+D.+Wrightauthor=E.+Renardauthor=A.+Trifilieffauthor=R.+A.+Fairhurstauthor=S.+J.+Charlton&title=Long+receptor+residence+time+of+C26+contributes+to+super+agonist+activity+at+the+human+%CE%B22-receptor&doi=10.1124%2Fmol.115.101253"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1124%2Fmol.115.101253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.115.101253%26sid%3Dliteratum%253Aachs%26aulast%3DRosethorne%26aufirst%3DE.%2BM.%26aulast%3DBradley%26aufirst%3DM.%2BE.%26aulast%3DGherbi%26aufirst%3DK.%26aulast%3DSykes%26aufirst%3DD.%2BA.%26aulast%3DSattikar%26aufirst%3DA.%26aulast%3DWright%26aufirst%3DJ.%2BD.%26aulast%3DRenard%26aufirst%3DE.%26aulast%3DTrifilieff%26aufirst%3DA.%26aulast%3DFairhurst%26aufirst%3DR.%2BA.%26aulast%3DCharlton%26aufirst%3DS.%2BJ.%26atitle%3DLong%2520receptor%2520residence%2520time%2520of%2520C26%2520contributes%2520to%2520super%2520agonist%2520activity%2520at%2520the%2520human%2520%25CE%25B22-receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2016%26volume%3D89%26spage%3D467%26epage%3D475%26doi%3D10.1124%2Fmol.115.101253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faeh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span> <span> </span><span class="NLM_article-title">Fluorine in pharmaceuticals: looking beyond intuition</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>317</i></span>,  <span class="NLM_fpage">1881</span>– <span class="NLM_lpage">1886</span>, <span class="refDoi"> DOI: 10.1126/science.1131943</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1126%2Fscience.1131943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=17901324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BD2srnvVOnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2007&pages=1881-1886&author=K.+Mullerauthor=C.+Faehauthor=F.+Diederich&title=Fluorine+in+pharmaceuticals%3A+looking+beyond+intuition&doi=10.1126%2Fscience.1131943"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in pharmaceuticals: looking beyond intuition</span></div><div class="casAuthors">Muller Klaus; Faeh Christoph; Diederich Francois</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">5846</span>),
    <span class="NLM_cas:pages">1881-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Fluorine substituents have become a widespread and important drug component, their introduction facilitated by the development of safe and selective fluorinating agents.  Organofluorine affects nearly all physical and adsorption, distribution, metabolism, and excretion properties of a lead compound.  Its inductive effects are relatively well understood, enhancing bioavailability, for example, by reducing the basicity of neighboring amines.  In contrast, exploration of the specific influence of carbon-fluorine single bonds on docking interactions, whether through direct contact with the protein or through stereoelectronic effects on molecular conformation of the drug, has only recently begun.  Here, we review experimental progress in this vein and add complementary analysis based on comprehensive searches in the Cambridge Structural Database and the Protein Data Bank.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQekuTGhVzexmgRQsDqrjW_fW6udTcc2eaiGGg9lD8yo7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srnvVOnuw%253D%253D&md5=f624ab3733f7fc9d4b1711f2f3566ca2</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1126%2Fscience.1131943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1131943%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DK.%26aulast%3DFaeh%26aufirst%3DC.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DFluorine%2520in%2520pharmaceuticals%253A%2520looking%2520beyond%2520intuition%26jtitle%3DScience%26date%3D2007%26volume%3D317%26spage%3D1881%26epage%3D1886%26doi%3D10.1126%2Fscience.1131943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vulpetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvit, C.</span></span> <span> </span><span class="NLM_article-title">Fluorine local environment: from screening to drug design</span>. <i>Drug Discov. Today</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">890</span>– <span class="NLM_lpage">897</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2012.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.drudis.2012.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=22480871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvVSluro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=890-897&author=A.+Vulpettiauthor=C.+Dalvit&title=Fluorine+local+environment%3A+from+screening+to+drug+design&doi=10.1016%2Fj.drudis.2012.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine local environment: from screening to drug design</span></div><div class="casAuthors">Vulpetti, Anna; Dalvit, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">15-16</span>),
    <span class="NLM_cas:pages">890-897</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Fluorine is widely used in the lead optimization phase of drug discovery projects.  More recently, fluorine NMR-based spectroscopy has emerged as a versatile, reliable and efficient tool for performing binding and biochem. assays.  Different libraries of fluorinated compds., designed by maximizing the chem. space around the fluorine atom, are screened for identifying binding fragments and for detecting putative fluorophilic hot spots on the desired macromol. target.  A statistical anal. of the fluorine NMR chem. shift, which is a marker of the fluorine local environment, and of the X-ray structures of fluorinated mols. has resulted in the development of the 'rule of shielding'.  This method could become a useful tool for lead optimization and for designing novel chem. scaffolds that recognize distinct protein structural motifs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWqEJk54cQArVg90H21EOLACvtfcHk0ljhYrFEpV3Aig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvVSluro%253D&md5=0023aca3cd342f48898357b83c7eaf47</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2012.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2012.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DDalvit%26aufirst%3DC.%26atitle%3DFluorine%2520local%2520environment%253A%2520from%2520screening%2520to%2520drug%2520design%26jtitle%3DDrug%2520Discov.%2520Today%26date%3D2012%26volume%3D17%26spage%3D890%26epage%3D897%26doi%3D10.1016%2Fj.drudis.2012.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopatina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inzhutova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshihara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishiyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagitani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukaida, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hori, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshioka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherepanov, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmina, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span> <span> </span><span class="NLM_article-title">Displays of paternal mouse pup retrieval following communicative interaction with maternal mates</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1346</span>, <span class="refDoi"> DOI: 10.1038/ncomms2336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1038%2Fncomms2336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=23299896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BC3s3nvVWjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1346&author=H.-X.+Liuauthor=O.+Lopatinaauthor=C.+Higashidaauthor=H.+Fujimotoauthor=S.+Aktherauthor=A.+Inzhutovaauthor=M.+Liangauthor=J.+Zhongauthor=T.+Tsujiauthor=T.+Yoshiharaauthor=K.+Sumiauthor=M.+Ishiyamaauthor=W.+J.+Maauthor=M.+Ozakiauthor=S.+Yagitaniauthor=S.+Yokoyamaauthor=N.+Mukaidaauthor=T.+Sakuraiauthor=O.+Horiauthor=K.+Yoshiokaauthor=A.+Hiraoauthor=Y.+Katoauthor=K.+Ishiharaauthor=I.+Katoauthor=H.+Okamotoauthor=S.+M.+Cherepanovauthor=A.+B.+Salminaauthor=H.+Hiraiauthor=M.+Asanoauthor=D.+A.+Brownauthor=I.+Naganoauthor=H.+Higashida&title=Displays+of+paternal+mouse+pup+retrieval+following+communicative+interaction+with+maternal+mates&doi=10.1038%2Fncomms2336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Displays of paternal mouse pup retrieval following communicative interaction with maternal mates</span></div><div class="casAuthors">Liu Hong-Xiang; Lopatina Olga; Higashida Chiharu; Fujimoto Hiroko; Akther Shirin; Inzhutova Alena; Liang Mingkun; Zhong Jing; Tsuji Takahiro; Yoshihara Toru; Sumi Kohei; Ishiyama Mizuho; Ma Wen-Jie; Ozaki Mitsunori; Yagitani Satoshi; Yokoyama Shigeru; Mukaida Naofumi; Sakurai Takeshi; Hori Osamu; Yoshioka Katsuji; Hirao Atsushi; Kato Yukio; Ishihara Katsuhiko; Kato Ichiro; Okamoto Hiroshi; Cherepanov Stanislav M; Salmina Alla B; Hirai Hirokazu; Asano Masahide; Brown David A; Nagano Isamu; Higashida Haruhiro</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1346</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Compared with the knowledge of maternal care, much less is known about the factors required for paternal parental care.  Here we report that new sires of laboratory mice, though not spontaneously parental, can be induced to show maternal-like parental care (pup retrieval) using signals from dams separated from their pups.  During this interaction, the maternal mates emit 38-kHz ultrasonic vocalizations to their male partners, which are equivalent to vocalizations that occur following pheromone stimulation.  Without these signals or in the absence of maternal mates, the sires do not retrieve their pups within 5 min.  These results show that, in mice, the maternal parent communicates to the paternal parent to encourage pup care.  This new paradigm may be useful in the analysis of the parental brain during paternal care induced by interactive communication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRnfgpXeTc_99hSDZx9hyjKfW6udTcc2eaiGGg9lD8yo7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3nvVWjtw%253D%253D&md5=8600f6cdb3d073d32c2b7be9cc932ce6</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fncomms2336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms2336%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.-X.%26aulast%3DLopatina%26aufirst%3DO.%26aulast%3DHigashida%26aufirst%3DC.%26aulast%3DFujimoto%26aufirst%3DH.%26aulast%3DAkther%26aufirst%3DS.%26aulast%3DInzhutova%26aufirst%3DA.%26aulast%3DLiang%26aufirst%3DM.%26aulast%3DZhong%26aufirst%3DJ.%26aulast%3DTsuji%26aufirst%3DT.%26aulast%3DYoshihara%26aufirst%3DT.%26aulast%3DSumi%26aufirst%3DK.%26aulast%3DIshiyama%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DW.%2BJ.%26aulast%3DOzaki%26aufirst%3DM.%26aulast%3DYagitani%26aufirst%3DS.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DMukaida%26aufirst%3DN.%26aulast%3DSakurai%26aufirst%3DT.%26aulast%3DHori%26aufirst%3DO.%26aulast%3DYoshioka%26aufirst%3DK.%26aulast%3DHirao%26aufirst%3DA.%26aulast%3DKato%26aufirst%3DY.%26aulast%3DIshihara%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DI.%26aulast%3DOkamoto%26aufirst%3DH.%26aulast%3DCherepanov%26aufirst%3DS.%2BM.%26aulast%3DSalmina%26aufirst%3DA.%2BB.%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DAsano%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DD.%2BA.%26aulast%3DNagano%26aufirst%3DI.%26aulast%3DHigashida%26aufirst%3DH.%26atitle%3DDisplays%2520of%2520paternal%2520mouse%2520pup%2520retrieval%2520following%2520communicative%2520interaction%2520with%2520maternal%2520mates%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D1346%26doi%3D10.1038%2Fncomms2336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gutkowska, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jankowski, M.</span></span> <span> </span><span class="NLM_article-title">Oxytocin revisited: its role in cardiovascular regulation</span>. <i>J. Neuroendocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2826.2011.02235.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1111%2Fj.1365-2826.2011.02235.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=21981277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFKrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2012&pages=599-608&author=J.+Gutkowskaauthor=M.+Jankowski&title=Oxytocin+revisited%3A+its+role+in+cardiovascular+regulation&doi=10.1111%2Fj.1365-2826.2011.02235.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin revisited: its role in cardiovascular regulation</span></div><div class="casAuthors">Gutkowska, J.; Jankowski, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroendocrinology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">599-608</span>CODEN:
                <span class="NLM_cas:coden">JOUNE2</span>;
        ISSN:<span class="NLM_cas:issn">0953-8194</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Traditionally assocd. with female reprodn., oxytocin (OT) was revisited recently and was revealed to have several new roles in the cardiovascular system.  Functional OT receptors have been discovered in the rat and human heart, as well as in vascular beds.  The cardiovascular activities of OT include: (i) lowering blood pressure; (ii) neg. cardiac inotropy and chronotropy; (iii) parasympathetic neuromodulation; (iv) vasodilatation; (v) anti-inflammatory; (vi) antioxidative; and (vii) metabolic effects.  These outcomes are mediated, at least in part, by stimulating cardioprotective mediators, such as nitric oxide and atrial natriuretic peptide.  OT and its extended form OT-Gly-Lys-Arg have been shown to be abundant in the fetal mouse heart.  OT has the capacity to generate cardiomyocytes from various types of stem cells, including the cardiac side population.  Mesenchymal cells transfected with OT-Gly-Lys-Arg, or preconditioned with OT, are resistant to apoptosis and express endothelial cell markers.  OT increases glucose uptake in cultured cardiomyocytes from newborn and adult rats, in normal, hypoxic and even insulin resistance conditions.  In rats with exptl.-induced myocardial infarction, continuous in vivo OT delivery improves the cardiac healing process, as well as cardiac work, reduces inflammation and stimulates angiogenesis.  Therefore, in pathol. conditions, OT exerts anti-inflammatory and cardioprotective properties, and improves vascular and metabolic functions.  Thus, OT has potential for therapeutic use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-22hhU9Rnh7Vg90H21EOLACvtfcHk0ljGefcDExRZqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFKrtr4%253D&md5=8245746d84d7ad7a2bbfbe01ec1b38d0</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2826.2011.02235.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2826.2011.02235.x%26sid%3Dliteratum%253Aachs%26aulast%3DGutkowska%26aufirst%3DJ.%26aulast%3DJankowski%26aufirst%3DM.%26atitle%3DOxytocin%2520revisited%253A%2520its%2520role%2520in%2520cardiovascular%2520regulation%26jtitle%3DJ.%2520Neuroendocrinol.%26date%3D2012%26volume%3D24%26spage%3D599%26epage%3D608%26doi%3D10.1111%2Fj.1365-2826.2011.02235.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lopatina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amina, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashii, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span> <span> </span><span class="NLM_article-title">Oxytocin-induced elevation of ADP-ribosyl cyclase activity, cyclic ADP-riboseor Ca2+ concentrations is involved in autoregulation of oxytocin secretionin the hypothalamus and posterior pituitary in male mice</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2009.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.neuropharm.2009.06.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=19540855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BD1Mjjs1eltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2010&pages=50-55&author=O.+Lopatinaauthor=H.-X.+Liuauthor=S.+Aminaauthor=M.+Hashiiauthor=H.+Higashida&title=Oxytocin-induced+elevation+of+ADP-ribosyl+cyclase+activity%2C+cyclic+ADP-riboseor+Ca2%2B+concentrations+is+involved+in+autoregulation+of+oxytocin+secretionin+the+hypothalamus+and+posterior+pituitary+in+male+mice&doi=10.1016%2Fj.neuropharm.2009.06.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin-induced elevation of ADP-ribosyl cyclase activity, cyclic ADP-ribose or Ca(2+) concentrations is involved in autoregulation of oxytocin secretion in the hypothalamus and posterior pituitary in male mice</span></div><div class="casAuthors">Lopatina Olga; Liu Hong-Xiang; Amina Sarwat; Hashii Minako; Higashida Haruhiro</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Locally released oxytocin (OT) activates OT receptors (2.1:OXY:1:OT:) in neighboring neurons in the hypothalamus and their terminals in the posterior pituitary, resulting in further OT release, best known in autoregulation occurring during labor or milk ejection in reproductive females.  OT also plays a critical role in social behavior of non-reproductive females and even in males in mammals from rodents to humans.  Social behavior is disrupted when elevation of free intracellular Ca(2+) concentration ([Ca(2+)](i)) and OT secretion are reduced in male and female CD38 knockout mice.  Therefore, it is interesting to investigate whether ADP-ribosyl cyclase-dependent signaling is involved in OT-induced OT release for social recognition in males, independent from female reproduction, and to determine its molecular mechanism.  Here, we report that ADP-ribosyl cyclase activity was increased by OT in crude membrane preparations of the hypothalamus and posterior pituitary in male mice, and that OT elicited an increase in [Ca(2+)](i) in the isolated terminals over a period of 5 min.  The increases in cyclase and [Ca(2+)](i) were partially inhibited by nonspecific protein kinase inhibitors and a protein kinase C specific inhibitor, calphostin C.  Subsequently, OT-induced OT release was also inhibited by calphostin C to levels inhibited by vasotocin, an OT receptor antagonist, and 8-bromo-cADP-ribose.  These results demonstrate that OT receptors are functionally coupled to membrane-bound ADP-ribosyl cyclase and/or CD38 and suggest that cADPR-mediated intracellular calcium signaling is involved in autoregulation of OT release, which is sensitive to protein kinase C, in the hypothalamus and neurohypophysis in male mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQOi4ky_YbawEPI-fCgwosgfW6udTcc2eZof8DvVjPYNLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mjjs1eltQ%253D%253D&md5=b01aa824e66a5c133179f3787a7dcafb</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2009.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2009.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DLopatina%26aufirst%3DO.%26aulast%3DLiu%26aufirst%3DH.-X.%26aulast%3DAmina%26aufirst%3DS.%26aulast%3DHashii%26aufirst%3DM.%26aulast%3DHigashida%26aufirst%3DH.%26atitle%3DOxytocin-induced%2520elevation%2520of%2520ADP-ribosyl%2520cyclase%2520activity%252C%2520cyclic%2520ADP-riboseor%2520Ca2%252B%2520concentrations%2520is%2520involved%2520in%2520autoregulation%2520of%2520oxytocin%2520secretionin%2520the%2520hypothalamus%2520and%2520posterior%2520pituitary%2520in%2520male%2520mice%26jtitle%3DNeuropharmacology%26date%3D2010%26volume%3D58%26spage%3D50%26epage%3D55%26doi%3D10.1016%2Fj.neuropharm.2009.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moy, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolova, V. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddick, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Deusen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janzen, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarstfer, M. B.</span></span> <span> </span><span class="NLM_article-title">Prosocial effects of an oxytocin metabolite, but not synthetic oxytocin receptor agonists, in a mouse model of autism</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">311</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2018.10.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.neuropharm.2018.10.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=30399367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFyqs7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2019&pages=301-311&author=S.+S.+Moyauthor=B.+L.+Tengauthor=V.+D.+Nikolovaauthor=N.+V.+Riddickauthor=C.+D.+Simpsonauthor=A.+Van+Deusenauthor=W.+P.+Janzenauthor=M.+F.+Sassanoauthor=C.+A.+Pedersenauthor=M.+B.+Jarstfer&title=Prosocial+effects+of+an+oxytocin+metabolite%2C+but+not+synthetic+oxytocin+receptor+agonists%2C+in+a+mouse+model+of+autism&doi=10.1016%2Fj.neuropharm.2018.10.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Prosocial effects of an oxytocin metabolite, but not synthetic oxytocin receptor agonists, in a mouse model of autism</span></div><div class="casAuthors">Moy, Sheryl S.; Teng, Brian L.; Nikolova, Viktoriya D.; Riddick, Natallia V.; Simpson, Catherine D.; Van Deusen, Amy; Janzen, William P.; Sassano, Maria F.; Pedersen, Cort A.; Jarstfer, Michael B.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">301-311</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Currently, there are no established pharmaceutical strategies that effectively treat social deficits in autism spectrum disorder (ASD).  Oxytocin, a neurohormone that plays a role in multiple types of social behaviors, has been proposed as a possible therapeutic against social impairment and other symptoms in ASD.  However, from the standpoint of pharmacotherapy, oxytocin has several liabilities as a std. clin. treatment, including rapid metab., low brain penetrance, and activity at the vasopressin (antidiuretic hormone) receptors.  The present studies describe findings from a preclin. screening program to evaluate oxytocin receptor (OXTR) agonists and oxytocin metabolites for potential clin. use as more optimal treatments.  We first investigated two synthetic oxytocin analogs, TC-OT-39 and carbetocin, using in vitro cell-based assays for pharmacol. characterization and behavioral tests in the BALB/cByJ mouse model of ASD-like social deficits.  Although both TC-OT-39 and carbetocin selectively activate the OXTR, neither synthetic agonist had prosocial efficacy in the BALB/cByJ model.  We next evaluated two oxytocin metabolites: OT(4-9) and OT(5-9).  While OT(5-9) failed to affect social deficits, the metabolite OT(4-9) led to significant social preference in the BALB/cByJ model, in a dose-dependent manner.  The increased sociability was obsd. at both 24 h and 12 days following the end of a subchronic regimen with OT(4-9) (2.0 mg/kg).  Overall, these results suggest that the prosocial effects of oxytocin could be mediated by downstream activity of oxytocin metabolites, raising the possibility of new pathways to target for drug discovery relevant to ASD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1HRdMtMK2erVg90H21EOLACvtfcHk0ljGefcDExRZqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFyqs7fE&md5=aeef8ff89768e7add24e1f9b55ff80e8</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2018.10.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2018.10.036%26sid%3Dliteratum%253Aachs%26aulast%3DMoy%26aufirst%3DS.%2BS.%26aulast%3DTeng%26aufirst%3DB.%2BL.%26aulast%3DNikolova%26aufirst%3DV.%2BD.%26aulast%3DRiddick%26aufirst%3DN.%2BV.%26aulast%3DSimpson%26aufirst%3DC.%2BD.%26aulast%3DVan%2BDeusen%26aufirst%3DA.%26aulast%3DJanzen%26aufirst%3DW.%2BP.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DPedersen%26aufirst%3DC.%2BA.%26aulast%3DJarstfer%26aufirst%3DM.%2BB.%26atitle%3DProsocial%2520effects%2520of%2520an%2520oxytocin%2520metabolite%252C%2520but%2520not%2520synthetic%2520oxytocin%2520receptor%2520agonists%252C%2520in%2520a%2520mouse%2520model%2520of%2520autism%26jtitle%3DNeuropharmacology%26date%3D2019%26volume%3D144%26spage%3D301%26epage%3D311%26doi%3D10.1016%2Fj.neuropharm.2018.10.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grinevich, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knobloch-Bollmann, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliava, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busnelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chini, B.</span></span> <span> </span><span class="NLM_article-title">Assembling the puzzle: Pathways of oxytocin signaling in the brain</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">164</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2015.04.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.biopsych.2015.04.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=26001309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC2MXos1Oku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=155-164&author=V.+Grinevichauthor=H.+S.+Knobloch-Bollmannauthor=M.+Eliavaauthor=M.+Busnelliauthor=B.+Chini&title=Assembling+the+puzzle%3A+Pathways+of+oxytocin+signaling+in+the+brain&doi=10.1016%2Fj.biopsych.2015.04.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Assembling the Puzzle: Pathways of Oxytocin Signaling in the Brain</span></div><div class="casAuthors">Grinevich, Valery; Knobloch-Bollmann, H. Sophie; Eliava, Marina; Busnelli, Marta; Chini, Bice</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">155-164</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Oxytocin (OT) is a neuropeptide, which can be seen to be one of the mols. of the decade due to its profound prosocial effects in nonvertebrate and vertebrate species, including humans.  Although OT can be detected in various physiol. fluids (blood, saliva, urine, cerebrospinal fluid) and brain tissue, it is unclear whether peripheral and central OT releases match and synergize.  Moreover, the pathways of OT delivery to brain regions involved in specific behaviors are far from clear.  Here, we discuss the evolutionarily and ontogenetically detd. pathways of OT delivery and OT signaling, which orchestrate activity of the mesolimbic social decision-making network.  Furthermore, we speculate that both the alteration in OT delivery and OT receptor expression may cause behavioral abnormalities in patients afflicted with psychosocial diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6gjPAwBbAP7Vg90H21EOLACvtfcHk0lhPpGbpootklQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXos1Oku7g%253D&md5=4b8181c48d1a7dacc13144a675893e1d</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2015.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2015.04.013%26sid%3Dliteratum%253Aachs%26aulast%3DGrinevich%26aufirst%3DV.%26aulast%3DKnobloch-Bollmann%26aufirst%3DH.%2BS.%26aulast%3DEliava%26aufirst%3DM.%26aulast%3DBusnelli%26aufirst%3DM.%26aulast%3DChini%26aufirst%3DB.%26atitle%3DAssembling%2520the%2520puzzle%253A%2520Pathways%2520of%2520oxytocin%2520signaling%2520in%2520the%2520brain%26jtitle%3DBiol.%2520Psychiatry%26date%3D2016%26volume%3D79%26spage%3D155%26epage%3D164%26doi%3D10.1016%2Fj.biopsych.2015.04.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlton, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlton, S. J.</span></span> <span> </span><span class="NLM_article-title">Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M3 receptor</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">927</span>– <span class="NLM_lpage">937</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0706819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1038%2Fsj.bjp.0706819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=16847442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFWrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2006&pages=927-937&author=M.+R.+Dowlingauthor=S.+J.+Charltonauthor=S.+J.+Charlton&title=Quantifying+the+association+and+dissociation+rates+of+unlabelled+antagonists+at+the+muscarinic+M3+receptor&doi=10.1038%2Fsj.bjp.0706819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M3 receptor</span></div><div class="casAuthors">Dowling, Mark R.; Charlton, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">927-937</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Slow receptor dissocn. kinetics has been implicated in the long clin. duration of action of the muscarinic receptor antagonist tiotropium.  However, despite the potential benefits of new drugs with slow dissocn. kinetics, the rate parameters of new compds. are seldom measured due to tech. difficulties and financial implications assocd. with radiolabeling multiple ligands.  Here we describe the development and optimization of a medium throughput assay which is capable of measuring the kinetic parameters of novel, unlabeled compds.  Radioligand binding studies were performed with membranes derived from CHO cells recombinantly expressing the human M3 muscarinic receptor.  Initial characterization of the radioligand [3H]-NMS yielded on and off rates of 4.1±0.2×108 M-1 min-1 and 0.015±0.0005 min-1, resp.  The specific binding of [3H]-NMS was measured over time in the presence and absence of several concns. of unlabeled competitor compds.  These data were analyzed using a competition kinetic model to provide on and off rates for the unlabeled competitor.  Comparison of the kinetically derived Kd (koff/kon) with Ki values generated at equil. showed an excellent correlation (r2=0.99), providing good validation of the method.  The on and off rates were also used in theor. computer simulations to successfully predict the effect of incubation time on apparent IC50 values.  This study demonstrates that a medium-throughput competition kinetic binding assay can be used to det. accurate on and off rates of unlabeled compds., providing the opportunity to optimize for kinetic parameters early in the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwZ8YOvAS0F7Vg90H21EOLACvtfcHk0lhPpGbpootklQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFWrurc%253D&md5=99194c7f2158c3706aa09c4ec83bfbb4</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706819%26sid%3Dliteratum%253Aachs%26aulast%3DDowling%26aufirst%3DM.%2BR.%26aulast%3DCharlton%26aufirst%3DS.%2BJ.%26aulast%3DCharlton%26aufirst%3DS.%2BJ.%26atitle%3DQuantifying%2520the%2520association%2520and%2520dissociation%2520rates%2520of%2520unlabelled%2520antagonists%2520at%2520the%2520muscarinic%2520M3%2520receptor%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D148%26spage%3D927%26epage%3D937%26doi%3D10.1038%2Fsj.bjp.0706819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leighton-Davies, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawcett, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trifilieff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlton, S. J.</span></span> <span> </span><span class="NLM_article-title">The influence of receptor kinetics on the onset and duration of action and the therapeutic index of NVA237 and tiotropium</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>343</i></span>,  <span class="NLM_fpage">520</span>– <span class="NLM_lpage">528</span>, <span class="refDoi"> DOI: 10.1124/jpet.112.194456</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1124%2Fjpet.112.194456" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=22854200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKktb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2012&pages=520-528&author=D.+A.+Sykesauthor=M.+R.+Dowlingauthor=J.+Leighton-Daviesauthor=T.+C.+Kentauthor=L.+Fawcettauthor=E.+Renardauthor=A.+Trifilieffauthor=S.+J.+Charlton&title=The+influence+of+receptor+kinetics+on+the+onset+and+duration+of+action+and+the+therapeutic+index+of+NVA237+and+tiotropium&doi=10.1124%2Fjpet.112.194456"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of receptor kinetics on the onset and duration of action and the therapeutic index of NVA237 and tiotropium</span></div><div class="casAuthors">Sykes, David A.; Dowling, Mark R.; Leighton-Davies, Juliet; Kent, Toby C.; Fawcett, Lindsay; Renard, Emilie; Trifilieff, Alexandre; Charlton, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">520-528</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Studies under nonphysiol. conditions suggest that long receptor residency time is responsible for the 24-h duration of action of the long-acting muscarinic antagonist (LAMA) tiotropium.  Our aim was to det. how clin. relevant dissocn. rates under more physiol. conditions influence the differences in onset of action between tiotropium and 3-[(cyclopentylhydroxyphenylacetyl oxy]-1,1-dimethyl-pyrrolidinium bromide (NVA237), a once-daily dry-powder formulation of the LAMA glycopyrronium bromide in development for chronic obstructive pulmonary disease.  In addn., we have investigated kinetic selectivity at each of the muscarinic receptor subtypes to det. whether the improved cardiovascular therapeutic index obtained with NVA237 in animal models is attributable to differences in kinetic rate consts.  The binding of radioligand [3H]N-methyl-scopolamine was measured in the presence/absence of several concns. of unlabeled competitors, and data were analyzed using a competition kinetic model to provide on/off rates for the competitor.  We found shorter dissocn. half-lives for NVA237 and tiotropium under physiol. (11.4 and 46.2 min, resp.) vs. nonphysiol. conditions (173 and 462 min, resp.).  NVA237 had a more rapid onset of action (3-4.8 times) vs. tiotropium, detd. in an vitro calcium and rat tracheal strip assay.  Simulations suggested that the more rapid onset of NVA237 action could be explained by differences in kinetic parameters.  NVA237 had greater equil. binding and kinetic selectivity for muscarinic type 3 (M3) vs. muscarinic type 2 (M2) receptors, with a faster off rate from M2 vs. M3 receptors than tiotropium, potentially affording it a more favorable therapeutic index.  This study suggests that the 24-h duration of action of NVA237 and tiotropium is not solely the result of their slow dissocn. from the M3 receptor and highlights the importance of conducting in vitro expts. in conditions reflecting those in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPg9FL15nv-bVg90H21EOLACvtfcHk0lhPpGbpootklQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKktb3M&md5=922e31d6cafa771f3cc66aad519c07e8</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.194456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.194456%26sid%3Dliteratum%253Aachs%26aulast%3DSykes%26aufirst%3DD.%2BA.%26aulast%3DDowling%26aufirst%3DM.%2BR.%26aulast%3DLeighton-Davies%26aufirst%3DJ.%26aulast%3DKent%26aufirst%3DT.%2BC.%26aulast%3DFawcett%26aufirst%3DL.%26aulast%3DRenard%26aufirst%3DE.%26aulast%3DTrifilieff%26aufirst%3DA.%26aulast%3DCharlton%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520influence%2520of%2520receptor%2520kinetics%2520on%2520the%2520onset%2520and%2520duration%2520of%2520action%2520and%2520the%2520therapeutic%2520index%2520of%2520NVA237%2520and%2520tiotropium%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D343%26spage%3D520%26epage%3D528%26doi%3D10.1124%2Fjpet.112.194456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dagani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sisti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Paolo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raimondi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocchi, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saviotti, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scocco, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balestrieri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Girolamo, G.</span></span> <span> </span><span class="NLM_article-title">Do we need oxytocin to treat schizophrenia? A randomized clinical trial</span>. <i>Schizophr. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">158</span>– <span class="NLM_lpage">164</span>, <span class="refDoi"> DOI: 10.1016/j.schres.2016.02.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.schres.2016.02.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=26883950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BC28jhtlOisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2016&pages=158-164&author=J.+Daganiauthor=D.+Sistiauthor=M.+Abelliauthor=L.+Di+Paoloauthor=S.+Piniauthor=S.+Raimondiauthor=M.+B.+Rocchiauthor=F.+M.+Saviottiauthor=P.+Scoccoauthor=S.+Totaroauthor=M.+Balestrieriauthor=G.+de+Girolamo&title=Do+we+need+oxytocin+to+treat+schizophrenia%3F+A+randomized+clinical+trial&doi=10.1016%2Fj.schres.2016.02.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Do we need oxytocin to treat schizophrenia? A randomized clinical trial</span></div><div class="casAuthors">Dagani Jessica; Sisti Davide; Rocchi Marco B; Abelli Marianna; Di Paolo Luca; Pini Stefano; Raimondi Sara; Saviotti Francesco M; Scocco Paolo; Totaro Stefano; Balestrieri Matteo; de Girolamo Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Schizophrenia research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">158-64</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Schizophrenia is a disabling complex mental disorder and despite all available treatment, many patients unfortunately remain partial- or non-responders.  A large body of research has shown that oxytocin is an important prosocial peptide and there is initial evidence that the central oxytocin system is altered in several mental disorders.  The aim of this study was to test the efficacy of oxytocin, as augmentation therapy, in a sample of patients with schizophrenia.  METHODS:  We conducted an 8-month randomized, double-blind, controlled trial with a crossover design.  We wanted to test the hypothesis that intranasal oxytocin could reduce symptoms in 32 patients with schizophrenia aged 18-45 with short-medium illness duration (<11 years).  Patients were randomly assigned to either 40 International Units oxytocin once daily or a vehicle placebo group, in addition to their pre-study antipsychotic medication regimen.  We subsequently conducted a multi-dimensional assessment including psychopathological, psychosocial and neuropsychological aspects.  RESULTS:  Positive and Negative Syndrome Scale scores showed no significant differences in treatment effects between the experimental group and controls.  Furthermore, no treatment effects were shown in any of the rating scales used in this study.  However, a statistically significant period effect was shown in most outcome measurements.  CONCLUSIONS:  In our trial, oxytocin did not add any significant beneficial effects to anti-psychotic treatment in terms of clinical symptoms or psychosocial functioning.  Further research should focus on different ways to administer oxytocin, or investigate predictors (such as past traumas, or biomarkers), which could identify subgroups of patients with different treatment responses to oxytocin.  ClinicalTrials.gov Identifier: NCT01699997.  ID number: RF-2010-2311148.  URL: https://clinicaltrials.gov/ct2/show/NCT01699997.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRzRKBith_Kyr5XHngOXiV_fW6udTcc2eZB3ZllzvUkXrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jhtlOisw%253D%253D&md5=c99f91c7ceb957316cb64bd70cdab8ea</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.schres.2016.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.schres.2016.02.011%26sid%3Dliteratum%253Aachs%26aulast%3DDagani%26aufirst%3DJ.%26aulast%3DSisti%26aufirst%3DD.%26aulast%3DAbelli%26aufirst%3DM.%26aulast%3DDi%2BPaolo%26aufirst%3DL.%26aulast%3DPini%26aufirst%3DS.%26aulast%3DRaimondi%26aufirst%3DS.%26aulast%3DRocchi%26aufirst%3DM.%2BB.%26aulast%3DSaviotti%26aufirst%3DF.%2BM.%26aulast%3DScocco%26aufirst%3DP.%26aulast%3DTotaro%26aufirst%3DS.%26aulast%3DBalestrieri%26aufirst%3DM.%26aulast%3Dde%2BGirolamo%26aufirst%3DG.%26atitle%3DDo%2520we%2520need%2520oxytocin%2520to%2520treat%2520schizophrenia%253F%2520A%2520randomized%2520clinical%2520trial%26jtitle%3DSchizophr.%2520Res.%26date%3D2016%26volume%3D172%26spage%3D158%26epage%3D164%26doi%3D10.1016%2Fj.schres.2016.02.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scantamburlo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansenne, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geenen, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legros, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansseau, M.</span></span> <span> </span><span class="NLM_article-title">Additional intranasal oxytocin to escitalopram improves depressive symptoms in resistant depression: an open trial</span>. <i>Eur. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1016/j.eurpsy.2014.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.eurpsy.2014.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=25282363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BC2M7ntlSqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2015&pages=65-68&author=G.+Scantamburloauthor=M.+Hansenneauthor=V.+Geenenauthor=J.+J.+Legrosauthor=M.+Ansseau&title=Additional+intranasal+oxytocin+to+escitalopram+improves+depressive+symptoms+in+resistant+depression%3A+an+open+trial&doi=10.1016%2Fj.eurpsy.2014.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Additional intranasal oxytocin to escitalopram improves depressive symptoms in resistant depression: an open trial</span></div><div class="casAuthors">Scantamburlo G; Hansenne M; Geenen V; Legros J J; Ansseau M</div><div class="citationInfo"><span class="NLM_cas:title">European psychiatry : the journal of the Association of European Psychiatrists</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The aim of this open trial was to assess the antidepressant/anxiolytic effects of oxytocin used as an adjunct to antidepressant in treatment-resistant depression.  Fourteen patients, who have not responded to 40mg of escitalopram, received intranasal synthetic oxytocin during 4 weeks, in association with antidepressant.  This is the first open trial study suggesting OT in association with escitalopram significantly reduced scores on Hamilton Depression Rating Scale.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRowSWOqbMPPFMGsG_HTXYFfW6udTcc2eamTGnXYY3jrbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7ntlSqtg%253D%253D&md5=1e620f1da6f4454d2eb6ef29159d1027</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.eurpsy.2014.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.eurpsy.2014.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DScantamburlo%26aufirst%3DG.%26aulast%3DHansenne%26aufirst%3DM.%26aulast%3DGeenen%26aufirst%3DV.%26aulast%3DLegros%26aufirst%3DJ.%2BJ.%26aulast%3DAnsseau%26aufirst%3DM.%26atitle%3DAdditional%2520intranasal%2520oxytocin%2520to%2520escitalopram%2520improves%2520depressive%2520symptoms%2520in%2520resistant%2520depression%253A%2520an%2520open%2520trial%26jtitle%3DEur.%2520Psychiatry%26date%3D2015%26volume%3D30%26spage%3D65%26epage%3D68%26doi%3D10.1016%2Fj.eurpsy.2014.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amina, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashii, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopatina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Islam, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span> <span> </span><span class="NLM_article-title">Intracellular calcium elevation induced by extracellular application of cyclic-ADP-ribose or oxytocin is temperature-sensitive in rodent NG108-15 neuronal cells with or without exogenous expression of human oxytocin receptors</span>. <i>J. Neuroendocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">460</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2826.2010.01978.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1111%2Fj.1365-2826.2010.01978.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=20163520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlslyjur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2010&pages=460-466&author=S.+Aminaauthor=M.+Hashiiauthor=W.-J.+Maauthor=S.+Yokoyamaauthor=O.+Lopatinaauthor=H.-X.+Liuauthor=M.+S.+Islamauthor=H.+Higashida&title=Intracellular+calcium+elevation+induced+by+extracellular+application+of+cyclic-ADP-ribose+or+oxytocin+is+temperature-sensitive+in+rodent+NG108-15+neuronal+cells+with+or+without+exogenous+expression+of+human+oxytocin+receptors&doi=10.1111%2Fj.1365-2826.2010.01978.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular calcium elevation induced by extracellular application of cyclic-ADP-ribose or oxytocin is temperature-sensitive in rodent NG108-15 neuronal cells with or without exogenous expression of human oxytocin receptors</span></div><div class="casAuthors">Amina, S.; Hashii, M.; Ma, W.-J.; Yokoyama, S.; Lopatina, O.; Liu, H.-X.; Islam, M. S.; Higashida, H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroendocrinology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">460-466</span>CODEN:
                <span class="NLM_cas:coden">JOUNE2</span>;
        ISSN:<span class="NLM_cas:issn">0953-8194</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">ADP-ribosyl cyclase and/or CD38 are activated after oxytocin receptor stimulation in the hypothalamus and pituitary in adult mice, leading to facilitation of oxytocin secretion.  Although cyclic adenosine 5'-diphosphoribose (cADPR) primarily acts as an intracellular second messenger, it has been suggested that extracellular cADPR stimulates intracellular ryanodine receptors after internalization via the nucleotide-transporting capacity of CD38 in fibroblasts and astrocytes.  However, little is known about whether extracellular cADPR activates neurons.  To address this question, we used a model neuronal cell line, NG108-15 mouse neuroblastoma × rat glioma hybrid cells possessing CD38 but not oxytocin receptors, and measured cytosolic free calcium concns. ([Ca2+]i).  Extracellular application of cADPR to NG108-15 cells elevated [Ca2+]i at 35°.  The elevation was significantly enhanced when measured at 40°.  The cADPR and heat-induced [Ca2+]i increase were blocked under extracellular Ca2+-free conditions and by 2-aminoethoxydiphenyl borate, an antagonist of melastatin-related transient receptor potential channel 2 (TRPM2) cation channels.  Reverse transcription-polymerase chain reaction analyses indicated that TRPM2 channels were expressed in NG108-15 cells.  Application of oxytocin elevated [Ca2+]i in NG108-15 cells transformed to transiently express cloned human oxytocin receptors.  The oxytocin-induced [Ca2+]i response was also enhanced by heat.  These results indicate that the extracellular application of cADPR, together with heat, activates cation influx downstream of oxytocin receptor signaling in NG108-15 neuronal cells, and suggest the possible involvement of TRPM2 channels in oxytocin release in the mammalian brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIJBynRUPurrVg90H21EOLACvtfcHk0lgKsamDB9Cb-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlslyjur4%253D&md5=eb4759e46559f4619a3d0c0998a97ea2</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2826.2010.01978.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2826.2010.01978.x%26sid%3Dliteratum%253Aachs%26aulast%3DAmina%26aufirst%3DS.%26aulast%3DHashii%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DW.-J.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DLopatina%26aufirst%3DO.%26aulast%3DLiu%26aufirst%3DH.-X.%26aulast%3DIslam%26aufirst%3DM.%2BS.%26aulast%3DHigashida%26aufirst%3DH.%26atitle%3DIntracellular%2520calcium%2520elevation%2520induced%2520by%2520extracellular%2520application%2520of%2520cyclic-ADP-ribose%2520or%2520oxytocin%2520is%2520temperature-sensitive%2520in%2520rodent%2520NG108-15%2520neuronal%2520cells%2520with%2520or%2520without%2520exogenous%2520expression%2520of%2520human%2520oxytocin%2520receptors%26jtitle%3DJ.%2520Neuroendocrinol.%26date%3D2010%26volume%3D22%26spage%3D460%26epage%3D466%26doi%3D10.1111%2Fj.1365-2826.2010.01978.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stucki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Py, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundschober, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gee, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Building bridges for highly selective, potent and stable oxytocin and vasopressin analogs</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3039</span>– <span class="NLM_lpage">3045</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.03.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.bmc.2018.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=29602673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmt1altbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=3039-3045&author=R.+Beardauthor=A.+Stuckiauthor=M.+Schmittauthor=G.+Pyauthor=C.+Grundschoberauthor=A.+D.+Geeauthor=E.+W.+Tate&title=Building+bridges+for+highly+selective%2C+potent+and+stable+oxytocin+and+vasopressin+analogs&doi=10.1016%2Fj.bmc.2018.03.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Building bridges for highly selective, potent and stable oxytocin and vasopressin analogs</span></div><div class="casAuthors">Beard, Rhiannon; Stucki, Andy; Schmitt, Muriel; Py, Gabrielle; Grundschober, Christophe; Gee, Antony D.; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3039-3045</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Oxytocin (OT) is an exciting potential therapeutic agent, but it is highly sensitive to modification and suffers extensive degrdn. at elevated temp. and in vivo.  Here we report studies towards OT analogs with favorable selectivity, affinity and potency towards the oxytocin receptor (OTR), in addn. to improving stability of the peptide by bridging the disulfide region with substituted dibromo-xylene analogs.  We found a sensitive structure-activity relationship in which meta-cyclized analogs (dOTmeta) gave highest affinity (50nM Ki), selectivity (34-fold), and agonist potency (34nM EC50, 87-fold selectivity) towards OTR.  Surprisingly, ortho-cyclized analogs demonstrated OTR and vasopressin V1a receptor subtype affinity (220nM and 69nM, resp.) and pharmacol. activity (294nM and 35nM, resp.).  V1a binding and selectivity for ortho-cyclized peptides could be improved 6-fold by substituting a neutral residue at position 8 with a basic amino acid, providing potent antagonists (14nM IC50) that displayed no activation of the OTR.  Furthermore, xylene-bridged analogs demonstrated increased stability compared to OT at elevated temp., demonstrating promising therapeutic potential for these analogs which warrants further study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYKg2TnF3CUbVg90H21EOLACvtfcHk0lgKsamDB9Cb-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmt1altbk%253D&md5=76eb52b06286e61a2e38f88108e0123b</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DBeard%26aufirst%3DR.%26aulast%3DStucki%26aufirst%3DA.%26aulast%3DSchmitt%26aufirst%3DM.%26aulast%3DPy%26aufirst%3DG.%26aulast%3DGrundschober%26aufirst%3DC.%26aulast%3DGee%26aufirst%3DA.%2BD.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DBuilding%2520bridges%2520for%2520highly%2520selective%252C%2520potent%2520and%2520stable%2520oxytocin%2520and%2520vasopressin%2520analogs%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D3039%26epage%3D3045%26doi%3D10.1016%2Fj.bmc.2018.03.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miki, N.</span></span> <span> </span><span class="NLM_article-title">A single class of neurotensin receptors with high affinity in neuroblastoma X glioma NG108-15 hybrid cells that mediate facilitation of synaptic transmission</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1653</span>– <span class="NLM_lpage">1661</span>, <span class="refDoi"> DOI: 10.1523/jneurosci.04-06-01653.1984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1523%2Fjneurosci.04-06-01653.1984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=6327939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADyaL2cXks1Klsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1984&pages=1653-1661&author=Y.+Nakagawaauthor=H.+Higashidaauthor=N.+Miki&title=A+single+class+of+neurotensin+receptors+with+high+affinity+in+neuroblastoma+X+glioma+NG108-15+hybrid+cells+that+mediate+facilitation+of+synaptic+transmission&doi=10.1523%2Fjneurosci.04-06-01653.1984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">A single class of neurotensin receptors with high affinity in neuroblastoma × glioma NG108-15 hybrid cells that mediate facilitation of synaptic transmission</span></div><div class="casAuthors">Nakagawa, Yuzo; Higashida, Haruhiro; Miki, Naomasa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1653-61</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    </div><div class="casAbstract">Receptor binding of 3H-labeled neurotensin  [39379-15-2] was examd. on membrane prepns. derived from neuroblastoma × glioma NG108-15 hybrid cells.  The specific binding was saturable and reversible and a dissocn. const. (Kd) was ∼0.24 nM.  Scatchard anal. of neurotensin binding at equil. revealed a single class of binding sites with a Kd of 0.86 nM and a maximal binding capacity (Bmax) of 250 fmol/mg of protein (7700 receptor sites/cell).  [9-D-Arginine]-neurotensin  [63770-62-7] had a high affinity (IC50 = 0.5 nM) for the neurotensin receptors, but [11-D-phenylalanine]-neurotensin  [64088-66-0] had a lower affinity (IC50 = 280 nM), whereas angiotensin II and bradykinin had almost no affinity for [3H]neurotensin-binding sites.  Under similar conditions [3H]neurotensin binding to mouse and rat brain synaptosomal fractions showed 2 binding sites with high (0.56 and 0.44 nM) and low (13 and 19 nM) affinities.  Several possible physiol. consequences of neurotensin receptor binding were examd.  Neurotensin (10 μM) exhibited no influence on adenylate cyclase activity, 45Ca uptake, or 32Pi incorporation into phosphatidylinositol fractions of NG108-15 cells.  Electrophysiol. study of isolated NG108-15 cells revealed neurotensin induced transient hyperpolarization followed by sustained depolarization with enhanced membrane excitability.  Application of neurotensin to NG108-15 cells that had formed synapses with cultured striated muscle cells caused a considerable increase in frequency of miniature endplate potentials from the muscle cells.  Apparently, NG108-15 cells possess a single class of neurotensin receptors similar to a high-affinity site of synaptosomal membranes from the murine brains.  Neurotensin facilitation of synaptic transmission is probably mediated through receptors coupled to ionotropic processes rather than to cellular metabolic ones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIoyYP7U3xXbVg90H21EOLACvtfcHk0lgbsYr0QMtq8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXks1Klsrk%253D&md5=4d566d55aaa06b5eee8557f335b39d3b</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1523%2Fjneurosci.04-06-01653.1984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252Fjneurosci.04-06-01653.1984%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa%26aufirst%3DY.%26aulast%3DHigashida%26aufirst%3DH.%26aulast%3DMiki%26aufirst%3DN.%26atitle%3DA%2520single%2520class%2520of%2520neurotensin%2520receptors%2520with%2520high%2520affinity%2520in%2520neuroblastoma%2520X%2520glioma%2520NG108-15%2520hybrid%2520cells%2520that%2520mediate%2520facilitation%2520of%2520synaptic%2520transmission%26jtitle%3DJ.%2520Neurosci.%26date%3D1984%26volume%3D4%26spage%3D1653%26epage%3D1661%26doi%3D10.1523%2Fjneurosci.04-06-01653.1984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yung-Chi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=4202581" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=C.+Yung-Chiauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28Ki%29+and+the+concentration+of+inhibitor+which+causes+50+per+cent+inhibition+%28I50%29+of+an+enzymatic+reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DYung-Chi%26aufirst%3DC.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528Ki%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2520per%2520cent%2520inhibition%2520%2528I50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashii, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munesue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamagishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span> <span> </span><span class="NLM_article-title">Non-synonymous single-nucleotide variations of the human oxytocin receptor gene and autism spectrum disorders: a case-control study in a Japanese population and functional analysis</span>. <i>Mol. Autism.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">22</span>, <span class="refDoi"> DOI: 10.1186/2040-2392-4-22</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1186%2F2040-2392-4-22" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=23815867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1WjsrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=22&author=W.-J.+Maauthor=M.+Hashiiauthor=T.+Munesueauthor=K.+Hayashiauthor=K.+Yagiauthor=M.+Yamagishiauthor=H.+Higashidaauthor=S.+Yokoyama&title=Non-synonymous+single-nucleotide+variations+of+the+human+oxytocin+receptor+gene+and+autism+spectrum+disorders%3A+a+case-control+study+in+a+Japanese+population+and+functional+analysis&doi=10.1186%2F2040-2392-4-22"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Non-synonymous single-nucleotide variations of the human oxytocin receptor gene and autism spectrum disorders: a case-control study in a Japanese population and functional analysis</span></div><div class="casAuthors">Ma, Wen-Jie; Hashii, Minako; Munesue, Toshio; Hayashi, Kenshi; Yagi, Kunimasa; Yamagishi, Masakazu; Higashida, Haruhiro; Yokoyama, Shigeru</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Autism</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22</span>CODEN:
                <span class="NLM_cas:coden">MAOUBR</span>;
        ISSN:<span class="NLM_cas:issn">2040-2392</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The human oxytocin receptor (hOXTR) is implicated in the etiol. of autism spectrum disorders (ASDs) and is a potential target for therapeutic intervention.  Several studies have reported single-nucleotide polymorphisms (SNPs) of the OXTR gene assocd. with ASDs.  These SNPs, however, reside outside the protein-coding region.  Not much is known about genetic variations that cause amino acid substitutions that alter receptor functions.  Methods: Variations in the OXTR gene were analyzed in 132 ASD patients at Kanazawa University Hospital in Japan and 248 unrelated healthy Japanese volunteers by re-sequencing and real-time polymerase chain reaction-based genotyping.  Functional changes in variant OXTRs were assessed by radioligand binding assay and measurements of intracellular free calcium concns. ([Ca2+]i) and inositol 1,4,5-trisphosphate (IP3) levels.  Results: Six subjects (4.5%) in the ASD group and two in the control group (0.8%) were identified as heterozygotes carrying the R376G variation (rs35062132; c.1126C>G); one individual from the ASD group (0.8%) and three members of the control group (1.2%) were found to be carrying R376C (c.1126C>T).  The C/G genotype significantly correlated with an increased risk of ASDs (odds ratio (OR) = 5.83; 95% confidence interval (CI) = 1.16 to 29.33; P = 0.024, Fisher's exact test).  Consistently, the G allele showed a correlation with an increased likelihood of ASDs (OR = 5.73; 95% CI = 1.15 to 28.61; P = 0.024, Fisher's exact test).  The frequencies of the C/T genotype and the T allele in the ASD and control groups did not differ significantly.  We also examd. changes in agonist-induced cellular responses mediated by the variant receptors hOXTR-376G and hOXTR-376C.  OXT-induced receptor internalization and recycling were faster in hOXTR-376G-expressing HEK-293 cells than in cells expressing hOXTR-376R or hOXTR-376C.  In addn., the elevation in [Ca2+]i and IP3 formation decreased in the cells expressing hOXTR-376G and hOXTR-376C tagged with enhanced green fluorescent protein (EGFP), in comparison with the cells expressing the common-type hOXTR-376R tagged with EGFP.  Conclusions: These results suggest that the rare genetic variation rs35062132 might contribute to the pathogenesis of ASDs, and could provide a mol. basis of individual differences in OXTR-mediated modulation of social behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaN25l6TR1_bVg90H21EOLACvtfcHk0lgbsYr0QMtq8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1WjsrzF&md5=7267206bc8512e28035e27ae97ca54ed</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1186%2F2040-2392-4-22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2040-2392-4-22%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DW.-J.%26aulast%3DHashii%26aufirst%3DM.%26aulast%3DMunesue%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DK.%26aulast%3DYagi%26aufirst%3DK.%26aulast%3DYamagishi%26aufirst%3DM.%26aulast%3DHigashida%26aufirst%3DH.%26aulast%3DYokoyama%26aufirst%3DS.%26atitle%3DNon-synonymous%2520single-nucleotide%2520variations%2520of%2520the%2520human%2520oxytocin%2520receptor%2520gene%2520and%2520autism%2520spectrum%2520disorders%253A%2520a%2520case-control%2520study%2520in%2520a%2520Japanese%2520population%2520and%2520functional%2520analysis%26jtitle%3DMol.%2520Autism.%26date%3D2013%26volume%3D4%26spage%3D22%26doi%3D10.1186%2F2040-2392-4-22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':[],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 7 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Julien C. Vantourout, Srinivasa Rao Adusumalli, Kyle W. Knouse, Dillon T. Flood, Antonio Ramirez, Natalia M. Padial, Alena Istrate, Katarzyna Maziarz, Justine N. deGruyter, Rohan R. Merchant, Jennifer X. Qiao, Michael A. Schmidt, Michael J. Deery, Martin D. Eastgate, Philip E. Dawson, Gonçalo J. L. Bernardes, <span class="NLM_string-name hlFld-ContribAuthor">Phil S. Baran</span>. </span><span class="cited-content_cbyCitation_article-title">Serine-Selective Bioconjugation. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2020,</strong> <em>142 </em>
                                    (41)
                                     , 17236-17242. <a href="https://doi.org/10.1021/jacs.0c05595" title="DOI URL">https://doi.org/10.1021/jacs.0c05595</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.0c05595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.0c05595%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DSerine-Selective%252BBioconjugation%26aulast%3DVantourout%26aufirst%3DJulien%2BC.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D22052020%26date%3D05102020%26date%3D23092020%26volume%3D142%26issue%3D41%26spage%3D17236%26epage%3D17242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Niklas H.  Fischer</span>, <span class="hlFld-ContribAuthor ">Daniel S.  Nielsen</span>, <span class="hlFld-ContribAuthor ">Daniel  Palmer</span>, <span class="hlFld-ContribAuthor ">Morten  Meldal</span>, <span class="hlFld-ContribAuthor ">Frederik  Diness</span>. </span><span class="cited-content_cbyCitation_article-title">C-Terminal lactamization of peptides. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2021,</strong> <em>57 </em>
                                    (7)
                                     , 895-898. <a href="https://doi.org/10.1039/D0CC06018F" title="DOI URL">https://doi.org/10.1039/D0CC06018F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC06018F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC06018F%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DC-Terminal%252Blactamization%252Bof%252Bpeptides%26aulast%3DFischer%26aufirst%3DNiklas%2BH.%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D7%26spage%3D895%26epage%3D898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yun‐Kun  Qi</span>, <span class="hlFld-ContribAuthor ">Qian  Qu</span>, <span class="hlFld-ContribAuthor ">Donald  Bierer</span>, <span class="hlFld-ContribAuthor ">Lei  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">A Diaminodiacid (DADA) Strategy for the Development of Disulfide Surrogate Peptides. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – An Asian Journal</span><span> <strong>2020,</strong> <em>15 </em>
                                    (18)
                                     , 2793-2802. <a href="https://doi.org/10.1002/asia.202000609" title="DOI URL">https://doi.org/10.1002/asia.202000609</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/asia.202000609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fasia.202000609%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520An%2520Asian%2520Journal%26atitle%3DA%252BDiaminodiacid%252B%252528DADA%252529%252BStrategy%252Bfor%252Bthe%252BDevelopment%252Bof%252BDisulfide%252BSurrogate%252BPeptides%26aulast%3DQi%26aufirst%3DYun%25E2%2580%2590Kun%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D18%26spage%3D2793%26epage%3D2802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth A.  Lawson</span>, <span class="hlFld-ContribAuthor ">Pawel K.  Olszewski</span>, <span class="hlFld-ContribAuthor ">Aron  Weller</span>, <span class="hlFld-ContribAuthor ">James E.  Blevins</span>. </span><span class="cited-content_cbyCitation_article-title">The role of oxytocin in regulation of appetitive behaviour, body weight and glucose homeostasis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neuroendocrinology</span><span> <strong>2020,</strong> <em>32 </em>
                                    (4)
                                     <a href="https://doi.org/10.1111/jne.12805" title="DOI URL">https://doi.org/10.1111/jne.12805</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jne.12805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjne.12805%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neuroendocrinology%26atitle%3DThe%252Brole%252Bof%252Boxytocin%252Bin%252Bregulation%252Bof%252Bappetitive%252Bbehaviour%25252C%252Bbody%252Bweight%252Band%252Bglucose%252Bhomeostasis%26aulast%3DLawson%26aufirst%3DElizabeth%2BA.%26date%3D2020%26date%3D2019%26volume%3D32%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haruhiro  Higashida</span>, <span class="hlFld-ContribAuthor ">Minako  Hashii</span>, <span class="hlFld-ContribAuthor ">Yukie  Tanaka</span>, <span class="hlFld-ContribAuthor ">Shigeru  Matsukawa</span>, <span class="hlFld-ContribAuthor ">Yoshihiro  Higuchi</span>, <span class="hlFld-ContribAuthor ">Ryosuke  Gabata</span>, <span class="hlFld-ContribAuthor ">Makoto  Tsubomoto</span>, <span class="hlFld-ContribAuthor ">Noriko  Seishima</span>, <span class="hlFld-ContribAuthor ">Mitsuyo  Teramachi</span>, <span class="hlFld-ContribAuthor ">Taiki  Kamijima</span>, <span class="hlFld-ContribAuthor ">Tsuyoshi  Hattori</span>, <span class="hlFld-ContribAuthor ">Osamu  Hori</span>, <span class="hlFld-ContribAuthor ">Chiharu  Tsuji</span>, <span class="hlFld-ContribAuthor ">Stanislav M.  Cherepanov</span>, <span class="hlFld-ContribAuthor ">Anna A.  Shabalova</span>, <span class="hlFld-ContribAuthor ">Maria  Gerasimenko</span>, <span class="hlFld-ContribAuthor ">Kana  Minami</span>, <span class="hlFld-ContribAuthor ">Shigeru  Yokoyama</span>, <span class="hlFld-ContribAuthor ">Sei-ichi  Munesue</span>, <span class="hlFld-ContribAuthor ">Ai  Harashima</span>, <span class="hlFld-ContribAuthor ">Yasuhiko  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Alla B.  Salmina</span>, <span class="hlFld-ContribAuthor ">Olga  Lopatina</span>. </span><span class="cited-content_cbyCitation_article-title">CD38, CD157, and RAGE as Molecular Determinants for Social Behavior. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2020,</strong> <em>9 </em>
                                    (1)
                                     , 62. <a href="https://doi.org/10.3390/cells9010062" title="DOI URL">https://doi.org/10.3390/cells9010062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells9010062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells9010062%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DCD38%25252C%252BCD157%25252C%252Band%252BRAGE%252Bas%252BMolecular%252BDeterminants%252Bfor%252BSocial%252BBehavior%26aulast%3DHigashida%26aufirst%3DHaruhiro%26date%3D2020%26date%3D2019%26volume%3D9%26issue%3D1%26spage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irena  Voinsky</span>, <span class="hlFld-ContribAuthor ">Sirish C.  Bennuri</span>, <span class="hlFld-ContribAuthor ">Julie  Svigals</span>, <span class="hlFld-ContribAuthor ">Richard E.  Frye</span>, <span class="hlFld-ContribAuthor ">Shannon  Rose</span>, <span class="hlFld-ContribAuthor ">David  Gurwitz</span>. </span><span class="cited-content_cbyCitation_article-title">Peripheral Blood Mononuclear Cell Oxytocin and Vasopressin Receptor Expression Positively Correlates with Social and Behavioral Function in Children with Autism. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-49617-9" title="DOI URL">https://doi.org/10.1038/s41598-019-49617-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-49617-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-49617-9%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DPeripheral%252BBlood%252BMononuclear%252BCell%252BOxytocin%252Band%252BVasopressin%252BReceptor%252BExpression%252BPositively%252BCorrelates%252Bwith%252BSocial%252Band%252BBehavioral%252BFunction%252Bin%252BChildren%252Bwith%252BAutism%26aulast%3DVoinsky%26aufirst%3DIrena%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stanislav M.  Cherepanov</span>, <span class="hlFld-ContribAuthor ">Risako  Miura</span>, <span class="hlFld-ContribAuthor ">Anna A.  Shabalova</span>, <span class="hlFld-ContribAuthor ">Wataru  Ichinose</span>, <span class="hlFld-ContribAuthor ">Shigeru  Yokoyama</span>, <span class="hlFld-ContribAuthor ">Hayato  Fukuda</span>, <span class="hlFld-ContribAuthor ">Mizuki  Watanabe</span>, <span class="hlFld-ContribAuthor ">Haruhiro  Higashida</span>, <span class="hlFld-ContribAuthor ">Satoshi  Shuto</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of oxytocin derivatives lipidated via a carbonate or carbamate linkage as a long-acting therapeutic agent for social impairment-like behaviors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (15)
                                     , 3358-3363. <a href="https://doi.org/10.1016/j.bmc.2019.06.018" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.06.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.06.018%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252Boxytocin%252Bderivatives%252Blipidated%252Bvia%252Ba%252Bcarbonate%252Bor%252Bcarbamate%252Blinkage%252Bas%252Ba%252Blong-acting%252Btherapeutic%252Bagent%252Bfor%252Bsocial%252Bimpairment-like%252Bbehaviors%26aulast%3DCherepanov%26aufirst%3DStanislav%2BM.%26date%3D2019%26volume%3D27%26issue%3D15%26spage%3D3358%26epage%3D3363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/medium/jm-2018-01691m_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01691&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/medium/jm-2018-01691m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of OT Analogues <b>2</b>, <b>3</b>, <b>5</b>, and <b>6</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01691&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/medium/jm-2018-01691m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative radioligand concentration displacement curves for OT, AVP, OT, and compounds <b>1–6</b>. All curves were normalized to the percentage of displacement of [<sup>3</sup>H]OT. Data are means ± standard error of the mean from results obtained from two experiments, each performed in duplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01691&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/medium/jm-2018-01691m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Agonistic activities of OT analogues: Agonistic activities of <b>2</b> (A) and <b>5</b> (B) for hOTR, hV<sub>1a</sub>R, and hV<sub>1b</sub>R. Activities of OT, AVP, <b>2</b>, and <b>5</b> for hOTR (C) and hV<sub>1a</sub>R (D), determined by [Ca<sup>2+</sup>]<sub>i</sub> microspectrofluorometric measurement. A value of 100% indicated the maximum Ca<sup>2+</sup>-release after OT application. Number of independent experiments: <i>n</i> = 3. Each experiment was performed in duplicate and number of measured cells in each cell dish: 20.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01691&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/medium/jm-2018-01691m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Pup retrieval behavior by sires: The latencies for pup retrieval by WT or CD38KO sires at 30 min (A) and the time-course (B) after a single intraperitoneal injection of PBS, OT, <b>2</b>, or <b>5</b> (100 ng/100 g body weight); <i>n</i> = 10/group. One-way ANOVA followed by Bonferroni’s post hoc test was performed for 30 min (<i>F</i><sub>4,45</sub> = 8.45 and <i>p</i> = 0.0001), and two-way ANOVA followed by Bonferroni’s post hoc test was performed for the time course (time <i>F</i><sub>4,180</sub> = 3.74, <i>p</i> = 0.006; treatment <i>F</i><sub>3,180</sub> = 28.94, <i>p</i> = 0.0001; interaction <i>F</i><sub>12,180</sub> = 4.31, <i>p</i> = 0.0001). The significance levels of the Bonferroni post hoc test performed to compare the test treatments with the CD38KO treated by PBS were *<i>p</i> < 0.05 and **<i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01691&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/medium/jm-2018-01691m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Tail suspension test: Immobility time of male CD38KOCC mice at 30 min and 24 h after a single intraperitoneal injection of PBS, OT, 2, and 5. <i>n</i> = 5–8 per group. Two-way ANOVA followed by Bonferroni’s post hoc test showed a significant effect of treatment (<i>F</i><sub>3,31</sub> = 10.55, <i>p</i> = 0.0001) and time (<i>F</i><sub>1,31</sub> = 7.103, <i>p</i> = 0.0121). *<i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01691&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/medium/jm-2018-01691m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Sucrose preference test: Preference of CD38KOCC males for 1% sucrose solution consumption at 1 (A) or 24 h (B) after treatment with PBS, OT, <b>2</b>, or <b>5</b> (single intraperitoneal injection), <i>n</i> = 5–8. One-way ANOVA followed by Bonferroni’s post hoc test was performed for 60 min (<i>F</i><sub>3,19</sub> = 22.13 and <i>p</i> = 0.0001) and 24 h (time <i>F</i><sub>3,19</sub> = 3.26, <i>p</i> = 0.044) after and showed significant differences for *<i>p</i> < 0.05 and **<i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01691&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/medium/jm-2018-01691m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Plasma concentrations of OT, and <b>2</b>, or <b>5</b> after intravenous administration of OT (A), <b>2</b> (B), and <b>5</b> (C). ICR mice were administered with OT, <b>2</b>, or <b>5</b> at a dose of 3 μg/mouse via the tail vein. Blood samples were collected at the indicated times after injection. Each point represents the mean ± standard error of three to five mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01691&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/medium/jm-2018-01691m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Competition kinetics curves for OT (A), <b>2</b> (B), and <b>5</b> (C). HEK-293 hOTR membranes were incubated with 500 pM [<sup>3</sup>H]OT and varying concentrations of the competitors. Plates were incubated for the indicated times, and nonspecific binding levels were determined in the presence of cold OT (1 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01691/20190404/images/large/jm-2018-01691m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01691&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i44">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46240" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46240" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 69 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kirsch, P.</span></span> <span> </span><span class="NLM_article-title">Oxytocin in the socioemotional brain: implications for psychiatric disorders</span>. <i>Dialogues Clin Neurosci</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=26869847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BC28jgt1SmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=463-476&author=P.+Kirsch&title=Oxytocin+in+the+socioemotional+brain%3A+implications+for+psychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin in the socioemotional brain: implications for psychiatric disorders</span></div><div class="casAuthors">Kirsch Peter</div><div class="citationInfo"><span class="NLM_cas:title">Dialogues in clinical neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">463-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The neuropeptide oxytocin (OXT), highly conserved during evolution, is an important modulator of social and emotional processes across many species.  During the last decade, a large body of literature has revealed its effects on different aspects of social behavior, including social stress and anxiety, social memory, affiliation and bonding, emotion recognition, mentalizing, empathy, and interpersonal trust.  In addition, as impairments in these social domains can be observed in a number of neuropsychiatric disorders, such as autism, social anxiety disorder, depression, schizophrenia, and borderline personality disorder, the role of OXT in mental disorders and their treatment has been intensively studied.  The present paper gives a short overview of these lines of research and shows how OXT has become a promising target for novel treatment approaches for mental disorders characterized by social impairments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5nHtyXvC7wb0AGQpJZWpJfW6udTcc2eYb84Nj7Twd9Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jgt1SmtQ%253D%253D&md5=5bce2dbeaa3a3a4afe7dc5f02a39c4e7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKirsch%26aufirst%3DP.%26atitle%3DOxytocin%2520in%2520the%2520socioemotional%2520brain%253A%2520implications%2520for%2520psychiatric%2520disorders%26jtitle%3DDialogues%2520Clin%2520Neurosci%26date%3D2015%26volume%3D17%26spage%3D463%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bealer, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, W. R.</span></span> <span> </span><span class="NLM_article-title">Oxytocin release in magnocellular nuclei: neurochemical mediators and functional significance during gestation</span>. <i>Am. J. Physiol.: Regul., Integr. Comp. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>299</i></span>,  <span class="NLM_fpage">R452</span>– <span class="NLM_lpage">R458</span>, <span class="refDoi"> DOI: 10.1152/ajpregu.00217.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1152%2Fajpregu.00217.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=20554931" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2010&pages=R452-R458&author=S.+L.+Bealerauthor=W.+E.+Armstrongauthor=W.+R.+Crowley&title=Oxytocin+release+in+magnocellular+nuclei%3A+neurochemical+mediators+and+functional+significance+during+gestation&doi=10.1152%2Fajpregu.00217.2010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1152%2Fajpregu.00217.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpregu.00217.2010%26sid%3Dliteratum%253Aachs%26aulast%3DBealer%26aufirst%3DS.%2BL.%26aulast%3DArmstrong%26aufirst%3DW.%2BE.%26aulast%3DCrowley%26aufirst%3DW.%2BR.%26atitle%3DOxytocin%2520release%2520in%2520magnocellular%2520nuclei%253A%2520neurochemical%2520mediators%2520and%2520functional%2520significance%2520during%2520gestation%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Regul.%252C%2520Integr.%2520Comp.%2520Physiol.%26date%3D2010%26volume%3D299%26spage%3DR452%26epage%3DR458%26doi%3D10.1152%2Fajpregu.00217.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rilling, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, L. J.</span></span> <span> </span><span class="NLM_article-title">The biology of mammalian parenting and its effect on offspring social development</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>345</i></span>,  <span class="NLM_fpage">771</span>– <span class="NLM_lpage">776</span>, <span class="refDoi"> DOI: 10.1126/science.1252723</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1126%2Fscience.1252723" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=25124431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlejtL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2014&pages=771-776&author=J.+K.+Rillingauthor=L.+J.+Young&title=The+biology+of+mammalian+parenting+and+its+effect+on+offspring+social+development&doi=10.1126%2Fscience.1252723"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The biology of mammalian parenting and its effect on offspring social development</span></div><div class="casAuthors">Rilling, James K.; Young, Larry J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">345</span>
        (<span class="NLM_cas:issue">6198</span>),
    <span class="NLM_cas:pages">771-776</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Parents know the transformative nature of having and caring for a child.  Among many mammals, giving birth leads from an aversion to infant stimuli to irresistible attraction.  Here, we review the biol. mechanisms governing this shift in parental motivation in mammals.  Estrogen and progesterone prep. the uterus for embryo implantation and placental development.  Prolactin stimulates milk prodn., whereas oxytocin initiates labor and triggers milk ejection during nursing.  These same mols., interacting with dopamine, also activate specific neural pathways to motivate parents to nurture, bond with, and protect their offspring.  Parenting in turn shapes the neural development of the infant social brain.  Recent work suggests that many of the principles governing parental behavior and its effect on infant development are conserved from rodent to humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTAg-8FTVmQrVg90H21EOLACvtfcHk0lg9FbHLGnXq4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlejtL%252FI&md5=2dbd540da66206ee5d63adad70075f95</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.1252723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1252723%26sid%3Dliteratum%253Aachs%26aulast%3DRilling%26aufirst%3DJ.%2BK.%26aulast%3DYoung%26aufirst%3DL.%2BJ.%26atitle%3DThe%2520biology%2520of%2520mammalian%2520parenting%2520and%2520its%2520effect%2520on%2520offspring%2520social%2520development%26jtitle%3DScience%26date%3D2014%26volume%3D345%26spage%3D771%26epage%3D776%26doi%3D10.1126%2Fscience.1252723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marlin, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froemke, R. C.</span></span> <span> </span><span class="NLM_article-title">Oxytocin modulation of neural circuits for social behavior</span>. <i>Dev. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1002/dneu.22452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1002%2Fdneu.22452" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=27626613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslWhtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2017&pages=169-189&author=B.+J.+Marlinauthor=R.+C.+Froemke&title=Oxytocin+modulation+of+neural+circuits+for+social+behavior&doi=10.1002%2Fdneu.22452"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin modulation of neural circuits for social behavior</span></div><div class="casAuthors">Marlin, Bianca J.; Froemke, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Neurobiology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">169-189</span>CODEN:
                <span class="NLM_cas:coden">DNEEAM</span>;
        ISSN:<span class="NLM_cas:issn">1932-8451</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Oxytocin is a hypothalamic neuropeptide that has gained attention for the effects on social behavior.  Recent findings shed new light on the mechanisms of oxytocin in synaptic plasticity and adaptively modifying neural circuits for social interactions such as conspecific recognition, pair bonding, and maternal care.  Here, we review several of these newer studies on oxytocin in the context of previous findings, with an emphasis on social behavior and circuit plasticity in various brain regions shown to be enriched for oxytocin receptors.  We provide a framework that highlights current circuit-level mechanisms underlying the widespread action of oxytocin. © 2016 Wiley Periodicals, Inc.  Develop Neurobiol 77: 169-189, 2017.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMnT0PBU34W7Vg90H21EOLACvtfcHk0ljMW9m0hSGe6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslWhtLo%253D&md5=e7b4a4e9fb709259f3397844c8058b8e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fdneu.22452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fdneu.22452%26sid%3Dliteratum%253Aachs%26aulast%3DMarlin%26aufirst%3DB.%2BJ.%26aulast%3DFroemke%26aufirst%3DR.%2BC.%26atitle%3DOxytocin%2520modulation%2520of%2520neural%2520circuits%2520for%2520social%2520behavior%26jtitle%3DDev.%2520Neurobiol.%26date%3D2017%26volume%3D77%26spage%3D169%26epage%3D189%26doi%3D10.1002%2Fdneu.22452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lai, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baron-Cohen, S.</span></span> <span> </span><span class="NLM_article-title">Autism</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>383</i></span>,  <span class="NLM_fpage">896</span>– <span class="NLM_lpage">910</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(13)61539-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fs0140-6736%2813%2961539-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=24074734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FhvFeqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=383&publication_year=2014&pages=896-910&author=M.-C.+Laiauthor=M.+V.+Lombardoauthor=S.+Baron-Cohen&title=Autism&doi=10.1016%2Fs0140-6736%2813%2961539-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Autism</span></div><div class="casAuthors">Lai Meng-Chuan; Lombardo Michael V; Baron-Cohen Simon</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">383</span>
        (<span class="NLM_cas:issue">9920</span>),
    <span class="NLM_cas:pages">896-910</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Autism is a set of heterogeneous neurodevelopmental conditions, characterised by early-onset difficulties in social communication and unusually restricted, repetitive behaviour and interests.  The worldwide population prevalence is about 1%.  Autism affects more male than female individuals, and comorbidity is common (>70% have concurrent conditions).  Individuals with autism have atypical cognitive profiles, such as impaired social cognition and social perception, executive dysfunction, and atypical perceptual and information processing.  These profiles are underpinned by atypical neural development at the systems level.  Genetics has a key role in the aetiology of autism, in conjunction with developmentally early environmental factors.  Large-effect rare mutations and small-effect common variants contribute to risk.  Assessment needs to be multidisciplinary and developmental, and early detection is essential for early intervention.  Early comprehensive and targeted behavioural interventions can improve social communication and reduce anxiety and aggression.  Drugs can reduce comorbid symptoms, but do not directly improve social communication.  Creation of a supportive environment that accepts and respects that the individual is different is crucial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSyg9jmEI_2w1WTCLT8lX9SfW6udTcc2eZeflg3baVbjbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FhvFeqtQ%253D%253D&md5=146b8454fe450b91073c3751e7b41699</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fs0140-6736%2813%2961539-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0140-6736%252813%252961539-1%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DM.-C.%26aulast%3DLombardo%26aufirst%3DM.%2BV.%26aulast%3DBaron-Cohen%26aufirst%3DS.%26atitle%3DAutism%26jtitle%3DLancet%26date%3D2014%26volume%3D383%26spage%3D896%26epage%3D910%26doi%3D10.1016%2Fs0140-6736%2813%2961539-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peñagarikano, O.</span></span> <span> </span><span class="NLM_article-title">New therapeutic options for autism spectrum disorder: experimental evidences</span>. <i>Exp. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">311</span>, <span class="refDoi"> DOI: 10.5607/en.2015.24.4.301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.5607%2Fen.2015.24.4.301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=26713078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BC28rls12iuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=301-311&author=O.+Pe%C3%B1agarikano&title=New+therapeutic+options+for+autism+spectrum+disorder%3A+experimental+evidences&doi=10.5607%2Fen.2015.24.4.301"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">New Therapeutic Options for Autism Spectrum Disorder: Experimental Evidences</span></div><div class="casAuthors">Penagarikano Olga</div><div class="citationInfo"><span class="NLM_cas:title">Experimental neurobiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">301-11</span>
        ISSN:<span class="NLM_cas:issn">1226-2560</span>.
    </div><div class="casAbstract">Autism spectrum disorder (ASD) is characterized by impairment in two behavioral domains: social interaction/communication together with the presence of stereotyped behaviors and restricted interests.  The heterogeneity in the phenotype among patients and the complex etiology of the disorder have long impeded the advancement of the development of successful pharmacotherapies.  However, in the recent years, the integration of findings of multiple levels of research, from human genetics to mouse models, have made considerable progress towards the understanding of ASD pathophysiology, allowing the development of more effective targeted drug therapies.  The present review discusses the current state of pharmacological research in ASD based on the emerging common pathophysiology signature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRrttl-His734McDoIzZtNkfW6udTcc2eZeflg3baVbjbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rls12iuw%253D%253D&md5=26f70a17e704f9073e5b0b45ec9497c6</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.5607%2Fen.2015.24.4.301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5607%252Fen.2015.24.4.301%26sid%3Dliteratum%253Aachs%26aulast%3DPe%25C3%25B1agarikano%26aufirst%3DO.%26atitle%3DNew%2520therapeutic%2520options%2520for%2520autism%2520spectrum%2520disorder%253A%2520experimental%2520evidences%26jtitle%3DExp.%2520Neurobiol.%26date%3D2015%26volume%3D24%26spage%3D301%26epage%3D311%26doi%3D10.5607%2Fen.2015.24.4.301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lacivita, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margari, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leopoldo, M.</span></span> <span> </span><span class="NLM_article-title">Targets for drug therapy for autism spectrum disorder: challenges and future directions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">9114</span>– <span class="NLM_lpage">9141</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00965</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00965" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1KnsLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9114-9141&author=E.+Lacivitaauthor=R.+Perroneauthor=L.+Margariauthor=M.+Leopoldo&title=Targets+for+drug+therapy+for+autism+spectrum+disorder%3A+challenges+and+future+directions&doi=10.1021%2Facs.jmedchem.7b00965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions</span></div><div class="casAuthors">Lacivita, Enza; Perrone, Roberto; Margari, Lucia; Leopoldo, Marcello</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9114-9141</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by persistent deficits in social communication and interaction and restricted, repetitive patterns of behavior, interests, and activities.  Various factors are involved in the etiopathogenesis of ASD, including genetic factors, environmental toxins and stressors, impaired immune responses, mitochondrial dysfunction, and neuroinflammation.  The heterogeneity in the phenotype among ASD patients and the complex etiol. of the condition have long impeded the advancement of the development of pharmacol. therapies.  In the recent years, the integration of findings from mouse models to human genetics resulted in considerable progress toward the understanding of ASD pathophysiol.  Currently, strategies to treat core symptoms of ASD are directed to correct synaptic dysfunctions, abnormalities in central oxytocin, vasopressin, and serotonin neurotransmission, and neuroinflammation.  Here, we present a survey of the studies that have suggested mol. targets for drug development for ASD and the state-of-the-art of medicinal chem. efforts in related areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBnoRlTN2U9rVg90H21EOLACvtfcHk0lgxINAc74iE4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1KnsLnL&md5=32311ccf6d8bc345129c00fe6dc0a23a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00965%26sid%3Dliteratum%253Aachs%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DMargari%26aufirst%3DL.%26aulast%3DLeopoldo%26aufirst%3DM.%26atitle%3DTargets%2520for%2520drug%2520therapy%2520for%2520autism%2520spectrum%2520disorder%253A%2520challenges%2520and%2520future%2520directions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D9114%26epage%3D9141%26doi%3D10.1021%2Facs.jmedchem.7b00965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">James, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gales, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gales, B. J.</span></span> <span> </span><span class="NLM_article-title">Bumetanide for Autism Spectrum Disorder in Children: A Review of Randomized Controlled Trials</span>. <i>Ann. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">106002801881730</span>, <span class="refDoi"> DOI: 10.1177/1060028018817304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1177%2F1060028018817304" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2018&pages=106002801881730&author=B.+J.+Jamesauthor=M.+A.+Galesauthor=B.+J.+Gales&title=Bumetanide+for+Autism+Spectrum+Disorder+in+Children%3A+A+Review+of+Randomized+Controlled+Trials&doi=10.1177%2F1060028018817304"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1177%2F1060028018817304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1060028018817304%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DB.%2BJ.%26aulast%3DGales%26aufirst%3DM.%2BA.%26aulast%3DGales%26aufirst%3DB.%2BJ.%26atitle%3DBumetanide%2520for%2520Autism%2520Spectrum%2520Disorder%2520in%2520Children%253A%2520A%2520Review%2520of%2520Randomized%2520Controlled%2520Trials%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2018%26volume%3D52%26spage%3D106002801881730%26doi%3D10.1177%2F1060028018817304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shamay-Tsoory, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, L. J.</span></span> <span> </span><span class="NLM_article-title">Understanding the oxytocin system and its relevance to psychiatry</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">150</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2015.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.biopsych.2015.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=26723107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BC28rmsFyksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=150-152&author=S.+Shamay-Tsooryauthor=L.+J.+Young&title=Understanding+the+oxytocin+system+and+its+relevance+to+psychiatry&doi=10.1016%2Fj.biopsych.2015.10.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the Oxytocin System and Its Relevance to Psychiatry</span></div><div class="casAuthors">Shamay-Tsoory Simone; Young Larry J</div><div class="citationInfo"><span class="NLM_cas:title">Biological psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">150-2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSo-UULW7rzwiEJCPKhJPuqfW6udTcc2eZPpWw6xmMZ3rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rmsFyksQ%253D%253D&md5=cf90449ad5cf959338cb2af3b19ce468</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2015.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2015.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DShamay-Tsoory%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DL.%2BJ.%26atitle%3DUnderstanding%2520the%2520oxytocin%2520system%2520and%2520its%2520relevance%2520to%2520psychiatry%26jtitle%3DBiol.%2520Psychiatry%26date%3D2016%26volume%3D79%26spage%3D150%26epage%3D152%26doi%3D10.1016%2Fj.biopsych.2015.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alabdali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Ayadhi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Ansary, A.</span></span> <span> </span><span class="NLM_article-title">Association of social and cognitive impairment and biomarkers in autism spectrum disorders</span>. <i>J. Neuroinflammation</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">4</span>, <span class="refDoi"> DOI: 10.1186/1742-2094-11-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1186%2F1742-2094-11-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=24400970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivVagu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=4&author=A.+Alabdaliauthor=A.+Al-Ayadhiauthor=A.+El-Ansary&title=Association+of+social+and+cognitive+impairment+and+biomarkers+in+autism+spectrum+disorders&doi=10.1186%2F1742-2094-11-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Association of social and cognitive impairment and biomarkers in autism spectrum disorders</span></div><div class="casAuthors">Alabdali, Altaf; Al-Ayadhi, Laila; El-Ansary, Afaf</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4/1-4/14, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Objectives: The neurol. basis for autism is still not fully understood, and the role of the interaction between neuro-inflammation and neurotransmission impairment needs to be clearer.  This study aims to test the possible assocn. between impaired levels of gamma aminobutyric acid (GABA), serotonin, dopamine, oxytocin, and interferon-γ-induced protein-16 (IFI16) and the severity of social and cognitive dysfunctions in individuals with autism spectrum disorders.  Materials and methods: GABA, serotonin, dopamine, oxytocin, and IFI16 as biochem. parameters related to neurochem. and inflammation were detd. in the plasma of 52 Saudi autistic male patients, categorized as mild-moderate and severe as indicated by their Childhood Autism Rating Scale (CARS) or social responsiveness scale (SRS), and compared to 30 age- and gender-matched control samples.  Results: The data indicated that Saudi patients with autism have remarkably impaired plasma levels of the measured parameters compared to age and gender-matched controls.  While serotonin in platelet-free plasma and dopamine did not correlated with the severity in social and cognitive dysfunction, GABA, oxytocin, and IFI16 were remarkably assocd. with the severity of both tested scores (SRS and CARS).  Conclusions: The relationship between the selected parameters confirms the role of impaired neurochem. and neuro-inflammation in the etiol. of autism spectrum disorders and the possibility of using GABA, oxytocin, and IFI16 as markers of autism severity.  Receiver operating characteristic anal. together with predictiveness diagrams proved that the measured parameters could be used as predictive biomarkers of clin. symptoms and provide significant guidance for future therapeutic strategy to re-establish physiol. homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU2x5EzxJ6jrVg90H21EOLACvtfcHk0lgxINAc74iE4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivVagu7w%253D&md5=790ed1e8c3e6ab5e5ee79e2712b7ce5d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-11-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-11-4%26sid%3Dliteratum%253Aachs%26aulast%3DAlabdali%26aufirst%3DA.%26aulast%3DAl-Ayadhi%26aufirst%3DA.%26aulast%3DEl-Ansary%26aufirst%3DA.%26atitle%3DAssociation%2520of%2520social%2520and%2520cognitive%2520impairment%2520and%2520biomarkers%2520in%2520autism%2520spectrum%2520disorders%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2014%26volume%3D11%26spage%3D4%26doi%3D10.1186%2F1742-2094-11-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagoory-Sharon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisman, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneiderman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maoz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shalev, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebstein, R. P.</span></span> <span> </span><span class="NLM_article-title">Sensitive parenting is associated with plasma oxytocin and polymorphisms in the OXTR and CD38 genes</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">181</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2011.12.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.biopsych.2011.12.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=22336563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVehsLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=175-181&author=R.+Feldmanauthor=O.+Zagoory-Sharonauthor=O.+Weismanauthor=I.+Schneidermanauthor=I.+Gordonauthor=R.+Maozauthor=I.+Shalevauthor=R.+P.+Ebstein&title=Sensitive+parenting+is+associated+with+plasma+oxytocin+and+polymorphisms+in+the+OXTR+and+CD38+genes&doi=10.1016%2Fj.biopsych.2011.12.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitive Parenting Is Associated with Plasma Oxytocin and Polymorphisms in the OXTR and CD38 Genes</span></div><div class="casAuthors">Feldman, Ruth; Zagoory-Sharon, Orna; Weisman, Omri; Schneiderman, Inna; Gordon, Ilanit; Maoz, Rina; Shalev, Idan; Ebstein, Richard P.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">175-181</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Research in mammals has demonstrated the involvement of oxytocin (OT) in social bond formation; yet, its role in human bonding remains unclear.  Plasma OT has been used as a proxy for central activity and studies indicate its assocn. with human affiliative behaviors.  Mol. genetic studies also reveal a role for OT neuropathways in shaping the social brain.  However, the links between peripheral OT, genetic markers, and their combined contribution to human parenting are unknown.  Participants included 352 individuals: 272 mothers and fathers and their 4- to 6-mo-old-infants and 80 nonparents.  Plasma OT was assayed from adults who were genotyped for oxytocin receptor (OXTR) and CD38 risk alleles assocd. with social dysfunctions.  CD38 is an ectoenzyme that mediates the release of brain OT.  Parent-infant interactions were microcoded for parental touch and gaze synchrony and participants reported on parental care in childhood.  OXTR (rs2254298 and rs1042778) and CD38 (rs3796863) risk alleles were each assocd. with lower plasma OT.  Reduced plasma OT and both OXTR and CD38 risk alleles were related to less parental touch.  The interaction of high plasma OT and low-risk CD38 alleles predicted longer durations of parent-infant gaze synchrony.  Parents reporting greater parental care showed higher plasma OT, low-risk CD38 alleles, and more touch toward their infants.  Results indicate that peripheral and genetic markers of the extended OT pathway are interrelated and underpin core behaviors assocd. with human parenting and social engagement.  These findings may have important implications for understanding neuropsychiatric disorders marked by early social dysfunctions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbCvDRP9RKALVg90H21EOLACvtfcHk0lg1-d7blpnvWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVehsLfP&md5=a72b304d6ed7f40cd6f2a4d39d41fc04</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2011.12.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2011.12.025%26sid%3Dliteratum%253Aachs%26aulast%3DFeldman%26aufirst%3DR.%26aulast%3DZagoory-Sharon%26aufirst%3DO.%26aulast%3DWeisman%26aufirst%3DO.%26aulast%3DSchneiderman%26aufirst%3DI.%26aulast%3DGordon%26aufirst%3DI.%26aulast%3DMaoz%26aufirst%3DR.%26aulast%3DShalev%26aufirst%3DI.%26aulast%3DEbstein%26aufirst%3DR.%2BP.%26atitle%3DSensitive%2520parenting%2520is%2520associated%2520with%2520plasma%2520oxytocin%2520and%2520polymorphisms%2520in%2520the%2520OXTR%2520and%2520CD38%2520genes%26jtitle%3DBiol.%2520Psychiatry%26date%3D2012%26volume%3D72%26spage%3D175%26epage%3D181%26doi%3D10.1016%2Fj.biopsych.2011.12.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">LoParo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldman, I. D.</span></span> <span> </span><span class="NLM_article-title">The oxytocin receptor gene (<i>OXTR</i>) is associated with autism spectrum disorder: a meta-analysis</span>. <i>Mol. Psychiatr.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">640</span>– <span class="NLM_lpage">646</span>, <span class="refDoi"> DOI: 10.1038/mp.2014.77</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1038%2Fmp.2014.77" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=25092245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BC2cbovVSmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=640-646&author=D.+LoParoauthor=I.+D.+Waldman&title=The+oxytocin+receptor+gene+%28OXTR%29+is+associated+with+autism+spectrum+disorder%3A+a+meta-analysis&doi=10.1038%2Fmp.2014.77"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The oxytocin receptor gene (OXTR) is associated with autism spectrum disorder: a meta-analysis</span></div><div class="casAuthors">LoParo D; Waldman I D</div><div class="citationInfo"><span class="NLM_cas:title">Molecular psychiatry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">640-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The oxytocin receptor gene (OXTR) has been studied as a risk factor for autism spectrum disorder (ASD) owing to converging evidence from multiple levels of analysis that oxytocin (OXT) has an important role in the regulation of affiliative behavior and social bonding in both nonhuman mammals and humans.  Inconsistency in the effect sizes of the OXTR variants included in association studies render it unclear whether OXTR is truly associated with ASD, and, if so, which OXTR single-nucleotide polymorphisms (SNPs) are associated.  Thus, a meta-analytic review of extant studies is needed to determine whether OXTR shows association with ASD, and to elucidate which specific SNPs have a significant effect on ASD.  The current meta-analysis of 16 OXTR SNPs included 3941 individuals with ASD from 11 independent samples, although analyses of each individual SNP included a subset of this total.  We found significant associations between ASD and the SNPs rs7632287, rs237887, rs2268491 and rs2254298.  OXTR was also significantly associated with ASD in a gene-based test.  The current meta-analysis is the largest and most comprehensive investigation of the association of OXTR with ASD and the findings suggest directions for future studies of the etiology of ASD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTXbTryRKs-MBjv2lLSLOxFfW6udTcc2eaBmMaWjne1gbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbovVSmsA%253D%253D&md5=c4f507ef2ccd3c7a208b654e2bc69bcb</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fmp.2014.77&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmp.2014.77%26sid%3Dliteratum%253Aachs%26aulast%3DLoParo%26aufirst%3DD.%26aulast%3DWaldman%26aufirst%3DI.%2BD.%26atitle%3DThe%2520oxytocin%2520receptor%2520gene%2520%2528OXTR%2529%2520is%2520associated%2520with%2520autism%2520spectrum%2520disorder%253A%2520a%2520meta-analysis%26jtitle%3DMol.%2520Psychiatr.%26date%3D2015%26volume%3D20%26spage%3D640%26epage%3D646%26doi%3D10.1038%2Fmp.2014.77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torashima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopatina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shnayder, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seike, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takasawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koizumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiraishi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashii, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshihara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Islam, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsushima, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munesue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mochida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span> <span> </span><span class="NLM_article-title">CD38 is critical for social behaviour by regulating oxytocin secretion</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>446</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1038/nature05526</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1038%2Fnature05526" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=17287729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1arsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=446&publication_year=2007&pages=41-45&author=D.+Jinauthor=H.-X.+Liuauthor=H.+Hiraiauthor=T.+Torashimaauthor=T.+Nagaiauthor=O.+Lopatinaauthor=N.+A.+Shnayderauthor=K.+Yamadaauthor=M.+Nodaauthor=T.+Seikeauthor=K.+Fujitaauthor=S.+Takasawaauthor=S.+Yokoyamaauthor=K.+Koizumiauthor=Y.+Shiraishiauthor=S.+Tanakaauthor=M.+Hashiiauthor=T.+Yoshiharaauthor=K.+Higashidaauthor=M.+S.+Islamauthor=N.+Yamadaauthor=K.+Hayashiauthor=N.+Noguchiauthor=I.+Katoauthor=H.+Okamotoauthor=A.+Matsushimaauthor=A.+Salminaauthor=T.+Munesueauthor=N.+Shimizuauthor=S.+Mochidaauthor=M.+Asanoauthor=H.+Higashida&title=CD38+is+critical+for+social+behaviour+by+regulating+oxytocin+secretion&doi=10.1038%2Fnature05526"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">CD38 is critical for social behavior by regulating oxytocin secretion</span></div><div class="casAuthors">Jin, Duo; Liu, Hong-Xiang; Hirai, Hirokazu; Torashima, Takashi; Nagai, Taku; Lopatina, Olga; Shnayder, Natalia A.; Yamada, Kiyofumi; Noda, Mami; Seike, Toshihiro; Fujita, Kyota; Takasawa, Shin; Yokoyama, Shigeru; Koizumi, Keita; Shiraishi, Yoshitake; Tanaka, Shigenori; Hashii, Minako; Yoshihara, Toru; Higashida, Kazuhiro; Islam, Mohammad Saharul; Yamada, Nobuaki; Hayashi, Kenshi; Noguchi, Naoya; Kato, Ichiro; Okamoto, Hiroshi; Matsushima, Akihiro; Salmina, Alla; Munesue, Toshio; Shimizu, Nobuaki; Mochida, Sumiko; Asano, Masahide; Higashida, Haruhiro</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">446</span>
        (<span class="NLM_cas:issue">7131</span>),
    <span class="NLM_cas:pages">41-45</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">CD38, a transmembrane glycoprotein with ADP-Ribosyl cyclase activity, catalyzes the formation of Ca2+ signaling mols., but its role in the neuroendocrine system is unknown.  Here we show that adult CD38 knockout (CD38-/-) female and male mice show marked defects in maternal nurturing and social behavior, resp., with higher locomotor activity.  Consistently, the plasma level of oxytocin (OT), but not vasopressin, was strongly decreased in CD38-/- mice.  Replacement of OT by s.c. injection or lentiviral-vector-mediated delivery of human CD38 in the hypothalamus rescued social memory and maternal care in CD38-/- mice.  Depolarization-induced OT secretion and Ca2+ elevation in oxytocinergic neurohypophysial axon terminals were disrupted in CD38-/- mice; this was mimicked by CD38 metabolite antagonists in CD38+/+ mice.  These results reveal that CD38 has a key role in neuropeptide release, thereby critically regulating maternal and social behaviors, and may be an element in neuro-developmental disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplMtCpmjbVNrVg90H21EOLACvtfcHk0ljJArZLcXVChQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1arsLw%253D&md5=f9e5a484caaeefd77260e712553d915f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature05526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05526%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DH.-X.%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DTorashima%26aufirst%3DT.%26aulast%3DNagai%26aufirst%3DT.%26aulast%3DLopatina%26aufirst%3DO.%26aulast%3DShnayder%26aufirst%3DN.%2BA.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DNoda%26aufirst%3DM.%26aulast%3DSeike%26aufirst%3DT.%26aulast%3DFujita%26aufirst%3DK.%26aulast%3DTakasawa%26aufirst%3DS.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DKoizumi%26aufirst%3DK.%26aulast%3DShiraishi%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DHashii%26aufirst%3DM.%26aulast%3DYoshihara%26aufirst%3DT.%26aulast%3DHigashida%26aufirst%3DK.%26aulast%3DIslam%26aufirst%3DM.%2BS.%26aulast%3DYamada%26aufirst%3DN.%26aulast%3DHayashi%26aufirst%3DK.%26aulast%3DNoguchi%26aufirst%3DN.%26aulast%3DKato%26aufirst%3DI.%26aulast%3DOkamoto%26aufirst%3DH.%26aulast%3DMatsushima%26aufirst%3DA.%26aulast%3DSalmina%26aufirst%3DA.%26aulast%3DMunesue%26aufirst%3DT.%26aulast%3DShimizu%26aufirst%3DN.%26aulast%3DMochida%26aufirst%3DS.%26aulast%3DAsano%26aufirst%3DM.%26aulast%3DHigashida%26aufirst%3DH.%26atitle%3DCD38%2520is%2520critical%2520for%2520social%2520behaviour%2520by%2520regulating%2520oxytocin%2520secretion%26jtitle%3DNature%26date%3D2007%26volume%3D446%26spage%3D41%26epage%3D45%26doi%3D10.1038%2Fnature05526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lopatina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshihara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fakhrul, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuhara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inahata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koizumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petugina, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumarokov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmina, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hori, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiba, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span> <span> </span><span class="NLM_article-title">Anxiety- and depression-like behavior in mice lacking the CD157/BST1 gene, a risk factor for Parkinson’s disease</span>. <i>Front. Behav. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">133</span>, <span class="refDoi"> DOI: 10.3389/fnbeh.2014.00133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.3389%2Ffnbeh.2014.00133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=24795584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1GltLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=133&author=O.+Lopatinaauthor=T.+Yoshiharaauthor=T.+Nishimuraauthor=J.+Zhongauthor=S.+Aktherauthor=A.+A.+Fakhrulauthor=M.+Liangauthor=C.+Higashidaauthor=K.+Sumiauthor=K.+Furuharaauthor=Y.+Inahataauthor=J.+J.+Huangauthor=K.+Koizumiauthor=S.+Yokoyamaauthor=T.+Tsujiauthor=Y.+Petuginaauthor=A.+Sumarokovauthor=A.+B.+Salminaauthor=K.+Hashidaauthor=Y.+Kitaoauthor=O.+Horiauthor=M.+Asanoauthor=Y.+Kitamuraauthor=T.+Kozakaauthor=K.+Shibaauthor=F.+Zhongauthor=M.+J.+Xieauthor=M.+Satoauthor=K.+Ishiharaauthor=H.+Higashida&title=Anxiety-+and+depression-like+behavior+in+mice+lacking+the+CD157%2FBST1+gene%2C+a+risk+factor+for+Parkinson%E2%80%99s+disease&doi=10.3389%2Ffnbeh.2014.00133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Anxiety-and depression-like behavior in mice lacking the CD157/BST1 gene, a risk factor for Parkinson's disease</span></div><div class="casAuthors">Lopatina, Olga; Yoshihara, Toru; Nishimura, Tomoko; Zhong, Jing; Akther, Shirin; Fakhrul, Azam A. K. M.; Liang, Mingkun; Higashida, Chiharu; Sumi, Kohei; Furuhara, Kazumi; Inahata, Yuki; Huang, Jian-Jung; Koizumi, Keita; Yokoyama, Shigeru; Tsuji, Takahiro; Petugina, Yulia; Sumarokov, Andrei; Salmina, Alla B.; Hashida, Koji; Kitao, Yasuko; Hori, Osamu; Asano, Masahide; Kitamura, Yoji; Kozaka, Takashi; Shiba, Kazuhiro; Zhong, Fangfang; Xie, Min-Jue; Sato, Makoto; Ishihara, Katsuhiko; Higashida, Haruhiro</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Behavioral Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">133/1-133/18, 18 pp.</span>CODEN:
                <span class="NLM_cas:coden">FBNRAA</span>;
        ISSN:<span class="NLM_cas:issn">1662-5153</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">CD157, known as bone marrow stromal cell antigen-1, is a glycosylphosphatidylinositol-anchored ADP-ribosyl cyclase that supports the survival and function of B-lymphocytes and hematopoietic or intestinal stem cells.  Although CD157/Bst1 is a risk locus in Parkinson's disease (PD), little is known about the function of CD157 in the nervous system and contribution to PD progression.  Here, we show that no apparent motor dysfunction was obsd. in young knockout (CD157-/-) male mice under less aging-related effects on behaviors.  CD157-/- mice exhibited anxiety-related and depression-like behaviors compared with wild-type mice.  These behaviors were rescued through treatment with anti-psychiatric drugs and oxytocin.  CD157 was weakly expressed in the amygdala and c-Fos immunoreactivity in the amygdala was less evident in CD157-/- mice than in wild-type mice.  These results demonstrate for the first time that CD157 plays a role as a neuro-regulator and suggest a potential role in pre-motor symptoms in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEM-N-VwlsBrVg90H21EOLACvtfcHk0ljJArZLcXVChQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1GltLzK&md5=66eb8215cbfe7970071c3440ed94c731</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.3389%2Ffnbeh.2014.00133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnbeh.2014.00133%26sid%3Dliteratum%253Aachs%26aulast%3DLopatina%26aufirst%3DO.%26aulast%3DYoshihara%26aufirst%3DT.%26aulast%3DNishimura%26aufirst%3DT.%26aulast%3DZhong%26aufirst%3DJ.%26aulast%3DAkther%26aufirst%3DS.%26aulast%3DFakhrul%26aufirst%3DA.%2BA.%26aulast%3DLiang%26aufirst%3DM.%26aulast%3DHigashida%26aufirst%3DC.%26aulast%3DSumi%26aufirst%3DK.%26aulast%3DFuruhara%26aufirst%3DK.%26aulast%3DInahata%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DJ.%2BJ.%26aulast%3DKoizumi%26aufirst%3DK.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DTsuji%26aufirst%3DT.%26aulast%3DPetugina%26aufirst%3DY.%26aulast%3DSumarokov%26aufirst%3DA.%26aulast%3DSalmina%26aufirst%3DA.%2BB.%26aulast%3DHashida%26aufirst%3DK.%26aulast%3DKitao%26aufirst%3DY.%26aulast%3DHori%26aufirst%3DO.%26aulast%3DAsano%26aufirst%3DM.%26aulast%3DKitamura%26aufirst%3DY.%26aulast%3DKozaka%26aufirst%3DT.%26aulast%3DShiba%26aufirst%3DK.%26aulast%3DZhong%26aufirst%3DF.%26aulast%3DXie%26aufirst%3DM.%2BJ.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DIshihara%26aufirst%3DK.%26aulast%3DHigashida%26aufirst%3DH.%26atitle%3DAnxiety-%2520and%2520depression-like%2520behavior%2520in%2520mice%2520lacking%2520the%2520CD157%252FBST1%2520gene%252C%2520a%2520risk%2520factor%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DFront.%2520Behav.%2520Neurosci.%26date%3D2014%26volume%3D8%26spage%3D133%26doi%3D10.3389%2Ffnbeh.2014.00133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuhi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amina, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopatina, O.</span></span> <span> </span><span class="NLM_article-title">Oxytocin release via activation of TRPM2 and CD38 in the hypothalamus during hyperthermia in mice: implication for autism spectrum disorder</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1016/j.neuint.2017.07.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.neuint.2017.07.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=28736241" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2017&pages=42-48&author=H.+Higashidaauthor=T.+Yuhiauthor=S.+Aktherauthor=S.+Aminaauthor=J.+Zhongauthor=M.+Liangauthor=T.+Nishimuraauthor=H.-X.+Liuauthor=O.+Lopatina&title=Oxytocin+release+via+activation+of+TRPM2+and+CD38+in+the+hypothalamus+during+hyperthermia+in+mice%3A+implication+for+autism+spectrum+disorder&doi=10.1016%2Fj.neuint.2017.07.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2017.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2017.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DHigashida%26aufirst%3DH.%26aulast%3DYuhi%26aufirst%3DT.%26aulast%3DAkther%26aufirst%3DS.%26aulast%3DAmina%26aufirst%3DS.%26aulast%3DZhong%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DM.%26aulast%3DNishimura%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DH.-X.%26aulast%3DLopatina%26aufirst%3DO.%26atitle%3DOxytocin%2520release%2520via%2520activation%2520of%2520TRPM2%2520and%2520CD38%2520in%2520the%2520hypothalamus%2520during%2520hyperthermia%2520in%2520mice%253A%2520implication%2520for%2520autism%2520spectrum%2520disorder%26jtitle%3DNeurochem.%2520Int.%26date%3D2017%26volume%3D119%26spage%3D42%26epage%3D48%26doi%3D10.1016%2Fj.neuint.2017.07.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshihara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fakhrul, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherepanov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahmuda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerasimenko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopatina, O.</span></span> <span> </span><span class="NLM_article-title">An immunohistochemical, enzymatic, and behavioral study of CD157/BST-1 as a neuroregulator</span>. <i>BMC Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">35</span>, <span class="refDoi"> DOI: 10.1186/s12868-017-0350-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1186%2Fs12868-017-0350-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=28340569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkvVaiur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=35&author=H.+Higashidaauthor=M.+Liangauthor=T.+Yoshiharaauthor=S.+Aktherauthor=A.+Fakhrulauthor=S.+Cherepanovauthor=T.+S.+Namauthor=U.+H.+Kimauthor=S.+Kasaiauthor=T.+Nishimuraauthor=N.+Mahmudaauthor=S.+Yokoyamaauthor=K.+Ishiharaauthor=M.+Gerasimenkoauthor=A.+Salminaauthor=J.+Zhongauthor=T.+Tsujiauthor=C.+Tsujiauthor=O.+Lopatina&title=An+immunohistochemical%2C+enzymatic%2C+and+behavioral+study+of+CD157%2FBST-1+as+a+neuroregulator&doi=10.1186%2Fs12868-017-0350-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">An immunohistochemical, enzymatic, and behavioral study of CD157/BST-1 as a neuroregulator</span></div><div class="casAuthors">Higashida, Haruhiro; Liang, Mingkun; Yoshihara, Toru; Akther, Shirin; Fakhrul, Azam; Stanislav, Cherepanov; Nam, Tae-Sik; Kim, Uh-Hyun; Kasai, Satoka; Nishimura, Tomoko; Al Mahmuda, Naila; Yokoyama, Shigeru; Ishihara, Katsuhiko; Gerasimenko, Maria; Salmina, Alla; Zhong, Jing; Tsuji, Takahiro; Tsuji, Chiharu; Lopatina, Olga</div><div class="citationInfo"><span class="NLM_cas:title">BMC Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35/1-35/12</span>CODEN:
                <span class="NLM_cas:coden">BNMEA6</span>;
        ISSN:<span class="NLM_cas:issn">1471-2202</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Recent rodent and human studies provide evidence in support of the fact that CD157, well known as bone marrow stromal cell antigen-1 (BST-1) and a risk factor in Parkinson's disease, also meaningfully acts in the brain as a neuroregulator and affects social behaviors.  It has been shown that social behaviors are impaired in CD157 knockout mice without severe motor dysfunction and that CD157/BST1 gene single nucleotide polymorphisms are assocd. with autism spectrum disorder in humans.  However, it is still necessary to det. how this mol. contributes to the brain's physiol. and pathophysiol. functions.  Methods: To gain fresh insights about the relationship between the presence of CD157 in the brain and its enzymic activity, and aberrant social behavior, CD157 knockout mice of various ages were tested.  Results: CD157 immunoreactivity colocalized with nestin-pos. cells and elements in the ventricular zones in E17 embryos.  Brain CD157 mRNA levels were high in neonates but low in adults.  Weak but distinct immunoreactivity was detected in several areas in the adult brain, including the amygdala.  CD157 has little or no base exchange activity, but some ADP-ribosyl cyclase activity, indicating that CD157 formed cyclic ADP-ribose but much less nicotinic acid adenine dinucleotide phosphate, with both mobilizing Ca2+ from intracellular Ca2+ pools.  Social avoidance in CD157 knockout mice was rescued by a single i.p. injection of oxytocin.  Conclusions: CD157 may play a role in the embryonic and adult nervous systems.  The functional features of CD157 can be explained in part through the prodn. of cyclic ADP-ribose rather than nicotinic acid adenine dinucleotide phosphate.  Further expts. are required to elucidate how the embryonic expression of CD157 in neural stem cells contributes to behaviors in adults or to psychiatric symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2SEjqYOsYI7Vg90H21EOLACvtfcHk0lizKQ0M5hgjpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkvVaiur0%253D&md5=2d2812c40e3f954e6426adaf36357902</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1186%2Fs12868-017-0350-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12868-017-0350-7%26sid%3Dliteratum%253Aachs%26aulast%3DHigashida%26aufirst%3DH.%26aulast%3DLiang%26aufirst%3DM.%26aulast%3DYoshihara%26aufirst%3DT.%26aulast%3DAkther%26aufirst%3DS.%26aulast%3DFakhrul%26aufirst%3DA.%26aulast%3DCherepanov%26aufirst%3DS.%26aulast%3DNam%26aufirst%3DT.%2BS.%26aulast%3DKim%26aufirst%3DU.%2BH.%26aulast%3DKasai%26aufirst%3DS.%26aulast%3DNishimura%26aufirst%3DT.%26aulast%3DMahmuda%26aufirst%3DN.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DIshihara%26aufirst%3DK.%26aulast%3DGerasimenko%26aufirst%3DM.%26aulast%3DSalmina%26aufirst%3DA.%26aulast%3DZhong%26aufirst%3DJ.%26aulast%3DTsuji%26aufirst%3DT.%26aulast%3DTsuji%26aufirst%3DC.%26aulast%3DLopatina%26aufirst%3DO.%26atitle%3DAn%2520immunohistochemical%252C%2520enzymatic%252C%2520and%2520behavioral%2520study%2520of%2520CD157%252FBST-1%2520as%2520a%2520neuroregulator%26jtitle%3DBMC%2520Neurosci.%26date%3D2017%26volume%3D18%26spage%3D35%26doi%3D10.1186%2Fs12868-017-0350-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munesue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anitha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koizumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Islam, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, U.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ono, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakatani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyachi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichugina, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soumarokov, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takei, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsujii, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamagishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasue, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniike, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamada, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ooi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamiyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopatina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashii, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amina, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malavasi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsushima, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span> <span> </span><span class="NLM_article-title">Two genetic variants of CD38 in subjects with autism spectrum disorder and controls</span>. <i>Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1016/j.neures.2010.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.neures.2010.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=20435366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFaisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=181-191&author=T.+Munesueauthor=S.+Yokoyamaauthor=K.+Nakamuraauthor=A.+Anithaauthor=K.+Yamadaauthor=K.+Hayashiauthor=T.+Asakaauthor=H.-X.+Liuauthor=D.+Jinauthor=K.+Koizumiauthor=M.+S.+Islamauthor=J.-J.+Huangauthor=W.-J.+Maauthor=U.-H.+Kimauthor=S.-J.+Kimauthor=K.+Parkauthor=D.+Kimauthor=M.+Kikuchiauthor=Y.+Onoauthor=H.+Nakataniauthor=S.+Sudaauthor=T.+Miyachiauthor=H.+Hiraiauthor=A.+Salminaauthor=Y.+A.+Pichuginaauthor=A.+A.+Soumarokovauthor=N.+Takeiauthor=N.+Moriauthor=M.+Tsujiiauthor=T.+Sugiyamaauthor=K.+Yagiauthor=M.+Yamagishiauthor=T.+Sasakiauthor=H.+Yamasueauthor=N.+Katoauthor=R.+Hashimotoauthor=M.+Taniikeauthor=Y.+Hayashiauthor=J.+Hamadaauthor=S.+Suzukiauthor=A.+Ooiauthor=M.+Nodaauthor=Y.+Kamiyamaauthor=M.+A.+Kidoauthor=O.+Lopatinaauthor=M.+Hashiiauthor=S.+Aminaauthor=F.+Malavasiauthor=E.+J.+Huangauthor=J.+Zhangauthor=N.+Shimizuauthor=T.+Yoshikawaauthor=A.+Matsushimaauthor=Y.+Minabeauthor=H.+Higashida&title=Two+genetic+variants+of+CD38+in+subjects+with+autism+spectrum+disorder+and+controls&doi=10.1016%2Fj.neures.2010.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Two genetic variants of CD38 in subjects with autism spectrum disorder and controls</span></div><div class="casAuthors">Munesue, Toshio; Yokoyama, Shigeru; Nakamura, Kazuhiko; Anitha, Ayyappan; Yamada, Kazuo; Hayashi, Kenshi; Asaka, Tomoya; Liu, Hong-Xiang; Jin, Duo; Koizumi, Keita; Islam, Mohammad Saharul; Huang, Jian-Jun; Ma, Wen-Jie; Kim, Uh-Hyun; Kim, Sun-Jun; Park, Keunwan; Kim, Dongsup; Kikuchi, Mitsuru; Ono, Yasuki; Nakatani, Hideo; Suda, Shiro; Miyachi, Taishi; Hirai, Hirokazu; Salmina, Alla; Pichugina, Yu A.; Soumarokov, Andrei A.; Takei, Nori; Mori, Norio; Tsujii, Masatsugu; Sugiyama, Toshiro; Yagi, Kunimasa; Yamagishi, Masakazu; Sasaki, Tsukasa; Yamasue, Hidenori; Kato, Nobumasa; Hashimoto, Ryota; Taniike, Masako; Hayashi, Yutaka; Hamada, Junichiro; Suzuki, Shioto; Ooi, Akishi; Noda, Mami; Kamiyama, Yuko; Kido, Mizuho A.; Lopatina, Olga; Hashii, Minako; Amina, Sarwat; Malavasi, Fabio; Huang, Eric J.; Zhang, Jiasheng; Shimizu, Nobuaki; Yoshikawa, Takeo; Matsushima, Akihiro; Minabe, Yoshio; Higashida, Haruhiro</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Research (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-191</span>CODEN:
                <span class="NLM_cas:coden">NERADN</span>;
        ISSN:<span class="NLM_cas:issn">0168-0102</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">The neurobiol. basis of autism spectrum disorder (ASD) remains poorly understood.  Given the role of CD38 in social recognition through oxytocin (OT) release, we hypothesized that CD38 may play a role in the etiol. of ASD.  Here, we first examd. the immunohistochem. expression of CD38 in the hypothalamus of post-mortem brains of non-ASD subjects and found that CD38 was colocalized with OT in secretory neurons.  In studies of the assocn. between CD38 and autism, we analyzed 10 single nucleotide polymorphisms (SNPs) and mutations of CD38 by re-sequencing DNAs mainly from a case-control study in Japan, and Caucasian cases mainly recruited to the Autism Genetic Resource Exchange (AGRE).  The SNPs of CD38, rs6449197 (p < 0.040) and rs3796863 (p < 0.005) showed significant assocns. with a subset of ASD (IQ > 70; designated as high-functioning autism (HFA)) in the U.S. 104 AGRE family trios, but not with Japanese 188 HFA subjects.  A mutation that caused tryptophan to replace arginine at amino acid residue 140 (R140W; (rs1800561, 4693C>T)) was found in 0.6-4.6% of the Japanese population and was assocd. with ASD in the smaller case-control study.  The SNP was clustered in pedigrees in which the fathers and brothers of T-allele-carrier probands had ASD or ASD traits.  In this cohort OT plasma levels were lower in subjects with the T allele than in those without.  One proband with the T allele who was taking nasal OT spray showed relief of symptoms.  The two variant CD38 polymorphisms tested may be of interest with regard of the pathophysiol. of ASD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGox0YlYfJ3bVg90H21EOLACvtfcHk0lizKQ0M5hgjpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFaisLo%253D&md5=94428a0093d578814f7e35b4330fb4ce</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.neures.2010.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neures.2010.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DMunesue%26aufirst%3DT.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DAnitha%26aufirst%3DA.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DHayashi%26aufirst%3DK.%26aulast%3DAsaka%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DH.-X.%26aulast%3DJin%26aufirst%3DD.%26aulast%3DKoizumi%26aufirst%3DK.%26aulast%3DIslam%26aufirst%3DM.%2BS.%26aulast%3DHuang%26aufirst%3DJ.-J.%26aulast%3DMa%26aufirst%3DW.-J.%26aulast%3DKim%26aufirst%3DU.-H.%26aulast%3DKim%26aufirst%3DS.-J.%26aulast%3DPark%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DKikuchi%26aufirst%3DM.%26aulast%3DOno%26aufirst%3DY.%26aulast%3DNakatani%26aufirst%3DH.%26aulast%3DSuda%26aufirst%3DS.%26aulast%3DMiyachi%26aufirst%3DT.%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DSalmina%26aufirst%3DA.%26aulast%3DPichugina%26aufirst%3DY.%2BA.%26aulast%3DSoumarokov%26aufirst%3DA.%2BA.%26aulast%3DTakei%26aufirst%3DN.%26aulast%3DMori%26aufirst%3DN.%26aulast%3DTsujii%26aufirst%3DM.%26aulast%3DSugiyama%26aufirst%3DT.%26aulast%3DYagi%26aufirst%3DK.%26aulast%3DYamagishi%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DYamasue%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DN.%26aulast%3DHashimoto%26aufirst%3DR.%26aulast%3DTaniike%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DHamada%26aufirst%3DJ.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DOoi%26aufirst%3DA.%26aulast%3DNoda%26aufirst%3DM.%26aulast%3DKamiyama%26aufirst%3DY.%26aulast%3DKido%26aufirst%3DM.%2BA.%26aulast%3DLopatina%26aufirst%3DO.%26aulast%3DHashii%26aufirst%3DM.%26aulast%3DAmina%26aufirst%3DS.%26aulast%3DMalavasi%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DE.%2BJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DShimizu%26aufirst%3DN.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DMatsushima%26aufirst%3DA.%26aulast%3DMinabe%26aufirst%3DY.%26aulast%3DHigashida%26aufirst%3DH.%26atitle%3DTwo%2520genetic%2520variants%2520of%2520CD38%2520in%2520subjects%2520with%2520autism%2520spectrum%2520disorder%2520and%2520controls%26jtitle%3DNeurosci.%2520Res.%26date%3D2010%26volume%3D67%26spage%3D181%26epage%3D191%26doi%3D10.1016%2Fj.neures.2010.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Mahmuda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munesue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamagishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span> <span> </span><span class="NLM_article-title">Association study between the CD157/BST1 gene and autism spectrum disorders in a Japanese population</span>. <i>Brain Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">188</span>– <span class="NLM_lpage">200</span>, <span class="refDoi"> DOI: 10.3390/brainsci5020188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.3390%2Fbrainsci5020188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=26010484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsVKis7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=188-200&author=S.+Yokoyamaauthor=N.+Al+Mahmudaauthor=T.+Munesueauthor=K.+Hayashiauthor=K.+Yagiauthor=M.+Yamagishiauthor=H.+Higashida&title=Association+study+between+the+CD157%2FBST1+gene+and+autism+spectrum+disorders+in+a+Japanese+population&doi=10.3390%2Fbrainsci5020188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Association study between the CD157/BST1 gene and Autism spectrum disorders in a Japanese population</span></div><div class="casAuthors">Yokoyama, Shigeru; Al Mahmuda, Naila; Munesue, Toshio; Hayashi, Kenshi; Yagi, Kunimasa; Yamagishi, Masakazu; Higashida, Haruhiro</div><div class="citationInfo"><span class="NLM_cas:title">Brain Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">188-200</span>CODEN:
                <span class="NLM_cas:coden">BSRCCS</span>;
        ISSN:<span class="NLM_cas:issn">2076-3425</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">CD157, also referred to as bone marrow stromal cell antigen-1 (BST-1), is a glycosylphosphatidylinositol-anchored mol. that promotes pre-B-cell growth.  Previous studies have reported assocns. between single-nucleotide polymorphisms (SNPs) of the CD157/BST1 gene with Parkinson's disease.  In an attempt to det. whether SNPs or haplotypes in the CD157/BST1 are assocd. with other brain disorders, we performed a case-control study including 147 autism spectrum disorder (ASD) patients at Kanazawa University Hospital in Japan and 150 unselected Japanese volunteers by the sequence-specific primer-polymerase chain reaction method combined with fluorescence correlation spectroscopy.  Of 93 SNPs examd., two SNPs showed significantly higher allele frequencies in cases with ASDs than in unaffected controls (rs4301112, OR = 6.4, 95% CI = 1.9 to 22, p = 0.0007; and rs28532698, OR = 6.2, 95% CI = 1.8 to 21, p = 0.0012; Fisher's exact test; p < 0.002 was considered significant after multiple testing correction).  In addn., CT genotype in rs10001565 was more frequently obsd. in the ASD group than in the control group (OR = 15, 95% CI = 2.0 to 117, p = 0.0007; Fisher's exact test).  The present data indicate that genetic variation of the CD157/BST1 gene might confer susceptibility to ASDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmxmi8Q-5gv7Vg90H21EOLACvtfcHk0lh3m5L8qwOZbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsVKis7w%253D&md5=6243d9db1fb74b0e9c581bc84f982007</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.3390%2Fbrainsci5020188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbrainsci5020188%26sid%3Dliteratum%253Aachs%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DAl%2BMahmuda%26aufirst%3DN.%26aulast%3DMunesue%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DK.%26aulast%3DYagi%26aufirst%3DK.%26aulast%3DYamagishi%26aufirst%3DM.%26aulast%3DHigashida%26aufirst%3DH.%26atitle%3DAssociation%2520study%2520between%2520the%2520CD157%252FBST1%2520gene%2520and%2520autism%2520spectrum%2520disorders%2520in%2520a%2520Japanese%2520population%26jtitle%3DBrain%2520Sci.%26date%3D2015%26volume%3D5%26spage%3D188%26epage%3D200%26doi%3D10.3390%2Fbrainsci5020188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kato, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takasawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, H.</span></span> <span> </span><span class="NLM_article-title">CD38 Disruption Impairs Glucose-induced Increases in Cyclic ADP-ribose, [Ca2+]i, and Insulin Secretion</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">1869</span>– <span class="NLM_lpage">1872</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.4.1869</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1074%2Fjbc.274.4.1869" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=1869-1872&author=I.+Katoauthor=Y.+Yamamotoauthor=M.+Fujimuraauthor=N.+Noguchiauthor=S.+Takasawaauthor=H.+Okamoto&title=CD38+Disruption+Impairs+Glucose-induced+Increases+in+Cyclic+ADP-ribose%2C+%5BCa2%2B%5Di%2C+and+Insulin+Secretion&doi=10.1074%2Fjbc.274.4.1869"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.4.1869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.4.1869%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DI.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DFujimura%26aufirst%3DM.%26aulast%3DNoguchi%26aufirst%3DN.%26aulast%3DTakasawa%26aufirst%3DS.%26aulast%3DOkamoto%26aufirst%3DH.%26atitle%3DCD38%2520Disruption%2520Impairs%2520Glucose-induced%2520Increases%2520in%2520Cyclic%2520ADP-ribose%252C%2520%255BCa2%252B%255Di%252C%2520and%2520Insulin%2520Secretion%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D1869%26epage%3D1872%26doi%3D10.1074%2Fjbc.274.4.1869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munesue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopatina, O.</span></span> <span> </span><span class="NLM_article-title">CD38 gene knockout juvenile mice: a model of oxytocin signal defects in autism</span>. <i>Biol. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1369</span>– <span class="NLM_lpage">1372</span>, <span class="refDoi"> DOI: 10.1248/bpb.34.1369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1248%2Fbpb.34.1369" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=21881219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlGks7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2011&pages=1369-1372&author=H.+Higashidaauthor=S.+Yokoyamaauthor=T.+Munesueauthor=M.+Kikuchiauthor=Y.+Minabeauthor=O.+Lopatina&title=CD38+gene+knockout+juvenile+mice%3A+a+model+of+oxytocin+signal+defects+in+autism&doi=10.1248%2Fbpb.34.1369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Cd38 gene knockout juvenile mice: a model of oxytocin signal defects in autism</span></div><div class="casAuthors">Higashida, Haruhiro; Yokoyama, Shigeru; Munesue, Toshio; Kikuchi, Mitsuru; Minabe, Yoshio; Lopatina, Olga</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1369-1372</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A review.  Oxytocin (OXT) in the hypothalamus is the biol. basis of social recognition, trust, and bonding.  We showed that CD38, a leukemia cell marker, plays an important role in the hypothalamus in the process of OXT release in adult mice.  Disruption of Cd38 (Cd38-/-) produced impairment of maternal behavior and male social recognition in mice, similar to the behavior obsd. in Oxt and OXT receptor (Oxtr) gene knockout (Oxt-/- and Oxtr-/-, resp.) mice.  Locomotor activity induced by sepn. from the dam was higher and the no. of ultrasonic vocalization (USV) calls was lower in Cd38-/- than Cd38+/+ pups.  These phenotypes seemed to be caused by the high plasma OXT levels during development from neonates to 3-wk-old juvenile mice.  ADP-ribosyl cyclase activity was markedly lower in the knockout mice from birth, suggesting that weaning for mice is a crit. time window of differentiating plasma OXT.  Contribution by breastfeeding was an important exogenous source for regulating plasma OXT before weaning by the presence of OXT in milk and the dam's mammary glands.  The dissimilarity of Cd38-/- infant behavior to Oxt-/- or Oxtr-/- mice can be explained partly by this exogenous source of OXT.  These results suggest that secretion of OXT into the brain in a CD38-dependent manner may play an important role in the development of social behavior, and mice with OXT signaling deficiency, including Cd38-/-, Oxt-/- and Oxtr-/- mice are good animal models for developmental disorders, such as autism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD672oxj06vbVg90H21EOLACvtfcHk0lh3m5L8qwOZbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlGks7%252FN&md5=9a4f91334b50b1eeeb9fdf27860b5c93</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1248%2Fbpb.34.1369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.34.1369%26sid%3Dliteratum%253Aachs%26aulast%3DHigashida%26aufirst%3DH.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DMunesue%26aufirst%3DT.%26aulast%3DKikuchi%26aufirst%3DM.%26aulast%3DMinabe%26aufirst%3DY.%26aulast%3DLopatina%26aufirst%3DO.%26atitle%3DCD38%2520gene%2520knockout%2520juvenile%2520mice%253A%2520a%2520model%2520of%2520oxytocin%2520signal%2520defects%2520in%2520autism%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2011%26volume%3D34%26spage%3D1369%26epage%3D1372%26doi%3D10.1248%2Fbpb.34.1369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korshnova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherepanov, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopatina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komleva, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmina, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fakhrul, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takasawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span> <span> </span><span class="NLM_article-title">CD38 in the nucleus accumbens and oxytocin are related to paternal behavior in mice</span>. <i>Mol. Brain</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">41</span>, <span class="refDoi"> DOI: 10.1186/1756-6606-6-41</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1186%2F1756-6606-6-41" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=24059452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntVKitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=41&author=S.+Aktherauthor=N.+Korshnovaauthor=J.+Zhongauthor=M.+Liangauthor=S.+M.+Cherepanovauthor=O.+Lopatinaauthor=Y.+K.+Komlevaauthor=A.+B.+Salminaauthor=T.+Nishimuraauthor=A.+A.+Fakhrulauthor=H.+Hiraiauthor=I.+Katoauthor=Y.+Yamamotoauthor=S.+Takasawaauthor=H.+Okamotoauthor=H.+Higashida&title=CD38+in+the+nucleus+accumbens+and+oxytocin+are+related+to+paternal+behavior+in+mice&doi=10.1186%2F1756-6606-6-41"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">CD38 in the nucleus accumbens and oxytocin are related to paternal behavior in mice</span></div><div class="casAuthors">Akther, Shirin; Korshnova, Natalia; Zhong, Jing; Liang, Mingkun; Cherepanov, Stanislav M.; Lopatina, Olga; Komleva, Yulia K.; Salmina, Alla B.; Nishimura, Tomoko; Fakhrul, Azam A. K. M.; Hirai, Hirokazu; Kato, Ichiro; Yamamoto, Yasuhiko; Takasawa, Shin; Okamoto, Hiroshi; Higashida, Haruhiro</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">41/1-41/10</span>CODEN:
                <span class="NLM_cas:coden">MBORAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-6606</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Mammalian sires participate in infant care.  We previously demonstrated that sires of a strain of nonmonogamous lab. mice initiate parental retrieval behavior in response to olfactory and auditory signals from the dam during isolation in a new environment.  This behavior is rapidly lost in the absence of such signals when the sires are caged alone.  The neural circuitry and hormones that control paternal behavior are not well understood.  CD38, a membrane glycoprotein, catalyzes synthesis of cyclic ADP-ribose and facilitates oxytocin (OT) secretion due to cyclic ADP-ribose-dependent increases in cytosolic free calcium concns. in oxytocinergic neurons in the hypothalamus.  In this paper, we studied CD38 in the nucleus accumbens (NAcc) and the role of OT on paternal pup retrieval behavior using CD38 knockout (CD38-/-) mice of the ICR strain.  Results: CD38-/- sires failed to retrieve when they were reunited with their pups after isolation together with the mate dams, but not with pup, in a novel cage for 10 min.  CD38-/- sires treated with a single s.c. injection of OT exhibited recovery in the retrieval events when caged with CD38-/- dams treated with OT.  We introduced human CD38 in the NAcc of CD38-/- sires using a lentiviral infection technique and examd. the effects of local expression of CD38.  Pairs of knockout dams treated with OT and sires expressing CD38 in the NAcc showed more retrieval (83% of wild-type sire levels).  Complete recovery of retrieval was obtained in sires with the expression of CD38 in the NAcc in combination with OT administration.  Other paternal behaviors, including pup grooming, crouching and huddling, were also more common in CD38-/- sires with CD38 expression in the NAcc compared with those in CD38-/- sires without CD38 expression in the NAcc.  Conclusions: CD38 in the NAcc and OT are crit. in paternal behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf8ou2Wt3BmLVg90H21EOLACvtfcHk0lhY15C5_j2n0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntVKitb8%253D&md5=456d349e437d62b905debd4729d100da</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1186%2F1756-6606-6-41&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-6606-6-41%26sid%3Dliteratum%253Aachs%26aulast%3DAkther%26aufirst%3DS.%26aulast%3DKorshnova%26aufirst%3DN.%26aulast%3DZhong%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DM.%26aulast%3DCherepanov%26aufirst%3DS.%2BM.%26aulast%3DLopatina%26aufirst%3DO.%26aulast%3DKomleva%26aufirst%3DY.%2BK.%26aulast%3DSalmina%26aufirst%3DA.%2BB.%26aulast%3DNishimura%26aufirst%3DT.%26aulast%3DFakhrul%26aufirst%3DA.%2BA.%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DI.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DTakasawa%26aufirst%3DS.%26aulast%3DOkamoto%26aufirst%3DH.%26aulast%3DHigashida%26aufirst%3DH.%26atitle%3DCD38%2520in%2520the%2520nucleus%2520accumbens%2520and%2520oxytocin%2520are%2520related%2520to%2520paternal%2520behavior%2520in%2520mice%26jtitle%3DMol.%2520Brain%26date%3D2013%26volume%3D6%26spage%3D41%26doi%3D10.1186%2F1756-6606-6-41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cherepanov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shabalova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichinose, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span> <span> </span><span class="NLM_article-title">Effects of three lipidated oxytocin analogs on behavioral deficits in CD38 knockout mice</span>. <i>Brain Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">132</span>, <span class="refDoi"> DOI: 10.3390/brainsci7100132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.3390%2Fbrainsci7100132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvVKlt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=132&author=S.+Cherepanovauthor=S.+Aktherauthor=T.+Nishimuraauthor=A.+Shabalovaauthor=A.+Mizunoauthor=W.+Ichinoseauthor=S.+Shutoauthor=Y.+Yamamotoauthor=S.+Yokoyamaauthor=H.+Higashida&title=Effects+of+three+lipidated+oxytocin+analogs+on+behavioral+deficits+in+CD38+knockout+mice&doi=10.3390%2Fbrainsci7100132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of three lipidated oxytocin analogs on behavioral deficits in CD38 knockout mice</span></div><div class="casAuthors">Cherepanov, Stanislav M.; Akther, Shirin; Nishimura, Tomoko; Shabalova, Anna A.; Mizuno, Akira; Ichinose, Wataru; Shuto, Satoshi; Yamamoto, Yasuhiko; Yokoyama, Shigeru; Higashida, Haruhiro</div><div class="citationInfo"><span class="NLM_cas:title">Brain Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">132/1-132/15</span>CODEN:
                <span class="NLM_cas:coden">BSRCCS</span>;
        ISSN:<span class="NLM_cas:issn">2076-3425</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Oxytocin (OT) is a nonapeptide that plays an important role in social behavior.  Nasal administration of OT has been shown to improve trust in healthy humans and social interaction in autistic subjects.  As is consistent with the nature of a peptide, OT has some unfavorable characteristics: it has a short half-life in plasma and shows poor permeability across the blood-brain barrier.  Analogs with long-lasting effects may overcome these drawbacks.  To this end, we have synthesized three analogs: lipo-oxytocin-1 (LOT-1), in which two palmitoyl groups are conjugated to the cysteine and tyrosine residues, lipo-oxytocin-2 (LOT-2) and lipo-oxytocin-3 (LOT-3), which include one palmitoyl group conjugated at the cysteine or tyrosine residue, resp.  The following behavioral deficits were obsd. in CD38 knockout (CD38-/-) mice: a lack of paternal nurturing in CD38-/- sires, decreased ability for social recognition, and decreased sucrose consumption.  OT demonstrated the ability to recover these disturbances to the level of wild-type mice for 30 min after injection.  LOT-2 and LOT-3 partially recovered the behaviors for a short period.  Conversely, LOT-1 restored the behavioral parameters, not for 30 min, but for 24 h.  These data suggest that the lipidation of OT has some therapeutic benefits, and LOT-1 would be most useful because of its long-last activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrinQahzSd3g7Vg90H21EOLACvtfcHk0lhY15C5_j2n0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvVKlt7Y%253D&md5=531162bc51ca6aa31131d548c302db4d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.3390%2Fbrainsci7100132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbrainsci7100132%26sid%3Dliteratum%253Aachs%26aulast%3DCherepanov%26aufirst%3DS.%26aulast%3DAkther%26aufirst%3DS.%26aulast%3DNishimura%26aufirst%3DT.%26aulast%3DShabalova%26aufirst%3DA.%26aulast%3DMizuno%26aufirst%3DA.%26aulast%3DIchinose%26aufirst%3DW.%26aulast%3DShuto%26aufirst%3DS.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DHigashida%26aufirst%3DH.%26atitle%3DEffects%2520of%2520three%2520lipidated%2520oxytocin%2520analogs%2520on%2520behavioral%2520deficits%2520in%2520CD38%2520knockout%2520mice%26jtitle%3DBrain%2520Sci.%26date%3D2017%26volume%3D7%26spage%3D132%26doi%3D10.3390%2Fbrainsci7100132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Domes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrichs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumbier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauenstein, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herpertz, S. C.</span></span> <span> </span><span class="NLM_article-title">Effects of intranasal oxytocin on the neural basis of face processing in autism spectrum disorder</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">164</span>– <span class="NLM_lpage">171</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2013.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.biopsych.2013.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=23510581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksV2jtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2013&pages=164-171&author=G.+Domesauthor=M.+Heinrichsauthor=E.+Kumbierauthor=A.+Grossmannauthor=K.+Hauensteinauthor=S.+C.+Herpertz&title=Effects+of+intranasal+oxytocin+on+the+neural+basis+of+face+processing+in+autism+spectrum+disorder&doi=10.1016%2Fj.biopsych.2013.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Intranasal Oxytocin on the Neural Basis of Face Processing in Autism Spectrum Disorder</span></div><div class="casAuthors">Domes, Gregor; Heinrichs, Markus; Kumbier, Ekkehardt; Grossmann, Annette; Hauenstein, Karlheinz; Herpertz, Sabine C.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">164-171</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Background: Autism spectrum disorder (ASD) is assocd. with altered face processing and decreased activity in brain regions involved in face processing.  The neuropeptide oxytocin has been shown to promote face processing and modulate brain activity in healthy adults.  The present study examd. the effects of oxytocin on the neural basis of face processing in adults with Asperger syndrome (AS).  Methods: A group of 14 individuals with AS and a group of 14 neurotypical control participants performed a face-matching and a house-matching task during functional magnetic resonance imaging.  The effects of a single dose of 24 IU intranasally administered oxytocin were tested in a randomized, placebo-controlled, within-subject, cross-over design.  Results: Under placebo, the AS group showed decreased activity in the right amygdala, fusiform gyrus, and inferior occipital gyrus compared with the control group during face processing.  After oxytocin treatment, right amygdala activity to facial stimuli increased in the AS group.  Conclusions: These findings indicate that oxytocin increases the saliency of social stimuli and in ASD and suggest that oxytocin might promote face processing and eye contact in individuals with ASD as prerequisites for neurotypical social interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrThR5xUWpbIrVg90H21EOLACvtfcHk0lhY15C5_j2n0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksV2jtbk%253D&md5=cd0d31448b6374b0f42d208bea69749e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2013.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2013.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DDomes%26aufirst%3DG.%26aulast%3DHeinrichs%26aufirst%3DM.%26aulast%3DKumbier%26aufirst%3DE.%26aulast%3DGrossmann%26aufirst%3DA.%26aulast%3DHauenstein%26aufirst%3DK.%26aulast%3DHerpertz%26aufirst%3DS.%2BC.%26atitle%3DEffects%2520of%2520intranasal%2520oxytocin%2520on%2520the%2520neural%2520basis%2520of%2520face%2520processing%2520in%2520autism%2520spectrum%2520disorder%26jtitle%3DBiol.%2520Psychiatry%26date%3D2013%26volume%3D74%26spage%3D164%26epage%3D171%26doi%3D10.1016%2Fj.biopsych.2013.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Auyeung, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrichs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakrabarti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sule, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deakin, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bethlehem, R. A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickens, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mooney, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sipple, J. A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiemann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baron-Cohen, S.</span></span> <span> </span><span class="NLM_article-title">Oxytocin increases eye contact during a real-time, naturalistic social interaction in males with and without autism</span>. <i>Transl. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e507</span> <span class="refDoi"> DOI: 10.1038/tp.2014.146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1038%2Ftp.2014.146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=25668435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFCgt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&author=B.+Auyeungauthor=M.+V.+Lombardoauthor=M.+Heinrichsauthor=B.+Chakrabartiauthor=A.+Suleauthor=J.+B.+Deakinauthor=R.+A.+I.+Bethlehemauthor=L.+Dickensauthor=N.+Mooneyauthor=J.+A.+N.+Sippleauthor=P.+Thiemannauthor=S.+Baron-Cohen&title=Oxytocin+increases+eye+contact+during+a+real-time%2C+naturalistic+social+interaction+in+males+with+and+without+autism&doi=10.1038%2Ftp.2014.146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin increases eye contact during a real-time, naturalistic social interaction in males with and without autism</span></div><div class="casAuthors">Auyeung, B.; Lombardo, M. V.; Heinrichs, M.; Chakrabarti, B.; Sule, A.; Deakin, J. B.; Bethlehem, R. A. I.; Dickens, L.; Mooney, N.; Sipple, J. A. N.; Thiemann, P.; Baron-Cohen, S.</div><div class="citationInfo"><span class="NLM_cas:title">Translational Psychiatry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e507</span>CODEN:
                <span class="NLM_cas:coden">TPRSCF</span>;
        ISSN:<span class="NLM_cas:issn">2158-3188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autism spectrum conditions (autism) affect ∼1% of the population and are characterized by deficits in social communication.  Oxytocin has been widely reported to affect social-communicative function and its neural underpinnings.  Here we report the first evidence that intranasal oxytocin administration improves a core problem that individuals with autism have in using eye contact appropriately in real-world social settings.  A randomized double-blind, placebo-controlled, within-subjects design is used to examine how intranasal administration of 24 IU of oxytocin affects gaze behavior for 32 adult males with autism and 34 controls in a real-time interaction with a researcher.  This interactive paradigm bypasses many of the limitations encountered with conventional static or computer-based stimuli.  Eye movements are recorded using eye tracking, providing an objective measurement of looking patterns.  The measure is shown to be sensitive to the reduced eye contact commonly reported in autism, with the autism group spending less time looking to the eye region of the face than controls.  Oxytocin administration selectively enhanced gaze to the eyes in both the autism and control groups (transformed mean eye-fixation difference per s=0.082; 95% CI:0.025-0.14, P=0.006).  Within the autism group, oxytocin has the most effect on fixation duration in individuals with impaired levels of eye contact at baseline (Cohen's d=0.86).  These findings demonstrate that the potential benefits of oxytocin in autism extend to a real-time interaction, providing evidence of a therapeutic effect in a key aspect of social communication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplKgtAe3rzhbVg90H21EOLACvtfcHk0lh-3r6Oqv-VQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFCgt7c%253D&md5=6bd13bfd402ab6df8b4ee8682cced347</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Ftp.2014.146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Ftp.2014.146%26sid%3Dliteratum%253Aachs%26aulast%3DAuyeung%26aufirst%3DB.%26aulast%3DLombardo%26aufirst%3DM.%2BV.%26aulast%3DHeinrichs%26aufirst%3DM.%26aulast%3DChakrabarti%26aufirst%3DB.%26aulast%3DSule%26aufirst%3DA.%26aulast%3DDeakin%26aufirst%3DJ.%2BB.%26aulast%3DBethlehem%26aufirst%3DR.%2BA.%2BI.%26aulast%3DDickens%26aufirst%3DL.%26aulast%3DMooney%26aufirst%3DN.%26aulast%3DSipple%26aufirst%3DJ.%2BA.%2BN.%26aulast%3DThiemann%26aufirst%3DP.%26aulast%3DBaron-Cohen%26aufirst%3DS.%26atitle%3DOxytocin%2520increases%2520eye%2520contact%2520during%2520a%2520real-time%252C%2520naturalistic%2520social%2520interaction%2520in%2520males%2520with%2520and%2520without%2520autism%26jtitle%3DTransl.%2520Psychiatry%26date%3D2015%26volume%3D5%26doi%3D10.1038%2Ftp.2014.146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dadds, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cauchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, J.</span></span> <span> </span><span class="NLM_article-title">Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial</span>. <i>J. Autism Dev. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">521</span>– <span class="NLM_lpage">531</span>, <span class="refDoi"> DOI: 10.1007/s10803-013-1899-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1007%2Fs10803-013-1899-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=23888359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BC3sfktFyntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2014&pages=521-531&author=M.+R.+Daddsauthor=E.+MacDonaldauthor=A.+Cauchiauthor=K.+Williamsauthor=F.+Levyauthor=J.+Brennan&title=Nasal+oxytocin+for+social+deficits+in+childhood+autism%3A+a+randomized+controlled+trial&doi=10.1007%2Fs10803-013-1899-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial</span></div><div class="casAuthors">Dadds Mark R; MacDonald Elayne; Cauchi Avril; Williams Katrina; Levy Florence; Brennan John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of autism and developmental disorders</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">521-31</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The last two decades have witnessed a surge in research investigating the application of oxytocin as a method of enhancing social behaviour in humans.  Preliminary evidence suggests oxytocin may have potential as an intervention for autism.  We evaluated a 5-day 'live-in' intervention using a double-blind randomized control trial. 38 male youths (7-16 years old) with autism spectrum disorders were administered 24 or 12 international units (depending on weight) intranasal placebo or oxytocin once daily over four consecutive days.  The oxytocin or placebo was administered during parent-child interaction training sessions.  Parent and child behaviours were assessed using parent reports, clinician ratings, and independent observations, at multiple time points to measure side-effects; social interaction skills; repetitive behaviours; emotion recognition and diagnostic status.  Compared to placebo, intranasal oxytocin did not significantly improve emotion recognition, social interaction skills, or general behavioral adjustment in male youths with autism spectrum disorders.  The results show that the benefits of nasal oxytocin for young individuals with autism spectrum disorders may be more circumscribed than suggested by previous studies, and suggest caution in recommending it as an intervention that is broadly effective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCr6Wb1tqsnNy3lHz94U-GfW6udTcc2eZ3ESQoYHe8crntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfktFyntQ%253D%253D&md5=dd8a1a7c59e80f2dd8d04f52e522d6ab</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs10803-013-1899-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10803-013-1899-3%26sid%3Dliteratum%253Aachs%26aulast%3DDadds%26aufirst%3DM.%2BR.%26aulast%3DMacDonald%26aufirst%3DE.%26aulast%3DCauchi%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DLevy%26aufirst%3DF.%26aulast%3DBrennan%26aufirst%3DJ.%26atitle%3DNasal%2520oxytocin%2520for%2520social%2520deficits%2520in%2520childhood%2520autism%253A%2520a%2520randomized%2520controlled%2520trial%26jtitle%3DJ.%2520Autism%2520Dev.%2520Disord.%26date%3D2014%26volume%3D44%26spage%3D521%26epage%3D531%26doi%3D10.1007%2Fs10803-013-1899-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guastella, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rinehart, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvares, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonge, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickie, I. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keating, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacciotti-Saija, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Einfeld, S. L.</span></span> <span> </span><span class="NLM_article-title">The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial</span>. <i>J. Child Psychol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">444</span>– <span class="NLM_lpage">452</span>, <span class="refDoi"> DOI: 10.1111/jcpp.12305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1111%2Fjcpp.12305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=25087908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BC2cbotlKrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=444-452&author=A.+J.+Guastellaauthor=K.+M.+Grayauthor=N.+J.+Rinehartauthor=G.+A.+Alvaresauthor=B.+J.+Tongeauthor=I.+B.+Hickieauthor=C.+M.+Keatingauthor=C.+Cacciotti-Saijaauthor=S.+L.+Einfeld&title=The+effects+of+a+course+of+intranasal+oxytocin+on+social+behaviors+in+youth+diagnosed+with+autism+spectrum+disorders%3A+a+randomized+controlled+trial&doi=10.1111%2Fjcpp.12305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial</span></div><div class="casAuthors">Guastella Adam J; Gray Kylie M; Rinehart Nicole J; Alvares Gail A; Tonge Bruce J; Hickie Ian B; Keating Caroline M; Cacciotti-Saija Cristina; Einfeld Stewart L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of child psychology and psychiatry, and allied disciplines</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">444-52</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  There is increasing interest in oxytocin as a therapeutic to treat social deficits in autism spectrum disorders (ASD).  The aim of this study was to investigate the efficacy of a course of oxytocin nasal spray to improve social behavior in youth with ASD.  METHODS:  In a double-blind, placebo-controlled trial across two Australian university sites between February 2009 and January 2012, 50 male participants aged between 12 and 18 years, with Autistic or Asperger's Disorder, were randomized to receive either oxytocin (n = 26) or placebo (n = 24) nasal sprays (either 18 or 24 International Units), administered twice-daily for 8 weeks.  Participants were assessed at baseline, after 4- and 8-weeks of treatment, and at 3-month follow-up.  Primary outcomes were change in total scores on the caregiver-completed Social Responsiveness Scale and clinician-ratings on the Clinical Global Impressions-Improvement scale.  Secondary assessments included caregiver reports of repetitive and other developmental behaviors and social cognition.  CLINICAL TRIAL REGISTRATION:  Australian New Zealand Clinical Trials Registry www.anzctr.org.au ACTRN12609000513213.  RESULTS:  Participants who received oxytocin showed no benefit following treatment on primary or secondary outcomes.  However, caregivers who believed their children received oxytocin reported greater improvements compared to caregivers who believed their child received placebo.  Nasal sprays were well tolerated and there was no evidence of increased side effects resulting from oxytocin administration.  CONCLUSIONS:  This is the first evaluation of the efficacy for a course of oxytocin treatment for youth with ASD.  Although results did not suggest clinical efficacy, further research is needed to explore alternative delivery methods, earlier age of intervention, and the influence of caregiver expectation on treatment response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKShCj3lOaLPIW7hznt0zpfW6udTcc2eZ3ESQoYHe8crntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbotlKrtQ%253D%253D&md5=2c2dd0ea7341ef28cfbd32de2da7c83a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1111%2Fjcpp.12305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjcpp.12305%26sid%3Dliteratum%253Aachs%26aulast%3DGuastella%26aufirst%3DA.%2BJ.%26aulast%3DGray%26aufirst%3DK.%2BM.%26aulast%3DRinehart%26aufirst%3DN.%2BJ.%26aulast%3DAlvares%26aufirst%3DG.%2BA.%26aulast%3DTonge%26aufirst%3DB.%2BJ.%26aulast%3DHickie%26aufirst%3DI.%2BB.%26aulast%3DKeating%26aufirst%3DC.%2BM.%26aulast%3DCacciotti-Saija%26aufirst%3DC.%26aulast%3DEinfeld%26aufirst%3DS.%2BL.%26atitle%3DThe%2520effects%2520of%2520a%2520course%2520of%2520intranasal%2520oxytocin%2520on%2520social%2520behaviors%2520in%2520youth%2520diagnosed%2520with%2520autism%2520spectrum%2520disorders%253A%2520a%2520randomized%2520controlled%2520trial%26jtitle%3DJ.%2520Child%2520Psychol.%2520Psychiatry%26date%3D2015%26volume%3D56%26spage%3D444%26epage%3D452%26doi%3D10.1111%2Fjcpp.12305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munesue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anme, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanba, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsubouchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horike, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakatani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span> <span> </span><span class="NLM_article-title">Oxytocin for male subjects with autism spectrum disorder and comorbid intellectual disabilities: a randomized pilot study</span>. <i>Front. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2</span>, <span class="refDoi"> DOI: 10.3389/fpsyt.2016.00002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.3389%2Ffpsyt.2016.00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=26834651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BC28nmslOmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=2&author=T.+Munesueauthor=H.+Nakamuraauthor=M.+Kikuchiauthor=Y.+Miuraauthor=N.+Takeuchiauthor=T.+Anmeauthor=E.+Nanbaauthor=K.+Adachiauthor=K.+Tsubouchiauthor=Y.+Saiauthor=K.+Miyamotoauthor=S.+Horikeauthor=S.+Yokoyamaauthor=H.+Nakataniauthor=Y.+Niidaauthor=H.+Kosakaauthor=Y.+Minabeauthor=H.+Higashida&title=Oxytocin+for+male+subjects+with+autism+spectrum+disorder+and+comorbid+intellectual+disabilities%3A+a+randomized+pilot+study&doi=10.3389%2Ffpsyt.2016.00002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin for Male Subjects with Autism Spectrum Disorder and Comorbid Intellectual Disabilities: A Randomized Pilot Study</span></div><div class="casAuthors">Munesue Toshio; Kikuchi Mitsuru; Miura Yui; Takeuchi Noriyuki; Yokoyama Shigeru; Higashida Haruhiro; Nakamura Hiroyuki; Anme Tokie; Nanba Eiji; Adachi Kaori; Tsubouchi Kiyotaka; Sai Yoshimichi; Miyamoto Ken-Ichi; Horike Shin-Ichi; Nakatani Hideo; Minabe Yoshio; Niida Yo; Kosaka Hirotaka</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2</span>
        ISSN:<span class="NLM_cas:issn">1664-0640</span>.
    </div><div class="casAbstract">UNLABELLED:  Approximately half of autism spectrum disorder (ASD) individuals suffer from comorbid intellectual disabilities (IDs).  Oxytocin (OXT) receptors are highly expressed in temporal lobe structures and are likely to play a modulatory role in excitatory/inhibitory balance, at least based on animal model findings.  Thus, it is feasible that in the highly representative group of Kanner-type ASD subjects, OXT could have a beneficial effect on social communication and social interaction.  The aim of this pilot study is to investigate the feasibility and adverse events, such as epilepsy, of the long-term administration of intranasal OXT for adolescent and adult ASD subjects with ID because such patients frequently have seizures.  We also addressed the question on how to scale the OXT effects to the core symptoms of social deficits because of the relative difficulty in obtaining objective measurements.  Twenty-nine males (aged 15-40 years old) participated in a randomized, double-blind, and placebo-controlled crossover study (each for 8 weeks) with OXT (16 IU/day).  Except for seizures experienced by one participant, other serious adverse events did not occur.  The primary and secondary outcomes measured using the Childhood Autism Rating Scale and several standard scales, respectively, revealed no difference between the OXT and placebo groups.  Instead, in an exploratory analysis, the social interactions observed in the play sessions or in daily life were significantly more frequent in the initial half period in the OXT-first arm of the crossover trial.  There were also significant correlations between the plasma OXT concentration and subscale scores for irritability on the Aberrant Behavior Checklist.  In conclusion, this pilot study demonstrates that long-term administration of intranasal OXT is tolerable in a representative cohort of ASD individuals with ID and suggests that future multicenter trials of OXT are warranted and should include measurements of reciprocal social interactions based on daily life under closer surveillance for epilepsy.  TRIAL REGISTRATION:  UMIN000007250.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQGkT-vVqjel4qdXsLcGTEUfW6udTcc2eYesTAY5JEkGrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28nmslOmug%253D%253D&md5=e322f9798adde3575b34cf0e83bbf0d5</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.3389%2Ffpsyt.2016.00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffpsyt.2016.00002%26sid%3Dliteratum%253Aachs%26aulast%3DMunesue%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DKikuchi%26aufirst%3DM.%26aulast%3DMiura%26aufirst%3DY.%26aulast%3DTakeuchi%26aufirst%3DN.%26aulast%3DAnme%26aufirst%3DT.%26aulast%3DNanba%26aufirst%3DE.%26aulast%3DAdachi%26aufirst%3DK.%26aulast%3DTsubouchi%26aufirst%3DK.%26aulast%3DSai%26aufirst%3DY.%26aulast%3DMiyamoto%26aufirst%3DK.%26aulast%3DHorike%26aufirst%3DS.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DNakatani%26aufirst%3DH.%26aulast%3DNiida%26aufirst%3DY.%26aulast%3DKosaka%26aufirst%3DH.%26aulast%3DMinabe%26aufirst%3DY.%26aulast%3DHigashida%26aufirst%3DH.%26atitle%3DOxytocin%2520for%2520male%2520subjects%2520with%2520autism%2520spectrum%2520disorder%2520and%2520comorbid%2520intellectual%2520disabilities%253A%2520a%2520randomized%2520pilot%2520study%26jtitle%3DFront.%2520Psychiatry%26date%3D2016%26volume%3D7%26spage%3D2%26doi%3D10.3389%2Ffpsyt.2016.00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parker, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oztan, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libove, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumiyoshi, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karhson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summers, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinman, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motonaga, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garner, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardan, A. Y.</span></span> <span> </span><span class="NLM_article-title">Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">8119</span>– <span class="NLM_lpage">8124</span>, <span class="refDoi"> DOI: 10.1073/pnas.1705521114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1073%2Fpnas.1705521114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=8119-8124&author=K.+J.+Parkerauthor=O.+Oztanauthor=R.+A.+Liboveauthor=R.+D.+Sumiyoshiauthor=L.+P.+Jacksonauthor=D.+S.+Karhsonauthor=J.+E.+Summersauthor=K.+E.+Hinmanauthor=K.+S.+Motonagaauthor=J.+M.+Phillipsauthor=D.+S.+Carsonauthor=J.+P.+Garnerauthor=A.+Y.+Hardan&title=Intranasal+oxytocin+treatment+for+social+deficits+and+biomarkers+of+response+in+children+with+autism&doi=10.1073%2Fpnas.1705521114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1705521114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1705521114%26sid%3Dliteratum%253Aachs%26aulast%3DParker%26aufirst%3DK.%2BJ.%26aulast%3DOztan%26aufirst%3DO.%26aulast%3DLibove%26aufirst%3DR.%2BA.%26aulast%3DSumiyoshi%26aufirst%3DR.%2BD.%26aulast%3DJackson%26aufirst%3DL.%2BP.%26aulast%3DKarhson%26aufirst%3DD.%2BS.%26aulast%3DSummers%26aufirst%3DJ.%2BE.%26aulast%3DHinman%26aufirst%3DK.%2BE.%26aulast%3DMotonaga%26aufirst%3DK.%2BS.%26aulast%3DPhillips%26aufirst%3DJ.%2BM.%26aulast%3DCarson%26aufirst%3DD.%2BS.%26aulast%3DGarner%26aufirst%3DJ.%2BP.%26aulast%3DHardan%26aufirst%3DA.%2BY.%26atitle%3DIntranasal%2520oxytocin%2520treatment%2520for%2520social%2520deficits%2520and%2520biomarkers%2520of%2520response%2520in%2520children%2520with%2520autism%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2017%26volume%3D114%26spage%3D8119%26epage%3D8124%26doi%3D10.1073%2Fpnas.1705521114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yatawara, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Einfeld, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickie, I. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davenport, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guastella, A. J.</span></span> <span> </span><span class="NLM_article-title">The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial</span>. <i>Mol. Psychiatr.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1225</span>– <span class="NLM_lpage">1231</span>, <span class="refDoi"> DOI: 10.1038/mp.2015.162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1038%2Fmp.2015.162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=26503762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsleks7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=1225-1231&author=C.+J.+Yatawaraauthor=S.+L.+Einfeldauthor=I.+B.+Hickieauthor=T.+A.+Davenportauthor=A.+J.+Guastella&title=The+effect+of+oxytocin+nasal+spray+on+social+interaction+deficits+observed+in+young+children+with+autism%3A+a+randomized+clinical+crossover+trial&doi=10.1038%2Fmp.2015.162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial</span></div><div class="casAuthors">Yatawara, C. J.; Einfeld, S. L.; Hickie, I. B.; Davenport, T. A.; Guastella, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1225-1231</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Interventions for autism are limited.  The synthetic hormone oxytocin may provide a potential treatment to improve core social and behavioral difficulties in autism, but its efficacy has yet to be evaluated in young children who potentially may benefit to a greater extent.  We investigated the efficacy, tolerability and safety of oxytocin treatment in young children with autism using a double-blind, randomized, placebo-controlled, crossover, clin. trial.  Thirty-one children with autism received 12 IU (IU) of oxytocin and placebo nasal spray morning and night (24 IU per day) for 5 wk, with a 4-wk washout period between each treatment.  Compared with placebo, oxytocin led to significant improvements on the primary outcome of caregiver-rated social responsiveness.  Overall, nasal spray was well tolerated, and the most common reported adverse events were thirst, urination and constipation.  This study is the first clin. trial to support the potential of oxytocin as an early intervention for young children with autism to help improve social interaction deficits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYvRBN9eJKqLVg90H21EOLACvtfcHk0lhIN7UuXzRetg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsleks7zI&md5=37397699a7098e3572851c47c2ff2948</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fmp.2015.162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmp.2015.162%26sid%3Dliteratum%253Aachs%26aulast%3DYatawara%26aufirst%3DC.%2BJ.%26aulast%3DEinfeld%26aufirst%3DS.%2BL.%26aulast%3DHickie%26aufirst%3DI.%2BB.%26aulast%3DDavenport%26aufirst%3DT.%2BA.%26aulast%3DGuastella%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520effect%2520of%2520oxytocin%2520nasal%2520spray%2520on%2520social%2520interaction%2520deficits%2520observed%2520in%2520young%2520children%2520with%2520autism%253A%2520a%2520randomized%2520clinical%2520crossover%2520trial%26jtitle%3DMol.%2520Psychiatr.%26date%3D2016%26volume%3D21%26spage%3D1225%26epage%3D1231%26doi%3D10.1038%2Fmp.2015.162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mizuno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherepanov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fakhrul, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshihara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span> <span> </span><span class="NLM_article-title">Lipo-oxytocin-1, a novel oxytocin Analog conjugated with two palmitoyl groups, has long-lasting effects on anxiety-related behavior and social avoidance in <i>CD157</i> knockout mice</span>. <i>Brain Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.3390/brainsci5010003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.3390%2Fbrainsci5010003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=25612002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsVKjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=3-13&author=A.+Mizunoauthor=S.+Cherepanovauthor=Y.+Kikuchiauthor=A.+Fakhrulauthor=S.+Aktherauthor=K.+Deguchiauthor=T.+Yoshiharaauthor=K.+Ishiharaauthor=S.+Shutoauthor=H.+Higashida&title=Lipo-oxytocin-1%2C+a+novel+oxytocin+Analog+conjugated+with+two+palmitoyl+groups%2C+has+long-lasting+effects+on+anxiety-related+behavior+and+social+avoidance+in+CD157+knockout+mice&doi=10.3390%2Fbrainsci5010003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Lipo-oxytocin-1, a novel oxytocin analog conjugated with two palmitoyl groups, has long-lasting effects on anxiety-related behavior and social avoidance in CD157 knockout mice</span></div><div class="casAuthors">Mizuno, Akira; Cherepanov, Stanislav M.; Kikuchi, Yusuke; Fakhrul, Azam A. K. M.; Akther, Shirin; Deguchi, Kisaburo; Yoshihara, Toru; Ishihara, Katsuhiko; Shuto, Satoshi; Higashida, Haruhiro</div><div class="citationInfo"><span class="NLM_cas:title">Brain Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-13</span>CODEN:
                <span class="NLM_cas:coden">BSRCCS</span>;
        ISSN:<span class="NLM_cas:issn">2076-3425</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Oxytocin (OT) is a nonapeptide hormone that is secreted into the brain and blood circulation.  OT has not only classical neurohormonal roles in uterine contraction and milk ejection during the reproductive phase in females, but has also been shown to have new pivotal neuromodulatory roles in social recognition and interaction in both genders.  A single administration of OT through nasal spray increases mutual recognition and trust in healthy subjects and psychiatric patients, suggesting that OT is a potential therapeutic drug for autism spectrum disorders, schizophrenia, and some other psychiatric disorders.  Although the mechanism is not well understood, it is likely that OT can be transported into the brain where it activates OT receptors to exert its function in the brain.  However, the amt. transported into the brain may be low.  To ensure equiv. effects, an OT analog with long-lasting and effective blood-brain barrier penetration properties would be beneficial for use as a therapeutic drug.  Here, we designed and synthesized a new oxytocin analog, lipo-oxytocin-1 (LOT-1), in which two palmitoyl groups are conjugated at the amino group of the cysteine9 residue and the phenolic hydroxyl group of the tyrosine8 residue of the OT mol.  To det. whether LOT-1 actually has an effect on the central nervous system, we examd. its effects in a CD157 knockout model mouse of the non-motor psychiatric symptoms of Parkinson's disease.  Similar to OT, this analog rescued anxiety-like behavior and social avoidance in the open field test with the social target in a central arena 30 min after i.p. injection in CD157 knockout mice.  When examd. 24 h after injection, the mice treated with LOT-1 displayed more recovery than those given OT.  The results suggest that LOT-1 has a functional advantage in recovery of social behavioral impairment, such as those caused by neurodegenerative diseases, autism spectrum disorders, and schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKKlOuCvYJ4LVg90H21EOLACvtfcHk0lghIrDCvMFiLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsVKjtbc%253D&md5=79df6ed1c81b50d0521049bf38decef0</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.3390%2Fbrainsci5010003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbrainsci5010003%26sid%3Dliteratum%253Aachs%26aulast%3DMizuno%26aufirst%3DA.%26aulast%3DCherepanov%26aufirst%3DS.%26aulast%3DKikuchi%26aufirst%3DY.%26aulast%3DFakhrul%26aufirst%3DA.%26aulast%3DAkther%26aufirst%3DS.%26aulast%3DDeguchi%26aufirst%3DK.%26aulast%3DYoshihara%26aufirst%3DT.%26aulast%3DIshihara%26aufirst%3DK.%26aulast%3DShuto%26aufirst%3DS.%26aulast%3DHigashida%26aufirst%3DH.%26atitle%3DLipo-oxytocin-1%252C%2520a%2520novel%2520oxytocin%2520Analog%2520conjugated%2520with%2520two%2520palmitoyl%2520groups%252C%2520has%2520long-lasting%2520effects%2520on%2520anxiety-related%2520behavior%2520and%2520social%2520avoidance%2520in%2520CD157%2520knockout%2520mice%26jtitle%3DBrain%2520Sci.%26date%3D2015%26volume%3D5%26spage%3D3%26epage%3D13%26doi%3D10.3390%2Fbrainsci5010003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cherepanov, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichinose, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopatina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shabalova, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmina, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span> <span> </span><span class="NLM_article-title">Structure-specific effects of lipidated oxytocin analogs on intracellular calcium levels, parental behavior, and oxytocin concentrations in the plasma and cerebrospinal fluid in mice</span>. <i>Pharmacol. Res. Perspect.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e00290</span> <span class="refDoi"> DOI: 10.1002/prp2.290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1002%2Fprp2.290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=28596839" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2017&author=S.+M.+Cherepanovauthor=S.+Yokoyamaauthor=A.+Mizunoauthor=W.+Ichinoseauthor=O.+Lopatinaauthor=A.+A.+Shabalovaauthor=A.+B.+Salminaauthor=Y.+Yamamotoauthor=H.+Okamotoauthor=S.+Shutoauthor=H.+Higashida&title=Structure-specific+effects+of+lipidated+oxytocin+analogs+on+intracellular+calcium+levels%2C+parental+behavior%2C+and+oxytocin+concentrations+in+the+plasma+and+cerebrospinal+fluid+in+mice&doi=10.1002%2Fprp2.290"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fprp2.290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprp2.290%26sid%3Dliteratum%253Aachs%26aulast%3DCherepanov%26aufirst%3DS.%2BM.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DMizuno%26aufirst%3DA.%26aulast%3DIchinose%26aufirst%3DW.%26aulast%3DLopatina%26aufirst%3DO.%26aulast%3DShabalova%26aufirst%3DA.%2BA.%26aulast%3DSalmina%26aufirst%3DA.%2BB.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DOkamoto%26aufirst%3DH.%26aulast%3DShuto%26aufirst%3DS.%26aulast%3DHigashida%26aufirst%3DH.%26atitle%3DStructure-specific%2520effects%2520of%2520lipidated%2520oxytocin%2520analogs%2520on%2520intracellular%2520calcium%2520levels%252C%2520parental%2520behavior%252C%2520and%2520oxytocin%2520concentrations%2520in%2520the%2520plasma%2520and%2520cerebrospinal%2520fluid%2520in%2520mice%26jtitle%3DPharmacol.%2520Res.%2520Perspect.%26date%3D2017%26volume%3D5%26doi%3D10.1002%2Fprp2.290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Widmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piaggio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osoti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owa, O. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coomarasamy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Aleem, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallapur, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qureshi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lumbiganon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawole, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goudar, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujar, Y. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neilson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmeyr, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira de Carvalho, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugerwa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiragur, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byamugisha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gülmezoglu, A. M.</span></span> <span> </span><span class="NLM_article-title">Heat-stable carbetocin versus oxytocin to prevent hemorrhage after vaginal birth</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>379</i></span>,  <span class="NLM_fpage">743</span>– <span class="NLM_lpage">752</span>, <span class="refDoi"> DOI: 10.1056/nejmoa1805489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1056%2Fnejmoa1805489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=29949473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1eqsrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=2018&pages=743-752&author=M.+Widmerauthor=G.+Piaggioauthor=T.+M.+H.+Nguyenauthor=A.+Osotiauthor=O.+O.+Owaauthor=S.+Misraauthor=A.+Coomarasamyauthor=H.+Abdel-Aleemauthor=A.+A.+Mallapurauthor=Z.+Qureshiauthor=P.+Lumbiganonauthor=A.+B.+Patelauthor=G.+Carroliauthor=B.+Fawoleauthor=S.+S.+Goudarauthor=Y.+V.+Pujarauthor=J.+Neilsonauthor=G.+J.+Hofmeyrauthor=L.+L.+Suauthor=J.+Ferreira+de+Carvalhoauthor=U.+Pandeyauthor=K.+Mugerwaauthor=S.+S.+Shiragurauthor=J.+Byamugishaauthor=D.+Giordanoauthor=D.+Giordanoauthor=A.+M.+G%C3%BClmezoglu&title=Heat-stable+carbetocin+versus+oxytocin+to+prevent+hemorrhage+after+vaginal+birth&doi=10.1056%2Fnejmoa1805489"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Heat-stable carbetocin versus oxytocin to prevent hemorrhage after vaginal birth</span></div><div class="casAuthors">Widmer, M.; Piaggio, G.; Nguyen, T. M. H.; Osoti, A.; Owa, O. O.; Misra, S.; Coomarasamy, A.; Abdel-Aleem, H.; Mallapur, A. A.; Qureshi, Z.; Lumbiganon, P.; Patel, A. B.; Carroli, G.; Fawole, B.; Goudar, S. S.; Pujar, Y. V.; Neilson, J.; Hofmeyr, G. J.; Su, L. L.; Ferreira de Carvalho, J.; Pandey, U.; Mugerwa, K.; Shiragur, S. S.; Byamugisha, J.; Giordano, D.; Gulmezoglu, A. M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">743-752</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background Postpartum hemorrhage is the most common cause of maternal death.  Oxytocin is the std. therapy for the prevention of postpartum hemorrhage, but it requires cold storage, which is not available in many countries.  In a large trial, we compared a novel formulation of heat-stable carbetocin with oxytocin. methods We enrolled women across 23 sites in 10 countries in a randomized, double-blind, noninferiority trial comparing i.m. injections of heat-stable carbetocin (at a dose of 100 μg) with oxytocin (at a dose of 10 IU) administered immediately after vaginal birth.  Both drugs were kept in cold storage (2 to 8°C) to maintain double-blinding.  There were two primary outcomes: the proportion of women with blood loss of at least 500 mL or the use of addnl. uterotonic agents, and the proportion of women with blood loss of at least 1000 mL.  The noninferiority margins for the relative risks of these outcomes were 1.16 and 1.23, resp. results A total of 29,645 women underwent randomization.  The frequency of blood loss of at least 500 mL or the use of addnl. uterotonic agents was 14.5% in the carbetocin group and 14.4% in the oxytocin group (relative risk, 1.01; 95% confidence interval [CI], 0.95 to 1.06), a finding that was consistent with noninferiority.  The frequency of blood loss of at least 1000 mL was 1.51% in the carbetocin group and 1.45% in the oxytocin group (relative risk, 1.04; 95% CI, 0.87 to 1.25), with the confidence interval crossing the margin of noninferiority.  The use of addnl. uterotonic agents, interventions to stop bleeding, and adverse effects did not differ significantly between the two groups. conclusions Heat-stable carbetocin was noninferior to oxytocin for the prevention of blood loss of at least 500 mL or the use of addnl. uterotonic agents.  Noninferiority was not shown for the outcome of blood loss of at least 1000 mL; low event rates for this outcome reduced the power of the trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowHGuSePtWz7Vg90H21EOLACvtfcHk0lghIrDCvMFiLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1eqsrbE&md5=d3d1de818397fbba0d68000b4b1f416c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1056%2Fnejmoa1805489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252Fnejmoa1805489%26sid%3Dliteratum%253Aachs%26aulast%3DWidmer%26aufirst%3DM.%26aulast%3DPiaggio%26aufirst%3DG.%26aulast%3DNguyen%26aufirst%3DT.%2BM.%2BH.%26aulast%3DOsoti%26aufirst%3DA.%26aulast%3DOwa%26aufirst%3DO.%2BO.%26aulast%3DMisra%26aufirst%3DS.%26aulast%3DCoomarasamy%26aufirst%3DA.%26aulast%3DAbdel-Aleem%26aufirst%3DH.%26aulast%3DMallapur%26aufirst%3DA.%2BA.%26aulast%3DQureshi%26aufirst%3DZ.%26aulast%3DLumbiganon%26aufirst%3DP.%26aulast%3DPatel%26aufirst%3DA.%2BB.%26aulast%3DCarroli%26aufirst%3DG.%26aulast%3DFawole%26aufirst%3DB.%26aulast%3DGoudar%26aufirst%3DS.%2BS.%26aulast%3DPujar%26aufirst%3DY.%2BV.%26aulast%3DNeilson%26aufirst%3DJ.%26aulast%3DHofmeyr%26aufirst%3DG.%2BJ.%26aulast%3DSu%26aufirst%3DL.%2BL.%26aulast%3DFerreira%2Bde%2BCarvalho%26aufirst%3DJ.%26aulast%3DPandey%26aufirst%3DU.%26aulast%3DMugerwa%26aufirst%3DK.%26aulast%3DShiragur%26aufirst%3DS.%2BS.%26aulast%3DByamugisha%26aufirst%3DJ.%26aulast%3DGiordano%26aufirst%3DD.%26aulast%3DGiordano%26aufirst%3DD.%26aulast%3DG%25C3%25BClmezoglu%26aufirst%3DA.%2BM.%26atitle%3DHeat-stable%2520carbetocin%2520versus%2520oxytocin%2520to%2520prevent%2520hemorrhage%2520after%2520vaginal%2520birth%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2018%26volume%3D379%26spage%3D743%26epage%3D752%26doi%3D10.1056%2Fnejmoa1805489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asami, T.</span></span> <span> </span><span class="NLM_article-title">Potent and selective oxytocin receptor agonists without disulfide bridges</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2331</span>– <span class="NLM_lpage">2335</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.04.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.bmcl.2017.04.030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2331-2335&author=Y.+Adachiauthor=K.+Sakimuraauthor=Y.+Shimizuauthor=M.+Nakayamaauthor=Y.+Teraoauthor=T.+Yanoauthor=T.+Asami&title=Potent+and+selective+oxytocin+receptor+agonists+without+disulfide+bridges&doi=10.1016%2Fj.bmcl.2017.04.030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.04.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.04.030%26sid%3Dliteratum%253Aachs%26aulast%3DAdachi%26aufirst%3DY.%26aulast%3DSakimura%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DY.%26aulast%3DNakayama%26aufirst%3DM.%26aulast%3DTerao%26aufirst%3DY.%26aulast%3DYano%26aufirst%3DT.%26aulast%3DAsami%26aufirst%3DT.%26atitle%3DPotent%2520and%2520selective%2520oxytocin%2520receptor%2520agonists%2520without%2520disulfide%2520bridges%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2331%26epage%3D2335%26doi%3D10.1016%2Fj.bmcl.2017.04.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="note"><p class="first last">Muttenthaler has reported that the transformation at the disulfide linker was also important for modulating the OT potency and deamination at Cys<sup>1</sup> residue to earn the chemical stability and hydrophobicity: see ref <a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muttenthaler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Araujo, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alewood, P. F.</span></span> <span> </span><span class="NLM_article-title">Modulating oxytocin activity and plasma stability by disulfide bond engineering</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">8585</span>– <span class="NLM_lpage">8596</span>, <span class="refDoi"> DOI: 10.1021/jm100989w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100989w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2gtrvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8585-8596&author=M.+Muttenthalerauthor=A.+Anderssonauthor=A.+D.+De+Araujoauthor=Z.+Dekanauthor=R.+J.+Lewisauthor=P.+F.+Alewood&title=Modulating+oxytocin+activity+and+plasma+stability+by+disulfide+bond+engineering&doi=10.1021%2Fjm100989w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Modulating Oxytocin Activity and Plasma Stability by Disulfide Bond Engineering</span></div><div class="casAuthors">Muttenthaler, Markus; Andersson, Asa; de Araujo, Aline D.; Dekan, Zoltan; Lewis, Richard J.; Alewood, Paul F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8585-8596</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Disulfide bond engineering is an important approach to improve the metabolic half-life of cysteine-contg. peptides.  Eleven analogs of oxytocin were synthesized including disulfide bond replacements by thioether, selenylsulfide, diselenide, and ditelluride bridges, and their stabilities in human plasma and activity at the human oxytocin receptor were assessed.  The cystathionine (Ki = 1.5 nM, and EC50 = 32 nM), selenylsulfide (Ki = 0.29/0.72 nM, and EC50 = 2.6/154 nM), diselenide (Ki = 11.8 nM, and EC50 = 18 nM), and ditelluride analogs (Ki = 7.6 nM, and EC50 = 27.3 nM) retained considerable affinity and functional potency as compared to oxytocin (Ki = 0.79 nM, and EC50 = 15 nM), while shortening the disulfide bridge abolished binding and functional activity.  The mimetics showed a 1.5-3-fold enhancement of plasma stability as compared to oxytocin (t1/2 = 12 h).  By contrast, the all-D-oxytocin and head to tail cyclic oxytocin analogs, while significantly more stable with half-lives greater than 48 h, had little or no detectable binding or functional activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0MUtVq6ITRbVg90H21EOLACvtfcHk0lijGgahA4OSjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2gtrvN&md5=19509d7aa69dd0c6e1751db0c4d1339f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm100989w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100989w%26sid%3Dliteratum%253Aachs%26aulast%3DMuttenthaler%26aufirst%3DM.%26aulast%3DAndersson%26aufirst%3DA.%26aulast%3DDe%2BAraujo%26aufirst%3DA.%2BD.%26aulast%3DDekan%26aufirst%3DZ.%26aulast%3DLewis%26aufirst%3DR.%2BJ.%26aulast%3DAlewood%26aufirst%3DP.%2BF.%26atitle%3DModulating%2520oxytocin%2520activity%2520and%2520plasma%2520stability%2520by%2520disulfide%2520bond%2520engineering%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8585%26epage%3D8596%26doi%3D10.1021%2Fjm100989w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Araujo, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetter, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muttenthaler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brierley, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alewood, P. F.</span></span> <span> </span><span class="NLM_article-title">Selenoether oxytocin analogues have analgesic properties in a mouse model of chronic abdominal pain</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">3165</span>, <span class="refDoi"> DOI: 10.1038/ncomms4165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1038%2Fncomms4165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=24476666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BC2cvgtlOrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=3165&author=A.+D.+De%0AAraujoauthor=M.+Mobliauthor=J.+Castroauthor=A.+M.+Harringtonauthor=I.+Vetterauthor=Z.+Dekanauthor=M.+Muttenthalerauthor=J.+Wanauthor=R.+J.+Lewisauthor=G.+F.+Kingauthor=S.+M.+Brierleyauthor=P.+F.+Alewood&title=Selenoether+oxytocin+analogues+have+analgesic+properties+in+a+mouse+model+of+chronic+abdominal+pain&doi=10.1038%2Fncomms4165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Selenoether oxytocin analogues have analgesic properties in a mouse model of chronic abdominal pain</span></div><div class="casAuthors">de Araujo Aline Dantas; Vetter Irina; Dekan Zoltan; Wan JingJing; Lewis Richard J; King Glenn F; Alewood Paul F; Mobli Mehdi; Castro Joel; Harrington Andrea M; Muttenthaler Markus; Brierley Stuart M</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3165</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Poor oral availability and susceptibility to reduction and protease degradation is a major hurdle in peptide drug development.  However, drugable receptors in the gut present an attractive niche for peptide therapeutics.  Here we demonstrate, in a mouse model of chronic abdominal pain, that oxytocin receptors are significantly upregulated in nociceptors innervating the colon.  Correspondingly, we develop chemical strategies to engineer non-reducible and therefore more stable oxytocin analogues.  Chemoselective selenide macrocyclization yields stabilized analogues equipotent to native oxytocin.  Ultra-high-field nuclear magnetic resonance structural analysis of native oxytocin and the seleno-oxytocin derivatives reveals that oxytocin has a pre-organized structure in solution, in marked contrast to earlier X-ray crystallography studies.  Finally, we show that these seleno-oxytocin analogues potently inhibit colonic nociceptors both in vitro and in vivo in mice with chronic visceral hypersensitivity.  Our findings have potentially important implications for clinical use of oxytocin analogues and disulphide-rich peptides in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTleAzA3UqCBVw2ofyr07jXfW6udTcc2eZmz29mzNuw87ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cvgtlOrsw%253D%253D&md5=6da2e2a79c2576eaff8b641e61b84da0</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fncomms4165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms4165%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BAraujo%26aufirst%3DA.%2BD.%26aulast%3DMobli%26aufirst%3DM.%26aulast%3DCastro%26aufirst%3DJ.%26aulast%3DHarrington%26aufirst%3DA.%2BM.%26aulast%3DVetter%26aufirst%3DI.%26aulast%3DDekan%26aufirst%3DZ.%26aulast%3DMuttenthaler%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DR.%2BJ.%26aulast%3DKing%26aufirst%3DG.%2BF.%26aulast%3DBrierley%26aufirst%3DS.%2BM.%26aulast%3DAlewood%26aufirst%3DP.%2BF.%26atitle%3DSelenoether%2520oxytocin%2520analogues%2520have%2520analgesic%2520properties%2520in%2520a%2520mouse%2520model%2520of%2520chronic%2520abdominal%2520pain%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D3165%26doi%3D10.1038%2Fncomms4165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muttenthaler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, Å.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetter, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busnelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragnarsson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergmayr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuis, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palpant, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wray, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruber, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alewood, P. F.</span></span> <span> </span><span class="NLM_article-title">Subtle modifications to oxytocin produce ligands that retain potency and improved selectivity across species</span>. <i>Sci. Signal.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">eaan3398</span> <span class="refDoi"> DOI: 10.1126/scisignal.aan3398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1126%2Fscisignal.aan3398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=29208680" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&author=M.+Muttenthalerauthor=%C3%85.+Anderssonauthor=I.+Vetterauthor=R.+Menonauthor=M.+Busnelliauthor=L.+Ragnarssonauthor=C.+Bergmayrauthor=S.+Arrowsmithauthor=J.+R.+Deuisauthor=H.+S.+Chiuauthor=N.+J.+Palpantauthor=M.+O%E2%80%99Brienauthor=T.+J.+Smithauthor=S.+Wrayauthor=I.+D.+Neumannauthor=C.+W.+Gruberauthor=R.+J.+Lewisauthor=P.+F.+Alewood&title=Subtle+modifications+to+oxytocin+produce+ligands+that+retain+potency+and+improved+selectivity+across+species&doi=10.1126%2Fscisignal.aan3398"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.aan3398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.aan3398%26sid%3Dliteratum%253Aachs%26aulast%3DMuttenthaler%26aufirst%3DM.%26aulast%3DAndersson%26aufirst%3D%25C3%2585.%26aulast%3DVetter%26aufirst%3DI.%26aulast%3DMenon%26aufirst%3DR.%26aulast%3DBusnelli%26aufirst%3DM.%26aulast%3DRagnarsson%26aufirst%3DL.%26aulast%3DBergmayr%26aufirst%3DC.%26aulast%3DArrowsmith%26aufirst%3DS.%26aulast%3DDeuis%26aufirst%3DJ.%2BR.%26aulast%3DChiu%26aufirst%3DH.%2BS.%26aulast%3DPalpant%26aufirst%3DN.%2BJ.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DT.%2BJ.%26aulast%3DWray%26aufirst%3DS.%26aulast%3DNeumann%26aufirst%3DI.%2BD.%26aulast%3DGruber%26aufirst%3DC.%2BW.%26aulast%3DLewis%26aufirst%3DR.%2BJ.%26aulast%3DAlewood%26aufirst%3DP.%2BF.%26atitle%3DSubtle%2520modifications%2520to%2520oxytocin%2520produce%2520ligands%2520that%2520retain%2520potency%2520and%2520improved%2520selectivity%2520across%2520species%26jtitle%3DSci.%2520Signal.%26date%3D2017%26volume%3D10%26doi%3D10.1126%2Fscisignal.aan3398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scibola, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetz, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duplantier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanase-Frawley, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kablaoui, N. M.</span></span> <span> </span><span class="NLM_article-title">Systematic <i>N</i>-methylation of oxytocin: Impact on pharmacology and intramolecular hydrogen bonding network</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3513</span>– <span class="NLM_lpage">3520</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.05.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.bmc.2016.05.062" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=3513-3520&author=S.+Scibolaauthor=G.+H.+Goetzauthor=G.+Baiauthor=B.+N.+Rogersauthor=D.+L.+Grayauthor=A.+Duplantierauthor=K.+R.+Fonsecaauthor=M.+A.+Vanase-Frawleyauthor=N.+M.+Kablaoui&title=Systematic+N-methylation+of+oxytocin%3A+Impact+on+pharmacology+and+intramolecular+hydrogen+bonding+network&doi=10.1016%2Fj.bmc.2016.05.062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DScibola%26aufirst%3DS.%26aulast%3DGoetz%26aufirst%3DG.%2BH.%26aulast%3DBai%26aufirst%3DG.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DGray%26aufirst%3DD.%2BL.%26aulast%3DDuplantier%26aufirst%3DA.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DVanase-Frawley%26aufirst%3DM.%2BA.%26aulast%3DKablaoui%26aufirst%3DN.%2BM.%26atitle%3DSystematic%2520N-methylation%2520of%2520oxytocin%253A%2520Impact%2520on%2520pharmacology%2520and%2520intramolecular%2520hydrogen%2520bonding%2520network%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D3513%26epage%3D3520%26doi%3D10.1016%2Fj.bmc.2016.05.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Modi, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majchrzak, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osgood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanase-Frawley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feyfant, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McInnes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darvari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhl, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kablaoui, N. M.</span></span> <span> </span><span class="NLM_article-title">Peripheral administration of a long-acting peptide oxytocin receptor agonist inhibits fear-induced freezing</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>358</i></span>,  <span class="NLM_fpage">164</span>– <span class="NLM_lpage">172</span>, <span class="refDoi"> DOI: 10.1124/jpet.116.232702</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1124%2Fjpet.116.232702" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=27217590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslCqtbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2016&pages=164-172&author=M.+E.+Modiauthor=M.+J.+Majchrzakauthor=K.+R.+Fonsecaauthor=A.+Doranauthor=S.+Osgoodauthor=M.+Vanase-Frawleyauthor=E.+Feyfantauthor=H.+McInnesauthor=R.+Darvariauthor=D.+L.+Buhlauthor=N.+M.+Kablaoui&title=Peripheral+administration+of+a+long-acting+peptide+oxytocin+receptor+agonist+inhibits+fear-induced+freezing&doi=10.1124%2Fjpet.116.232702"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral administration of a long-acting peptide oxytocin receptor agonist inhibits fear-induced freezing</span></div><div class="casAuthors">Modi, Meera E.; Majchrzak, Mark J.; Fonseca, Kari R.; Doran, Angela; Osgood, Sarah; Vanase-Frawley, Michelle; Feyfant, Eric; McInnes, Heather; Darvari, Ramin; Buhl, Derek L.; Kablaoui, Natasha M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">164-172</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Oxytocin (OT) modulates the expression of social and emotional behaviors and consequently has been proposed as a pharmacol. treatment of psychiatric diseases, including autism spectrum disorders and schizophrenia; however, endogenous OT has a short half-life in plasma and poor permeability across the blood-brain barrier.  Recent efforts have focused on the development of novel drug delivery methods to enhance brain penetration, but few efforts have aimed at improving its half-life.  To explore the behavioral efficacy of an OT analog with enhanced plasma stability, we developed PF-06655075 (PF1), a novel non-brain-penetrant OT receptor agonist with increased selectivity for the OT receptor and significantly increased pharmaco- kinetic stability.  PF-06478939 was generated with only increased stability to disambiguate changes to selectivity vs. stability.  The efficacy of these compds. in evoking behavioral effects was tested in a conditioned fear paradigm.  Both central and peripheral administration of PF1 inhibited freezing in response to a conditioned fear stimulus.  Peripheral administration of PF1 resulted in a sustained level of plasma concns. for greater than 20 h but no detectable accumulation in brain tissue, suggesting that plasma or cerebrospinal fluid exposure was sufficient to evoke behavioral effects.  Behavioral efficacy of peripherally administered OT receptor agonists on conditioned fear response opens the door to potential peripheral mechanisms in other behavioral paradigms, whether they are mediated by direct peripheral activation or feed-forward responses.  Compd. PF1 is freely available as a tool compd. to further explore the role of peripheral OT in behavioral response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzDYP-scpGKbVg90H21EOLACvtfcHk0liL0FejHueKLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslCqtbbM&md5=923c89516e0c712184e9a4c826a0b79a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1124%2Fjpet.116.232702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.116.232702%26sid%3Dliteratum%253Aachs%26aulast%3DModi%26aufirst%3DM.%2BE.%26aulast%3DMajchrzak%26aufirst%3DM.%2BJ.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DDoran%26aufirst%3DA.%26aulast%3DOsgood%26aufirst%3DS.%26aulast%3DVanase-Frawley%26aufirst%3DM.%26aulast%3DFeyfant%26aufirst%3DE.%26aulast%3DMcInnes%26aufirst%3DH.%26aulast%3DDarvari%26aufirst%3DR.%26aulast%3DBuhl%26aufirst%3DD.%2BL.%26aulast%3DKablaoui%26aufirst%3DN.%2BM.%26atitle%3DPeripheral%2520administration%2520of%2520a%2520long-acting%2520peptide%2520oxytocin%2520receptor%2520agonist%2520inhibits%2520fear-induced%2520freezing%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D358%26spage%3D164%26epage%3D172%26doi%3D10.1124%2Fjpet.116.232702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ring, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schechter, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platt, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grauer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulicicchio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Resnick, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sukoff Rizzo, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyer, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logue, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig-Lipson, S.</span></span> <span> </span><span class="NLM_article-title">Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2009.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.neuropharm.2009.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=19615387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BD1Mjjs1GqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2010&pages=69-77&author=R.+H.+Ringauthor=L.+E.+Schechterauthor=S.+K.+Leonardauthor=J.+M.+Dwyerauthor=B.+J.+Plattauthor=R.+Grafauthor=S.+Grauerauthor=C.+Pulicicchioauthor=L.+Resnickauthor=Z.+Rahmanauthor=S.+J.+Sukoff+Rizzoauthor=B.+Luoauthor=C.+E.+Beyerauthor=S.+F.+Logueauthor=K.+L.+Marquisauthor=Z.+A.+Hughesauthor=S.+Rosenzweig-Lipson&title=Receptor+and+behavioral+pharmacology+of+WAY-267464%2C+a+non-peptide+oxytocin+receptor+agonist&doi=10.1016%2Fj.neuropharm.2009.07.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist</span></div><div class="casAuthors">Ring Robert H; Schechter Lee E; Leonard Sarah K; Dwyer Jason M; Platt Brian J; Graf Radka; Grauer Steven; Pulicicchio Claudine; Resnick Lynn; Rahman Zia; Sukoff Rizzo Stacey J; Luo Bin; Beyer Chad E; Logue Sheree F; Marquis Karen L; Hughes Zoe A; Rosenzweig-Lipson Sharon</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-77</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The widely reported effects of oxytocin (OT) on CNS function has generated considerable interest in the therapeutic potential for targeting this system for a variety of human psychiatric diseases, including anxiety disorders, autism, schizophrenia, and depression.  The utility of synthetic OT, as both a research tool and neurotherapeutic, is limited by the physiochemical properties inherent in most neuropeptides, notably its short half-life and poor blood brain barrier penetration.  Subsequently, the discovery and development of non-peptide molecules that act as selective agonists of the oxytocin receptor (OTR) has been an important goal of the field.  In this study, we report the receptor and behavioral pharmacology of WAY-267464, a first generation small-molecule OTR agonist.  WAY-267464 is a high-affinity, potent, and selective (vs.  V1a, V2, V1b) agonist of the OTR.  In assays measuring both behavioral (four-plate test, elevated zero maze) and autonomic (stress-induced hyperthermia) parameters of the anxiety response, WAY-267464 exhibits an anxiolytic-like profile similar to OT.  We have demonstrated that the anxiolytic-like profile of WAY-267464 is mediated through central sites of action.  WAY-267464 also significantly reverses disruption in prepulse inhibition of the acoustic startle reflex induced by either MK-801 or amphetamine, similar to the antipsychotic-like effects previously reported for OT.  Interestingly, in the mouse tail suspension test, WAY-267464 failed to produce changes in immobility that are seen with OT, raising the question of whether the antidepressant-like activity of OT may be working independently of the OTR.  A selective OTR antagonist also failed to block the effects of OT on immobility in the TST.  The significance of these findings for shaping the clinical development of OTR agonists is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ8S-KlSxighgMthz5_Rx5rfW6udTcc2eZ-d3AYvylc6bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mjjs1GqsQ%253D%253D&md5=699434bd2c444cd29345d24db54fbbb5</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2009.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2009.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DRing%26aufirst%3DR.%2BH.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DLeonard%26aufirst%3DS.%2BK.%26aulast%3DDwyer%26aufirst%3DJ.%2BM.%26aulast%3DPlatt%26aufirst%3DB.%2BJ.%26aulast%3DGraf%26aufirst%3DR.%26aulast%3DGrauer%26aufirst%3DS.%26aulast%3DPulicicchio%26aufirst%3DC.%26aulast%3DResnick%26aufirst%3DL.%26aulast%3DRahman%26aufirst%3DZ.%26aulast%3DSukoff%2BRizzo%26aufirst%3DS.%2BJ.%26aulast%3DLuo%26aufirst%3DB.%26aulast%3DBeyer%26aufirst%3DC.%2BE.%26aulast%3DLogue%26aufirst%3DS.%2BF.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26aulast%3DHughes%26aufirst%3DZ.%2BA.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26atitle%3DReceptor%2520and%2520behavioral%2520pharmacology%2520of%2520WAY-267464%252C%2520a%2520non-peptide%2520oxytocin%2520receptor%2520agonist%26jtitle%3DNeuropharmacology%26date%3D2010%26volume%3D58%26spage%3D69%26epage%3D77%26doi%3D10.1016%2Fj.neuropharm.2009.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Engstøm, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barth, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilhardt, H.</span></span> <span> </span><span class="NLM_article-title">Oxytocin receptor binding and uterotonic activity of carbetocin and its metabolites following enzymatic degradation</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>355</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">210</span>, <span class="refDoi"> DOI: 10.1016/s0014-2999(98)00513-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fs0014-2999%2898%2900513-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=9760035" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=1998&pages=203-210&author=T.+Engst%C3%B8mauthor=T.+Barthauthor=P.+Melinauthor=H.+Vilhardt&title=Oxytocin+receptor+binding+and+uterotonic+activity+of+carbetocin+and+its+metabolites+following+enzymatic+degradation&doi=10.1016%2Fs0014-2999%2898%2900513-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fs0014-2999%2898%2900513-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0014-2999%252898%252900513-5%26sid%3Dliteratum%253Aachs%26aulast%3DEngst%25C3%25B8m%26aufirst%3DT.%26aulast%3DBarth%26aufirst%3DT.%26aulast%3DMelin%26aufirst%3DP.%26aulast%3DVilhardt%26aufirst%3DH.%26atitle%3DOxytocin%2520receptor%2520binding%2520and%2520uterotonic%2520activity%2520of%2520carbetocin%2520and%2520its%2520metabolites%2520following%2520enzymatic%2520degradation%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1998%26volume%3D355%26spage%3D203%26epage%3D210%26doi%3D10.1016%2Fs0014-2999%2898%2900513-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rath, W.</span></span> <span> </span><span class="NLM_article-title">Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin</span>. <i>Eur. J. Obstet. Gynecol. Reprod. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>147</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1016/j.ejogrb.2009.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.ejogrb.2009.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=19616358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1OnsL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2009&pages=15-20&author=W.+Rath&title=Prevention+of+postpartum+haemorrhage+with+the+oxytocin+analogue+carbetocin&doi=10.1016%2Fj.ejogrb.2009.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of postpartum hemorrhage with the oxytocin analogue carbetocin</span></div><div class="casAuthors">Rath, Werner</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Obstetrics & Gynecology and Reproductive Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-20</span>CODEN:
                <span class="NLM_cas:coden">EOGRAL</span>;
        ISSN:<span class="NLM_cas:issn">0301-2115</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Postpartum hemorrhage is the leading cause of maternal mortality worldwide: 67-80% of cases are caused by uterine atony.  Preventive measures include prophylactic drug use to aid uterine contraction after delivery, thus avoiding severe blood loss and reducing maternal morbidity and mortality.  Carbetocin is a synthetic analog of oxytocin with a half-life approx. 4-10 times longer than that reported for oxytocin.  It combines the safety and tolerability profile of oxytocin with the sustained uterotonic activity of injectable ergot alkaloids.  Furthermore, carbetocin can be administered as a single dose injection either i.v. or i.m. rather than as an infusion over several hours as is the case with oxytocin.  Carbetocin is currently indicated for prevention of uterine atony after delivery by cesarean section in spinal or epidural anesthesia.  Data from three randomized controlled trials in cesarean delivery and a meta-anal. indicate that carbetocin significantly reduces the need for addnl. uterotonic agents or uterine massage to prevent excessive bleeding compared with placebo or oxytocin.  The risk of headache, tremor, hypotension, flushing, nausea, abdominal pain, pruritus and feeling of warmth was similar in women who received carbetocin or oxytocin.  The findings from two more recent double-blind randomized trials and one retrospective study suggest that carbetocin may also represent a good alternative to conventional uterotonic agents for prevention of postpartum hemorrhage after vaginal deliveries.  A reduced need for addnl. uterotonics was obsd. with carbetocin vs. oxytocin in high-risk women and carbetocin was at least as effective as syntometrine in low-risk women.  In these studies of vaginal deliveries, carbetocin was assocd. with a low incidence of adverse effects and demonstrated a better tolerability profile than syntometrine.  Carbetocin had a long duration of action compared with i.v. oxytocin alone and a better cardiovascular side effect profile compared with syntometrine.  In addn. to being an effective treatment for the prevention of postpartum hemorrhage following cesarean delivery, carbetocin may also become the drug of choice for postpartum hemorrhage prevention after vaginal delivery in high-risk women and those who suffer from hypertensive disorders in pregnancy.  Preeclampsia is still a contraindication to the administration of carbetocin in the EU, and further studies would be required to assess the cardiovascular effects of carbetocin before it can be advocated for routine use in preeclamptic patients.  Further research is required to assess whether prophylactic carbetocin is superior to conventional uterotonic agents following vaginal delivery in low-risk women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCwjaxvxKDx7Vg90H21EOLACvtfcHk0lhGEULisdfiiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1OnsL3N&md5=d8f9b4d738dc4245f18d280446ae7527</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.ejogrb.2009.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejogrb.2009.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DRath%26aufirst%3DW.%26atitle%3DPrevention%2520of%2520postpartum%2520haemorrhage%2520with%2520the%2520oxytocin%2520analogue%2520carbetocin%26jtitle%3DEur.%2520J.%2520Obstet.%2520Gynecol.%2520Reprod.%2520Biol.%26date%3D2009%26volume%3D147%26spage%3D15%26epage%3D20%26doi%3D10.1016%2Fj.ejogrb.2009.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wiśniewski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alagarsamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galyean, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tariga, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ly, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiśniewski, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croston, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laporte, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivière, P. J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schteingart, C. D.</span></span> <span> </span><span class="NLM_article-title">New, potent, and selective peptidic oxytocin receptor agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5306</span>– <span class="NLM_lpage">5317</span>, <span class="refDoi"> DOI: 10.1021/jm500365s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500365s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVWhs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5306-5317&author=K.+Wi%C5%9Bniewskiauthor=S.+Alagarsamyauthor=R.+Galyeanauthor=H.+Tarigaauthor=D.+Thompsonauthor=B.+Lyauthor=H.+Wi%C5%9Bniewskiauthor=S.+Qiauthor=G.+Crostonauthor=R.+Laporteauthor=P.+J.-M.+Rivi%C3%A8reauthor=C.+D.+Schteingart&title=New%2C+potent%2C+and+selective+peptidic+oxytocin+receptor+agonists&doi=10.1021%2Fjm500365s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">New, Potent, and Selective Peptidic Oxytocin Receptor Agonists</span></div><div class="casAuthors">Wisniewski, Kazimierz; Alagarsamy, Sudarkodi; Galyean, Robert; Tariga, Hiroe; Thompson, Dorain; Ly, Brian; Wisniewska, Halina; Qi, Steve; Croston, Glenn; Laporte, Regent; Riviere, Pierre J.-M.; Schteingart, Claudio D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5306-5317</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mothers of preterm babies frequently have difficulty establishing or maintaining lactation, thought to be due to interference with the milk ejection reflex.  Administration of exogenous oxytocin can produce alveolar contraction and adequate breast emptying resulting in establishment of successful lactation.  The natural hormone oxytocin is not receptor-selective and may cause hyponatremia via V2 receptor mediated antidiuresis.  We have designed a series of potent oxytocin analogs contg. N-alkylglycines in position 7 with excellent selectivity vs. the related V1a, V1b, and V2 vasopressin receptors and short half-life: agonists 31([2-ThiMeGly7]dOT), 47 (carba-6-[Phe2,BuGly7]dOT), 55 (carba-6-[3-MeBzlGly7]dOT), and 57 (carba-1-[4-FBzlGly7]dOT) have EC50 values at hOTR < 0.1 nM, selectivity ratios vs. related human vasopressin receptors of >2000, IC50 at hV1aR > 500 nM, and total clearance in rats in the range of 60-80 mL min-1 kg-1.  Compd. 57 (FE 202767) is currently in clin. development for the treatment of preterm mothers requiring lactation support.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_ykZz5KXVXbVg90H21EOLACvtfcHk0lhGEULisdfiiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVWhs78%253D&md5=8076f2bbeb06371908b462d1c8f25321</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm500365s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500365s%26sid%3Dliteratum%253Aachs%26aulast%3DWi%25C5%259Bniewski%26aufirst%3DK.%26aulast%3DAlagarsamy%26aufirst%3DS.%26aulast%3DGalyean%26aufirst%3DR.%26aulast%3DTariga%26aufirst%3DH.%26aulast%3DThompson%26aufirst%3DD.%26aulast%3DLy%26aufirst%3DB.%26aulast%3DWi%25C5%259Bniewski%26aufirst%3DH.%26aulast%3DQi%26aufirst%3DS.%26aulast%3DCroston%26aufirst%3DG.%26aulast%3DLaporte%26aufirst%3DR.%26aulast%3DRivi%25C3%25A8re%26aufirst%3DP.%2BJ.-M.%26aulast%3DSchteingart%26aufirst%3DC.%2BD.%26atitle%3DNew%252C%2520potent%252C%2520and%2520selective%2520peptidic%2520oxytocin%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5306%26epage%3D5317%26doi%3D10.1021%2Fjm500365s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">ClinicalTrials.gov, NIH</span>, <a href="https://www.clinicaltrials.gov/ct2/show/NCT02545127?lead=ferring&amp;gndr=Female&amp;phase=01&amp;rank=5" class="extLink">https://www.clinicaltrials.gov/ct2/show/NCT02545127?lead=ferring&gndr=Female&phase=01&rank=5</a> (accessed on February 26, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov%2C+NIH%2C+https%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT02545127%3Flead%3Dferring%26gndr%3DFemale%26phase%3D01%26rank%3D5+%28accessed+on+February+26%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wellings, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atherton, E.</span></span> <span> </span><span class="NLM_article-title">[4] Standard Fmoc protocols</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1016/s0076-6879(97)89043-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fs0076-6879%2897%2989043-x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1997&pages=44-67&author=D.+A.+Wellingsauthor=E.+Atherton&title=%5B4%5D+Standard+Fmoc+protocols&doi=10.1016%2Fs0076-6879%2897%2989043-x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fs0076-6879%2897%2989043-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0076-6879%252897%252989043-x%26sid%3Dliteratum%253Aachs%26aulast%3DWellings%26aufirst%3DD.%2BA.%26aulast%3DAtherton%26aufirst%3DE.%26atitle%3D%255B4%255D%2520Standard%2520Fmoc%2520protocols%26jtitle%3DMethods%2520Enzymol.%26date%3D1997%26volume%3D289%26spage%3D44%26epage%3D67%26doi%3D10.1016%2Fs0076-6879%2897%2989043-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ran, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konermann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwala, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fine, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shalem, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cradick, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marraffini, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span> <span> </span><span class="NLM_article-title">DNA targeting specificity of RNA-guided Cas9 nucleases</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">827</span>– <span class="NLM_lpage">832</span>, <span class="refDoi"> DOI: 10.1038/nbt.2647</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1038%2Fnbt.2647" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=23873081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFCit7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=827-832&author=P.+D.+Hsuauthor=D.+A.+Scottauthor=J.+A.+Weinsteinauthor=F.+A.+Ranauthor=S.+Konermannauthor=V.+Agarwalaauthor=Y.+Liauthor=E.+J.+Fineauthor=X.+Wuauthor=O.+Shalemauthor=T.+J.+Cradickauthor=L.+A.+Marraffiniauthor=G.+Baoauthor=F.+Zhang&title=DNA+targeting+specificity+of+RNA-guided+Cas9+nucleases&doi=10.1038%2Fnbt.2647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">DNA targeting specificity of RNA-guided Cas9 nucleases</span></div><div class="casAuthors">Hsu, Patrick D.; Scott, David A.; Weinstein, Joshua A.; Ran, F. Ann; Konermann, Silvana; Agarwala, Vineeta; Li, Yinqing; Fine, Eli J.; Wu, Xuebing; Shalem, Ophir; Cradick, Thomas J.; Marraffini, Luciano A.; Bao, Gang; Zhang, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">827-832</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Streptococcus pyogenes Cas9 (SpCas9) nuclease can be efficiently targeted to genomic loci by means of single-guide RNAs (sgRNAs) to enable genome editing.  Here, the authors characterize SpCas9 targeting specificity in human cells to inform the selection of target sites and avoid off-target effects.  This study evaluates >700 guide RNA variants and SpCas9-induced indel mutation levels at >100 predicted genomic off-target loci in 293T and 293FT cells.  SpCas9 tolerates mismatches between guide RNA and target DNA at different positions in a sequence-dependent manner, sensitive to the no., position and distribution of mismatches.  Also, SpCas9-mediated cleavage is unaffected by DNA methylation and that the dosage of SpCas9 and sgRNA can be titrated to minimize off-target modification.  To facilitate mammalian genome engineering applications, the authors provide a web-based software tool to guide the selection and validation of target sequences as well as off-target analyses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0dL9TCYREWbVg90H21EOLACvtfcHk0lj12yShuNbEFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFCit7nJ&md5=0babfdd7b0a644ba422d8fd46dbdf8ae</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2647%26sid%3Dliteratum%253Aachs%26aulast%3DHsu%26aufirst%3DP.%2BD.%26aulast%3DScott%26aufirst%3DD.%2BA.%26aulast%3DWeinstein%26aufirst%3DJ.%2BA.%26aulast%3DRan%26aufirst%3DF.%2BA.%26aulast%3DKonermann%26aufirst%3DS.%26aulast%3DAgarwala%26aufirst%3DV.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DFine%26aufirst%3DE.%2BJ.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DShalem%26aufirst%3DO.%26aulast%3DCradick%26aufirst%3DT.%2BJ.%26aulast%3DMarraffini%26aufirst%3DL.%2BA.%26aulast%3DBao%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DF.%26atitle%3DDNA%2520targeting%2520specificity%2520of%2520RNA-guided%2520Cas9%2520nucleases%26jtitle%3DNat.%2520Biotechnol.%26date%3D2013%26volume%3D31%26spage%3D827%26epage%3D832%26doi%3D10.1038%2Fnbt.2647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Motulsky, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahan, L. C.</span></span> <span> </span><span class="NLM_article-title">The kinetics of competitive radioligand binding predicted by the law of mass action</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=6708928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADyaL2c7mslOmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1984&pages=1-9&author=H.+J.+Motulskyauthor=L.+C.+Mahan&title=The+kinetics+of+competitive+radioligand+binding+predicted+by+the+law+of+mass+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">The kinetics of competitive radioligand binding predicted by the law of mass action</span></div><div class="casAuthors">Motulsky H J; Mahan L C</div><div class="citationInfo"><span class="NLM_cas:title">Molecular pharmacology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">Although equilibrium competitive radioligand binding studies are often used to characterize hormone and neurotransmitter receptors, the kinetics of such experiments have not been extensively explored.  The interactions of the radioligand and competitor with the receptors can be described by two differential equations which can be solved to yield a single equation describing the binding of the radioligand as a function of time.  This equation has several applications: First, it can be used to simulate competitive binding reactions under defined conditions.  Second, fitting experimental data to this equation allows one to determine the association and dissociation rate constants of the competing ligand, parameters that cannot be derived from equilibrium experiments.  Furthermore, this method can be used to determine the KI of the competing drug from data acquired before equilibrium is reached.  Third, mathematical analysis of the binding equation allowed us to answer two specific questions regarding the kinetics of competitive radioligand binding: how long such an incubation takes to equilibrate, and how the IC50 varies over time.  The answers to these questions depended, to a large extent, on the relative values of the dissociation rate constants of the radioligand and competitor, which can be determined as noted above.  When the competitor dissociates from the receptors more rapidly than the radioligand, the IC50 first decreases and then increases, but never has a value less than the KI.  At low radioligand concentrations, equilibrium is reached in the same amount of time required of the radioligand to dissociate completely from the receptors as determined in an "off-rate experiment." At higher concentrations of radioligand this time is halved.  When the competitor dissociates from the receptor more slowly than does the radioligand, then the time required to equilibrate depends only on the dissociation rate constant of the competitor, and the IC50 decreases over time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRCXDwvoK7MbN1QT_1O5WBYfW6udTcc2ebUk28QHF2psLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2c7mslOmtQ%253D%253D&md5=f0c09a16d7f8947fe0d72c256e2e4914</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMotulsky%26aufirst%3DH.%2BJ.%26aulast%3DMahan%26aufirst%3DL.%2BC.%26atitle%3DThe%2520kinetics%2520of%2520competitive%2520radioligand%2520binding%2520predicted%2520by%2520the%2520law%2520of%2520mass%2520action%26jtitle%3DMol.%2520Pharmacol.%26date%3D1984%26volume%3D25%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ihara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimomura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattelle, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komai, K.</span></span> <span> </span><span class="NLM_article-title">Super Agonist Actions of Clothianidin and Related Compounds on the SADβ2 Nicotinic Acetylcholine Receptor Expressed inXenopus laevisOocytes</span>. <i>Biosci. Biotechnol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">763</span>, <span class="refDoi"> DOI: 10.1271/bbb.68.761</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1271%2Fbbb.68.761" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2004&pages=761-763&author=M.+Iharaauthor=K.+Matsudaauthor=M.+Shimomuraauthor=D.+B.+Sattelleauthor=K.+Komai&title=Super+Agonist+Actions+of+Clothianidin+and+Related+Compounds+on+the+SAD%CE%B22+Nicotinic+Acetylcholine+Receptor+Expressed+inXenopus+laevisOocytes&doi=10.1271%2Fbbb.68.761"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1271%2Fbbb.68.761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1271%252Fbbb.68.761%26sid%3Dliteratum%253Aachs%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DMatsuda%26aufirst%3DK.%26aulast%3DShimomura%26aufirst%3DM.%26aulast%3DSattelle%26aufirst%3DD.%2BB.%26aulast%3DKomai%26aufirst%3DK.%26atitle%3DSuper%2520Agonist%2520Actions%2520of%2520Clothianidin%2520and%2520Related%2520Compounds%2520on%2520the%2520SAD%25CE%25B22%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Expressed%2520inXenopus%2520laevisOocytes%26jtitle%3DBiosci.%2520Biotechnol.%2520Biochem.%26date%3D2004%26volume%3D68%26spage%3D761%26epage%3D763%26doi%3D10.1271%2Fbbb.68.761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckingham, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattelle, D. B.</span></span> <span> </span><span class="NLM_article-title">Neonicotinoid insecticides display partial and super agonist actions on native insect nicotinic acetylcholine receptors</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">608</span>– <span class="NLM_lpage">615</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2006.04084.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1111%2Fj.1471-4159.2006.04084.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=16899070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtF2rsLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2006&pages=608-615&author=L.+A.+Brownauthor=M.+Iharaauthor=S.+D.+Buckinghamauthor=K.+Matsudaauthor=D.+B.+Sattelle&title=Neonicotinoid+insecticides+display+partial+and+super+agonist+actions+on+native+insect+nicotinic+acetylcholine+receptors&doi=10.1111%2Fj.1471-4159.2006.04084.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Neonicotinoid insecticides display partial and super agonist actions on native insect nicotinic acetylcholine receptors</span></div><div class="casAuthors">Brown, Laurence A.; Ihara, Makoto; Buckingham, Steven D.; Matsuda, Kazuhiko; Sattelle, David B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">608-615</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Nicotinic acetylcholine receptors (nAChRs) are present in high d. in insect nervous tissue and are targeted by neonicotinoid insecticides.  Improved understanding of the actions of these insecticides will assist in the development of new compds.  Whole-cell patch-clamp recording of cholinergic neurons cultured from the central nervous system of 3rd instar Drosophila larvae were used to examine the actions of acetylcholine (ACh) and nicotine, as well as the neonicotinoids imidacloprid, clothianidin and P-CH-clothianidin on native nAChRs of these neurons.  Dose-response data yield an EC50 value for ACh of 19 μM.  Both nicotine and imidacloprid act as low efficacy agonists at native nAChRs, evoking maximal current amplitudes 10-14% of those obsd. for ACh.  Conversely, clothianidin and P-CH-clothianidin evoke maximal current amplitudes up to 56% greater than those evoked by 100 μM ACh in the same neurons.  This is the first demonstration of 'super' agonist actions of an insecticide on native insect nAChRs.  Cell-attached recordings indicate that super agonism results from more frequent openings at the largest (63.5 pS) conductance state obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPQFP6g23FGbVg90H21EOLACvtfcHk0lgfp0WD5BnvIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtF2rsLnO&md5=e719f86c3f854c4adc29bf76301f9986</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04084.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04084.x%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DL.%2BA.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DBuckingham%26aufirst%3DS.%2BD.%26aulast%3DMatsuda%26aufirst%3DK.%26aulast%3DSattelle%26aufirst%3DD.%2BB.%26atitle%3DNeonicotinoid%2520insecticides%2520display%2520partial%2520and%2520super%2520agonist%2520actions%2520on%2520native%2520insect%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D99%26spage%3D608%26epage%3D615%26doi%3D10.1111%2Fj.1471-4159.2006.04084.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Engel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monga, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northup, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gershengorn, M. C.</span></span> <span> </span><span class="NLM_article-title">Low Affinity Analogs of Thyrotropin-releasing Hormone Are Super-agonists</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">13103</span>– <span class="NLM_lpage">13109</span>, <span class="refDoi"> DOI: 10.1074/jbc.m600440200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1074%2Fjbc.m600440200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=13103-13109&author=S.+Engelauthor=S.+Neumannauthor=N.+Kaurauthor=V.+Mongaauthor=R.+Jainauthor=J.+Northupauthor=M.+C.+Gershengorn&title=Low+Affinity+Analogs+of+Thyrotropin-releasing+Hormone+Are+Super-agonists&doi=10.1074%2Fjbc.m600440200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m600440200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m600440200%26sid%3Dliteratum%253Aachs%26aulast%3DEngel%26aufirst%3DS.%26aulast%3DNeumann%26aufirst%3DS.%26aulast%3DKaur%26aufirst%3DN.%26aulast%3DMonga%26aufirst%3DV.%26aulast%3DJain%26aufirst%3DR.%26aulast%3DNorthup%26aufirst%3DJ.%26aulast%3DGershengorn%26aufirst%3DM.%2BC.%26atitle%3DLow%2520Affinity%2520Analogs%2520of%2520Thyrotropin-releasing%2520Hormone%2520Are%2520Super-agonists%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D13103%26epage%3D13109%26doi%3D10.1074%2Fjbc.m600440200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Langmead, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">Supra-physiological efficacy at GPCRs: superstition or super agonists?</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1111/bph.12142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1111%2Fbph.12142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=23441648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvFSgt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2013&pages=353-356&author=C.+J.+Langmeadauthor=A.+Christopoulos&title=Supra-physiological+efficacy+at+GPCRs%3A+superstition+or+super+agonists%3F&doi=10.1111%2Fbph.12142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Supra-physiological efficacy at GPCRs: superstition or super agonists?</span></div><div class="casAuthors">Langmead, Christopher J.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The concept of "super agonism" has been described since the discovery of peptide hormone analogs that yielded greater functional responses than the endogenous agonists, in the early 1980s.  It has remained an area of debate as to whether such compds. can really display greater efficacy than an endogenous agonist.  However, recent pharmacol. data, combined with crystal structures of different GPCR conformations and improved anal. methods for quantifying drug action, are starting to shed light on this phenomenon and indicate that super agonists may be more than superstition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrquBL04A_rILVg90H21EOLACvtfcHk0lgfp0WD5BnvIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvFSgt7g%253D&md5=50b127c3cda2d82b859df07e556dc463</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1111%2Fbph.12142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12142%26sid%3Dliteratum%253Aachs%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DSupra-physiological%2520efficacy%2520at%2520GPCRs%253A%2520superstition%2520or%2520super%2520agonists%253F%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D169%26spage%3D353%26epage%3D356%26doi%3D10.1111%2Fbph.12142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alix, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosier, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casterlow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyce, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulte, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukat, M.</span></span> <span> </span><span class="NLM_article-title">Superagonist, full agonist, partial agonist, and antagonist actions of arylguanidines at 5-hydroxytryptamine-3 (5-HT<sub>3</sub>) subunit A receptors</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1565</span>– <span class="NLM_lpage">1574</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.6b00196</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00196" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlKnurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1565-1574&author=K.+Alixauthor=S.+Khatriauthor=P.+D.+Mosierauthor=S.+Casterlowauthor=D.+Yanauthor=H.+L.+Nyceauthor=M.+M.+Whiteauthor=M.+K.+Schulteauthor=M.+Dukat&title=Superagonist%2C+full+agonist%2C+partial+agonist%2C+and+antagonist+actions+of+arylguanidines+at+5-hydroxytryptamine-3+%285-HT3%29+subunit+A+receptors&doi=10.1021%2Facschemneuro.6b00196"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Superagonist, Full Agonist, Partial Agonist, and Antagonist Actions of Arylguanidines at 5-Hydroxytryptamine-3 (5-HT3) Subunit A Receptors</span></div><div class="casAuthors">Alix, Katie; Khatri, Shailesh; Mosier, Philip D.; Casterlow, Samantha; Yan, Dong; Nyce, Heather L.; White, Michael M.; Schulte, Marvin K.; Dukat, Malgorzata</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1565-1574</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Introduction of minor variations to the substitution pattern of arylguanidine 5-HT3 ligands resulted in a broad spectrum of functionally-active ligands from antagonist to super-agonist.  Introduction of an addnl. Cl-substituent(s) to the lead full agonist N-(3-chlorophenyl)guanidine (mCPG) I (efficacy % = 106) yielded three super-agonists (efficacy % = 186, 139, and 129, resp.).  A positional isomer of I, p-Cl analog, displayed partial agonist actions (efficacy % = 12) replacing the halogen atom at the meta or para position with an electron donating OCH3 group or a stronger electron withdrawing (i.e., CF3) group resulted in four more antagonists.  The authors conclude based on combined mutagenesis, crystallog., and computational analyses that for the 5-HT3 receptor, the arylguanidines that are better able to simultaneously engage the primary and complementary subunits, thus keeping them in close proximity, have greater agonist character while those that are deficient in this ability are antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOxZMYAx3GZrVg90H21EOLACvtfcHk0lgfp0WD5BnvIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlKnurfI&md5=b8b96cb2284ebec508a9f68b23930baf</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00196%26sid%3Dliteratum%253Aachs%26aulast%3DAlix%26aufirst%3DK.%26aulast%3DKhatri%26aufirst%3DS.%26aulast%3DMosier%26aufirst%3DP.%2BD.%26aulast%3DCasterlow%26aufirst%3DS.%26aulast%3DYan%26aufirst%3DD.%26aulast%3DNyce%26aufirst%3DH.%2BL.%26aulast%3DWhite%26aufirst%3DM.%2BM.%26aulast%3DSchulte%26aufirst%3DM.%2BK.%26aulast%3DDukat%26aufirst%3DM.%26atitle%3DSuperagonist%252C%2520full%2520agonist%252C%2520partial%2520agonist%252C%2520and%2520antagonist%2520actions%2520of%2520arylguanidines%2520at%25205-hydroxytryptamine-3%2520%25285-HT3%2529%2520subunit%2520A%2520receptors%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D1565%26epage%3D1574%26doi%3D10.1021%2Facschemneuro.6b00196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosethorne, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gherbi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattikar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trifilieff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairhurst, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlton, S. J.</span></span> <span> </span><span class="NLM_article-title">Long receptor residence time of C26 contributes to super agonist activity at the human β<sub>2</sub>-receptor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">467</span>– <span class="NLM_lpage">475</span>, <span class="refDoi"> DOI: 10.1124/mol.115.101253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1124%2Fmol.115.101253" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2016&pages=467-475&author=E.+M.+Rosethorneauthor=M.+E.+Bradleyauthor=K.+Gherbiauthor=D.+A.+Sykesauthor=A.+Sattikarauthor=J.+D.+Wrightauthor=E.+Renardauthor=A.+Trifilieffauthor=R.+A.+Fairhurstauthor=S.+J.+Charlton&title=Long+receptor+residence+time+of+C26+contributes+to+super+agonist+activity+at+the+human+%CE%B22-receptor&doi=10.1124%2Fmol.115.101253"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1124%2Fmol.115.101253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.115.101253%26sid%3Dliteratum%253Aachs%26aulast%3DRosethorne%26aufirst%3DE.%2BM.%26aulast%3DBradley%26aufirst%3DM.%2BE.%26aulast%3DGherbi%26aufirst%3DK.%26aulast%3DSykes%26aufirst%3DD.%2BA.%26aulast%3DSattikar%26aufirst%3DA.%26aulast%3DWright%26aufirst%3DJ.%2BD.%26aulast%3DRenard%26aufirst%3DE.%26aulast%3DTrifilieff%26aufirst%3DA.%26aulast%3DFairhurst%26aufirst%3DR.%2BA.%26aulast%3DCharlton%26aufirst%3DS.%2BJ.%26atitle%3DLong%2520receptor%2520residence%2520time%2520of%2520C26%2520contributes%2520to%2520super%2520agonist%2520activity%2520at%2520the%2520human%2520%25CE%25B22-receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2016%26volume%3D89%26spage%3D467%26epage%3D475%26doi%3D10.1124%2Fmol.115.101253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faeh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span> <span> </span><span class="NLM_article-title">Fluorine in pharmaceuticals: looking beyond intuition</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>317</i></span>,  <span class="NLM_fpage">1881</span>– <span class="NLM_lpage">1886</span>, <span class="refDoi"> DOI: 10.1126/science.1131943</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1126%2Fscience.1131943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=17901324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BD2srnvVOnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2007&pages=1881-1886&author=K.+Mullerauthor=C.+Faehauthor=F.+Diederich&title=Fluorine+in+pharmaceuticals%3A+looking+beyond+intuition&doi=10.1126%2Fscience.1131943"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in pharmaceuticals: looking beyond intuition</span></div><div class="casAuthors">Muller Klaus; Faeh Christoph; Diederich Francois</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">5846</span>),
    <span class="NLM_cas:pages">1881-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Fluorine substituents have become a widespread and important drug component, their introduction facilitated by the development of safe and selective fluorinating agents.  Organofluorine affects nearly all physical and adsorption, distribution, metabolism, and excretion properties of a lead compound.  Its inductive effects are relatively well understood, enhancing bioavailability, for example, by reducing the basicity of neighboring amines.  In contrast, exploration of the specific influence of carbon-fluorine single bonds on docking interactions, whether through direct contact with the protein or through stereoelectronic effects on molecular conformation of the drug, has only recently begun.  Here, we review experimental progress in this vein and add complementary analysis based on comprehensive searches in the Cambridge Structural Database and the Protein Data Bank.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQekuTGhVzexmgRQsDqrjW_fW6udTcc2eZGfqEuO_JVsrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srnvVOnuw%253D%253D&md5=f624ab3733f7fc9d4b1711f2f3566ca2</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1126%2Fscience.1131943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1131943%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DK.%26aulast%3DFaeh%26aufirst%3DC.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DFluorine%2520in%2520pharmaceuticals%253A%2520looking%2520beyond%2520intuition%26jtitle%3DScience%26date%3D2007%26volume%3D317%26spage%3D1881%26epage%3D1886%26doi%3D10.1126%2Fscience.1131943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vulpetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvit, C.</span></span> <span> </span><span class="NLM_article-title">Fluorine local environment: from screening to drug design</span>. <i>Drug Discov. Today</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">890</span>– <span class="NLM_lpage">897</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2012.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.drudis.2012.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=22480871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvVSluro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=890-897&author=A.+Vulpettiauthor=C.+Dalvit&title=Fluorine+local+environment%3A+from+screening+to+drug+design&doi=10.1016%2Fj.drudis.2012.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine local environment: from screening to drug design</span></div><div class="casAuthors">Vulpetti, Anna; Dalvit, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">15-16</span>),
    <span class="NLM_cas:pages">890-897</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Fluorine is widely used in the lead optimization phase of drug discovery projects.  More recently, fluorine NMR-based spectroscopy has emerged as a versatile, reliable and efficient tool for performing binding and biochem. assays.  Different libraries of fluorinated compds., designed by maximizing the chem. space around the fluorine atom, are screened for identifying binding fragments and for detecting putative fluorophilic hot spots on the desired macromol. target.  A statistical anal. of the fluorine NMR chem. shift, which is a marker of the fluorine local environment, and of the X-ray structures of fluorinated mols. has resulted in the development of the 'rule of shielding'.  This method could become a useful tool for lead optimization and for designing novel chem. scaffolds that recognize distinct protein structural motifs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWqEJk54cQArVg90H21EOLACvtfcHk0li_fAKFmGPsGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvVSluro%253D&md5=0023aca3cd342f48898357b83c7eaf47</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2012.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2012.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DDalvit%26aufirst%3DC.%26atitle%3DFluorine%2520local%2520environment%253A%2520from%2520screening%2520to%2520drug%2520design%26jtitle%3DDrug%2520Discov.%2520Today%26date%3D2012%26volume%3D17%26spage%3D890%26epage%3D897%26doi%3D10.1016%2Fj.drudis.2012.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopatina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inzhutova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshihara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishiyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagitani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukaida, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hori, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshioka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherepanov, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmina, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span> <span> </span><span class="NLM_article-title">Displays of paternal mouse pup retrieval following communicative interaction with maternal mates</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1346</span>, <span class="refDoi"> DOI: 10.1038/ncomms2336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1038%2Fncomms2336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=23299896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BC3s3nvVWjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1346&author=H.-X.+Liuauthor=O.+Lopatinaauthor=C.+Higashidaauthor=H.+Fujimotoauthor=S.+Aktherauthor=A.+Inzhutovaauthor=M.+Liangauthor=J.+Zhongauthor=T.+Tsujiauthor=T.+Yoshiharaauthor=K.+Sumiauthor=M.+Ishiyamaauthor=W.+J.+Maauthor=M.+Ozakiauthor=S.+Yagitaniauthor=S.+Yokoyamaauthor=N.+Mukaidaauthor=T.+Sakuraiauthor=O.+Horiauthor=K.+Yoshiokaauthor=A.+Hiraoauthor=Y.+Katoauthor=K.+Ishiharaauthor=I.+Katoauthor=H.+Okamotoauthor=S.+M.+Cherepanovauthor=A.+B.+Salminaauthor=H.+Hiraiauthor=M.+Asanoauthor=D.+A.+Brownauthor=I.+Naganoauthor=H.+Higashida&title=Displays+of+paternal+mouse+pup+retrieval+following+communicative+interaction+with+maternal+mates&doi=10.1038%2Fncomms2336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Displays of paternal mouse pup retrieval following communicative interaction with maternal mates</span></div><div class="casAuthors">Liu Hong-Xiang; Lopatina Olga; Higashida Chiharu; Fujimoto Hiroko; Akther Shirin; Inzhutova Alena; Liang Mingkun; Zhong Jing; Tsuji Takahiro; Yoshihara Toru; Sumi Kohei; Ishiyama Mizuho; Ma Wen-Jie; Ozaki Mitsunori; Yagitani Satoshi; Yokoyama Shigeru; Mukaida Naofumi; Sakurai Takeshi; Hori Osamu; Yoshioka Katsuji; Hirao Atsushi; Kato Yukio; Ishihara Katsuhiko; Kato Ichiro; Okamoto Hiroshi; Cherepanov Stanislav M; Salmina Alla B; Hirai Hirokazu; Asano Masahide; Brown David A; Nagano Isamu; Higashida Haruhiro</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1346</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Compared with the knowledge of maternal care, much less is known about the factors required for paternal parental care.  Here we report that new sires of laboratory mice, though not spontaneously parental, can be induced to show maternal-like parental care (pup retrieval) using signals from dams separated from their pups.  During this interaction, the maternal mates emit 38-kHz ultrasonic vocalizations to their male partners, which are equivalent to vocalizations that occur following pheromone stimulation.  Without these signals or in the absence of maternal mates, the sires do not retrieve their pups within 5 min.  These results show that, in mice, the maternal parent communicates to the paternal parent to encourage pup care.  This new paradigm may be useful in the analysis of the parental brain during paternal care induced by interactive communication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRnfgpXeTc_99hSDZx9hyjKfW6udTcc2eaxsO8hnZqZcLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3nvVWjtw%253D%253D&md5=8600f6cdb3d073d32c2b7be9cc932ce6</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fncomms2336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms2336%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.-X.%26aulast%3DLopatina%26aufirst%3DO.%26aulast%3DHigashida%26aufirst%3DC.%26aulast%3DFujimoto%26aufirst%3DH.%26aulast%3DAkther%26aufirst%3DS.%26aulast%3DInzhutova%26aufirst%3DA.%26aulast%3DLiang%26aufirst%3DM.%26aulast%3DZhong%26aufirst%3DJ.%26aulast%3DTsuji%26aufirst%3DT.%26aulast%3DYoshihara%26aufirst%3DT.%26aulast%3DSumi%26aufirst%3DK.%26aulast%3DIshiyama%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DW.%2BJ.%26aulast%3DOzaki%26aufirst%3DM.%26aulast%3DYagitani%26aufirst%3DS.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DMukaida%26aufirst%3DN.%26aulast%3DSakurai%26aufirst%3DT.%26aulast%3DHori%26aufirst%3DO.%26aulast%3DYoshioka%26aufirst%3DK.%26aulast%3DHirao%26aufirst%3DA.%26aulast%3DKato%26aufirst%3DY.%26aulast%3DIshihara%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DI.%26aulast%3DOkamoto%26aufirst%3DH.%26aulast%3DCherepanov%26aufirst%3DS.%2BM.%26aulast%3DSalmina%26aufirst%3DA.%2BB.%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DAsano%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DD.%2BA.%26aulast%3DNagano%26aufirst%3DI.%26aulast%3DHigashida%26aufirst%3DH.%26atitle%3DDisplays%2520of%2520paternal%2520mouse%2520pup%2520retrieval%2520following%2520communicative%2520interaction%2520with%2520maternal%2520mates%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D1346%26doi%3D10.1038%2Fncomms2336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gutkowska, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jankowski, M.</span></span> <span> </span><span class="NLM_article-title">Oxytocin revisited: its role in cardiovascular regulation</span>. <i>J. Neuroendocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2826.2011.02235.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1111%2Fj.1365-2826.2011.02235.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=21981277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFKrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2012&pages=599-608&author=J.+Gutkowskaauthor=M.+Jankowski&title=Oxytocin+revisited%3A+its+role+in+cardiovascular+regulation&doi=10.1111%2Fj.1365-2826.2011.02235.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin revisited: its role in cardiovascular regulation</span></div><div class="casAuthors">Gutkowska, J.; Jankowski, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroendocrinology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">599-608</span>CODEN:
                <span class="NLM_cas:coden">JOUNE2</span>;
        ISSN:<span class="NLM_cas:issn">0953-8194</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Traditionally assocd. with female reprodn., oxytocin (OT) was revisited recently and was revealed to have several new roles in the cardiovascular system.  Functional OT receptors have been discovered in the rat and human heart, as well as in vascular beds.  The cardiovascular activities of OT include: (i) lowering blood pressure; (ii) neg. cardiac inotropy and chronotropy; (iii) parasympathetic neuromodulation; (iv) vasodilatation; (v) anti-inflammatory; (vi) antioxidative; and (vii) metabolic effects.  These outcomes are mediated, at least in part, by stimulating cardioprotective mediators, such as nitric oxide and atrial natriuretic peptide.  OT and its extended form OT-Gly-Lys-Arg have been shown to be abundant in the fetal mouse heart.  OT has the capacity to generate cardiomyocytes from various types of stem cells, including the cardiac side population.  Mesenchymal cells transfected with OT-Gly-Lys-Arg, or preconditioned with OT, are resistant to apoptosis and express endothelial cell markers.  OT increases glucose uptake in cultured cardiomyocytes from newborn and adult rats, in normal, hypoxic and even insulin resistance conditions.  In rats with exptl.-induced myocardial infarction, continuous in vivo OT delivery improves the cardiac healing process, as well as cardiac work, reduces inflammation and stimulates angiogenesis.  Therefore, in pathol. conditions, OT exerts anti-inflammatory and cardioprotective properties, and improves vascular and metabolic functions.  Thus, OT has potential for therapeutic use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-22hhU9Rnh7Vg90H21EOLACvtfcHk0lgorLRHP_sfng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFKrtr4%253D&md5=8245746d84d7ad7a2bbfbe01ec1b38d0</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2826.2011.02235.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2826.2011.02235.x%26sid%3Dliteratum%253Aachs%26aulast%3DGutkowska%26aufirst%3DJ.%26aulast%3DJankowski%26aufirst%3DM.%26atitle%3DOxytocin%2520revisited%253A%2520its%2520role%2520in%2520cardiovascular%2520regulation%26jtitle%3DJ.%2520Neuroendocrinol.%26date%3D2012%26volume%3D24%26spage%3D599%26epage%3D608%26doi%3D10.1111%2Fj.1365-2826.2011.02235.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lopatina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amina, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashii, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span> <span> </span><span class="NLM_article-title">Oxytocin-induced elevation of ADP-ribosyl cyclase activity, cyclic ADP-riboseor Ca2+ concentrations is involved in autoregulation of oxytocin secretionin the hypothalamus and posterior pituitary in male mice</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2009.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.neuropharm.2009.06.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=19540855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BD1Mjjs1eltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2010&pages=50-55&author=O.+Lopatinaauthor=H.-X.+Liuauthor=S.+Aminaauthor=M.+Hashiiauthor=H.+Higashida&title=Oxytocin-induced+elevation+of+ADP-ribosyl+cyclase+activity%2C+cyclic+ADP-riboseor+Ca2%2B+concentrations+is+involved+in+autoregulation+of+oxytocin+secretionin+the+hypothalamus+and+posterior+pituitary+in+male+mice&doi=10.1016%2Fj.neuropharm.2009.06.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin-induced elevation of ADP-ribosyl cyclase activity, cyclic ADP-ribose or Ca(2+) concentrations is involved in autoregulation of oxytocin secretion in the hypothalamus and posterior pituitary in male mice</span></div><div class="casAuthors">Lopatina Olga; Liu Hong-Xiang; Amina Sarwat; Hashii Minako; Higashida Haruhiro</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Locally released oxytocin (OT) activates OT receptors (2.1:OXY:1:OT:) in neighboring neurons in the hypothalamus and their terminals in the posterior pituitary, resulting in further OT release, best known in autoregulation occurring during labor or milk ejection in reproductive females.  OT also plays a critical role in social behavior of non-reproductive females and even in males in mammals from rodents to humans.  Social behavior is disrupted when elevation of free intracellular Ca(2+) concentration ([Ca(2+)](i)) and OT secretion are reduced in male and female CD38 knockout mice.  Therefore, it is interesting to investigate whether ADP-ribosyl cyclase-dependent signaling is involved in OT-induced OT release for social recognition in males, independent from female reproduction, and to determine its molecular mechanism.  Here, we report that ADP-ribosyl cyclase activity was increased by OT in crude membrane preparations of the hypothalamus and posterior pituitary in male mice, and that OT elicited an increase in [Ca(2+)](i) in the isolated terminals over a period of 5 min.  The increases in cyclase and [Ca(2+)](i) were partially inhibited by nonspecific protein kinase inhibitors and a protein kinase C specific inhibitor, calphostin C.  Subsequently, OT-induced OT release was also inhibited by calphostin C to levels inhibited by vasotocin, an OT receptor antagonist, and 8-bromo-cADP-ribose.  These results demonstrate that OT receptors are functionally coupled to membrane-bound ADP-ribosyl cyclase and/or CD38 and suggest that cADPR-mediated intracellular calcium signaling is involved in autoregulation of OT release, which is sensitive to protein kinase C, in the hypothalamus and neurohypophysis in male mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQOi4ky_YbawEPI-fCgwosgfW6udTcc2eaxsO8hnZqZcLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mjjs1eltQ%253D%253D&md5=b01aa824e66a5c133179f3787a7dcafb</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2009.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2009.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DLopatina%26aufirst%3DO.%26aulast%3DLiu%26aufirst%3DH.-X.%26aulast%3DAmina%26aufirst%3DS.%26aulast%3DHashii%26aufirst%3DM.%26aulast%3DHigashida%26aufirst%3DH.%26atitle%3DOxytocin-induced%2520elevation%2520of%2520ADP-ribosyl%2520cyclase%2520activity%252C%2520cyclic%2520ADP-riboseor%2520Ca2%252B%2520concentrations%2520is%2520involved%2520in%2520autoregulation%2520of%2520oxytocin%2520secretionin%2520the%2520hypothalamus%2520and%2520posterior%2520pituitary%2520in%2520male%2520mice%26jtitle%3DNeuropharmacology%26date%3D2010%26volume%3D58%26spage%3D50%26epage%3D55%26doi%3D10.1016%2Fj.neuropharm.2009.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moy, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolova, V. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddick, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Deusen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janzen, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarstfer, M. B.</span></span> <span> </span><span class="NLM_article-title">Prosocial effects of an oxytocin metabolite, but not synthetic oxytocin receptor agonists, in a mouse model of autism</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">311</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2018.10.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.neuropharm.2018.10.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=30399367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFyqs7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2019&pages=301-311&author=S.+S.+Moyauthor=B.+L.+Tengauthor=V.+D.+Nikolovaauthor=N.+V.+Riddickauthor=C.+D.+Simpsonauthor=A.+Van+Deusenauthor=W.+P.+Janzenauthor=M.+F.+Sassanoauthor=C.+A.+Pedersenauthor=M.+B.+Jarstfer&title=Prosocial+effects+of+an+oxytocin+metabolite%2C+but+not+synthetic+oxytocin+receptor+agonists%2C+in+a+mouse+model+of+autism&doi=10.1016%2Fj.neuropharm.2018.10.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Prosocial effects of an oxytocin metabolite, but not synthetic oxytocin receptor agonists, in a mouse model of autism</span></div><div class="casAuthors">Moy, Sheryl S.; Teng, Brian L.; Nikolova, Viktoriya D.; Riddick, Natallia V.; Simpson, Catherine D.; Van Deusen, Amy; Janzen, William P.; Sassano, Maria F.; Pedersen, Cort A.; Jarstfer, Michael B.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">301-311</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Currently, there are no established pharmaceutical strategies that effectively treat social deficits in autism spectrum disorder (ASD).  Oxytocin, a neurohormone that plays a role in multiple types of social behaviors, has been proposed as a possible therapeutic against social impairment and other symptoms in ASD.  However, from the standpoint of pharmacotherapy, oxytocin has several liabilities as a std. clin. treatment, including rapid metab., low brain penetrance, and activity at the vasopressin (antidiuretic hormone) receptors.  The present studies describe findings from a preclin. screening program to evaluate oxytocin receptor (OXTR) agonists and oxytocin metabolites for potential clin. use as more optimal treatments.  We first investigated two synthetic oxytocin analogs, TC-OT-39 and carbetocin, using in vitro cell-based assays for pharmacol. characterization and behavioral tests in the BALB/cByJ mouse model of ASD-like social deficits.  Although both TC-OT-39 and carbetocin selectively activate the OXTR, neither synthetic agonist had prosocial efficacy in the BALB/cByJ model.  We next evaluated two oxytocin metabolites: OT(4-9) and OT(5-9).  While OT(5-9) failed to affect social deficits, the metabolite OT(4-9) led to significant social preference in the BALB/cByJ model, in a dose-dependent manner.  The increased sociability was obsd. at both 24 h and 12 days following the end of a subchronic regimen with OT(4-9) (2.0 mg/kg).  Overall, these results suggest that the prosocial effects of oxytocin could be mediated by downstream activity of oxytocin metabolites, raising the possibility of new pathways to target for drug discovery relevant to ASD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1HRdMtMK2erVg90H21EOLACvtfcHk0ljZPtTIPxkE9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFyqs7fE&md5=aeef8ff89768e7add24e1f9b55ff80e8</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2018.10.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2018.10.036%26sid%3Dliteratum%253Aachs%26aulast%3DMoy%26aufirst%3DS.%2BS.%26aulast%3DTeng%26aufirst%3DB.%2BL.%26aulast%3DNikolova%26aufirst%3DV.%2BD.%26aulast%3DRiddick%26aufirst%3DN.%2BV.%26aulast%3DSimpson%26aufirst%3DC.%2BD.%26aulast%3DVan%2BDeusen%26aufirst%3DA.%26aulast%3DJanzen%26aufirst%3DW.%2BP.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DPedersen%26aufirst%3DC.%2BA.%26aulast%3DJarstfer%26aufirst%3DM.%2BB.%26atitle%3DProsocial%2520effects%2520of%2520an%2520oxytocin%2520metabolite%252C%2520but%2520not%2520synthetic%2520oxytocin%2520receptor%2520agonists%252C%2520in%2520a%2520mouse%2520model%2520of%2520autism%26jtitle%3DNeuropharmacology%26date%3D2019%26volume%3D144%26spage%3D301%26epage%3D311%26doi%3D10.1016%2Fj.neuropharm.2018.10.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grinevich, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knobloch-Bollmann, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliava, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busnelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chini, B.</span></span> <span> </span><span class="NLM_article-title">Assembling the puzzle: Pathways of oxytocin signaling in the brain</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">164</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2015.04.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.biopsych.2015.04.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=26001309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC2MXos1Oku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=155-164&author=V.+Grinevichauthor=H.+S.+Knobloch-Bollmannauthor=M.+Eliavaauthor=M.+Busnelliauthor=B.+Chini&title=Assembling+the+puzzle%3A+Pathways+of+oxytocin+signaling+in+the+brain&doi=10.1016%2Fj.biopsych.2015.04.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Assembling the Puzzle: Pathways of Oxytocin Signaling in the Brain</span></div><div class="casAuthors">Grinevich, Valery; Knobloch-Bollmann, H. Sophie; Eliava, Marina; Busnelli, Marta; Chini, Bice</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">155-164</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Oxytocin (OT) is a neuropeptide, which can be seen to be one of the mols. of the decade due to its profound prosocial effects in nonvertebrate and vertebrate species, including humans.  Although OT can be detected in various physiol. fluids (blood, saliva, urine, cerebrospinal fluid) and brain tissue, it is unclear whether peripheral and central OT releases match and synergize.  Moreover, the pathways of OT delivery to brain regions involved in specific behaviors are far from clear.  Here, we discuss the evolutionarily and ontogenetically detd. pathways of OT delivery and OT signaling, which orchestrate activity of the mesolimbic social decision-making network.  Furthermore, we speculate that both the alteration in OT delivery and OT receptor expression may cause behavioral abnormalities in patients afflicted with psychosocial diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6gjPAwBbAP7Vg90H21EOLACvtfcHk0ljZPtTIPxkE9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXos1Oku7g%253D&md5=4b8181c48d1a7dacc13144a675893e1d</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2015.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2015.04.013%26sid%3Dliteratum%253Aachs%26aulast%3DGrinevich%26aufirst%3DV.%26aulast%3DKnobloch-Bollmann%26aufirst%3DH.%2BS.%26aulast%3DEliava%26aufirst%3DM.%26aulast%3DBusnelli%26aufirst%3DM.%26aulast%3DChini%26aufirst%3DB.%26atitle%3DAssembling%2520the%2520puzzle%253A%2520Pathways%2520of%2520oxytocin%2520signaling%2520in%2520the%2520brain%26jtitle%3DBiol.%2520Psychiatry%26date%3D2016%26volume%3D79%26spage%3D155%26epage%3D164%26doi%3D10.1016%2Fj.biopsych.2015.04.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlton, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlton, S. J.</span></span> <span> </span><span class="NLM_article-title">Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M3 receptor</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">927</span>– <span class="NLM_lpage">937</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0706819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1038%2Fsj.bjp.0706819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=16847442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFWrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2006&pages=927-937&author=M.+R.+Dowlingauthor=S.+J.+Charltonauthor=S.+J.+Charlton&title=Quantifying+the+association+and+dissociation+rates+of+unlabelled+antagonists+at+the+muscarinic+M3+receptor&doi=10.1038%2Fsj.bjp.0706819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M3 receptor</span></div><div class="casAuthors">Dowling, Mark R.; Charlton, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">927-937</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Slow receptor dissocn. kinetics has been implicated in the long clin. duration of action of the muscarinic receptor antagonist tiotropium.  However, despite the potential benefits of new drugs with slow dissocn. kinetics, the rate parameters of new compds. are seldom measured due to tech. difficulties and financial implications assocd. with radiolabeling multiple ligands.  Here we describe the development and optimization of a medium throughput assay which is capable of measuring the kinetic parameters of novel, unlabeled compds.  Radioligand binding studies were performed with membranes derived from CHO cells recombinantly expressing the human M3 muscarinic receptor.  Initial characterization of the radioligand [3H]-NMS yielded on and off rates of 4.1±0.2×108 M-1 min-1 and 0.015±0.0005 min-1, resp.  The specific binding of [3H]-NMS was measured over time in the presence and absence of several concns. of unlabeled competitor compds.  These data were analyzed using a competition kinetic model to provide on and off rates for the unlabeled competitor.  Comparison of the kinetically derived Kd (koff/kon) with Ki values generated at equil. showed an excellent correlation (r2=0.99), providing good validation of the method.  The on and off rates were also used in theor. computer simulations to successfully predict the effect of incubation time on apparent IC50 values.  This study demonstrates that a medium-throughput competition kinetic binding assay can be used to det. accurate on and off rates of unlabeled compds., providing the opportunity to optimize for kinetic parameters early in the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwZ8YOvAS0F7Vg90H21EOLACvtfcHk0ljZPtTIPxkE9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFWrurc%253D&md5=99194c7f2158c3706aa09c4ec83bfbb4</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706819%26sid%3Dliteratum%253Aachs%26aulast%3DDowling%26aufirst%3DM.%2BR.%26aulast%3DCharlton%26aufirst%3DS.%2BJ.%26aulast%3DCharlton%26aufirst%3DS.%2BJ.%26atitle%3DQuantifying%2520the%2520association%2520and%2520dissociation%2520rates%2520of%2520unlabelled%2520antagonists%2520at%2520the%2520muscarinic%2520M3%2520receptor%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D148%26spage%3D927%26epage%3D937%26doi%3D10.1038%2Fsj.bjp.0706819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leighton-Davies, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawcett, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trifilieff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlton, S. J.</span></span> <span> </span><span class="NLM_article-title">The influence of receptor kinetics on the onset and duration of action and the therapeutic index of NVA237 and tiotropium</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>343</i></span>,  <span class="NLM_fpage">520</span>– <span class="NLM_lpage">528</span>, <span class="refDoi"> DOI: 10.1124/jpet.112.194456</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1124%2Fjpet.112.194456" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=22854200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKktb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2012&pages=520-528&author=D.+A.+Sykesauthor=M.+R.+Dowlingauthor=J.+Leighton-Daviesauthor=T.+C.+Kentauthor=L.+Fawcettauthor=E.+Renardauthor=A.+Trifilieffauthor=S.+J.+Charlton&title=The+influence+of+receptor+kinetics+on+the+onset+and+duration+of+action+and+the+therapeutic+index+of+NVA237+and+tiotropium&doi=10.1124%2Fjpet.112.194456"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of receptor kinetics on the onset and duration of action and the therapeutic index of NVA237 and tiotropium</span></div><div class="casAuthors">Sykes, David A.; Dowling, Mark R.; Leighton-Davies, Juliet; Kent, Toby C.; Fawcett, Lindsay; Renard, Emilie; Trifilieff, Alexandre; Charlton, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">520-528</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Studies under nonphysiol. conditions suggest that long receptor residency time is responsible for the 24-h duration of action of the long-acting muscarinic antagonist (LAMA) tiotropium.  Our aim was to det. how clin. relevant dissocn. rates under more physiol. conditions influence the differences in onset of action between tiotropium and 3-[(cyclopentylhydroxyphenylacetyl oxy]-1,1-dimethyl-pyrrolidinium bromide (NVA237), a once-daily dry-powder formulation of the LAMA glycopyrronium bromide in development for chronic obstructive pulmonary disease.  In addn., we have investigated kinetic selectivity at each of the muscarinic receptor subtypes to det. whether the improved cardiovascular therapeutic index obtained with NVA237 in animal models is attributable to differences in kinetic rate consts.  The binding of radioligand [3H]N-methyl-scopolamine was measured in the presence/absence of several concns. of unlabeled competitors, and data were analyzed using a competition kinetic model to provide on/off rates for the competitor.  We found shorter dissocn. half-lives for NVA237 and tiotropium under physiol. (11.4 and 46.2 min, resp.) vs. nonphysiol. conditions (173 and 462 min, resp.).  NVA237 had a more rapid onset of action (3-4.8 times) vs. tiotropium, detd. in an vitro calcium and rat tracheal strip assay.  Simulations suggested that the more rapid onset of NVA237 action could be explained by differences in kinetic parameters.  NVA237 had greater equil. binding and kinetic selectivity for muscarinic type 3 (M3) vs. muscarinic type 2 (M2) receptors, with a faster off rate from M2 vs. M3 receptors than tiotropium, potentially affording it a more favorable therapeutic index.  This study suggests that the 24-h duration of action of NVA237 and tiotropium is not solely the result of their slow dissocn. from the M3 receptor and highlights the importance of conducting in vitro expts. in conditions reflecting those in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPg9FL15nv-bVg90H21EOLACvtfcHk0lhCaF8xW--wkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKktb3M&md5=922e31d6cafa771f3cc66aad519c07e8</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.194456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.194456%26sid%3Dliteratum%253Aachs%26aulast%3DSykes%26aufirst%3DD.%2BA.%26aulast%3DDowling%26aufirst%3DM.%2BR.%26aulast%3DLeighton-Davies%26aufirst%3DJ.%26aulast%3DKent%26aufirst%3DT.%2BC.%26aulast%3DFawcett%26aufirst%3DL.%26aulast%3DRenard%26aufirst%3DE.%26aulast%3DTrifilieff%26aufirst%3DA.%26aulast%3DCharlton%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520influence%2520of%2520receptor%2520kinetics%2520on%2520the%2520onset%2520and%2520duration%2520of%2520action%2520and%2520the%2520therapeutic%2520index%2520of%2520NVA237%2520and%2520tiotropium%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D343%26spage%3D520%26epage%3D528%26doi%3D10.1124%2Fjpet.112.194456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dagani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sisti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Paolo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raimondi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocchi, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saviotti, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scocco, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balestrieri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Girolamo, G.</span></span> <span> </span><span class="NLM_article-title">Do we need oxytocin to treat schizophrenia? A randomized clinical trial</span>. <i>Schizophr. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">158</span>– <span class="NLM_lpage">164</span>, <span class="refDoi"> DOI: 10.1016/j.schres.2016.02.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.schres.2016.02.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=26883950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BC28jhtlOisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2016&pages=158-164&author=J.+Daganiauthor=D.+Sistiauthor=M.+Abelliauthor=L.+Di+Paoloauthor=S.+Piniauthor=S.+Raimondiauthor=M.+B.+Rocchiauthor=F.+M.+Saviottiauthor=P.+Scoccoauthor=S.+Totaroauthor=M.+Balestrieriauthor=G.+de+Girolamo&title=Do+we+need+oxytocin+to+treat+schizophrenia%3F+A+randomized+clinical+trial&doi=10.1016%2Fj.schres.2016.02.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Do we need oxytocin to treat schizophrenia? A randomized clinical trial</span></div><div class="casAuthors">Dagani Jessica; Sisti Davide; Rocchi Marco B; Abelli Marianna; Di Paolo Luca; Pini Stefano; Raimondi Sara; Saviotti Francesco M; Scocco Paolo; Totaro Stefano; Balestrieri Matteo; de Girolamo Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Schizophrenia research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">158-64</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Schizophrenia is a disabling complex mental disorder and despite all available treatment, many patients unfortunately remain partial- or non-responders.  A large body of research has shown that oxytocin is an important prosocial peptide and there is initial evidence that the central oxytocin system is altered in several mental disorders.  The aim of this study was to test the efficacy of oxytocin, as augmentation therapy, in a sample of patients with schizophrenia.  METHODS:  We conducted an 8-month randomized, double-blind, controlled trial with a crossover design.  We wanted to test the hypothesis that intranasal oxytocin could reduce symptoms in 32 patients with schizophrenia aged 18-45 with short-medium illness duration (<11 years).  Patients were randomly assigned to either 40 International Units oxytocin once daily or a vehicle placebo group, in addition to their pre-study antipsychotic medication regimen.  We subsequently conducted a multi-dimensional assessment including psychopathological, psychosocial and neuropsychological aspects.  RESULTS:  Positive and Negative Syndrome Scale scores showed no significant differences in treatment effects between the experimental group and controls.  Furthermore, no treatment effects were shown in any of the rating scales used in this study.  However, a statistically significant period effect was shown in most outcome measurements.  CONCLUSIONS:  In our trial, oxytocin did not add any significant beneficial effects to anti-psychotic treatment in terms of clinical symptoms or psychosocial functioning.  Further research should focus on different ways to administer oxytocin, or investigate predictors (such as past traumas, or biomarkers), which could identify subgroups of patients with different treatment responses to oxytocin.  ClinicalTrials.gov Identifier: NCT01699997.  ID number: RF-2010-2311148.  URL: https://clinicaltrials.gov/ct2/show/NCT01699997.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRzRKBith_Kyr5XHngOXiV_fW6udTcc2eZR9iPNwzjyxbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jhtlOisw%253D%253D&md5=c99f91c7ceb957316cb64bd70cdab8ea</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.schres.2016.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.schres.2016.02.011%26sid%3Dliteratum%253Aachs%26aulast%3DDagani%26aufirst%3DJ.%26aulast%3DSisti%26aufirst%3DD.%26aulast%3DAbelli%26aufirst%3DM.%26aulast%3DDi%2BPaolo%26aufirst%3DL.%26aulast%3DPini%26aufirst%3DS.%26aulast%3DRaimondi%26aufirst%3DS.%26aulast%3DRocchi%26aufirst%3DM.%2BB.%26aulast%3DSaviotti%26aufirst%3DF.%2BM.%26aulast%3DScocco%26aufirst%3DP.%26aulast%3DTotaro%26aufirst%3DS.%26aulast%3DBalestrieri%26aufirst%3DM.%26aulast%3Dde%2BGirolamo%26aufirst%3DG.%26atitle%3DDo%2520we%2520need%2520oxytocin%2520to%2520treat%2520schizophrenia%253F%2520A%2520randomized%2520clinical%2520trial%26jtitle%3DSchizophr.%2520Res.%26date%3D2016%26volume%3D172%26spage%3D158%26epage%3D164%26doi%3D10.1016%2Fj.schres.2016.02.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scantamburlo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansenne, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geenen, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legros, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansseau, M.</span></span> <span> </span><span class="NLM_article-title">Additional intranasal oxytocin to escitalopram improves depressive symptoms in resistant depression: an open trial</span>. <i>Eur. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1016/j.eurpsy.2014.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.eurpsy.2014.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=25282363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A280%3ADC%252BC2M7ntlSqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2015&pages=65-68&author=G.+Scantamburloauthor=M.+Hansenneauthor=V.+Geenenauthor=J.+J.+Legrosauthor=M.+Ansseau&title=Additional+intranasal+oxytocin+to+escitalopram+improves+depressive+symptoms+in+resistant+depression%3A+an+open+trial&doi=10.1016%2Fj.eurpsy.2014.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Additional intranasal oxytocin to escitalopram improves depressive symptoms in resistant depression: an open trial</span></div><div class="casAuthors">Scantamburlo G; Hansenne M; Geenen V; Legros J J; Ansseau M</div><div class="citationInfo"><span class="NLM_cas:title">European psychiatry : the journal of the Association of European Psychiatrists</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The aim of this open trial was to assess the antidepressant/anxiolytic effects of oxytocin used as an adjunct to antidepressant in treatment-resistant depression.  Fourteen patients, who have not responded to 40mg of escitalopram, received intranasal synthetic oxytocin during 4 weeks, in association with antidepressant.  This is the first open trial study suggesting OT in association with escitalopram significantly reduced scores on Hamilton Depression Rating Scale.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRowSWOqbMPPFMGsG_HTXYFfW6udTcc2eZR9iPNwzjyxbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7ntlSqtg%253D%253D&md5=1e620f1da6f4454d2eb6ef29159d1027</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.eurpsy.2014.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.eurpsy.2014.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DScantamburlo%26aufirst%3DG.%26aulast%3DHansenne%26aufirst%3DM.%26aulast%3DGeenen%26aufirst%3DV.%26aulast%3DLegros%26aufirst%3DJ.%2BJ.%26aulast%3DAnsseau%26aufirst%3DM.%26atitle%3DAdditional%2520intranasal%2520oxytocin%2520to%2520escitalopram%2520improves%2520depressive%2520symptoms%2520in%2520resistant%2520depression%253A%2520an%2520open%2520trial%26jtitle%3DEur.%2520Psychiatry%26date%3D2015%26volume%3D30%26spage%3D65%26epage%3D68%26doi%3D10.1016%2Fj.eurpsy.2014.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amina, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashii, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopatina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Islam, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span> <span> </span><span class="NLM_article-title">Intracellular calcium elevation induced by extracellular application of cyclic-ADP-ribose or oxytocin is temperature-sensitive in rodent NG108-15 neuronal cells with or without exogenous expression of human oxytocin receptors</span>. <i>J. Neuroendocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">460</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2826.2010.01978.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1111%2Fj.1365-2826.2010.01978.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=20163520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlslyjur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2010&pages=460-466&author=S.+Aminaauthor=M.+Hashiiauthor=W.-J.+Maauthor=S.+Yokoyamaauthor=O.+Lopatinaauthor=H.-X.+Liuauthor=M.+S.+Islamauthor=H.+Higashida&title=Intracellular+calcium+elevation+induced+by+extracellular+application+of+cyclic-ADP-ribose+or+oxytocin+is+temperature-sensitive+in+rodent+NG108-15+neuronal+cells+with+or+without+exogenous+expression+of+human+oxytocin+receptors&doi=10.1111%2Fj.1365-2826.2010.01978.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular calcium elevation induced by extracellular application of cyclic-ADP-ribose or oxytocin is temperature-sensitive in rodent NG108-15 neuronal cells with or without exogenous expression of human oxytocin receptors</span></div><div class="casAuthors">Amina, S.; Hashii, M.; Ma, W.-J.; Yokoyama, S.; Lopatina, O.; Liu, H.-X.; Islam, M. S.; Higashida, H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroendocrinology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">460-466</span>CODEN:
                <span class="NLM_cas:coden">JOUNE2</span>;
        ISSN:<span class="NLM_cas:issn">0953-8194</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">ADP-ribosyl cyclase and/or CD38 are activated after oxytocin receptor stimulation in the hypothalamus and pituitary in adult mice, leading to facilitation of oxytocin secretion.  Although cyclic adenosine 5'-diphosphoribose (cADPR) primarily acts as an intracellular second messenger, it has been suggested that extracellular cADPR stimulates intracellular ryanodine receptors after internalization via the nucleotide-transporting capacity of CD38 in fibroblasts and astrocytes.  However, little is known about whether extracellular cADPR activates neurons.  To address this question, we used a model neuronal cell line, NG108-15 mouse neuroblastoma × rat glioma hybrid cells possessing CD38 but not oxytocin receptors, and measured cytosolic free calcium concns. ([Ca2+]i).  Extracellular application of cADPR to NG108-15 cells elevated [Ca2+]i at 35°.  The elevation was significantly enhanced when measured at 40°.  The cADPR and heat-induced [Ca2+]i increase were blocked under extracellular Ca2+-free conditions and by 2-aminoethoxydiphenyl borate, an antagonist of melastatin-related transient receptor potential channel 2 (TRPM2) cation channels.  Reverse transcription-polymerase chain reaction analyses indicated that TRPM2 channels were expressed in NG108-15 cells.  Application of oxytocin elevated [Ca2+]i in NG108-15 cells transformed to transiently express cloned human oxytocin receptors.  The oxytocin-induced [Ca2+]i response was also enhanced by heat.  These results indicate that the extracellular application of cADPR, together with heat, activates cation influx downstream of oxytocin receptor signaling in NG108-15 neuronal cells, and suggest the possible involvement of TRPM2 channels in oxytocin release in the mammalian brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIJBynRUPurrVg90H21EOLACvtfcHk0ljREhdAf4ghYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlslyjur4%253D&md5=eb4759e46559f4619a3d0c0998a97ea2</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2826.2010.01978.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2826.2010.01978.x%26sid%3Dliteratum%253Aachs%26aulast%3DAmina%26aufirst%3DS.%26aulast%3DHashii%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DW.-J.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DLopatina%26aufirst%3DO.%26aulast%3DLiu%26aufirst%3DH.-X.%26aulast%3DIslam%26aufirst%3DM.%2BS.%26aulast%3DHigashida%26aufirst%3DH.%26atitle%3DIntracellular%2520calcium%2520elevation%2520induced%2520by%2520extracellular%2520application%2520of%2520cyclic-ADP-ribose%2520or%2520oxytocin%2520is%2520temperature-sensitive%2520in%2520rodent%2520NG108-15%2520neuronal%2520cells%2520with%2520or%2520without%2520exogenous%2520expression%2520of%2520human%2520oxytocin%2520receptors%26jtitle%3DJ.%2520Neuroendocrinol.%26date%3D2010%26volume%3D22%26spage%3D460%26epage%3D466%26doi%3D10.1111%2Fj.1365-2826.2010.01978.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stucki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Py, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundschober, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gee, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Building bridges for highly selective, potent and stable oxytocin and vasopressin analogs</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3039</span>– <span class="NLM_lpage">3045</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.03.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2Fj.bmc.2018.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=29602673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmt1altbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=3039-3045&author=R.+Beardauthor=A.+Stuckiauthor=M.+Schmittauthor=G.+Pyauthor=C.+Grundschoberauthor=A.+D.+Geeauthor=E.+W.+Tate&title=Building+bridges+for+highly+selective%2C+potent+and+stable+oxytocin+and+vasopressin+analogs&doi=10.1016%2Fj.bmc.2018.03.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Building bridges for highly selective, potent and stable oxytocin and vasopressin analogs</span></div><div class="casAuthors">Beard, Rhiannon; Stucki, Andy; Schmitt, Muriel; Py, Gabrielle; Grundschober, Christophe; Gee, Antony D.; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3039-3045</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Oxytocin (OT) is an exciting potential therapeutic agent, but it is highly sensitive to modification and suffers extensive degrdn. at elevated temp. and in vivo.  Here we report studies towards OT analogs with favorable selectivity, affinity and potency towards the oxytocin receptor (OTR), in addn. to improving stability of the peptide by bridging the disulfide region with substituted dibromo-xylene analogs.  We found a sensitive structure-activity relationship in which meta-cyclized analogs (dOTmeta) gave highest affinity (50nM Ki), selectivity (34-fold), and agonist potency (34nM EC50, 87-fold selectivity) towards OTR.  Surprisingly, ortho-cyclized analogs demonstrated OTR and vasopressin V1a receptor subtype affinity (220nM and 69nM, resp.) and pharmacol. activity (294nM and 35nM, resp.).  V1a binding and selectivity for ortho-cyclized peptides could be improved 6-fold by substituting a neutral residue at position 8 with a basic amino acid, providing potent antagonists (14nM IC50) that displayed no activation of the OTR.  Furthermore, xylene-bridged analogs demonstrated increased stability compared to OT at elevated temp., demonstrating promising therapeutic potential for these analogs which warrants further study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYKg2TnF3CUbVg90H21EOLACvtfcHk0ljREhdAf4ghYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmt1altbk%253D&md5=76eb52b06286e61a2e38f88108e0123b</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DBeard%26aufirst%3DR.%26aulast%3DStucki%26aufirst%3DA.%26aulast%3DSchmitt%26aufirst%3DM.%26aulast%3DPy%26aufirst%3DG.%26aulast%3DGrundschober%26aufirst%3DC.%26aulast%3DGee%26aufirst%3DA.%2BD.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DBuilding%2520bridges%2520for%2520highly%2520selective%252C%2520potent%2520and%2520stable%2520oxytocin%2520and%2520vasopressin%2520analogs%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D3039%26epage%3D3045%26doi%3D10.1016%2Fj.bmc.2018.03.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miki, N.</span></span> <span> </span><span class="NLM_article-title">A single class of neurotensin receptors with high affinity in neuroblastoma X glioma NG108-15 hybrid cells that mediate facilitation of synaptic transmission</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1653</span>– <span class="NLM_lpage">1661</span>, <span class="refDoi"> DOI: 10.1523/jneurosci.04-06-01653.1984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1523%2Fjneurosci.04-06-01653.1984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=6327939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADyaL2cXks1Klsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1984&pages=1653-1661&author=Y.+Nakagawaauthor=H.+Higashidaauthor=N.+Miki&title=A+single+class+of+neurotensin+receptors+with+high+affinity+in+neuroblastoma+X+glioma+NG108-15+hybrid+cells+that+mediate+facilitation+of+synaptic+transmission&doi=10.1523%2Fjneurosci.04-06-01653.1984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">A single class of neurotensin receptors with high affinity in neuroblastoma × glioma NG108-15 hybrid cells that mediate facilitation of synaptic transmission</span></div><div class="casAuthors">Nakagawa, Yuzo; Higashida, Haruhiro; Miki, Naomasa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1653-61</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    </div><div class="casAbstract">Receptor binding of 3H-labeled neurotensin  [39379-15-2] was examd. on membrane prepns. derived from neuroblastoma × glioma NG108-15 hybrid cells.  The specific binding was saturable and reversible and a dissocn. const. (Kd) was ∼0.24 nM.  Scatchard anal. of neurotensin binding at equil. revealed a single class of binding sites with a Kd of 0.86 nM and a maximal binding capacity (Bmax) of 250 fmol/mg of protein (7700 receptor sites/cell).  [9-D-Arginine]-neurotensin  [63770-62-7] had a high affinity (IC50 = 0.5 nM) for the neurotensin receptors, but [11-D-phenylalanine]-neurotensin  [64088-66-0] had a lower affinity (IC50 = 280 nM), whereas angiotensin II and bradykinin had almost no affinity for [3H]neurotensin-binding sites.  Under similar conditions [3H]neurotensin binding to mouse and rat brain synaptosomal fractions showed 2 binding sites with high (0.56 and 0.44 nM) and low (13 and 19 nM) affinities.  Several possible physiol. consequences of neurotensin receptor binding were examd.  Neurotensin (10 μM) exhibited no influence on adenylate cyclase activity, 45Ca uptake, or 32Pi incorporation into phosphatidylinositol fractions of NG108-15 cells.  Electrophysiol. study of isolated NG108-15 cells revealed neurotensin induced transient hyperpolarization followed by sustained depolarization with enhanced membrane excitability.  Application of neurotensin to NG108-15 cells that had formed synapses with cultured striated muscle cells caused a considerable increase in frequency of miniature endplate potentials from the muscle cells.  Apparently, NG108-15 cells possess a single class of neurotensin receptors similar to a high-affinity site of synaptosomal membranes from the murine brains.  Neurotensin facilitation of synaptic transmission is probably mediated through receptors coupled to ionotropic processes rather than to cellular metabolic ones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIoyYP7U3xXbVg90H21EOLACvtfcHk0ljREhdAf4ghYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXks1Klsrk%253D&md5=4d566d55aaa06b5eee8557f335b39d3b</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1523%2Fjneurosci.04-06-01653.1984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252Fjneurosci.04-06-01653.1984%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa%26aufirst%3DY.%26aulast%3DHigashida%26aufirst%3DH.%26aulast%3DMiki%26aufirst%3DN.%26atitle%3DA%2520single%2520class%2520of%2520neurotensin%2520receptors%2520with%2520high%2520affinity%2520in%2520neuroblastoma%2520X%2520glioma%2520NG108-15%2520hybrid%2520cells%2520that%2520mediate%2520facilitation%2520of%2520synaptic%2520transmission%26jtitle%3DJ.%2520Neurosci.%26date%3D1984%26volume%3D4%26spage%3D1653%26epage%3D1661%26doi%3D10.1523%2Fjneurosci.04-06-01653.1984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yung-Chi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=4202581" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=C.+Yung-Chiauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28Ki%29+and+the+concentration+of+inhibitor+which+causes+50+per+cent+inhibition+%28I50%29+of+an+enzymatic+reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DYung-Chi%26aufirst%3DC.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528Ki%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2520per%2520cent%2520inhibition%2520%2528I50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashii, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munesue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamagishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span> <span> </span><span class="NLM_article-title">Non-synonymous single-nucleotide variations of the human oxytocin receptor gene and autism spectrum disorders: a case-control study in a Japanese population and functional analysis</span>. <i>Mol. Autism.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">22</span>, <span class="refDoi"> DOI: 10.1186/2040-2392-4-22</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=10.1186%2F2040-2392-4-22" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=23815867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1WjsrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=22&author=W.-J.+Maauthor=M.+Hashiiauthor=T.+Munesueauthor=K.+Hayashiauthor=K.+Yagiauthor=M.+Yamagishiauthor=H.+Higashidaauthor=S.+Yokoyama&title=Non-synonymous+single-nucleotide+variations+of+the+human+oxytocin+receptor+gene+and+autism+spectrum+disorders%3A+a+case-control+study+in+a+Japanese+population+and+functional+analysis&doi=10.1186%2F2040-2392-4-22"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Non-synonymous single-nucleotide variations of the human oxytocin receptor gene and autism spectrum disorders: a case-control study in a Japanese population and functional analysis</span></div><div class="casAuthors">Ma, Wen-Jie; Hashii, Minako; Munesue, Toshio; Hayashi, Kenshi; Yagi, Kunimasa; Yamagishi, Masakazu; Higashida, Haruhiro; Yokoyama, Shigeru</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Autism</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22</span>CODEN:
                <span class="NLM_cas:coden">MAOUBR</span>;
        ISSN:<span class="NLM_cas:issn">2040-2392</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The human oxytocin receptor (hOXTR) is implicated in the etiol. of autism spectrum disorders (ASDs) and is a potential target for therapeutic intervention.  Several studies have reported single-nucleotide polymorphisms (SNPs) of the OXTR gene assocd. with ASDs.  These SNPs, however, reside outside the protein-coding region.  Not much is known about genetic variations that cause amino acid substitutions that alter receptor functions.  Methods: Variations in the OXTR gene were analyzed in 132 ASD patients at Kanazawa University Hospital in Japan and 248 unrelated healthy Japanese volunteers by re-sequencing and real-time polymerase chain reaction-based genotyping.  Functional changes in variant OXTRs were assessed by radioligand binding assay and measurements of intracellular free calcium concns. ([Ca2+]i) and inositol 1,4,5-trisphosphate (IP3) levels.  Results: Six subjects (4.5%) in the ASD group and two in the control group (0.8%) were identified as heterozygotes carrying the R376G variation (rs35062132; c.1126C>G); one individual from the ASD group (0.8%) and three members of the control group (1.2%) were found to be carrying R376C (c.1126C>T).  The C/G genotype significantly correlated with an increased risk of ASDs (odds ratio (OR) = 5.83; 95% confidence interval (CI) = 1.16 to 29.33; P = 0.024, Fisher's exact test).  Consistently, the G allele showed a correlation with an increased likelihood of ASDs (OR = 5.73; 95% CI = 1.15 to 28.61; P = 0.024, Fisher's exact test).  The frequencies of the C/T genotype and the T allele in the ASD and control groups did not differ significantly.  We also examd. changes in agonist-induced cellular responses mediated by the variant receptors hOXTR-376G and hOXTR-376C.  OXT-induced receptor internalization and recycling were faster in hOXTR-376G-expressing HEK-293 cells than in cells expressing hOXTR-376R or hOXTR-376C.  In addn., the elevation in [Ca2+]i and IP3 formation decreased in the cells expressing hOXTR-376G and hOXTR-376C tagged with enhanced green fluorescent protein (EGFP), in comparison with the cells expressing the common-type hOXTR-376R tagged with EGFP.  Conclusions: These results suggest that the rare genetic variation rs35062132 might contribute to the pathogenesis of ASDs, and could provide a mol. basis of individual differences in OXTR-mediated modulation of social behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaN25l6TR1_bVg90H21EOLACvtfcHk0liLC_ImWfOMSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1WjsrzF&md5=7267206bc8512e28035e27ae97ca54ed</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1186%2F2040-2392-4-22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2040-2392-4-22%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DW.-J.%26aulast%3DHashii%26aufirst%3DM.%26aulast%3DMunesue%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DK.%26aulast%3DYagi%26aufirst%3DK.%26aulast%3DYamagishi%26aufirst%3DM.%26aulast%3DHigashida%26aufirst%3DH.%26aulast%3DYokoyama%26aufirst%3DS.%26atitle%3DNon-synonymous%2520single-nucleotide%2520variations%2520of%2520the%2520human%2520oxytocin%2520receptor%2520gene%2520and%2520autism%2520spectrum%2520disorders%253A%2520a%2520case-control%2520study%2520in%2520a%2520Japanese%2520population%2520and%2520functional%2520analysis%26jtitle%3DMol.%2520Autism.%26date%3D2013%26volume%3D4%26spage%3D22%26doi%3D10.1186%2F2040-2392-4-22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i39"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01691">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_24073"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01691">10.1021/acs.jmedchem.8b01691</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Data on [<sup>3</sup>H]OT binding to membranes from hOTR-expressing HEK293 cells, comparison of wild type, CD38KO, and CD38KOCC mice in tail suspended and sucrose preference tests and characterization of the kinetic parameters of [<sup>3</sup>H]OT (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01691/suppl_file/jm8b01691_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01691/suppl_file/jm8b01691_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01691/suppl_file/jm8b01691_si_001.pdf">jm8b01691_si_001.pdf (256.51 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01691/suppl_file/jm8b01691_si_002.csv">jm8b01691_si_002.csv (1.09 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01691&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01691%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-7%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01691" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799b1c83c3ad18b","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
